data_1uep_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uep _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.76 0.314 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -116.0 139.91 49.79 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.9 152.31 24.61 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 164.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.38 127.84 34.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.18 149.53 27.87 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -139.24 107.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -76.07 143.43 41.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.12 131.24 32.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -82.19 153.63 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -108.25 87.35 2.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtm -143.88 -3.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.66 -64.14 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -126.29 -14.28 5.95 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.47 60.7 3.93 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 119.728 1.149 . . . . 0.0 112.382 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 85.5 93.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.608 2.363 . . . . 0.0 110.568 160.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.72 53.76 4.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.677 0.656 . . . . 0.0 112.325 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -130.44 173.51 10.77 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.373 1.086 . . . . 0.0 109.039 169.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -140.37 165.61 26.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.5 128.66 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -164.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -139.62 -177.13 4.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.526 1.93 . . . . 0.0 108.053 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.43 -146.67 36.2 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.57 31.97 52.94 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.186 0.993 . . . . 0.0 112.652 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.96 -30.92 56.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.083 -0.657 . . . . 0.0 112.145 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -114.85 158.9 39.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.73 91.09 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.245 2.63 . . . . 0.0 109.638 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.3 1.84 10.11 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.14 1.353 . . . . 0.0 114.17 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.5 159.88 56.34 Favored Pre-proline 0 C--O 1.239 0.54 0 CA-C-N 119.428 1.614 . . . . 0.0 109.237 163.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.82 145.35 56.51 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.654 2.236 . . . . 0.0 111.224 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.53 92.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -100.69 140.73 34.56 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.653 3.581 . . . . 0.0 109.543 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.81 109.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.653 1.581 . . . . 0.0 107.672 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.76 -46.55 31.16 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 127.661 2.553 . . . . 0.0 112.569 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 163.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.545 1.538 . . . . 0.0 107.424 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.59 131.9 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 161.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.11 107.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.34 132.01 47.03 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.753 0.658 . . . . 0.0 109.853 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.1 mtm 68.49 -5.94 0.88 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.537 1.935 . . . . 0.0 114.19 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.64 176.81 53.5 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.192 0.884 . . . . 0.0 111.811 -171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -60.48 -8.84 3.01 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.217 1.807 . . . . 0.0 115.018 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.78 -46.62 6.19 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 120.137 1.335 . . . . 0.0 111.609 168.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -56.4 -40.1 74.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.477 1.511 . . . . 0.0 110.306 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -69.89 -22.0 63.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -22.57 55.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.174 0.897 . . . . 0.0 110.129 170.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.8 60.3 8.94 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 125.643 1.592 . . . . 0.0 110.79 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -146.68 2.29 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -135.56 151.0 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -129.22 149.87 73.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 125.097 1.359 . . . . 0.0 109.053 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.81 130.58 34.74 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.556 2.838 . . . . 0.0 111.317 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.62 88.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.066 -1.408 . . . . 0.0 113.671 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 127.81 33.64 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.172 1.486 . . . . 0.0 107.761 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 119.28 18.06 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.83 164.4 10.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.878 1.671 . . . . 0.0 111.001 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.2 -52.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.203 1.401 . . . . 0.0 109.673 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.34 148.19 52.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.005 0.922 . . . . 0.0 108.553 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -137.0 113.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.58 5.23 0.44 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.876 2.47 . . . . 0.0 114.198 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.46 -5.94 6.67 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.947 2.689 . . . . 0.0 113.094 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.0 124.6 34.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 119.483 1.642 . . . . 0.0 107.747 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.65 114.71 4.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.42 3.413 . . . . 0.0 109.179 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.72 -7.46 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.75 1.22 . . . . 0.0 112.789 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.24 129.85 40.47 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.579 -0.701 . . . . 0.0 110.313 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.01 84.06 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.991 -0.443 . . . . 0.0 113.374 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -101.22 -166.95 1.36 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.604 1.561 . . . . 0.0 108.195 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -121.56 177.75 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.075 0.95 . . . . 0.0 110.892 -170.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -52.19 -56.27 15.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.616 0.766 . . . . 0.0 109.759 169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -55.69 -33.41 64.12 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.79 -50.93 62.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.816 0.846 . . . . 0.0 110.357 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.55 -38.19 78.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 124.947 1.299 . . . . 0.0 111.16 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.0 mm -56.53 -39.46 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.868 0.758 . . . . 0.0 109.224 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -37.77 85.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.944 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.37 -49.69 74.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.234 0.613 . . . . 0.0 111.047 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.46 -36.77 74.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 111.133 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.31 -14.51 56.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.263 1.025 . . . . 0.0 113.105 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.27 -49.29 5.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.15 1.38 . . . . 0.0 110.825 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.76 -41.33 73.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.126 0.97 . . . . 0.0 110.63 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.0 -22.02 65.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.311 -1.493 . . . . 0.0 113.152 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.62 -43.52 20.37 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.535 1.134 . . . . 0.0 109.517 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -54.91 -23.64 19.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.329 0.652 . . . . 0.0 110.975 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.73 13.76 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.475 1.036 . . . . 0.0 111.956 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.15 174.68 12.6 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.231 2.212 . . . . 0.0 106.751 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.47 164.68 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -129.21 133.01 47.36 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 166.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.1 mt -130.61 97.48 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.119 2.168 . . . . 0.0 105.386 -169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.1 m -85.49 117.07 24.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.19 170.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 108.743 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -152.9 145.89 24.55 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 119.594 -1.942 . . . . 0.0 112.326 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.57 130.57 17.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.754 0.706 . . . . 0.0 110.252 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.363 0 C-N-CA 125.072 1.349 . . . . 0.0 109.721 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.3 p90 . . . . . 0 C--O 1.241 0.61 0 CA-C-O 121.138 0.494 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -91.65 136.09 33.4 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.52 155.83 23.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.736 1.273 . . . . 0.0 108.122 151.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.32 116.93 10.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.158 2.183 . . . . 0.0 106.62 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.48 134.44 34.64 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.516 1.127 . . . . 0.0 109.767 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.6 t -129.04 143.36 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 127.014 2.125 . . . . 0.0 107.979 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -129.13 103.17 6.82 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.464 -0.773 . . . . 0.0 110.548 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -103.48 131.8 50.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.857 0.837 . . . . 0.0 109.772 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -86.86 160.73 18.64 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.418 0.687 . . . . 0.0 110.639 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -121.83 86.79 2.64 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.991 0.917 . . . . 0.0 110.488 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 mtp -130.41 -9.94 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.697 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.69 -100.32 0.19 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -29.73 70.7 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.12 1.327 . . . . 0.0 110.709 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.73 73.73 0.84 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 69.58 -115.8 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.308 1.843 . . . . 0.0 109.167 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.32 40.55 0.25 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 120.846 1.657 . . . . 0.0 112.742 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -123.22 175.52 6.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.045 1.338 . . . . 0.0 108.508 168.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.59 167.11 21.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.54 121.69 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.837 1.199 . . . . 0.0 109.07 -162.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.7 mt -138.26 147.09 43.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.32 -163.3 12.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.6 28.15 64.78 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 118.29 1.045 . . . . 0.0 112.458 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.22 -37.88 86.62 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.427 -1.043 . . . . 0.0 110.233 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.53 160.99 30.94 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.417 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.77 46.91 2.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.705 3.603 . . . . 0.0 112.588 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.13 48.29 0.12 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 109.858 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -123.26 164.05 30.17 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.596 1.159 . . . . 0.0 110.759 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.6 143.89 27.73 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.477 2.785 . . . . 0.0 108.463 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.58 100.38 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.95 151.01 23.12 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mm -57.56 112.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 162.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.12 -56.39 24.39 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 126.814 2.149 . . . . 0.0 111.763 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.58 167.86 28.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.571 1.949 . . . . 0.0 106.943 172.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.38 130.71 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 mm -79.93 115.39 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.46 -21.2 3.45 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.491 1.917 . . . . 0.0 115.085 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.7 mmt -122.28 7.06 9.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.73 1.612 . . . . 0.0 110.989 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.91 167.63 34.91 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 120.701 -1.249 . . . . 0.0 110.53 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -61.94 -12.86 20.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.292 1.037 . . . . 0.0 112.613 175.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.79 -69.12 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.997 0.817 . . . . 0.0 110.128 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.15 -43.75 78.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.643 0.656 . . . . 0.0 111.931 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 46' ' ' SER . 0.1 OUTLIER -65.97 -10.04 35.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.687 -1.149 . . . . 0.0 113.764 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.37 -46.51 15.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.807 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 37.28 4.37 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.849 1.214 . . . . 0.0 114.189 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -127.3 -62.69 1.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.001 1.401 . . . . 0.0 112.635 -171.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.17 143.52 55.36 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.046 0.938 . . . . 0.0 110.424 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -126.11 153.11 74.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 123.803 0.841 . . . . 0.0 109.756 166.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.75 141.81 64.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.95 1.767 . . . . 0.0 109.344 164.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 -8.55 63.81 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-O 117.45 -1.75 . . . . 0.0 114.495 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.04 126.5 27.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.953 1.876 . . . . 0.0 107.166 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -79.69 121.13 24.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.13 153.02 36.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.639 1.176 . . . . 0.0 110.002 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 t -130.99 -50.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.463 1.505 . . . . 0.0 109.088 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.32 143.71 50.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.24 122.06 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t0 54.84 21.82 3.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.714 1.205 . . . . 0.0 112.207 -167.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.95 -5.97 82.45 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 117.713 -1.604 . . . . 0.0 113.921 -174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -92.11 128.88 43.59 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 120.928 2.364 . . . . 0.0 106.592 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.71 119.05 6.07 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.994 2.463 . . . . 0.0 109.509 -173.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.34 -4.99 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.272 1.429 . . . . 0.0 110.619 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.06 115.96 4.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.561 1.144 . . . . 0.0 109.554 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.05 -1.92 21.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.908 0.766 . . . . 0.0 113.987 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 67.2 mmtt -80.94 164.96 22.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.616 2.208 . . . . 0.0 108.876 167.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.4 p -81.16 171.25 15.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.46 0.704 . . . . 0.0 110.577 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -53.23 -49.98 65.69 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.28 -1.513 . . . . 0.0 109.389 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.85 -28.23 69.34 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 51.9 t80 -48.98 -57.02 7.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.721 1.208 . . . . 0.0 109.779 169.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.8 -39.19 84.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.884 1.274 . . . . 0.0 110.435 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.42 -27.74 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.237 -0.914 . . . . 0.0 110.511 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -41.04 68.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.557 1.143 . . . . 0.0 111.219 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -52.03 67.44 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.836 0.854 . . . . 0.0 109.823 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 71.4 mmm -54.83 -39.13 68.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.036 0.835 . . . . 0.0 111.391 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -43.5 98.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.28 0.632 . . . . 0.0 110.801 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -49.0 64.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.847 1.259 . . . . 0.0 111.769 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.03 71.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.262 1.825 . . . . 0.0 110.275 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.99 76.9 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.378 -0.826 . . . . 0.0 111.913 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.46 -39.56 74.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.649 1.113 . . . . 0.0 110.917 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.02 -20.6 66.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.712 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.97 70.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.674 1.131 . . . . 0.0 112.522 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -163.72 162.15 23.84 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.441 1.496 . . . . 0.0 108.273 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.58 128.38 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -80.49 141.77 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 161.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.8 mt -135.4 105.13 6.11 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -100.52 116.32 32.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.2 m -105.16 167.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 107.946 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -149.38 153.59 37.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.698 -1.251 . . . . 0.0 111.582 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -144.32 132.29 21.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.268 1.027 . . . . 0.0 109.306 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.398 0 C-N-CA 124.699 1.2 . . . . 0.0 110.846 167.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 51.1 p90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 130.38 40.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.51 130.13 34.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 163.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.99 155.35 34.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.648 1.579 . . . . 0.0 108.217 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -133.43 132.02 40.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.941 0.896 . . . . 0.0 111.883 -171.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 t -124.45 108.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.96 1.304 . . . . 0.0 108.561 -174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -80.65 129.2 34.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.5 mt -123.38 123.39 40.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 157.82 36.95 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.174 0.589 . . . . 0.0 110.053 173.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -114.2 83.18 1.83 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.9 mtm -138.62 -9.6 1.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.598 0.635 . . . . 0.0 112.205 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -131.21 -102.5 0.28 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -74.58 -22.03 59.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.66 1.573 . . . . 0.0 114.347 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.03 77.42 0.5 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.879 1.218 . . . . 0.0 112.929 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 58.94 76.67 0.34 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 128.347 2.659 . . . . 0.0 112.214 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.52 70.54 2.64 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.755 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -142.37 147.72 36.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.867 1.334 . . . . 0.0 108.532 167.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -93.51 163.21 13.66 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.921 1.288 . . . . 0.0 108.227 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.87 139.4 49.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.105 1.362 . . . . 0.0 107.578 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.11 -177.5 5.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 108.273 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.38 -161.02 50.87 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.347 -0.846 . . . . 0.0 111.159 -170.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.71 75.24 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.749 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.98 -12.49 60.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.661 1.73 . . . . 0.0 113.366 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -141.6 160.12 57.74 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.822 1.649 . . . . 0.0 108.817 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 105.92 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.129 2.552 . . . . 0.0 109.252 -168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.07 30.86 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.661 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -66.67 162.25 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.44 1.62 . . . . 0.0 109.323 155.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.82 140.82 68.89 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.864 2.376 . . . . 0.0 109.013 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -116.04 83.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.06 142.27 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.906 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mm -61.2 126.94 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.41 -41.12 91.27 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.163 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 167.01 124.42 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.658 2.383 . . . . 0.0 107.768 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.47 150.03 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.536 1.134 . . . . 0.0 110.705 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -83.32 106.99 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.64 69.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -120.06 40.59 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.2 -178.03 31.85 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 125.817 1.675 . . . . 0.0 109.92 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -59.53 -28.36 67.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -57.04 4.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.126 1.33 . . . . 0.0 109.871 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.34 -38.25 88.75 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.928 0.87 . . . . 0.0 110.102 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.01 -8.87 52.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.346 1.058 . . . . 0.0 113.356 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.61 -17.38 36.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.393 1.452 . . . . 0.0 110.646 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.58 83.5 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.282 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -117.47 -54.52 2.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -166.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 161.28 30.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -140.65 146.02 42.84 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 121.498 -0.752 . . . . 0.0 110.166 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.24 132.3 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.788 2.325 . . . . 0.0 111.259 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.13 -2.32 78.77 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.732 1.158 . . . . 0.0 113.715 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.1 141.68 58.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.351 1.076 . . . . 0.0 108.777 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.94 121.01 28.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.24 155.02 37.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.956 0.903 . . . . 0.0 110.439 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -126.79 -55.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 109.443 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -128.66 147.98 50.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.155 0.982 . . . . 0.0 109.786 -174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.5 t -138.6 118.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 59.11 9.01 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.849 2.06 . . . . 0.0 114.111 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.14 -15.15 6.51 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.429 1.966 . . . . 0.0 112.898 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.89 129.87 23.41 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.386 1.593 . . . . 0.0 108.229 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.4 112.65 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.381 2.721 . . . . 0.0 109.249 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.18 -7.04 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.098 0.959 . . . . 0.0 111.051 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.3 114.5 3.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.075 1.35 . . . . 0.0 108.599 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.32 -5.42 60.84 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.919 0.771 . . . . 0.0 113.795 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HE3' ' CZ ' ' A' ' 74' ' ' TYR . 49.3 mmtt -101.47 -172.71 2.21 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.052 1.341 . . . . 0.0 109.623 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 174.27 5.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.943 1.297 . . . . 0.0 110.389 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -49.42 -56.08 10.9 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.875 1.67 . . . . 0.0 110.331 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -52.92 -36.39 59.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 112.795 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 45.2 t80 -54.2 -48.69 70.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.501 0.72 . . . . 0.0 110.281 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 t -70.29 -34.77 59.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 125.006 1.322 . . . . 0.0 110.211 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 mm -62.41 -37.9 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.211 0.914 . . . . 0.0 109.989 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.95 89.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.022 0.374 . . . . 0.0 110.551 173.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -50.74 66.81 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.429 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.6 mmm -56.98 -36.23 70.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.949 0.795 . . . . 0.0 111.161 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.79 -43.5 90.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.219 0.607 . . . . 0.0 111.335 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -45.99 72.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.656 0.783 . . . . 0.0 111.407 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.87 78.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.42 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -32.89 63.97 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.838 -1.164 . . . . 0.0 111.895 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -78.95 -29.55 44.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.351 1.06 . . . . 0.0 112.202 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -66.79 -22.27 66.03 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.01 -0.431 . . . . 0.0 110.928 168.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.88 6.51 89.07 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.039 -1.038 . . . . 0.0 112.484 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.04 173.12 14.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.269 2.227 . . . . 0.0 107.113 168.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.14 157.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 160.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.56 131.66 53.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.4 mt -126.68 98.17 5.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 53.5 m -87.72 117.42 26.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.1 m -100.92 173.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 125.599 1.56 . . . . 0.0 108.492 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 17.8 ptt85 -150.13 158.83 44.57 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.669 -1.269 . . . . 0.0 108.581 167.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.83 31.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.652 0.739 . . . . 0.0 110.928 164.44 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -88.38 123.64 33.15 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 110.95 18.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 160.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mp -101.12 148.3 25.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.26 159.63 15.23 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.312 -0.868 . . . . 0.0 110.242 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.44 137.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -126.16 124.87 41.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.296 0.953 . . . . 0.0 108.553 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.49 136.36 51.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.719 0.808 . . . . 0.0 110.153 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -89.73 154.93 19.55 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.111 0.964 . . . . 0.0 110.069 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -115.32 83.54 1.94 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtt -137.41 -34.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.576 -0.725 . . . . 0.0 110.987 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.23 -81.78 0.25 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -122.37 -3.1 8.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.2 78.08 1.13 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.96 0.8 . . . . 0.0 111.699 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 65.82 -133.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 52.69 0.01 OUTLIER Glycine 0 C--O 1.225 -0.453 0 CA-C-N 119.8 1.182 . . . . 0.0 110.454 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -137.77 172.66 12.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.91 0.855 . . . . 0.0 108.832 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -130.66 163.52 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.862 1.665 . . . . 0.0 106.653 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.405 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -141.24 122.64 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -169.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.7 mt -139.96 179.08 6.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.605 1.562 . . . . 0.0 107.478 -172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.33 -166.29 48.45 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.06 30.92 71.3 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.559 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.78 -32.48 74.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.698 1.749 . . . . 0.0 110.233 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.12 153.76 48.49 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 123.33 0.652 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.16 90.45 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.519 3.479 . . . . 0.0 107.792 -175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.73 -3.79 5.02 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 117.96 -1.467 . . . . 0.0 113.167 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.44 159.23 85.26 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.73 1.765 . . . . 0.0 109.909 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.16 144.32 68.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.483 2.122 . . . . 0.0 109.804 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -114.68 92.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.9 160.15 15.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.448 1.899 . . . . 0.0 110.993 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm -65.82 119.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 167.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -57.05 -45.06 92.79 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.078 2.275 . . . . 0.0 112.542 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.51 170.17 4.95 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.962 2.105 . . . . 0.0 107.402 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.39 138.41 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 168.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -85.41 117.39 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.34 80.62 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.064 0.852 . . . . 0.0 112.277 -168.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.8 mmt -94.8 37.99 1.13 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.86 166.77 14.87 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 125.907 1.717 . . . . 0.0 109.974 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.2 t -75.96 -14.12 60.24 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.935 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.43 -50.63 15.22 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.988 1.267 . . . . 0.0 111.193 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -53.47 -59.95 3.93 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.197 1.399 . . . . 0.0 108.84 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -60.51 -15.15 24.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.139 0.976 . . . . 0.0 113.426 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -20.77 62.17 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.404 -0.81 . . . . 0.0 111.102 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.61 32.13 25.42 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.814 1.197 . . . . 0.0 112.333 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt-85 -139.55 -65.25 0.48 Allowed 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.81 141.2 48.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.694 0.679 . . . . 0.0 110.009 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -135.5 155.12 78.67 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.48 1.112 . . . . 0.0 109.619 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.82 140.1 90.6 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.471 2.114 . . . . 0.0 110.745 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.88 86.19 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 117.939 -1.478 . . . . 0.0 114.727 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.56 129.11 39.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.988 1.894 . . . . 0.0 107.738 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.94 133.01 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.74 148.27 24.81 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.106 1.362 . . . . 0.0 107.743 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.08 -53.73 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.48 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -129.65 147.83 51.48 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.858 0.863 . . . . 0.0 109.097 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.9 t -139.77 124.79 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 64.13 4.06 1.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.527 1.531 . . . . 0.0 113.878 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.33 -14.01 12.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.009 1.766 . . . . 0.0 112.592 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.47 133.72 20.12 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 119.267 1.534 . . . . 0.0 108.878 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.46 108.85 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.766 2.977 . . . . 0.0 109.689 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.03 -6.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.634 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.29 108.67 3.29 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.629 -1.294 . . . . 0.0 110.111 -166.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.43 14.1 69.19 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.904 0.764 . . . . 0.0 113.294 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.618 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 37.1 mmtt -82.07 -161.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.285 1.434 . . . . 0.0 108.234 162.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -113.06 172.16 7.11 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.336 1.055 . . . . 0.0 110.676 171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -45.51 -55.28 6.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.747 2.019 . . . . 0.0 111.399 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.49 -35.34 67.88 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.533 -0.729 . . . . 0.0 112.338 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 32.2 t80 -49.52 -51.6 35.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.345 0.593 . . . . 0.0 109.611 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.73 -39.11 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.503 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm -58.65 -37.24 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.025 1.284 . . . . 0.0 110.522 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.68 -44.36 93.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.254 1.421 . . . . 0.0 110.196 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.81 -51.6 66.43 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.382 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.7 mmm -52.97 -39.7 63.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.103 0.865 . . . . 0.0 111.422 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.4 -34.95 74.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.948 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.97 -36.99 24.67 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.575 1.08 . . . . 0.0 112.922 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.674 1.125 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.74 71.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.395 -1.441 . . . . 0.0 112.97 171.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -78.53 -36.16 45.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 110.682 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -62.16 -15.32 45.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.954 1.302 . . . . 0.0 111.239 162.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 3.13 77.11 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.077 1.322 . . . . 0.0 112.453 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -160.85 151.76 18.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.136 1.468 . . . . 0.0 107.178 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.35 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -84.48 133.12 34.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 16.7 mt -131.18 103.53 6.54 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.5 m -85.5 124.44 32.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.23 171.39 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 126.04 1.736 . . . . 0.0 107.965 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -153.04 166.76 31.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 121.22 -0.925 . . . . 0.0 110.239 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 141.76 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.434 160.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 123.737 0.815 . . . . 0.0 111.129 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 p90 . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -122.19 131.79 54.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.35 139.89 32.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 163.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.76 116.79 20.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 10.7 p30 -80.89 153.18 27.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.214 0.916 . . . . 0.0 110.011 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.57 108.36 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -96.87 106.8 19.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.64 130.03 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.707 0.765 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -93.44 150.1 20.71 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.999 0.92 . . . . 0.0 109.527 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 30.1 ttt85 -122.83 85.84 2.49 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.847 -1.158 . . . . 0.0 109.245 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.0 mtp -141.82 -3.17 1.14 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -135.31 -88.24 0.35 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -77.03 -31.22 56.17 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.74 -158.29 44.74 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.456 1.025 . . . . 0.0 111.124 -167.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.2 m-85 -102.56 97.24 7.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.297 0.549 . . . . 0.0 112.071 -163.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.62 60.99 4.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.905 1.241 . . . . 0.0 112.898 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.0 p90 -141.58 158.45 43.82 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.526 1.163 . . . . 0.0 109.398 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -112.17 167.73 10.18 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.66 1.584 . . . . 0.0 108.169 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.4 130.29 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -143.25 -178.36 5.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.152 2.181 . . . . 0.0 108.678 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.91 -170.34 29.1 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.607 -1.308 . . . . 0.0 110.345 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.63 91.18 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 121.747 -0.854 . . . . 0.0 111.346 -172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -67.3 -35.11 78.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.959 0.88 . . . . 0.0 111.07 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -120.45 160.29 44.51 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 125.059 1.344 . . . . 0.0 108.39 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.48 57.89 5.3 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.511 3.474 . . . . 0.0 110.393 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.08 42.75 0.06 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.313 1.435 . . . . 0.0 110.476 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -124.88 168.12 14.21 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.46 1.904 . . . . 0.0 110.632 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -72.36 138.34 29.91 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.784 2.322 . . . . 0.0 108.979 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.1 mt -107.13 99.6 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 170.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt -95.29 136.55 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.955 2.502 . . . . 0.0 109.505 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm -49.47 127.46 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.23 -27.38 73.78 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.79 -1.005 . . . . 0.0 113.823 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 159.58 133.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.468 3.507 . . . . 0.0 106.339 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.41 148.69 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 119.907 1.231 . . . . 0.0 108.437 166.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mm -81.86 118.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -49.58 76.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 122.603 1.192 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 mmt -85.9 54.52 3.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.79 158.08 29.32 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.205 0.892 . . . . 0.0 111.848 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 m -63.07 -6.86 4.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.56 -48.19 14.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 120.961 1.71 . . . . 0.0 110.005 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.5 -53.15 61.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.71 1.204 . . . . 0.0 109.25 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -63.45 -18.64 63.96 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.364 1.066 . . . . 0.0 112.913 -171.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -17.35 62.69 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 110.817 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 18.4 73.7 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.468 1.032 . . . . 0.0 111.988 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -129.47 -70.69 0.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 112.493 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.27 146.29 50.72 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.09 143.2 46.21 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 124.041 0.936 . . . . 0.0 110.592 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.25 136.02 36.03 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 161.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.33 67.13 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 117.609 -1.662 . . . . 0.0 111.956 -168.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -76.54 134.13 39.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.425 2.112 . . . . 0.0 108.299 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -87.19 128.48 35.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.944 2.098 . . . . 0.0 107.777 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -78.03 162.99 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.222 1.809 . . . . 0.0 111.478 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.62 -55.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.604 1.962 . . . . 0.0 108.704 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.1 149.12 51.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.446 1.098 . . . . 0.0 109.25 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -137.64 122.9 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t0 57.23 17.5 3.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.325 1.85 . . . . 0.0 113.541 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.04 -11.07 48.51 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.17 1.843 . . . . 0.0 113.312 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.67 130.26 24.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 119.407 1.604 . . . . 0.0 107.671 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.0 125.82 10.71 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.299 2.666 . . . . 0.0 108.245 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.73 -4.84 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.733 0.813 . . . . 0.0 111.81 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 124.94 22.32 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.66 -0.65 . . . . 0.0 110.318 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 1.11 79.67 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.189 0.899 . . . . 0.0 113.958 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -88.28 171.5 10.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 119.616 1.708 . . . . 0.0 108.738 172.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.6 p -90.62 168.55 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.531 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -44.64 -47.89 10.5 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.103 1.761 . . . . 0.0 111.53 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -52.92 -36.81 60.12 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.596 1.158 . . . . 0.0 113.408 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.97 -49.92 65.15 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.406 0.683 . . . . 0.0 109.295 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.01 -38.03 79.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 C-N-CA 125.092 1.357 . . . . 0.0 110.772 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.59 -40.84 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.483 1.038 . . . . 0.0 109.819 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.06 91.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.205 0.602 . . . . 0.0 110.867 172.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -53.93 45.26 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.626 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.2 mmm -55.03 -37.0 66.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.049 0.841 . . . . 0.0 111.428 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -61.97 -38.71 89.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 117.565 -1.207 . . . . 0.0 111.918 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -70.41 -48.24 57.03 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.697 1.135 . . . . 0.0 111.289 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -42.09 80.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.975 1.31 . . . . 0.0 111.362 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.78 67.19 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.117 -0.99 . . . . 0.0 113.031 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -84.36 -36.15 22.7 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.612 1.096 . . . . 0.0 110.94 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -53.09 -34.04 54.83 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.71 61.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.737 1.161 . . . . 0.0 112.219 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -160.43 173.07 16.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.344 2.258 . . . . 0.0 107.251 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -148.21 127.89 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -80.94 127.04 32.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 161.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.4 mt -116.48 97.19 5.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 86.1 m -83.89 115.08 22.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.17 171.15 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.844 1.658 . . . . 0.0 108.275 174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -152.87 151.0 29.89 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 119.46 -2.025 . . . . 0.0 112.402 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -140.69 129.61 23.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.677 0.791 . . . . 0.0 109.447 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.239 0.526 0 C-N-CA 126.704 2.002 . . . . 0.0 111.243 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 p90 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.475 0.178 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -124.91 137.13 54.29 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.699 1.2 . . . . 0.0 108.931 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -93.71 154.47 17.78 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.736 1.214 . . . . 0.0 107.861 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mp -139.6 131.77 28.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.951 2.1 . . . . 0.0 106.701 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.56 133.05 33.85 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.334 1.054 . . . . 0.0 109.816 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -129.95 106.59 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.84 118.26 36.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.6 148.31 32.45 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.135 0.974 . . . . 0.0 109.5 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -86.82 164.41 16.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 164.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -117.57 95.48 4.97 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 164.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 ttt -143.77 -13.01 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.111 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.63 -108.41 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -65.24 -31.14 72.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.064 1.302 . . . . 0.0 113.016 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 93.66 0.58 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.624 1.107 . . . . 0.0 112.539 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 43.49 71.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 113.54 169.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.45 54.12 4.3 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.785 -1.197 . . . . 0.0 114.98 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -121.32 175.92 5.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.845 1.322 . . . . 0.0 109.409 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.12 165.21 26.6 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 167.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.6 130.62 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -171.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.17 146.39 27.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.422 1.089 . . . . 0.0 108.088 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.51 177.87 19.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.859 -2.096 . . . . 0.0 107.859 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.58 37.05 84.63 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 121.514 -0.992 . . . . 0.0 111.705 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.75 -36.42 67.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.596 1.198 . . . . 0.0 110.481 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -137.73 160.48 64.74 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.984 2.114 . . . . 0.0 107.766 -170.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.97 72.36 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.406 3.404 . . . . 0.0 110.537 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.14 -9.96 0.06 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 127.549 2.5 . . . . 0.0 111.826 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -72.98 158.21 87.5 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.834 1.317 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.45 137.73 31.23 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.77 2.314 . . . . 0.0 109.125 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -110.11 93.55 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.59 155.94 18.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.068 0.937 . . . . 0.0 110.36 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.83 107.54 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.11 -41.11 71.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.79 175.7 12.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.394 1.878 . . . . 0.0 107.575 168.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.43 148.99 29.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 mm -89.12 112.86 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.13 7.63 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.777 1.231 . . . . 0.0 113.548 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.7 mtm -90.04 -0.79 57.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 153.01 45.83 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -62.49 -6.93 3.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.69 29.16 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.539 1.518 . . . . 0.0 112.188 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.09 -52.26 50.4 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.947 0.794 . . . . 0.0 109.813 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -13.3 15.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 168.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.66 -17.73 62.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.246 1.385 . . . . 0.0 110.987 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.34 32.81 41.62 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.336 166.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -133.6 -66.34 0.65 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.343 1.572 . . . . 0.0 111.414 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.69 144.68 54.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.556 1.142 . . . . 0.0 111.489 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -130.94 151.7 79.38 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.749 1.219 . . . . 0.0 109.312 164.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -51.89 142.66 42.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.324 2.016 . . . . 0.0 110.694 163.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.18 64.24 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.954 -0.915 . . . . 0.0 113.798 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.61 134.23 53.9 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.697 1.749 . . . . 0.0 106.423 165.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.91 123.16 33.0 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.01 140.91 47.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.599 1.16 . . . . 0.0 109.022 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.8 -52.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 124.653 1.181 . . . . 0.0 108.825 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -130.03 146.74 51.72 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.17 124.41 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.17 14.44 6.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.056 1.742 . . . . 0.0 112.224 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.28 68.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.901 1.715 . . . . 0.0 112.517 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.63 126.12 35.17 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.717 1.607 . . . . 0.0 108.102 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.91 118.26 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.208 2.605 . . . . 0.0 109.209 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.74 -9.11 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.81 6.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.871 1.269 . . . . 0.0 109.71 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.46 3.77 61.14 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.553 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 21.4 mmtt -107.18 178.64 4.49 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.591 1.957 . . . . 0.0 108.728 174.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -95.22 -179.93 4.97 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.207 -0.308 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -49.91 -54.83 17.2 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.498 1.119 . . . . 0.0 110.924 169.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -26.83 68.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.73 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 64.9 t80 -46.54 -54.07 10.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.719 0.771 . . . . 0.0 110.608 169.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.04 -36.53 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.473 1.509 . . . . 0.0 110.082 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.6 mm -57.53 -41.02 78.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 119.126 0.876 . . . . 0.0 110.149 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.522 0.729 . . . . 0.0 111.359 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.96 -51.66 13.15 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.058 0.943 . . . . 0.0 110.828 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.6 mmm -55.09 -38.1 67.67 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.406 1.083 . . . . 0.0 110.867 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -60.79 2.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.809 1.644 . . . . 0.0 110.17 173.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -54.82 -51.08 66.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.512 1.125 . . . . 0.0 111.259 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.92 78.48 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.028 0.931 . . . . 0.0 111.534 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.4 66.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.773 -1.204 . . . . 0.0 112.194 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtt-85 -69.97 -49.91 47.04 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.207 1.367 . . . . 0.0 109.636 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -54.53 -38.21 66.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.769 0.827 . . . . 0.0 110.313 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.62 42.34 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.064 0.84 . . . . 0.0 111.858 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -151.36 166.76 30.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.802 1.301 . . . . 0.0 108.368 167.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.01 165.3 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -126.83 144.53 50.94 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 164.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.3 mt -138.11 97.39 3.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 103.061 -2.941 . . . . 0.0 103.061 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -86.4 112.98 21.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.35 165.92 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.478 0.711 . . . . 0.0 109.52 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -153.08 162.61 41.12 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.605 -1.309 . . . . 0.0 111.962 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -150.32 147.35 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.697 1.199 . . . . 0.0 109.991 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt . . . . . 0 C--O 1.234 0.281 0 C-N-CA 124.687 1.195 . . . . 0.0 111.358 164.298 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.13 138.31 54.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 169.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.15 145.8 28.2 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 158.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.39 121.76 33.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.015 2.126 . . . . 0.0 106.721 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 135.2 35.65 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.898 1.279 . . . . 0.0 109.348 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.91 107.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.56 0.695 . . . . 0.0 109.446 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.02 120.77 40.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 108.776 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -123.22 124.06 42.17 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.047 1.339 . . . . 0.0 108.94 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -74.44 153.18 39.3 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.784 169.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -102.94 114.55 28.93 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -69.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -73.79 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.614 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -126.11 1.92 7.2 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -148.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.21 57.48 8.41 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 123.946 0.784 . . . . 0.0 112.368 167.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.74 80.79 0.05 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.6 2.36 . . . . 0.0 113.006 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.0 75.64 1.1 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.281 0.943 . . . . 0.0 112.798 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -127.95 175.55 8.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.141 2.176 . . . . 0.0 106.187 159.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -123.02 162.46 22.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 157.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.27 127.28 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.4 -177.29 4.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 107.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.34 -156.26 48.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -170.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.63 -105.31 0.71 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -164.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.92 -52.81 0.25 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 129.308 3.043 . . . . 0.0 110.29 -167.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -100.39 160.87 25.8 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 110.861 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 96.11 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.408 3.406 . . . . 0.0 111.563 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.33 19.24 30.86 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 118.372 -1.238 . . . . 0.0 113.067 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -66.11 162.06 50.34 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.708 1.254 . . . . 0.0 109.387 164.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.4 132.66 21.12 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.673 2.249 . . . . 0.0 109.226 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.84 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -87.17 144.42 26.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 110.495 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.91 108.35 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -44.31 51.62 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 127.487 2.47 . . . . 0.0 112.248 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.76 160.97 29.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.589 0.756 . . . . 0.0 109.618 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.18 115.68 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 161.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -66.89 121.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -21.64 60.56 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -127.95 33.12 4.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.636 1.574 . . . . 0.0 108.353 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 176.65 17.64 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.831 1.205 . . . . 0.0 111.735 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -61.67 -25.71 67.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.534 0.733 . . . . 0.0 112.756 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -53.96 14.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.849 0.749 . . . . 0.0 109.501 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.86 -46.54 78.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.472 1.109 . . . . 0.0 111.735 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -28.39 65.53 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -72.49 -39.7 67.48 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.756 0.822 . . . . 0.0 110.21 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.2 35.9 19.46 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.992 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -124.2 -67.51 0.92 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.01 0.905 . . . . 0.0 110.725 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.47 137.48 48.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.85 149.41 62.71 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 110.253 174.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -57.6 132.1 48.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.338 2.025 . . . . 0.0 110.38 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 7.38 87.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 117.897 -1.502 . . . . 0.0 113.617 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.08 142.94 58.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.141 1.97 . . . . 0.0 108.271 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.16 125.84 35.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.123 -0.985 . . . . 0.0 108.673 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.19 154.37 26.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 109.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.6 -51.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 108.798 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.82 148.8 52.58 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.121 0.968 . . . . 0.0 109.705 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.92 105.54 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t70 54.63 22.95 4.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.295 1.838 . . . . 0.0 113.189 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.02 -13.63 57.41 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.973 2.225 . . . . 0.0 113.027 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' CG2' ' HH ' ' A' ' 74' ' ' TYR . 4.3 mp -88.43 125.56 63.13 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.114 1.457 . . . . 0.0 107.798 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -73.5 131.0 15.6 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.635 2.89 . . . . 0.0 109.425 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.43 -8.6 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 123.957 0.903 . . . . 0.0 111.633 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.94 57.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.755 -0.59 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.93 7.57 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.372 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 25.3 mmtt -95.88 -177.14 3.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.405 1.602 . . . . 0.0 110.155 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -109.99 175.77 5.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.757 2.023 . . . . 0.0 110.739 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -53.86 -57.09 12.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 109.135 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -45.85 -45.86 15.33 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 112.061 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 50.0 t80 -49.77 -40.24 40.58 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.682 0.614 . . . . 0.0 111.412 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.38 -41.6 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 110.757 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.45 -41.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.026 0.83 . . . . 0.0 109.608 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -23.97 64.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.756 1.622 . . . . 0.0 112.126 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.18 -45.12 16.83 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 123.681 0.792 . . . . 0.0 110.258 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mmm -56.87 -34.94 68.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.917 0.78 . . . . 0.0 111.878 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.87 -42.9 85.52 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.117 0.967 . . . . 0.0 111.51 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -45.35 74.07 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.469 0.707 . . . . 0.0 110.699 174.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.73 71.48 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.764 -1.21 . . . . 0.0 112.245 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.95 74.74 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.609 -0.682 . . . . 0.0 111.046 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -69.09 -36.82 77.98 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.194 0.998 . . . . 0.0 112.343 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -68.61 -12.22 61.06 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.565 0.62 . . . . 0.0 112.014 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.62 7.3 87.21 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.511 1.053 . . . . 0.0 112.936 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.6 169.11 10.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 120.843 -1.386 . . . . 0.0 107.586 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.85 159.7 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -122.12 145.07 48.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mt -138.11 99.34 3.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -84.58 114.02 21.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.28 170.69 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 166.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -151.27 164.21 37.13 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.051 -1.655 . . . . 0.0 109.885 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.36 133.57 15.27 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.537 1.135 . . . . 0.0 108.586 168.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.204 0 C-N-CA 123.571 0.748 . . . . 0.0 109.178 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.4 p90 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 143.09 47.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.109 1.364 . . . . 0.0 107.74 171.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.74 141.95 29.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 169.3 9.1 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.345 2.258 . . . . 0.0 107.186 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 128.13 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.856 1.662 . . . . 0.0 107.014 172.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.05 136.99 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -128.13 127.57 43.25 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 108.165 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.93 155.05 45.92 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.299 1.04 . . . . 0.0 109.374 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -105.29 165.86 10.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.102 0.953 . . . . 0.0 111.398 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -125.49 93.35 3.83 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 124.861 1.264 . . . . 0.0 109.211 174.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.9 mtp -144.34 -63.28 0.37 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -66.43 -69.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.835 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -114.76 -31.08 6.26 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . 78.18 85.71 0.5 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -164.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 72.97 -153.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.754 0.914 . . . . 0.0 108.697 167.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.9 55.14 0.02 OUTLIER Glycine 0 C--O 1.227 -0.312 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.36 172.87 12.17 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -141.35 142.27 33.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.023 0.929 . . . . 0.0 109.439 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 135.47 57.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.272 2.7 pp -148.98 -178.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.306 2.242 . . . . 0.0 108.644 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.7 -145.92 46.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.48 30.55 34.12 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 118.0 0.9 . . . . 0.0 111.598 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -90.82 -7.08 53.31 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 112.082 -163.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -129.7 155.59 80.13 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 126.891 2.076 . . . . 0.0 106.828 165.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.96 92.11 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 124.66 3.573 . . . . 0.0 108.161 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.91 -12.42 1.91 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.627 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -79.23 159.43 72.79 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 119.433 1.617 . . . . 0.0 112.192 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.42 147.01 51.59 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.222 1.948 . . . . 0.0 108.764 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -116.77 92.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.88 130.66 44.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.814 1.646 . . . . 0.0 109.16 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 mm -54.81 110.42 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.04 -43.58 81.13 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.442 -0.786 . . . . 0.0 111.738 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 139.89 14.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.43 147.15 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 159.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.12 110.61 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.25 -34.72 61.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 123.105 1.431 . . . . 0.0 112.009 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 33.1 mmt -95.91 20.8 9.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.591 1.156 . . . . 0.0 110.506 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 176.11 21.54 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.202 0.906 . . . . 0.0 111.552 -165.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -20.68 64.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.225 -0.893 . . . . 0.0 113.09 -160.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.52 -63.74 1.01 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.005 0.82 . . . . 0.0 109.743 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.61 -43.58 80.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.094 0.958 . . . . 0.0 110.751 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -70.62 -18.99 62.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.908 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.21 -22.6 33.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.616 1.553 . . . . 0.0 111.371 168.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.97 14.03 65.44 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.371 159.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.45 -43.81 4.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.381 1.591 . . . . 0.0 113.968 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.19 155.76 27.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -135.6 153.47 77.59 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.511 . . . . 0.0 110.586 155.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.58 112.95 3.35 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.817 1.678 . . . . 0.0 110.633 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.15 -13.09 5.76 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.232 2.348 . . . . 0.0 110.977 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.37 131.38 48.06 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 122.28 28.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 120.05 1.295 . . . . 0.0 107.697 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.2 153.52 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 109.788 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 t -130.07 -45.58 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.122 1.369 . . . . 0.0 109.511 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.37 149.23 51.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.352 1.061 . . . . 0.0 109.636 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.4 t -137.39 122.72 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 53.58 14.28 0.58 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.33 2.652 . . . . 0.0 113.555 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.7 30.92 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.447 2.451 . . . . 0.0 113.367 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.49 130.37 33.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 120.586 2.193 . . . . 0.0 106.895 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -71.91 111.01 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.958 2.439 . . . . 0.0 108.567 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -72.83 -8.25 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.335 0.654 . . . . 0.0 110.96 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.65 120.42 9.44 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.12 -9.2 70.53 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.284 1.421 . . . . 0.0 114.909 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -83.03 173.59 11.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.067 -1.255 . . . . 0.0 109.098 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.1 p -93.83 169.86 9.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -51.34 -46.62 62.72 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.454 1.102 . . . . 0.0 112.052 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 -59.22 -33.18 70.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.905 0.775 . . . . 0.0 112.56 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -48.1 -48.02 33.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.914 0.886 . . . . 0.0 109.554 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.62 -35.5 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.456 -0.778 . . . . 0.0 110.816 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.56 -35.21 69.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 120.91 -1.119 . . . . 0.0 110.321 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.43 -42.39 87.77 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.471 1.108 . . . . 0.0 109.82 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -47.13 85.49 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 111.491 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -27.83 45.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.733 0.813 . . . . 0.0 110.493 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -45.08 63.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.567 0.621 . . . . 0.0 110.63 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -63.3 -46.86 84.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 111.329 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.456 1.102 . . . . 0.0 110.79 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.74 -24.19 67.57 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.114 -0.991 . . . . 0.0 112.791 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -59.45 2.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 169.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -56.84 -39.33 74.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 124.622 1.201 . . . . 0.0 109.715 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 9.3 16.74 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.352 0.977 . . . . 0.0 112.692 170.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -149.48 175.83 11.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.5 128.46 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 156.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 139.32 31.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 161.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.4 mt -135.51 111.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.8 m -95.49 115.57 27.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.1 173.84 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 165.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -150.86 160.72 43.7 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 120.392 -1.442 . . . . 0.0 110.195 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -155.34 144.46 20.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 160.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 127.538 2.335 . . . . 0.0 109.887 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.406 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 24.7 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.542 0.687 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -106.71 131.15 54.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.01 159.54 21.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 158.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.32 121.67 11.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 173.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.98 135.76 36.46 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.3 t -126.15 107.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -95.59 127.77 41.9 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -121.35 124.16 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.963 0.905 . . . . 0.0 109.881 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -71.95 144.38 48.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -101.47 103.94 14.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.0 mtm -142.91 -53.16 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.04 -105.23 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.399 1.079 . . . . 0.0 110.713 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -69.91 -21.74 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.436 1.471 . . . . 0.0 112.139 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 67.17 2.13 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.19 100.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.485 2.314 . . . . 0.0 111.369 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.06 53.42 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.605 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -134.59 170.69 15.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.469 1.634 . . . . 0.0 110.034 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.97 151.73 48.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.71 2.404 . . . . 0.0 109.134 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.69 152.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.682 1.193 . . . . 0.0 107.809 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 -179.16 6.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.413 1.485 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.36 -142.82 43.31 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.81 20.72 62.38 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.937 0.78 . . . . 0.0 112.028 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.76 -45.96 87.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.242 1.417 . . . . 0.0 110.021 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -108.77 155.17 41.14 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.91 93.8 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.892 3.728 . . . . 0.0 109.528 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.34 2.87 2.55 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.82 1.2 . . . . 0.0 112.739 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -77.71 167.98 31.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.452 1.126 . . . . 0.0 109.824 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.57 131.7 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.304 2.67 . . . . 0.0 110.211 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.81 105.76 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 mt -101.68 162.8 12.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.851 1.66 . . . . 0.0 112.436 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.8 mm -65.79 121.5 14.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.22 -60.87 5.58 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 122.968 0.318 . . . . 0.0 112.633 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.43 114.78 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.9 2.08 . . . . 0.0 106.952 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.3 149.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.85 116.0 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.99 -29.74 44.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.312 1.845 . . . . 0.0 115.135 -165.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.4 mmt -135.12 10.72 3.56 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.455 1.102 . . . . 0.0 111.795 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.8 172.41 54.05 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -57.88 -11.86 2.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.19 -52.69 6.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.141 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.0 -43.66 73.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.184 1.356 . . . . 0.0 110.414 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -55.79 -28.63 57.09 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.84 -17.43 28.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.395 1.078 . . . . 0.0 111.978 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.54 23.74 67.14 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -122.44 -14.11 7.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.978 1.889 . . . . 0.0 114.31 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.14 168.8 12.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.294 0.952 . . . . 0.0 108.636 166.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.85 18.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.133 1.373 . . . . 0.0 107.838 158.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.44 123.77 11.59 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.894 2.396 . . . . 0.0 109.164 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.9 34.93 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.052 0.834 . . . . 0.0 113.288 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -64.39 153.83 37.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 118.643 1.221 . . . . 0.0 109.507 152.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -104.58 116.64 32.43 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.821 2.048 . . . . 0.0 108.276 166.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.22 136.83 37.87 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.32 2.248 . . . . 0.0 108.755 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.98 -52.95 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 123.596 0.758 . . . . 0.0 110.276 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -134.59 145.17 48.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.81 124.83 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 107.322 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.43 21.15 1.14 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.613 2.365 . . . . 0.0 112.09 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.48 -10.78 70.87 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.82 2.153 . . . . 0.0 113.788 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.77 133.19 38.26 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 119.575 1.687 . . . . 0.0 107.625 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -72.01 133.94 22.46 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.024 2.483 . . . . 0.0 108.295 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.07 -7.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.229 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.75 133.72 47.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.82 -9.04 25.87 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.7 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 69.7 mmtt -85.96 171.8 11.18 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.935 1.868 . . . . 0.0 108.723 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.8 p -92.3 172.97 8.06 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.137 0.575 . . . . 0.0 110.362 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -49.7 -56.07 11.53 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.717 1.207 . . . . 0.0 109.485 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -50.56 -41.77 54.56 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.62 1.568 . . . . 0.0 112.929 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 41.0 t80 -51.63 -47.14 63.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.753 0.787 . . . . 0.0 110.266 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 t -73.13 -34.35 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.791 0.836 . . . . 0.0 110.465 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -62.44 -35.44 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.878 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.5 -43.88 97.73 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.788 1.235 . . . . 0.0 110.105 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -53.88 46.15 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.625 0.77 . . . . 0.0 111.669 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.7 mmm -58.59 -35.22 72.07 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.235 0.614 . . . . 0.0 111.082 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -59.5 -45.14 92.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.482 -0.77 . . . . 0.0 111.2 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.62 -51.08 66.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.808 0.843 . . . . 0.0 111.683 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.77 71.82 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 111.678 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.22 78.5 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.036 -1.04 . . . . 0.0 111.288 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -72.14 -42.87 65.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.391 0.996 . . . . 0.0 111.183 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -55.35 -33.51 63.45 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.364 1.065 . . . . 0.0 110.227 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.63 10.64 65.01 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.182 0.896 . . . . 0.0 112.228 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -164.66 168.86 17.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.751 2.02 . . . . 0.0 107.053 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.38 159.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.36 88.97 2.35 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.632 1.173 . . . . 0.0 109.294 -170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.9 97.95 8.49 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -83.55 127.07 33.45 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.423 ' HB ' ' CG ' ' A' ' 57' ' ' ASP . 17.2 m -125.99 158.47 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 126.038 1.735 . . . . 0.0 107.051 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 11.6 ptt180 -151.3 161.32 42.93 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.674 -0.641 . . . . 0.0 111.085 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.21 146.36 22.71 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.446 0 C-N-CA 124.0 0.92 . . . . 0.0 110.411 166.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.4 p90 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -135.82 137.33 41.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 159.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -83.45 152.46 24.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 164.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.41 163.21 19.09 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -124.98 121.37 34.24 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.207 1.803 . . . . 0.0 107.706 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.9 t -121.59 109.1 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -78.18 144.52 36.28 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 mt -140.05 128.21 22.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.182 0.993 . . . . 0.0 108.8 166.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -72.95 160.06 32.71 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.741 0.416 . . . . 0.0 111.669 171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.506 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 8.5 ttt-85 -141.5 89.65 2.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.287 1.435 . . . . 0.0 107.439 166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mtm -154.27 -41.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 109.22 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -72.78 -163.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 142.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -64.73 8.32 0.12 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -148.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 174.2 50.22 Favored Glycine 0 N--CA 1.45 -0.398 0 O-C-N 120.672 -1.267 . . . . 0.0 112.287 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -65.99 160.83 22.76 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.57 72.32 0.29 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -143.31 171.87 13.52 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -132.18 158.67 41.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.126 1.371 . . . . 0.0 107.774 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.75 121.38 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.81 -177.23 3.08 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.474 2.31 . . . . 0.0 107.716 -168.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.49 -144.39 49.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.04 19.96 47.4 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.124 0.868 . . . . 0.0 112.904 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -26.28 68.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.011 0.925 . . . . 0.0 111.204 -168.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -140.39 160.25 60.28 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 126.114 1.766 . . . . 0.0 109.056 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.76 112.65 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 173.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.07 35.89 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.923 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.91 155.61 91.36 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.662 1.731 . . . . 0.0 108.466 166.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.63 152.41 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.517 2.811 . . . . 0.0 110.371 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.78 93.98 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 165.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -81.36 152.85 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.25 139.3 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 159.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.7 -56.79 1.39 Allowed Glycine 0 C--O 1.226 -0.372 0 O-C-N 121.492 -0.755 . . . . 0.0 111.639 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.84 145.76 36.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.42 123.78 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.61 110.62 7.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -171.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.8 149.16 11.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.269 0.98 . . . . 0.0 110.483 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.5 mmt 66.47 -6.75 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.988 2.115 . . . . 0.0 114.564 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -151.63 5.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.847 1.689 . . . . 0.0 111.416 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -66.5 -63.77 1.0 Allowed 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.918 -1.342 . . . . 0.0 110.725 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -45.26 94.55 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -157.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.52 -45.92 90.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.234 1.014 . . . . 0.0 111.535 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.9 -39.64 95.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.686 1.595 . . . . 0.0 112.616 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -36.89 83.45 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 110.368 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.2 15.32 65.26 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 125.486 1.517 . . . . 0.0 113.24 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -98.59 -32.85 11.22 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.574 1.549 . . . . 0.0 109.604 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.48 146.7 32.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.05 146.87 48.33 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.843 164.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -69.24 112.41 2.98 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.894 2.396 . . . . 0.0 110.674 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.14 5.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.709 1.623 . . . . 0.0 112.268 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.84 140.88 57.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 122.5 32.61 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.989 1.268 . . . . 0.0 108.583 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.06 156.83 38.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.102 0.961 . . . . 0.0 111.202 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.14 -53.01 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.902 1.681 . . . . 0.0 108.933 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.4 148.25 51.3 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.528 1.131 . . . . 0.0 109.618 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 64' ' ' GLY . 96.0 t -142.84 126.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.721 1.608 . . . . 0.0 107.019 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.11 -3.83 0.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.921 2.088 . . . . 0.0 112.708 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 125.58 -16.96 6.96 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.841 3.115 . . . . 0.0 111.914 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.27 134.87 20.96 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.868 1.334 . . . . 0.0 108.648 -167.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.16 118.83 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.382 2.722 . . . . 0.0 109.883 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.3 -7.3 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 111.023 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 118.29 8.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 109.992 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.97 -10.01 70.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.657 1.122 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -78.55 -172.53 2.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 108.712 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -100.63 171.89 7.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.685 1.194 . . . . 0.0 109.402 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -50.81 -53.65 30.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.389 1.476 . . . . 0.0 109.844 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.75 -24.26 67.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -51.71 -48.92 63.37 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.854 0.835 . . . . 0.0 110.21 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.65 -37.18 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.572 1.149 . . . . 0.0 110.126 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.02 -28.35 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.204 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -45.48 72.54 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.476 1.51 . . . . 0.0 110.415 169.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -49.62 76.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.191 0.596 . . . . 0.0 110.775 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.0 mmm -57.74 -19.88 30.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.942 0.497 . . . . 0.0 112.331 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -47.85 21.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.373 0.988 . . . . 0.0 111.103 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.43 -47.04 85.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 119.016 0.825 . . . . 0.0 111.111 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.35 -38.02 73.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.689 0.796 . . . . 0.0 111.713 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.78 -14.25 62.91 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 113.805 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -81.7 -43.74 18.07 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.033 1.288 . . . . 0.0 109.764 165.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -63.28 -17.35 62.42 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.747 1.219 . . . . 0.0 112.016 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.31 69.01 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.037 1.303 . . . . 0.0 112.406 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -157.31 168.7 26.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.031 1.732 . . . . 0.0 106.872 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.06 163.49 26.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -121.88 140.42 52.43 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 166.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.4 mt -137.01 106.67 6.17 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 m -97.31 112.58 24.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.44 164.77 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.65 151.75 32.97 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.567 -1.333 . . . . 0.0 110.839 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -151.02 136.05 17.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 166.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 p90 . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 122.156 0.979 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -97.0 147.3 24.14 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 112.918 -1.946 . . . . 0.0 106.253 164.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.02 154.19 23.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 160.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.06 118.08 23.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.51 130.44 39.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -135.08 107.15 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.26 128.27 41.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.76 165.46 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 109.409 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -127.35 145.75 50.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -98.94 101.48 12.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tpt -144.7 -63.51 0.36 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.28 -85.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.809 0.844 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -95.51 -31.02 13.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.919 0.327 . . . . 0.0 111.803 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.68 71.66 1.27 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.26 83.28 0.17 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.9 1.68 . . . . 0.0 111.155 168.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.39 59.44 2.83 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.893 0.759 . . . . 0.0 112.878 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.35 175.05 9.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.082 1.353 . . . . 0.0 109.613 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -129.57 166.91 18.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.99 1.316 . . . . 0.0 108.563 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.05 122.69 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.36 -176.5 4.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 108.593 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.27 -151.47 52.11 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -168.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.96 33.35 20.9 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 117.427 0.613 . . . . 0.0 111.578 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.63 -17.09 62.28 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.332 -1.099 . . . . 0.0 110.62 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -132.4 160.32 68.63 Favored Pre-proline 0 C--O 1.239 0.539 0 C-N-CA 126.715 2.006 . . . . 0.0 107.694 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.3 79.39 3.35 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.105 3.203 . . . . 0.0 109.153 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.09 51.38 0.27 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 125.697 1.618 . . . . 0.0 109.296 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -118.47 159.3 44.32 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.761 1.624 . . . . 0.0 107.506 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 144.34 47.89 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.788 1.659 . . . . 0.0 109.018 -170.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 7.2 mt -105.37 79.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 124.189 1.947 . . . . 0.0 107.329 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.34 124.37 31.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.316 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 mm -47.15 129.06 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.12 -0.81 89.67 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.902 2.668 . . . . 0.0 116.787 -166.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 127.35 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 C-N-CA 132.36 4.264 . . . . 0.0 108.824 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.2 t -77.41 149.89 5.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.74 117.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.36 -35.67 70.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -163.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.6 mtm -131.33 114.64 15.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.02 -177.84 38.08 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 m -51.84 -45.32 63.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.84 72.32 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.369 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.11 -41.4 99.34 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.916 0.486 . . . . 0.0 110.287 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -59.58 -46.53 88.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.227 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -21.22 66.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.434 0.561 . . . . 0.0 110.59 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 0.32 30.6 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.33 1.443 . . . . 0.0 113.673 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -99.35 -21.52 15.99 Favored 'General case' 0 C--O 1.228 -0.059 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.056 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mt -95.92 145.97 24.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.309 1.413 . . . . 0.0 108.147 172.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -140.22 -179.06 0.92 Allowed Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.926 1.691 . . . . 0.0 109.949 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -94.94 138.41 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 111.702 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 -3.69 59.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 125.867 1.698 . . . . 0.0 111.771 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.43 139.96 46.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.11 132.66 42.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.011 2.124 . . . . 0.0 106.878 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.14 152.18 23.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 109.369 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.01 -50.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 108.742 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -127.74 152.37 47.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.929 . . . . 0.0 110.011 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.13 123.72 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 106.81 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t0 55.6 19.21 3.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.591 2.356 . . . . 0.0 113.319 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.11 -16.03 27.78 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.862 2.172 . . . . 0.0 113.702 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.18 131.88 22.63 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 118.778 1.289 . . . . 0.0 108.433 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -72.27 111.65 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.651 2.901 . . . . 0.0 109.004 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.67 -4.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.981 0.913 . . . . 0.0 112.007 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.3 126.29 27.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 109.54 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.86 -7.47 81.68 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.301 0.953 . . . . 0.0 112.91 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -91.99 175.95 6.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.145 1.473 . . . . 0.0 108.974 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -95.09 167.89 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.76 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -48.78 -44.38 38.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 110.646 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -57.62 -35.72 70.84 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.631 0.772 . . . . 0.0 113.075 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -56.14 -44.14 78.91 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.27 -38.55 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.965 0.906 . . . . 0.0 110.406 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -56.97 -40.61 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 120.093 1.315 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -70.73 -33.4 70.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.747 0.248 . . . . 0.0 111.574 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.17 -46.77 72.96 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.663 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.4 mmm -63.54 -33.15 74.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.195 0.907 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.06 -45.25 75.31 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.175 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -49.66 64.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.856 0.862 . . . . 0.0 111.422 176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.35 66.85 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 110.539 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 -23.44 64.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.019 -1.051 . . . . 0.0 113.327 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -93.47 -31.37 14.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.207 1.003 . . . . 0.0 110.846 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -57.71 -25.2 60.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.329 0.652 . . . . 0.0 110.519 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.88 5.35 90.14 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 121.432 -0.792 . . . . 0.0 111.926 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -149.75 174.04 13.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.372 1.869 . . . . 0.0 107.195 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.48 147.84 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 160.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -115.71 108.83 16.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.7 mt -99.29 140.95 32.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -120.56 114.78 22.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.55 171.36 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -148.67 162.2 40.2 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.512 -1.367 . . . . 0.0 109.24 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -155.06 120.57 5.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 109.75 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.172 0 C-N-CA 125.378 1.471 . . . . 0.0 110.213 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 2.5 p90 . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 121.81 0.814 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 133.26 33.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 167.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.26 152.99 24.91 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 158.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -136.42 162.71 32.3 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.53 2.332 . . . . 0.0 107.511 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.52 116.93 22.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.314 1.054 . . . . 0.0 110.559 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.91 136.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 168.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -129.05 107.46 9.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 123.8 46.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -75.21 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -124.72 99.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 167.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.1 ptp -132.37 6.41 4.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.641 0.776 . . . . 0.0 110.687 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.2 -110.9 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -64.58 -30.42 71.44 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.551 1.069 . . . . 0.0 112.028 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.22 82.87 0.61 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 67.23 -171.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.148 1.379 . . . . 0.0 110.167 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.58 45.88 0.21 Allowed Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -139.58 152.05 46.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -108.6 167.16 10.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.703 2.401 . . . . 0.0 108.538 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.67 135.41 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 120.542 -1.349 . . . . 0.0 107.733 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -138.64 -176.82 4.61 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 128.563 2.745 . . . . 0.0 106.815 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.48 -159.91 41.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.67 24.8 54.25 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.719 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -64.33 -28.11 69.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.579 1.19 . . . . 0.0 110.714 -171.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -135.09 160.67 67.4 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 126.936 2.094 . . . . 0.0 108.03 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.32 35.18 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.752 1 C-N-CA 125.372 4.048 . . . . 0.0 113.603 -166.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.86 20.51 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.997 1.761 . . . . 0.0 111.528 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -89.7 154.07 47.96 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 118.92 1.36 . . . . 0.0 111.123 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.84 135.14 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.916 3.078 . . . . 0.0 109.286 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.2 92.51 2.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 mt -85.15 134.87 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.494 -0.754 . . . . 0.0 111.28 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.5 mm -54.04 112.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.696 1.998 . . . . 0.0 105.728 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.1 -74.86 0.3 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.713 1.625 . . . . 0.0 113.216 -170.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.92 119.27 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.631 1.973 . . . . 0.0 106.756 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.61 149.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.49 113.25 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.13 -23.75 56.2 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.156 1.382 . . . . 0.0 114.588 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.1 mmt -110.95 -0.05 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.23 -178.1 22.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.899 1.238 . . . . 0.0 111.181 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -66.14 -8.34 23.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.25 -40.45 18.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.086 1.766 . . . . 0.0 111.332 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.7 -53.04 24.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.447 1.099 . . . . 0.0 110.428 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -55.32 -29.18 57.77 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.54 -21.94 65.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.766 0.826 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.16 52.65 51.23 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.982 1.277 . . . . 0.0 111.022 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.78 -78.75 0.28 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.1 mt -69.13 142.05 54.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.054 0.843 . . . . 0.0 110.813 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -119.59 154.22 54.49 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.934 0.894 . . . . 0.0 108.978 159.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 142.89 34.83 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.85 1.7 . . . . 0.0 110.07 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.43 88.46 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.963 -0.91 . . . . 0.0 113.533 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -71.19 141.13 50.67 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 169.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.45 128.82 36.63 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.006 -1.059 . . . . 0.0 109.4 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.72 153.47 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.396 1.878 . . . . 0.0 110.923 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.94 -37.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.005 1.722 . . . . 0.0 109.516 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 66' ' ' PRO . 70.2 m-85 -137.18 151.92 49.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.084 0.953 . . . . 0.0 110.388 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.5 t -147.31 134.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 127.036 2.134 . . . . 0.0 106.954 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t0 58.83 17.03 4.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.299 1.44 . . . . 0.0 111.029 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.8 0.82 88.85 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.732 2.11 . . . . 0.0 114.066 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mm -94.78 136.03 23.31 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 127.036 2.134 . . . . 0.0 108.098 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 18.0 Cg_endo -74.07 145.59 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.358 2.039 . . . . 0.0 109.189 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.02 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.077 0.551 . . . . 0.0 112.379 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.8 102.14 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.041 -0.412 . . . . 0.0 110.239 -165.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.48 -3.8 50.53 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.529 1.061 . . . . 0.0 113.718 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 57.3 mmtt -78.83 -179.98 6.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.052 -1.264 . . . . 0.0 108.023 158.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.7 p -111.85 175.52 5.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.21 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -40.8 -64.24 0.56 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 109.792 170.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -55.43 -38.75 69.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.239 0.616 . . . . 0.0 112.577 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 9.1 t80 -55.01 -48.04 73.88 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.441 0.564 . . . . 0.0 109.488 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.12 -44.06 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.353 -1.308 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mm -57.16 -37.54 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.507 1.503 . . . . 0.0 109.785 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -54.52 46.02 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.053 0.941 . . . . 0.0 110.91 170.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.03 -35.04 77.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.268 0.627 . . . . 0.0 112.154 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -30.48 23.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.335 1.454 . . . . 0.0 109.388 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.9 -30.87 71.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.195 0.998 . . . . 0.0 111.339 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -51.04 59.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 173.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.18 74.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.456 1.103 . . . . 0.0 111.394 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -23.34 15.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.533 -1.354 . . . . 0.0 112.464 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -94.17 -21.73 18.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.926 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -61.92 -35.87 79.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.193 1.361 . . . . 0.0 110.696 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.47 -0.72 49.77 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.529 -0.732 . . . . 0.0 112.724 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -151.81 167.84 26.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.76 2.024 . . . . 0.0 106.672 165.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.02 122.13 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 162.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.53 128.16 33.27 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -130.8 128.41 40.66 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.4 m -112.06 122.53 48.01 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -111.09 164.81 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.442 1.097 . . . . 0.0 109.339 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -152.21 146.78 25.71 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.596 -1.315 . . . . 0.0 110.954 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -148.82 126.88 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.834 0.454 . . . . 0.0 110.204 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 124.197 0.999 . . . . 0.0 112.361 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 p90 . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.61 117.27 26.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -83.95 141.06 31.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 116.72 15.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.52 143.06 36.93 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.819 1.648 . . . . 0.0 109.176 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.59 108.72 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 126.248 1.819 . . . . 0.0 106.743 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.3 130.45 35.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -120.9 123.91 43.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.253 0.933 . . . . 0.0 109.276 164.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -74.42 158.58 33.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.185 165.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 51.9 ttt-85 -131.24 102.31 5.93 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 125.793 1.637 . . . . 0.0 107.11 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 ptp -155.66 8.77 0.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -136.75 -76.54 0.42 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.638 -1.288 . . . . 0.0 108.41 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.47 -7.7 12.83 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.66 1.584 . . . . 0.0 111.919 170.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.14 -179.95 41.43 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.159 0.885 . . . . 0.0 111.807 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.1 m-85 -62.48 147.08 49.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.61 51.15 0.87 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -134.7 153.51 51.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -110.97 163.93 13.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.666 1.987 . . . . 0.0 107.316 168.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.46 150.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.155 1.382 . . . . 0.0 108.642 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -134.59 -177.29 4.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.856 2.062 . . . . 0.0 108.549 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.12 -140.51 37.88 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.03 23.92 8.0 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 127.956 2.693 . . . . 0.0 112.922 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.37 -25.38 65.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.031 -0.688 . . . . 0.0 110.342 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -121.84 155.9 59.86 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 123.507 0.723 . . . . 0.0 110.145 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.07 133.09 29.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.112 1.874 . . . . 0.0 108.684 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.43 19.32 74.36 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.935 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -72.59 162.38 74.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.603 1.201 . . . . 0.0 110.34 168.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -71.09 119.27 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.289 1.993 . . . . 0.0 109.571 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -90.45 97.74 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -83.73 151.77 25.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 mm -55.83 122.23 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.21 -62.7 4.24 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 128.96 4.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.762 0.825 . . . . 0.0 108.799 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.79 128.0 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.5 mm -68.21 132.93 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.278 1.431 . . . . 0.0 108.611 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.82 65.77 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.756 1.223 . . . . 0.0 113.855 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.7 mtt -126.79 54.98 1.57 Allowed 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 169.45 12.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -6.99 20.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.325 -1.321 . . . . 0.0 114.08 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.54 -56.4 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 120.03 1.286 . . . . 0.0 110.507 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.61 -45.99 91.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.429 0.559 . . . . 0.0 110.562 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -18.94 48.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.96 -17.67 20.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.962 1.305 . . . . 0.0 111.835 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.71 45.38 53.05 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.955 -1.091 . . . . 0.0 113.869 165.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -133.37 -48.51 0.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.765 0.783 . . . . 0.0 111.436 166.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 mt -74.04 148.15 42.23 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.609 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -139.77 148.5 55.79 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 125.167 1.387 . . . . 0.0 112.327 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.94 92.59 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.816 3.011 . . . . 0.0 112.464 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.87 -13.61 1.51 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.202 1.858 . . . . 0.0 113.029 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.32 154.12 28.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.957 1.379 . . . . 0.0 109.694 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.32 131.78 42.49 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.81 155.83 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.11 0.964 . . . . 0.0 110.453 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.88 -51.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 125.071 1.348 . . . . 0.0 109.332 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.401 ' CE1' ' HB3' ' A' ' 66' ' ' PRO . 96.5 m-85 -132.65 146.72 52.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.8 116.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t0 57.99 25.04 11.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.586 1.555 . . . . 0.0 111.522 -166.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.44 0.77 59.11 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.503 1.049 . . . . 0.0 112.815 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 mm -86.27 127.62 60.63 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 119.798 1.799 . . . . 0.0 106.507 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 23.6 Cg_endo -69.82 128.36 15.86 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.503 2.802 . . . . 0.0 109.257 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -92.16 -3.65 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.708 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 149.11 48.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.203 0.91 . . . . 0.0 108.848 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.25 -28.12 0.33 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.017 1.294 . . . . 0.0 114.57 -172.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -74.71 173.72 10.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.054 1.342 . . . . 0.0 109.434 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -103.92 -177.36 3.35 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.726 1.61 . . . . 0.0 109.47 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.86 -55.01 40.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.254 1.822 . . . . 0.0 110.443 172.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -56.13 -35.27 66.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.382 0.992 . . . . 0.0 112.422 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -47.04 -50.34 19.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.261 0.625 . . . . 0.0 111.165 171.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.59 -35.78 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.453 1.101 . . . . 0.0 110.338 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.37 -27.86 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 119.935 1.243 . . . . 0.0 110.379 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.12 -41.28 74.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.354 -1.466 . . . . 0.0 110.686 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.98 -31.28 72.09 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.894 -1.129 . . . . 0.0 112.229 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.77 -35.02 77.93 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.024 1.33 . . . . 0.0 109.61 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.3 -60.33 3.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.486 0.714 . . . . 0.0 109.944 171.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -56.9 -49.37 75.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.351 1.061 . . . . 0.0 112.379 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.94 79.42 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 111.721 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.22 64.76 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.035 -1.04 . . . . 0.0 112.337 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -81.44 -42.59 20.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 110.428 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.07 -20.2 62.3 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.049 0.939 . . . . 0.0 110.708 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.87 11.61 76.37 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.129 0.871 . . . . 0.0 111.996 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.21 167.85 11.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.953 1.701 . . . . 0.0 107.046 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.29 150.77 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -105.29 126.09 51.71 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.65 99.27 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.4 m -87.49 116.69 25.78 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.86 169.85 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.436 1.095 . . . . 0.0 109.005 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -153.25 167.97 27.54 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.527 -1.358 . . . . 0.0 110.858 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.492 HH11 ' CB ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -150.14 149.11 29.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.164 161.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 122.56 1.171 . . . . 0.0 111.615 161.212 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.0 p90 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 130.45 52.6 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.83 138.18 33.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 162.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.84 134.56 53.57 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.765 2.026 . . . . 0.0 107.251 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -92.08 132.44 36.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.4 t -130.12 108.82 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.588 1.555 . . . . 0.0 106.977 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -86.4 126.89 34.69 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 168.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -117.61 123.14 45.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.187 0.903 . . . . 0.0 109.041 164.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -78.74 161.44 26.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 111.055 172.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 38.8 ttt-85 -139.88 93.62 2.67 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.741 1.216 . . . . 0.0 110.48 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.7 mtp -142.29 -8.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 161.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -131.22 -105.65 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -164.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 m -65.6 -23.45 66.83 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.08 -1.013 . . . . 0.0 112.285 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.44 -179.94 7.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.704 1.138 . . . . 0.0 111.729 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 3.1 m-85 -63.5 123.52 18.98 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.16 -1.2 . . . . 0.0 110.632 -165.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.75 53.42 0.59 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 124.148 0.88 . . . . 0.0 111.133 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.2 167.87 21.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.441 1.121 . . . . 0.0 108.66 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -123.43 162.36 22.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.801 2.04 . . . . 0.0 107.503 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.98 151.73 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.17 2.188 . . . . 0.0 106.99 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -149.03 -177.31 5.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.476 2.31 . . . . 0.0 107.806 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.59 56.0 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.232 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -11.0 59.74 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.906 1.853 . . . . 0.0 112.415 -170.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -132.1 160.34 68.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 127.225 2.21 . . . . 0.0 107.369 168.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.94 69.56 7.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.961 3.774 . . . . 0.0 110.058 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.1 7.12 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.27 1.414 . . . . 0.0 112.599 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.54 160.84 39.88 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.62 1.71 . . . . 0.0 109.76 159.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.86 140.87 51.98 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.669 1.58 . . . . 0.0 109.175 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -105.79 93.2 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.3 149.27 25.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.1 0.476 . . . . 0.0 110.339 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.79 121.33 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 158.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.49 -68.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 124.849 1.214 . . . . 0.0 110.081 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 144.55 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.729 1.612 . . . . 0.0 107.609 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.45 139.84 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 162.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mm -86.15 110.2 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.88 144.56 11.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.893 1.277 . . . . 0.0 111.076 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.0 mmt 47.09 69.99 0.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.105 1.762 . . . . 0.0 110.012 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.01 -179.94 44.97 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 m -57.71 -38.52 75.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.906 1.353 . . . . 0.0 114.64 -165.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 -44.43 50.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.872 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -42.49 65.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.212 1.005 . . . . 0.0 111.654 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -77.33 -21.42 53.43 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.089 -1.007 . . . . 0.0 112.296 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.74 -29.32 40.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.189 0.996 . . . . 0.0 110.524 171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.36 -3.49 4.49 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.11 2.291 . . . . 0.0 114.524 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -90.33 -42.14 11.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.658 1.229 . . . . 0.0 111.695 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -69.28 160.95 30.26 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.989 0.516 . . . . 0.0 109.643 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 155.61 72.4 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.679 1.191 . . . . 0.0 109.221 160.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.0 142.47 51.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.772 1.648 . . . . 0.0 108.838 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.26 -0.94 86.85 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.465 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.55 145.13 55.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.335 1.568 . . . . 0.0 107.433 166.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -93.71 133.57 36.93 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.746 1.157 . . . . 0.0 108.323 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -88.14 153.48 21.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.373 1.469 . . . . 0.0 110.173 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.0 -47.16 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.578 1.551 . . . . 0.0 109.426 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.21 150.31 48.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.879 1.672 . . . . 0.0 108.731 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 64' ' ' GLY . 69.5 t -145.44 118.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 69.85 -31.39 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.099 2.56 . . . . 0.0 112.427 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 157.63 -21.13 0.39 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 128.065 2.745 . . . . 0.0 110.485 171.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 mp -76.82 135.69 67.5 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 127.59 2.356 . . . . 0.0 107.457 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -72.92 151.49 50.72 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.425 2.083 . . . . 0.0 110.057 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.8 m -114.26 -7.77 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.26 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.23 102.83 2.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.68 2.13 30.65 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.855 1.216 . . . . 0.0 113.502 -174.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -98.17 173.23 7.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.875 1.837 . . . . 0.0 109.387 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -89.56 172.45 8.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.319 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -61.57 -46.4 90.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 111.137 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -62.61 -26.94 68.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.106 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -45.86 -48.87 15.87 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.268 1.027 . . . . 0.0 110.516 168.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.62 -36.16 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.442 1.097 . . . . 0.0 109.118 -169.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.14 -45.46 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.186 0.903 . . . . 0.0 109.783 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -70.35 -24.85 63.05 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -74.18 -46.71 40.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.477 0.711 . . . . 0.0 110.54 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 89.6 mmm -62.58 -24.58 67.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.926 1.239 . . . . 0.0 112.199 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.46 -50.82 72.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.934 167.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -50.45 56.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.291 1.836 . . . . 0.0 111.333 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.98 69.86 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.58 0.752 . . . . 0.0 111.264 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.31 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.629 -1.294 . . . . 0.0 112.15 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -69.26 -37.78 78.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.504 1.521 . . . . 0.0 111.187 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -62.78 -12.39 23.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.381 0.537 . . . . 0.0 112.14 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.44 9.68 85.88 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.282 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -170.76 166.38 7.89 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.355 1.862 . . . . 0.0 108.119 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 118.92 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -82.18 100.65 9.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.06 145.73 26.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.2 m -123.44 118.99 28.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 165.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.17 169.5 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 124.097 0.873 . . . . 0.0 108.99 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -151.35 161.04 43.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.868 -1.145 . . . . 0.0 110.183 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.83 134.46 14.53 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.531 169.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 124.915 1.286 . . . . 0.0 111.829 169.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.4 p90 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -112.59 145.22 40.73 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 170.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.16 158.58 21.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 164.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -129.09 138.96 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.433 1.893 . . . . 0.0 106.925 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.13 125.89 46.31 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 108.098 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.17 142.79 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.349 1.06 . . . . 0.0 108.677 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -130.18 125.52 35.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.56 165.07 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.927 0.785 . . . . 0.0 110.643 -174.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -132.99 159.98 38.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.811 0.845 . . . . 0.0 111.333 -174.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -126.03 85.07 2.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.828 1.251 . . . . 0.0 111.04 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.4 ttm -140.4 -17.2 0.91 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.258 0.623 . . . . 0.0 111.487 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -91.93 -128.33 0.1 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -67.23 -7.03 20.88 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.994 -1.066 . . . . 0.0 113.084 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.25 73.5 0.69 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -165.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 74.88 156.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.545 2.338 . . . . 0.0 111.718 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.28 36.62 2.75 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.914 0.768 . . . . 0.0 111.33 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -130.65 166.26 21.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.154 0.977 . . . . 0.0 108.973 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -123.05 164.96 17.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.54 1.936 . . . . 0.0 107.544 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.61 125.7 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -173.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt -132.29 -178.25 4.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.546 1.538 . . . . 0.0 108.312 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.58 -162.96 54.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -168.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.61 18.52 65.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.078 -1.401 . . . . 0.0 114.751 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.18 -60.43 3.34 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.107 1.453 . . . . 0.0 109.002 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.91 161.2 47.88 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 107.98 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.123 3.215 . . . . 0.0 109.422 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 -5.51 12.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.305 1.431 . . . . 0.0 113.382 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -63.43 163.8 17.91 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.429 1.491 . . . . 0.0 111.47 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.25 140.48 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.937 1.758 . . . . 0.0 109.558 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.74 106.61 21.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.88 153.72 18.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 mm -52.42 140.56 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 160.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.65 -124.01 0.83 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.21 116.68 29.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.797 2.039 . . . . 0.0 107.023 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.8 124.42 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.78 103.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.0 152.5 36.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.5 mtm 47.62 43.98 16.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.4 1.88 . . . . 0.0 111.198 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' A' ' 48' ' ' ASP . . . -143.89 178.75 21.74 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 125.677 1.608 . . . . 0.0 111.874 -167.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -70.15 -7.88 45.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -163.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.19 -53.44 3.79 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.332 1.053 . . . . 0.0 110.3 165.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -43.81 -47.35 8.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 112.696 175.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -60.16 -38.13 82.25 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.267 1.427 . . . . 0.0 113.119 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.54 -32.96 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 0.0 110.831 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 31.38 35.4 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.462 160.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -131.85 -45.64 0.95 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.006 1.403 . . . . 0.0 112.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.93 144.98 52.01 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.682 -0.636 . . . . 0.0 110.222 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -132.27 158.97 74.18 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 124.778 1.231 . . . . 0.0 108.656 161.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 145.85 85.23 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.221 1.947 . . . . 0.0 110.098 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.16 6.5 79.86 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.398 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -69.73 126.35 29.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.094 1.947 . . . . 0.0 107.569 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.8 124.74 26.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.534 0.607 . . . . 0.0 109.402 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.51 150.73 31.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.759 0.823 . . . . 0.0 109.906 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.81 -46.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.225 1.81 . . . . 0.0 109.108 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.17 145.85 51.75 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.177 0.991 . . . . 0.0 110.249 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.7 t -139.2 129.39 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.829 1.652 . . . . 0.0 107.11 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.11 18.06 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.763 2.425 . . . . 0.0 113.225 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -11.38 62.78 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.385 2.421 . . . . 0.0 112.836 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.31 132.88 34.38 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.866 1.666 . . . . 0.0 108.62 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -70.99 116.83 4.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.863 2.375 . . . . 0.0 109.59 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.92 -7.37 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.388 0.675 . . . . 0.0 111.625 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 114.46 2.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.197 1.399 . . . . 0.0 111.032 -171.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -14.9 56.11 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.428 1.49 . . . . 0.0 113.02 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 170.48 9.43 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.747 1.219 . . . . 0.0 110.634 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.1 p -85.72 171.67 11.43 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.63 0.772 . . . . 0.0 111.024 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -46.82 -54.28 10.18 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.81 1.644 . . . . 0.0 108.831 165.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 ttp-105 -55.62 -37.76 68.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.02 -44.04 74.25 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.495 0.589 . . . . 0.0 109.918 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.15 -41.35 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.917 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.56 -44.43 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.234 0.925 . . . . 0.0 110.451 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -45.36 95.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.901 1.28 . . . . 0.0 110.189 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.56 -45.84 71.05 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.713 0.688 . . . . 0.0 111.412 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.6 mmm -52.73 -36.52 57.78 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 0.0 110.275 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -18.67 60.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.241 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -85.11 -49.06 8.57 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.02 1.728 . . . . 0.0 109.216 172.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.39 40.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.447 1.099 . . . . 0.0 109.473 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.52 -36.45 23.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.483 1.113 . . . . 0.0 113.105 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 81' ' ' HIS . 2.0 mpt_? -68.36 -39.64 81.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -71.49 -13.83 61.93 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.784 1.234 . . . . 0.0 112.759 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.41 4.54 90.01 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 119.404 1.002 . . . . 0.0 113.876 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 6.1 pt20 -142.96 178.59 7.57 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.433 1.493 . . . . 0.0 109.246 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.09 128.58 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 162.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.18 139.92 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mt -139.78 125.59 19.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.532 1.969 . . . . 0.0 107.374 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.13 115.11 25.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.6 m -99.5 167.99 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -144.81 152.79 40.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 120.523 -1.36 . . . . 0.0 108.857 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -151.5 143.39 23.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.087 1.355 . . . . 0.0 109.633 173.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.513 0 C-N-CA 124.512 1.125 . . . . 0.0 110.263 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' CE2' ' HD2' ' A' ' 93' ' ' ARG . 36.0 p90 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.026 0.441 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 137.43 53.17 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.489 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -83.09 151.5 25.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.98 155.21 50.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.55 123.62 28.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.885 1.274 . . . . 0.0 108.538 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.91 151.01 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.734 2.014 . . . . 0.0 106.225 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -128.26 120.89 28.06 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.546 1.539 . . . . 0.0 108.615 166.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.85 123.51 44.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.05 20.52 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.902 0.319 . . . . 0.0 110.147 166.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.6 ttt180 -119.69 93.79 4.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.138 2.175 . . . . 0.0 105.718 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.29 -13.78 7.11 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.046 0.538 . . . . 0.0 110.69 170.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.86 -112.45 0.19 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -65.2 -18.69 65.51 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.96 -173.65 53.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.101 0.834 . . . . 0.0 112.39 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 4.1 m-85 -71.82 111.14 6.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.433 0.693 . . . . 0.0 110.11 -164.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.26 46.47 3.64 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.419 1.009 . . . . 0.0 114.241 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -135.1 163.39 30.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.222 1.511 . . . . 0.0 110.368 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -120.27 157.29 29.47 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.294 1.838 . . . . 0.0 107.876 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.62 135.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.93 -178.85 6.02 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.213 1.405 . . . . 0.0 107.463 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.71 -154.35 46.93 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.34 34.25 40.89 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.281 0.943 . . . . 0.0 112.402 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 -46.44 43.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -167.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.09 157.96 32.71 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.423 1.089 . . . . 0.0 108.537 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.69 96.04 0.82 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.723 2.949 . . . . 0.0 108.129 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.13 -24.56 2.06 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.942 1.734 . . . . 0.0 111.44 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -73.73 150.71 88.77 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 119.399 1.599 . . . . 0.0 112.753 -171.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.38 149.55 69.45 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.588 2.858 . . . . 0.0 109.377 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -113.45 88.72 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -93.3 125.98 38.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.9 mm -43.83 120.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.484 1.913 . . . . 0.0 106.87 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.96 -56.68 23.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 124.925 1.25 . . . . 0.0 111.709 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.58 153.48 31.48 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.1 t -112.96 112.79 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 118.89 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.981 1.712 . . . . 0.0 108.368 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.53 124.55 12.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.113 0.965 . . . . 0.0 110.536 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . 0.252 20.4 ptp 46.81 20.39 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.701 2.4 . . . . 0.0 115.283 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.74 -173.19 42.72 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -58.84 -39.06 80.13 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.217 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.07 -28.59 60.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 121.679 2.036 . . . . 0.0 111.973 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.56 -47.62 69.31 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.052 0.941 . . . . 0.0 109.241 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -60.51 -40.21 90.62 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.497 0.719 . . . . 0.0 111.177 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.16 -23.5 67.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.388 1.475 . . . . 0.0 111.929 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.82 72.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.214 1.388 . . . . 0.0 113.121 167.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -122.72 -13.2 7.97 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.147 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -119.99 151.3 39.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.907 1.23 . . . . 0.0 107.885 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -132.35 149.21 72.51 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.671 164.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.44 134.92 40.47 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.678 1.585 . . . . 0.0 108.203 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.17 1.05 76.27 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.243 -1.309 . . . . 0.0 113.961 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.12 140.68 58.82 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.563 2.181 . . . . 0.0 107.354 161.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -85.96 128.24 34.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.549 1.522 . . . . 0.0 108.767 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.26 158.0 36.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.887 0.767 . . . . 0.0 110.175 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.86 -53.29 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.499 1.919 . . . . 0.0 107.708 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -132.59 148.46 52.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.845 1.258 . . . . 0.0 108.894 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 64' ' ' GLY . 53.1 t -137.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 63.43 -2.48 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.431 2.293 . . . . 0.0 112.222 -169.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 108.93 -3.3 31.8 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 127.361 2.41 . . . . 0.0 112.096 -172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.3 125.31 50.55 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.73 127.02 14.01 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.136 2.557 . . . . 0.0 108.555 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.03 -2.94 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.836 0.854 . . . . 0.0 110.565 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.24 120.29 14.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.901 0.88 . . . . 0.0 110.687 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.89 -12.24 37.16 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.777 1.18 . . . . 0.0 112.75 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.42 177.35 8.57 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.08 1.352 . . . . 0.0 107.814 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -105.3 175.33 5.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.622 0.769 . . . . 0.0 110.431 -172.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -52.05 -48.61 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.781 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -55.37 -35.09 64.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.38 -50.3 62.71 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.43 -40.49 82.31 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 124.035 0.934 . . . . 0.0 110.909 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mm -50.66 -42.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.586 1.084 . . . . 0.0 111.231 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -39.2 70.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.705 0.402 . . . . 0.0 110.57 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -50.18 73.65 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 122.917 0.487 . . . . 0.0 110.616 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.31 -40.14 85.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.317 0.508 . . . . 0.0 110.944 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -32.35 73.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.41 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -70.73 -57.46 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.523 1.529 . . . . 0.0 111.133 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.42 69.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.103 0.961 . . . . 0.0 111.303 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.09 72.35 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.582 -1.324 . . . . 0.0 111.09 169.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -73.73 -35.92 65.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 117.389 -1.291 . . . . 0.0 111.704 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -56.52 -25.82 52.75 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.082 0.855 . . . . 0.0 110.031 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.44 9.2 86.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 123.936 0.779 . . . . 0.0 111.571 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -160.28 165.62 31.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.037 1.419 . . . . 0.0 109.279 170.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.33 127.32 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.17 139.13 35.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 160.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.71 105.66 6.57 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.8 m -91.04 121.19 32.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.01 170.17 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 8' ' ' TYR . 31.2 ptt180 -150.83 166.24 31.12 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.307 -1.496 . . . . 0.0 108.818 167.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -155.12 146.76 23.2 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? . . . . . 0 C--O 1.239 0.552 0 C-N-CA 124.871 1.269 . . . . 0.0 111.17 168.054 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -128.91 129.46 45.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.79 146.13 28.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.4 116.66 21.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.84 130.57 34.92 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.7 130.41 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.507 1.523 . . . . 0.0 107.29 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -126.46 122.12 34.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -169.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.63 123.38 43.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -75.04 158.28 33.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.384 0.612 . . . . 0.0 109.645 169.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.7 ttt85 -125.48 88.28 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 168.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 ptm -142.33 -12.81 0.81 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 173.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -132.83 -71.99 0.52 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.639 1.576 . . . . 0.0 107.657 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -119.34 0.06 11.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.35 -156.97 52.57 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.702 1.137 . . . . 0.0 112.452 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.8 m-85 -108.94 105.16 14.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.75 0.82 . . . . 0.0 110.158 -169.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.95 41.83 3.11 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.307 1.908 . . . . 0.0 114.296 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.32 150.54 52.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.632 1.716 . . . . 0.0 110.166 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.06 160.21 14.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.739 1.616 . . . . 0.0 108.952 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.79 138.34 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.76 163.12 38.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.205 2.202 . . . . 0.0 106.0 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.62 176.09 42.06 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.11 90.07 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 -149.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.8 -26.41 65.18 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.658 0.783 . . . . 0.0 110.437 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.64 160.53 46.04 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.95 53.01 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.688 3.592 . . . . 0.0 109.651 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.73 58.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -136.27 161.65 61.04 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 111.569 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -73.31 132.31 17.64 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.955 2.437 . . . . 0.0 109.409 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.65 108.1 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -100.01 149.66 23.23 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 mm -49.55 118.28 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.6 -72.81 0.84 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -171.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.1 117.15 4.83 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.861 0.865 . . . . 0.0 109.024 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.267 0.6 OUTLIER -80.0 149.26 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 121.308 0.575 . . . . 0.0 109.451 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -80.82 107.59 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -54.22 146.36 15.4 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 mmt 64.0 -10.86 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.236 1.814 . . . . 0.0 112.72 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -73.88 169.39 53.68 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -60.78 -23.03 64.7 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.13 -45.19 42.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.782 1.628 . . . . 0.0 110.96 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.13 -51.45 69.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -64.24 -34.53 78.32 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.489 -0.757 . . . . 0.0 112.237 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.76 -29.59 70.23 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.287 0.948 . . . . 0.0 110.792 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.39 28.32 52.89 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.816 161.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -136.78 -18.5 1.39 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.432 1.116 . . . . 0.0 113.343 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -90.01 148.25 23.18 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -135.32 157.04 77.47 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 125.062 1.345 . . . . 0.0 107.643 157.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.8 149.71 86.53 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.443 1.429 . . . . 0.0 108.881 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.63 -2.63 72.18 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.623 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.6 136.82 56.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.934 1.867 . . . . 0.0 107.276 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -85.37 127.36 34.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.766 1.166 . . . . 0.0 109.581 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.09 153.58 30.05 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.228 1.011 . . . . 0.0 110.224 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.5 -46.51 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 126.165 1.786 . . . . 0.0 109.055 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.4 148.42 42.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.403 1.081 . . . . 0.0 110.553 -176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.0 t -145.49 131.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 107.849 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 61.29 14.01 5.32 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.205 1.402 . . . . 0.0 111.333 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.08 -5.73 75.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 127.112 2.292 . . . . 0.0 113.444 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -104.36 133.99 19.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 121.069 2.434 . . . . 0.0 109.381 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.61 120.92 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.313 2.675 . . . . 0.0 110.786 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.62 -2.27 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.754 1.222 . . . . 0.0 112.62 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.62 125.12 22.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.357 1.063 . . . . 0.0 110.274 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.47 -7.12 9.07 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.367 0.984 . . . . 0.0 114.535 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.593 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 14.6 mmtt -82.88 174.29 11.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.412 1.485 . . . . 0.0 108.778 167.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.8 p -111.82 175.48 5.41 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.616 0.766 . . . . 0.0 110.696 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -38.69 -62.89 0.56 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.044 1.338 . . . . 0.0 110.586 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 ttp-105 -56.42 -34.09 66.43 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.593 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 76.0 t80 -58.12 -44.43 87.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.315 0.578 . . . . 0.0 110.978 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.97 -31.75 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.232 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.92 -41.48 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.265 -1.522 . . . . 0.0 111.272 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.88 -52.04 67.13 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.511 1.524 . . . . 0.0 109.042 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -51.3 69.78 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.277 0.631 . . . . 0.0 111.141 -175.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.2 mmm -61.98 -21.67 65.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 112.497 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 -32.59 53.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.723 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -66.27 -47.39 73.84 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.318 0.963 . . . . 0.0 110.126 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.05 70.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.41 73.99 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.9 -1.75 . . . . 0.0 112.887 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -68.68 -49.88 55.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.29 -20.6 7.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.432 1.493 . . . . 0.0 112.213 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.15 71.27 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.338 1.923 . . . . 0.0 111.329 170.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -177.47 170.56 2.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.441 2.296 . . . . 0.0 107.223 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.11 149.92 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.31 137.22 45.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.44 106.83 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -97.09 111.41 23.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.61 173.45 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -151.36 164.87 35.71 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.741 -1.225 . . . . 0.0 109.514 170.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.2 146.76 25.02 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.959 1.304 . . . . 0.0 108.322 164.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 C-N-CA 124.665 1.186 . . . . 0.0 110.632 170.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 135.37 52.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -84.28 145.14 28.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.71 116.83 21.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -102.56 111.09 23.24 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 107.766 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.95 150.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.369 1.868 . . . . 0.0 107.356 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -128.53 119.71 25.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.875 1.67 . . . . 0.0 111.59 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.7 mt -116.55 123.01 46.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -72.72 146.55 46.37 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 165.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.83 101.25 13.17 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 152.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.1 ptm -133.98 -9.75 2.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.057 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -138.04 -98.43 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.7 p -66.75 -20.41 65.95 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -162.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.78 73.62 0.66 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 54.74 93.7 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.187 2.595 . . . . 0.0 113.512 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.94 55.7 4.53 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.564 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -129.31 175.16 8.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.932 1.293 . . . . 0.0 108.311 167.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -137.74 153.54 49.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.011 1.324 . . . . 0.0 107.573 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.42 140.02 47.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.98 160.77 43.0 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.829 2.052 . . . . 0.0 105.662 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 -178.86 52.34 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.06 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.68 48.72 79.22 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 -143.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.98 -37.87 88.98 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.86 161.5 55.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.667 1.987 . . . . 0.0 108.904 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.39 53.98 4.95 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 125.208 3.938 . . . . 0.0 112.288 -163.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.57 0.95 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.552 2.025 . . . . 0.0 112.077 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -75.12 163.94 64.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.042 1.921 . . . . 0.0 111.398 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -74.5 143.49 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.025 2.483 . . . . 0.0 110.13 171.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.42 104.85 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -98.32 155.27 17.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -55.67 118.79 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 161.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.87 -56.35 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.24 155.3 42.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.292 1.037 . . . . 0.0 109.257 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 149.28 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 C-N-CA 127.425 2.29 . . . . 0.0 107.224 166.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.68 108.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.7 138.68 10.57 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.496 1.118 . . . . 0.0 110.146 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.8 mmt 59.8 0.95 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.043 2.137 . . . . 0.0 113.856 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.76 -175.99 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.783 1.659 . . . . 0.0 110.845 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -54.37 -35.85 63.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -164.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.85 -51.81 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.011 0.823 . . . . 0.0 110.438 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.55 -45.88 88.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.419 0.688 . . . . 0.0 110.687 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -60.21 -31.34 70.07 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.728 0.811 . . . . 0.0 113.028 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.85 -21.43 64.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.081 0.401 . . . . 0.0 111.728 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.58 45.99 86.78 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.446 1.022 . . . . 0.0 112.875 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -143.53 -47.63 0.29 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.379 1.471 . . . . 0.0 112.173 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.7 153.64 41.08 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.662 0.664 . . . . 0.0 109.489 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -142.36 155.63 64.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.211 1.004 . . . . 0.0 110.436 162.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -57.36 134.87 66.53 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.644 2.229 . . . . 0.0 108.957 167.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.4 7.09 69.98 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.44 0.543 . . . . 0.0 113.694 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -77.71 123.12 26.27 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 171.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 123.78 24.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.42 149.87 35.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.921 0.888 . . . . 0.0 109.253 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.11 -52.12 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -134.09 147.44 50.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.381 1.072 . . . . 0.0 109.464 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.8 t -145.51 123.32 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -171.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.14 -56.38 0.23 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.398 2.279 . . . . 0.0 109.107 -160.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.37 -7.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.694 2.093 . . . . 0.0 110.847 164.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mp -73.48 139.05 77.83 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 127.242 2.217 . . . . 0.0 107.442 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.57 127.76 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.099 2.532 . . . . 0.0 112.704 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.73 -9.14 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.711 0.804 . . . . 0.0 113.103 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.41 129.86 43.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.926 0.891 . . . . 0.0 110.525 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.49 -12.7 2.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.427 1.013 . . . . 0.0 115.456 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 69.0 mmtt -75.34 179.03 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.712 . . . . 0.0 108.134 169.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.5 p -115.52 171.34 7.79 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.768 -0.582 . . . . 0.0 110.043 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -34.58 -60.21 0.44 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.538 1.935 . . . . 0.0 112.142 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -53.33 -37.41 62.29 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.946 1.298 . . . . 0.0 113.111 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.466 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 49.6 t80 -52.14 -45.45 65.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.992 0.917 . . . . 0.0 110.01 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.82 -37.92 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 124.785 1.234 . . . . 0.0 110.188 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.22 -35.27 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 121.539 -0.725 . . . . 0.0 110.104 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.69 -39.85 95.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.676 0.79 . . . . 0.0 111.331 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.39 -37.4 68.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.106 0.962 . . . . 0.0 111.033 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -38.92 78.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.056 0.942 . . . . 0.0 109.604 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -43.8 97.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.682 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -46.9 72.02 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.303 0.956 . . . . 0.0 110.555 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.79 -34.61 69.8 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.156 0.582 . . . . 0.0 111.802 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.26 82.77 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.604 -0.685 . . . . 0.0 111.301 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.63 -41.34 65.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.332 1.053 . . . . 0.0 110.123 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -55.66 -24.27 32.96 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.554 1.541 . . . . 0.0 112.389 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.95 63.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.156 1.836 . . . . 0.0 113.039 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -171.51 160.74 6.04 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.365 1.583 . . . . 0.0 109.048 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.29 121.88 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.284 1.04 . . . . 0.0 109.253 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -80.42 132.51 35.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 162.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.3 mt -127.65 106.06 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 m -94.98 111.63 23.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -99.33 171.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -150.75 161.42 42.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 120.203 -1.561 . . . . 0.0 110.136 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.25 136.54 20.02 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.844 0.831 . . . . 0.0 111.049 165.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 C-N-CA 128.558 2.743 . . . . 0.0 111.843 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 p90 . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 122.405 1.098 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -132.83 130.15 39.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.7 120.95 26.63 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 116.82 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.66 129.88 34.98 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.932 2.093 . . . . 0.0 109.07 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.14 148.84 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.509 1.523 . . . . 0.0 107.107 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -130.72 133.98 46.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 167.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.57 129.36 50.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 124.011 0.819 . . . . 0.0 110.482 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.35 163.19 24.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.899 0.857 . . . . 0.0 110.136 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -114.92 102.38 9.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 164.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.557 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 8.9 ptp -146.62 -62.4 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 18' ' ' MET . 1.8 tm-20 -66.46 -171.55 0.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.004 1.721 . . . . 0.0 108.998 151.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -64.87 11.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.073 2.949 . . . . 0.0 117.006 -152.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 78.66 0.83 Allowed Glycine 0 N--CA 1.45 -0.401 0 O-C-N 121.155 -0.966 . . . . 0.0 112.343 160.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.04 81.71 0.13 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.985 2.114 . . . . 0.0 111.907 171.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.59 58.99 3.77 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.017 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.75 167.52 20.39 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.902 1.351 . . . . 0.0 109.808 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -118.64 163.98 16.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.008 2.123 . . . . 0.0 106.85 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 128.71 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.517 1.927 . . . . 0.0 106.319 -175.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.8 161.77 35.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.625 0.726 . . . . 0.0 110.149 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.94 -160.24 34.75 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 28.58 60.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -150.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.28 -30.81 62.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.054 0.542 . . . . 0.0 110.318 -162.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -104.05 161.51 22.71 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.911 2.085 . . . . 0.0 107.948 163.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.69 100.43 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.849 3.033 . . . . 0.0 108.809 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.75 6.51 7.16 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.241 1.401 . . . . 0.0 114.18 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -82.82 157.13 67.17 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 119.339 1.57 . . . . 0.0 110.862 172.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.72 138.89 39.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.49 2.127 . . . . 0.0 110.514 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.9 mt -102.56 95.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.05 145.67 25.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.81 117.03 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.74 -52.65 47.04 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 125.289 1.423 . . . . 0.0 111.471 -168.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.19 156.64 22.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.232 3.013 . . . . 0.0 105.137 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.7 130.48 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 169.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.64 117.12 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.16 -31.02 63.0 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.0 mmt -127.72 33.5 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.31 170.58 17.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -62.03 -12.94 21.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.22 -51.26 13.75 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.165 1.348 . . . . 0.0 109.668 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.07 -45.87 86.39 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -54.67 -46.73 74.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.304 0.502 . . . . 0.0 112.007 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.28 -30.51 71.38 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.8 0.273 . . . . 0.0 111.196 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.47 -37.69 3.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 127.437 2.446 . . . . 0.0 112.436 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -65.37 -21.88 66.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.548 1.139 . . . . 0.0 113.774 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.5 132.89 33.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -125.87 157.19 69.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 124.442 1.097 . . . . 0.0 109.309 160.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.28 148.45 74.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.431 1.421 . . . . 0.0 109.45 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.43 -7.19 79.95 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.529 -1.15 . . . . 0.0 112.562 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.04 128.97 37.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.497 1.648 . . . . 0.0 106.798 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.55 125.02 30.67 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 120.81 -1.181 . . . . 0.0 109.12 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.13 145.51 37.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.405 1.082 . . . . 0.0 109.773 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -120.13 -54.21 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.081 2.152 . . . . 0.0 108.245 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -128.57 146.03 50.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.128 1.371 . . . . 0.0 108.97 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -140.04 121.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t0 53.7 16.22 0.95 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.163 1.785 . . . . 0.0 111.963 -168.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.99 69.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 127.455 2.455 . . . . 0.0 114.199 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.12 125.9 71.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 120.834 2.317 . . . . 0.0 106.269 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.14 117.3 5.03 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.055 2.503 . . . . 0.0 108.466 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -79.1 -6.33 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.723 0.809 . . . . 0.0 111.669 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 121.35 16.86 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.146 0.578 . . . . 0.0 110.373 -171.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.41 -9.39 75.66 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.902 1.239 . . . . 0.0 112.978 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 66.5 mmtt -74.93 -164.34 0.29 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.282 1.433 . . . . 0.0 108.13 166.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -120.86 170.02 9.88 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.685 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -38.46 -61.44 0.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.956 1.702 . . . . 0.0 109.414 165.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -42.99 -46.22 5.38 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 128.46 2.704 . . . . 0.0 112.645 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.411 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 42.3 t80 -58.83 -40.91 85.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 111.118 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -75.44 -32.23 25.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.372 -0.83 . . . . 0.0 109.225 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -60.35 -40.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.763 1.165 . . . . 0.0 109.763 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.15 -45.69 92.21 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 110.269 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -48.96 78.52 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.644 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.8 mmm -60.11 -33.36 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.239 0.927 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -61.92 -45.3 94.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.208 0.603 . . . . 0.0 110.044 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -58.96 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.224 1.41 . . . . 0.0 111.355 175.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.65 73.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.192 1.397 . . . . 0.0 110.581 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.74 63.76 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.961 -1.087 . . . . 0.0 111.003 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -70.43 -41.78 72.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.79 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.01 -10.31 9.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.981 2.113 . . . . 0.0 113.365 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.76 1.5 83.91 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.012 1.291 . . . . 0.0 113.269 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -159.71 -178.59 7.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.979 2.112 . . . . 0.0 108.043 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.58 131.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.77 1.628 . . . . 0.0 106.752 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.69 141.89 34.44 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 162.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -135.8 122.81 21.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -115.7 113.18 23.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.24 168.71 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.92 148.91 29.68 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 119.678 -1.889 . . . . 0.0 110.208 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -147.2 123.99 11.23 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.461 1.504 . . . . 0.0 111.373 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.9 p90 . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.712 0.292 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -122.53 141.96 51.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.3 159.53 21.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 166.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.54 146.82 40.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.374 1.47 . . . . 0.0 107.39 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.42 139.01 38.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.281 1.833 . . . . 0.0 109.322 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.2 t -137.52 107.42 4.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -100.66 139.3 36.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.9 mt -134.83 149.99 50.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.767 0.827 . . . . 0.0 109.976 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -97.84 151.26 20.4 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 109.447 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 60.6 ttt-85 -125.92 76.89 1.63 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 0.0 108.835 177.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -143.61 13.48 1.74 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.232 0.613 . . . . 0.0 111.151 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -147.82 -121.58 0.06 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.362 1.865 . . . . 0.0 106.935 -175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -31.13 71.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.078 -1.639 . . . . 0.0 111.826 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.23 -177.28 39.73 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.86 155.29 40.78 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.9 0.88 . . . . 0.0 110.393 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.72 63.23 0.47 Allowed Glycine 0 C--N 1.337 0.639 0 C-N-CA 124.294 0.95 . . . . 0.0 111.902 -170.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -128.79 170.36 13.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.882 1.273 . . . . 0.0 109.098 172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -122.16 163.36 19.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 156.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.26 133.63 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.1 mt -142.85 121.73 12.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.52 179.51 15.76 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.21 29.93 76.53 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -167.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -66.47 -20.45 66.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.573 0.687 . . . . 0.0 110.166 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.57 155.32 80.44 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.914 1.686 . . . . 0.0 110.103 165.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.43 81.88 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.094 3.863 . . . . 0.0 115.165 -165.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.92 -12.75 1.92 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 124.974 1.273 . . . . 0.0 112.033 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -66.82 157.14 85.08 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 117.55 0.675 . . . . 0.0 110.529 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.69 113.04 3.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.733 2.289 . . . . 0.0 111.777 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.56 105.16 6.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 mt -93.43 158.48 15.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.421 1.088 . . . . 0.0 109.704 166.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.43 126.04 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 154.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.91 -77.88 0.18 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.35 144.9 29.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.636 1.175 . . . . 0.0 108.602 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 1.2 m -98.79 140.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 123.88 0.872 . . . . 0.0 110.14 169.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.83 111.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.64 -39.83 68.38 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.256 0.551 . . . . 0.0 112.053 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.6 mmt -106.12 44.42 1.05 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.002 0.921 . . . . 0.0 109.053 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.85 165.09 27.73 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.8 1.667 . . . . 0.0 109.643 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -69.11 -10.32 57.07 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 115.653 1.724 . . . . 0.0 115.653 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.05 56.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.092 1.315 . . . . 0.0 109.348 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.89 -43.5 92.71 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.141 0.9 . . . . 0.0 110.058 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -55.82 -43.04 76.57 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.242 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.33 -18.48 63.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.621 1.1 . . . . 0.0 112.643 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.26 54.64 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.448 1.023 . . . . 0.0 113.078 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -134.5 -38.46 0.83 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -74.16 170.16 16.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.777 1.171 . . . . 0.0 109.418 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.08 152.22 42.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.15 0.98 . . . . 0.0 109.445 156.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.94 120.08 6.79 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.11 2.54 . . . . 0.0 108.585 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.62 6.2 54.91 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.378 -1.235 . . . . 0.0 112.951 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.67 142.41 58.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.654 1.727 . . . . 0.0 108.383 159.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -86.72 125.8 34.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.312 1.045 . . . . 0.0 109.466 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.75 156.43 27.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.038 1.335 . . . . 0.0 110.809 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.39 -54.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.583 1.953 . . . . 0.0 111.693 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.61 143.87 49.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.508 1.523 . . . . 0.0 110.777 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 64' ' ' GLY . 41.3 t -133.46 111.99 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 72.32 -38.02 0.41 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.102 2.961 . . . . 0.0 111.25 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 164.32 -3.55 0.06 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 130.617 3.961 . . . . 0.0 109.797 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 125.87 38.41 Favored Pre-proline 0 N--CA 1.439 -1.023 0 O-C-N 120.562 -1.552 . . . . 0.0 107.058 -168.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.19 141.03 67.48 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.903 1.735 . . . . 0.0 109.662 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -90.15 -9.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.234 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.72 117.87 5.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.152 0.981 . . . . 0.0 110.12 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.04 83.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.849 0.738 . . . . 0.0 114.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 74' ' ' TYR . 26.3 mmmt -87.01 -171.83 3.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.304 1.441 . . . . 0.0 107.495 167.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -130.58 -179.55 5.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.168 0.987 . . . . 0.0 109.893 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -53.82 -57.44 10.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.661 0.784 . . . . 0.0 111.057 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.75 70.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.276 0.944 . . . . 0.0 112.879 -171.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 58.2 t80 -46.78 -59.67 2.9 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.038 0.935 . . . . 0.0 109.819 167.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.97 -36.61 76.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 123.37 0.668 . . . . 0.0 109.286 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.35 -32.63 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.652 -1.28 . . . . 0.0 111.507 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.84 -33.86 66.43 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.156 -1.59 . . . . 0.0 110.904 168.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.81 66.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.108 0.963 . . . . 0.0 111.357 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 62.3 mmm -58.58 -36.81 74.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.57 1.148 . . . . 0.0 111.279 166.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -73.04 -45.74 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.11 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -51.14 -55.55 17.24 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 125.257 1.423 . . . . 0.0 110.962 170.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.75 89.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.776 0.831 . . . . 0.0 111.058 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.0 -14.64 60.91 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.464 -1.397 . . . . 0.0 113.058 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -85.7 -36.67 20.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.83 1.195 . . . . 0.0 111.068 165.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -62.67 -15.85 54.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.85 21.03 79.18 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.935 1.731 . . . . 0.0 112.546 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -164.78 177.05 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.755 2.022 . . . . 0.0 106.811 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 p -154.58 160.16 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -141.76 91.09 2.33 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.68 0.792 . . . . 0.0 108.907 -170.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.24 99.5 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.49 1.516 . . . . 0.0 107.815 -170.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -87.9 131.35 34.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.4 167.7 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.411 1.884 . . . . 0.0 108.211 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -152.39 151.85 31.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 121.031 -1.043 . . . . 0.0 110.292 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -145.02 134.82 23.56 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.478 0.711 . . . . 0.0 109.116 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 C-N-CA 126.39 1.876 . . . . 0.0 111.112 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.717 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t 58.08 26.57 13.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.025 0.93 . . . . 0.0 112.187 -169.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 p -119.56 -25.7 5.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.445 1.098 . . . . 0.0 112.157 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.66 105.46 2.68 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -50.7 49.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.152 0.981 . . . . 0.0 111.037 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -147.66 132.51 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.76 -61.92 0.02 OUTLIER Glycine 0 C--O 1.224 -0.475 0 CA-C-O 118.14 -1.366 . . . . 0.0 110.837 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -125.27 155.71 39.73 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 120.509 2.155 . . . . 0.0 111.063 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -116.0 139.91 49.79 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.9 152.31 24.61 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 164.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.38 127.84 34.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.18 149.53 27.87 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -139.24 107.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -76.07 143.43 41.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.12 131.24 32.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -82.19 153.63 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -108.25 87.35 2.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtm -143.88 -3.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.66 -64.14 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -126.29 -14.28 5.95 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.47 60.7 3.93 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 119.728 1.149 . . . . 0.0 112.382 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 85.5 93.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.608 2.363 . . . . 0.0 110.568 160.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.72 53.76 4.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.677 0.656 . . . . 0.0 112.325 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -130.44 173.51 10.77 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.373 1.086 . . . . 0.0 109.039 169.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -140.37 165.61 26.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.5 128.66 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -164.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -139.62 -177.13 4.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.526 1.93 . . . . 0.0 108.053 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.43 -146.67 36.2 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.57 31.97 52.94 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.186 0.993 . . . . 0.0 112.652 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.96 -30.92 56.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.083 -0.657 . . . . 0.0 112.145 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -114.85 158.9 39.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.73 91.09 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.245 2.63 . . . . 0.0 109.638 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.3 1.84 10.11 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.14 1.353 . . . . 0.0 114.17 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.5 159.88 56.34 Favored Pre-proline 0 C--O 1.239 0.54 0 CA-C-N 119.428 1.614 . . . . 0.0 109.237 163.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.82 145.35 56.51 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.654 2.236 . . . . 0.0 111.224 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.53 92.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -100.69 140.73 34.56 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.653 3.581 . . . . 0.0 109.543 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.81 109.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.653 1.581 . . . . 0.0 107.672 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.76 -46.55 31.16 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 127.661 2.553 . . . . 0.0 112.569 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 163.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.545 1.538 . . . . 0.0 107.424 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.59 131.9 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 161.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.11 107.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.34 132.01 47.03 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.753 0.658 . . . . 0.0 109.853 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.1 mtm 68.49 -5.94 0.88 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.537 1.935 . . . . 0.0 114.19 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.64 176.81 53.5 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.192 0.884 . . . . 0.0 111.811 -171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.1 t -60.48 -8.84 3.01 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.217 1.807 . . . . 0.0 115.018 -167.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.78 -46.62 6.19 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 120.137 1.335 . . . . 0.0 111.609 168.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -56.4 -40.1 74.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.477 1.511 . . . . 0.0 110.306 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -69.89 -22.0 63.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -22.57 55.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.174 0.897 . . . . 0.0 110.129 170.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.8 60.3 8.94 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 125.643 1.592 . . . . 0.0 110.79 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -146.68 2.29 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -135.56 151.0 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -129.22 149.87 73.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 125.097 1.359 . . . . 0.0 109.053 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.81 130.58 34.74 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.556 2.838 . . . . 0.0 111.317 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.62 88.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.066 -1.408 . . . . 0.0 113.671 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 127.81 33.64 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.172 1.486 . . . . 0.0 107.761 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 119.28 18.06 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.83 164.4 10.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.878 1.671 . . . . 0.0 111.001 173.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.2 -52.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.203 1.401 . . . . 0.0 109.673 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.34 148.19 52.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.005 0.922 . . . . 0.0 108.553 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -137.0 113.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.58 5.23 0.44 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.876 2.47 . . . . 0.0 114.198 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.46 -5.94 6.67 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.947 2.689 . . . . 0.0 113.094 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.0 124.6 34.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 119.483 1.642 . . . . 0.0 107.747 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.65 114.71 4.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.42 3.413 . . . . 0.0 109.179 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.72 -7.46 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.75 1.22 . . . . 0.0 112.789 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.24 129.85 40.47 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.579 -0.701 . . . . 0.0 110.313 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.01 84.06 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.991 -0.443 . . . . 0.0 113.374 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -101.22 -166.95 1.36 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.604 1.561 . . . . 0.0 108.195 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -121.56 177.75 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.075 0.95 . . . . 0.0 110.892 -170.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -52.19 -56.27 15.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.616 0.766 . . . . 0.0 109.759 169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -55.69 -33.41 64.12 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.79 -50.93 62.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.816 0.846 . . . . 0.0 110.357 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.55 -38.19 78.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 124.947 1.299 . . . . 0.0 111.16 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.0 mm -56.53 -39.46 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.868 0.758 . . . . 0.0 109.224 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -37.77 85.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.944 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.37 -49.69 74.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.234 0.613 . . . . 0.0 111.047 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.46 -36.77 74.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 111.133 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.31 -14.51 56.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.263 1.025 . . . . 0.0 113.105 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.27 -49.29 5.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.15 1.38 . . . . 0.0 110.825 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.76 -41.33 73.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.126 0.97 . . . . 0.0 110.63 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.0 -22.02 65.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.311 -1.493 . . . . 0.0 113.152 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.62 -43.52 20.37 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.535 1.134 . . . . 0.0 109.517 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -54.91 -23.64 19.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.329 0.652 . . . . 0.0 110.975 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.73 13.76 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.475 1.036 . . . . 0.0 111.956 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.15 174.68 12.6 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.231 2.212 . . . . 0.0 106.751 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.47 164.68 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -129.21 133.01 47.36 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 166.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.1 mt -130.61 97.48 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.119 2.168 . . . . 0.0 105.386 -169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.1 m -85.49 117.07 24.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.19 170.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 108.743 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -152.9 145.89 24.55 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 119.594 -1.942 . . . . 0.0 112.326 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.57 130.57 17.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.754 0.706 . . . . 0.0 110.252 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.19 126.78 27.62 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.072 1.349 . . . . 0.0 109.721 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.82 118.61 23.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 127.254 2.221 . . . . 0.0 107.093 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.14 153.7 51.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.865 0.866 . . . . 0.0 109.352 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -157.97 158.58 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 129.7 3.2 . . . . 0.0 105.202 165.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 144.65 98.73 0.26 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.96 167.01 27.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.811 2.341 . . . . 0.0 111.079 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.6 m -158.0 -56.21 0.07 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.633 1.973 . . . . 0.0 107.902 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.22 158.24 43.96 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 108.196 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.712 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -86.65 160.62 18.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.613 0.72 . . . . 0.0 111.617 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -132.56 70.26 1.47 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.95 72.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -170.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.5 m -144.65 153.89 42.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 165.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m 48.68 75.83 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.836 0.854 . . . . 0.0 111.243 -171.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.49 -107.07 0.13 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 157.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -54.19 138.03 39.37 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 117.464 0.632 . . . . 0.0 111.657 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -91.65 136.09 33.4 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.52 155.83 23.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.736 1.273 . . . . 0.0 108.122 151.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.32 116.93 10.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.158 2.183 . . . . 0.0 106.62 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.48 134.44 34.64 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.516 1.127 . . . . 0.0 109.767 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.6 t -129.04 143.36 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 127.014 2.125 . . . . 0.0 107.979 174.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -129.13 103.17 6.82 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.464 -0.773 . . . . 0.0 110.548 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -103.48 131.8 50.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.857 0.837 . . . . 0.0 109.772 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -86.86 160.73 18.64 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.418 0.687 . . . . 0.0 110.639 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -121.83 86.79 2.64 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.991 0.917 . . . . 0.0 110.488 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 mtp -130.41 -9.94 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.697 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.69 -100.32 0.19 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -29.73 70.7 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.12 1.327 . . . . 0.0 110.709 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.73 73.73 0.84 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 69.58 -115.8 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.308 1.843 . . . . 0.0 109.167 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.32 40.55 0.25 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 120.846 1.657 . . . . 0.0 112.742 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -123.22 175.52 6.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.045 1.338 . . . . 0.0 108.508 168.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.59 167.11 21.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.54 121.69 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.837 1.199 . . . . 0.0 109.07 -162.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.7 mt -138.26 147.09 43.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.32 -163.3 12.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.6 28.15 64.78 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 118.29 1.045 . . . . 0.0 112.458 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.22 -37.88 86.62 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.427 -1.043 . . . . 0.0 110.233 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.53 160.99 30.94 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.417 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.77 46.91 2.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.705 3.603 . . . . 0.0 112.588 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.13 48.29 0.12 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 109.858 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -123.26 164.05 30.17 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.596 1.159 . . . . 0.0 110.759 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.6 143.89 27.73 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.477 2.785 . . . . 0.0 108.463 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.58 100.38 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.95 151.01 23.12 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mm -57.56 112.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 162.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.12 -56.39 24.39 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 126.814 2.149 . . . . 0.0 111.763 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.58 167.86 28.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.571 1.949 . . . . 0.0 106.943 172.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.38 130.71 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 mm -79.93 115.39 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.46 -21.2 3.45 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.491 1.917 . . . . 0.0 115.085 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.7 mmt -122.28 7.06 9.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.73 1.612 . . . . 0.0 110.989 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.91 167.63 34.91 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 120.701 -1.249 . . . . 0.0 110.53 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -61.94 -12.86 20.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.292 1.037 . . . . 0.0 112.613 175.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.79 -69.12 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.997 0.817 . . . . 0.0 110.128 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.15 -43.75 78.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.643 0.656 . . . . 0.0 111.931 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 46' ' ' SER . 0.1 OUTLIER -65.97 -10.04 35.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.687 -1.149 . . . . 0.0 113.764 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.37 -46.51 15.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.807 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 37.28 4.37 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.849 1.214 . . . . 0.0 114.189 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 50.6 mtp85 -127.3 -62.69 1.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.001 1.401 . . . . 0.0 112.635 -171.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.17 143.52 55.36 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.046 0.938 . . . . 0.0 110.424 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -126.11 153.11 74.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 123.803 0.841 . . . . 0.0 109.756 166.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.75 141.81 64.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.95 1.767 . . . . 0.0 109.344 164.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 -8.55 63.81 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-O 117.45 -1.75 . . . . 0.0 114.495 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.04 126.5 27.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.953 1.876 . . . . 0.0 107.166 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -79.69 121.13 24.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.13 153.02 36.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.639 1.176 . . . . 0.0 110.002 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 t -130.99 -50.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.463 1.505 . . . . 0.0 109.088 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.32 143.71 50.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.24 122.06 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t0 54.84 21.82 3.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.714 1.205 . . . . 0.0 112.207 -167.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.95 -5.97 82.45 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 117.713 -1.604 . . . . 0.0 113.921 -174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -92.11 128.88 43.59 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 120.928 2.364 . . . . 0.0 106.592 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.71 119.05 6.07 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.994 2.463 . . . . 0.0 109.509 -173.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.34 -4.99 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.272 1.429 . . . . 0.0 110.619 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.06 115.96 4.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.561 1.144 . . . . 0.0 109.554 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.05 -1.92 21.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.908 0.766 . . . . 0.0 113.987 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 67.2 mmtt -80.94 164.96 22.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.616 2.208 . . . . 0.0 108.876 167.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.4 p -81.16 171.25 15.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.46 0.704 . . . . 0.0 110.577 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -53.23 -49.98 65.69 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.28 -1.513 . . . . 0.0 109.389 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.85 -28.23 69.34 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 51.9 t80 -48.98 -57.02 7.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.721 1.208 . . . . 0.0 109.779 169.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.8 -39.19 84.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.884 1.274 . . . . 0.0 110.435 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.42 -27.74 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.237 -0.914 . . . . 0.0 110.511 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -41.04 68.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.557 1.143 . . . . 0.0 111.219 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -52.03 67.44 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.836 0.854 . . . . 0.0 109.823 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 71.4 mmm -54.83 -39.13 68.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.036 0.835 . . . . 0.0 111.391 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -43.5 98.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.28 0.632 . . . . 0.0 110.801 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -49.0 64.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.847 1.259 . . . . 0.0 111.769 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.03 71.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.262 1.825 . . . . 0.0 110.275 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.99 76.9 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.378 -0.826 . . . . 0.0 111.913 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.46 -39.56 74.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.649 1.113 . . . . 0.0 110.917 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.02 -20.6 66.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.712 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.97 70.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.674 1.131 . . . . 0.0 112.522 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -163.72 162.15 23.84 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.441 1.496 . . . . 0.0 108.273 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.58 128.38 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -80.49 141.77 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 161.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.8 mt -135.4 105.13 6.11 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -100.52 116.32 32.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.2 m -105.16 167.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 107.946 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -149.38 153.59 37.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.698 -1.251 . . . . 0.0 111.582 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -144.32 132.29 21.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.268 1.027 . . . . 0.0 109.306 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 139.78 18.33 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.699 1.2 . . . . 0.0 110.846 167.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.49 165.56 18.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 125.65 1.58 . . . . 0.0 106.759 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.52 -175.63 4.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.588 1.155 . . . . 0.0 108.32 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.0 t -143.76 -54.83 0.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.369 0.668 . . . . 0.0 110.561 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.77 -175.74 23.03 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.58 140.61 93.91 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.89 2.394 . . . . 0.0 111.803 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.85 127.09 31.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.18 1.792 . . . . 0.0 106.487 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 160.57 41.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.39 0 N-CA-C 105.854 -2.899 . . . . 0.0 105.854 -176.533 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -98.05 -63.48 1.12 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.862 0.831 . . . . 0.0 109.461 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 m -143.4 167.66 21.66 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.642 0.777 . . . . 0.0 109.691 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.15 84.16 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 106.371 -2.692 . . . . 0.0 106.371 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -68.47 83.49 0.27 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.96 -83.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.939 . . . . 0.0 110.248 -167.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.62 -2.74 5.26 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.955 1.252 . . . . 0.0 114.755 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 51.1 p90 -133.23 144.41 49.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.152 1.476 . . . . 0.0 107.994 157.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 130.38 40.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.51 130.13 34.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 163.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.99 155.35 34.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.648 1.579 . . . . 0.0 108.217 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -133.43 132.02 40.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.941 0.896 . . . . 0.0 111.883 -171.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 t -124.45 108.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.96 1.304 . . . . 0.0 108.561 -174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -80.65 129.2 34.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.5 mt -123.38 123.39 40.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 157.82 36.95 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.174 0.589 . . . . 0.0 110.053 173.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -114.2 83.18 1.83 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.9 mtm -138.62 -9.6 1.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.598 0.635 . . . . 0.0 112.205 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -131.21 -102.5 0.28 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -74.58 -22.03 59.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.66 1.573 . . . . 0.0 114.347 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.03 77.42 0.5 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.879 1.218 . . . . 0.0 112.929 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 58.94 76.67 0.34 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 128.347 2.659 . . . . 0.0 112.214 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.52 70.54 2.64 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.755 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -142.37 147.72 36.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.867 1.334 . . . . 0.0 108.532 167.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -93.51 163.21 13.66 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.921 1.288 . . . . 0.0 108.227 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.87 139.4 49.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.105 1.362 . . . . 0.0 107.578 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.11 -177.5 5.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 108.273 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.38 -161.02 50.87 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.347 -0.846 . . . . 0.0 111.159 -170.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.71 75.24 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.749 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.98 -12.49 60.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.661 1.73 . . . . 0.0 113.366 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -141.6 160.12 57.74 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.822 1.649 . . . . 0.0 108.817 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.12 105.92 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.129 2.552 . . . . 0.0 109.252 -168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.07 30.86 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.661 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -66.67 162.25 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.44 1.62 . . . . 0.0 109.323 155.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.82 140.82 68.89 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.864 2.376 . . . . 0.0 109.013 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -116.04 83.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.06 142.27 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.906 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mm -61.2 126.94 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.41 -41.12 91.27 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.163 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 167.01 124.42 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.658 2.383 . . . . 0.0 107.768 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.47 150.03 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.536 1.134 . . . . 0.0 110.705 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -83.32 106.99 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.64 69.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -120.06 40.59 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.2 -178.03 31.85 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 125.817 1.675 . . . . 0.0 109.92 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -59.53 -28.36 67.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -57.04 4.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.126 1.33 . . . . 0.0 109.871 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.34 -38.25 88.75 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.928 0.87 . . . . 0.0 110.102 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.01 -8.87 52.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.346 1.058 . . . . 0.0 113.356 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.61 -17.38 36.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.393 1.452 . . . . 0.0 110.646 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.58 83.5 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.282 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -117.47 -54.52 2.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -166.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 161.28 30.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -140.65 146.02 42.84 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 121.498 -0.752 . . . . 0.0 110.166 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.24 132.3 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.788 2.325 . . . . 0.0 111.259 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.13 -2.32 78.77 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.732 1.158 . . . . 0.0 113.715 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.1 141.68 58.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.351 1.076 . . . . 0.0 108.777 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.94 121.01 28.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.24 155.02 37.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.956 0.903 . . . . 0.0 110.439 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -126.79 -55.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 109.443 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -128.66 147.98 50.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.155 0.982 . . . . 0.0 109.786 -174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.5 t -138.6 118.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 59.11 9.01 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.849 2.06 . . . . 0.0 114.111 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.14 -15.15 6.51 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.429 1.966 . . . . 0.0 112.898 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mp -108.89 129.87 23.41 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.386 1.593 . . . . 0.0 108.229 -169.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.4 112.65 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.381 2.721 . . . . 0.0 109.249 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.18 -7.04 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.098 0.959 . . . . 0.0 111.051 171.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.3 114.5 3.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.075 1.35 . . . . 0.0 108.599 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.32 -5.42 60.84 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.919 0.771 . . . . 0.0 113.795 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HE3' ' CZ ' ' A' ' 74' ' ' TYR . 49.3 mmtt -101.47 -172.71 2.21 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.052 1.341 . . . . 0.0 109.623 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 174.27 5.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.943 1.297 . . . . 0.0 110.389 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -49.42 -56.08 10.9 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.875 1.67 . . . . 0.0 110.331 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -52.92 -36.39 59.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 112.795 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 45.2 t80 -54.2 -48.69 70.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.501 0.72 . . . . 0.0 110.281 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 t -70.29 -34.77 59.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 125.006 1.322 . . . . 0.0 110.211 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 mm -62.41 -37.9 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.211 0.914 . . . . 0.0 109.989 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.95 89.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.022 0.374 . . . . 0.0 110.551 173.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.23 -50.74 66.81 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.429 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.6 mmm -56.98 -36.23 70.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.949 0.795 . . . . 0.0 111.161 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.79 -43.5 90.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.219 0.607 . . . . 0.0 111.335 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -45.99 72.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.656 0.783 . . . . 0.0 111.407 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.87 78.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.42 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -32.89 63.97 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.838 -1.164 . . . . 0.0 111.895 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -78.95 -29.55 44.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.351 1.06 . . . . 0.0 112.202 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -66.79 -22.27 66.03 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.01 -0.431 . . . . 0.0 110.928 168.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.88 6.51 89.07 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.039 -1.038 . . . . 0.0 112.484 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.04 173.12 14.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.269 2.227 . . . . 0.0 107.113 168.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.14 157.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 160.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.56 131.66 53.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 26.4 mt -126.68 98.17 5.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 53.5 m -87.72 117.42 26.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.1 m -100.92 173.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 125.599 1.56 . . . . 0.0 108.492 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.405 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 17.8 ptt85 -150.13 158.83 44.57 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.669 -1.269 . . . . 0.0 108.581 167.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.83 31.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -50.3 153.7 1.43 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.652 0.739 . . . . 0.0 110.928 164.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 143.35 36.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.615 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.79 -74.73 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 170.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -146.33 -179.11 6.52 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.191 0.996 . . . . 0.0 109.651 157.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.02 130.0 3.85 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.129 1.823 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.37 179.24 6.36 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.641 2.894 . . . . 0.0 111.329 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -90.92 -46.12 8.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 161.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 t 51.87 62.73 2.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.918 1.287 . . . . 0.0 109.208 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.534 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 -150.29 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -155.51 -43.14 0.08 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.788 1.635 . . . . 0.0 109.956 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -141.46 -72.23 0.34 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.589 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 101.41 0.19 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.4 172.63 3.85 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.883 0.841 . . . . 0.0 110.439 164.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -65.64 144.32 57.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.863 0.465 . . . . 0.0 111.783 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.52 -92.57 0.79 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 124.92 1.248 . . . . 0.0 110.72 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -56.82 126.64 27.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -167.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -88.38 123.64 33.15 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 110.95 18.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 160.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mp -101.12 148.3 25.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.26 159.63 15.23 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.312 -0.868 . . . . 0.0 110.242 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.44 137.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -126.16 124.87 41.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.296 0.953 . . . . 0.0 108.553 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.49 136.36 51.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.719 0.808 . . . . 0.0 110.153 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -89.73 154.93 19.55 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.111 0.964 . . . . 0.0 110.069 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -115.32 83.54 1.94 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtt -137.41 -34.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.576 -0.725 . . . . 0.0 110.987 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.23 -81.78 0.25 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -122.37 -3.1 8.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.2 78.08 1.13 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.96 0.8 . . . . 0.0 111.699 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 65.82 -133.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 52.69 0.01 OUTLIER Glycine 0 C--O 1.225 -0.453 0 CA-C-N 119.8 1.182 . . . . 0.0 110.454 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -137.77 172.66 12.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.91 0.855 . . . . 0.0 108.832 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -130.66 163.52 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.862 1.665 . . . . 0.0 106.653 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.405 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -141.24 122.64 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -169.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.7 mt -139.96 179.08 6.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.605 1.562 . . . . 0.0 107.478 -172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.33 -166.29 48.45 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.06 30.92 71.3 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.559 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.78 -32.48 74.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.698 1.749 . . . . 0.0 110.233 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.12 153.76 48.49 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 123.33 0.652 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.16 90.45 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.519 3.479 . . . . 0.0 107.792 -175.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.73 -3.79 5.02 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 117.96 -1.467 . . . . 0.0 113.167 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.44 159.23 85.26 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.73 1.765 . . . . 0.0 109.909 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.16 144.32 68.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.483 2.122 . . . . 0.0 109.804 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -114.68 92.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.9 160.15 15.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.448 1.899 . . . . 0.0 110.993 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm -65.82 119.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 167.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -57.05 -45.06 92.79 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.078 2.275 . . . . 0.0 112.542 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.51 170.17 4.95 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.962 2.105 . . . . 0.0 107.402 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.39 138.41 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 168.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -85.41 117.39 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.34 80.62 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.064 0.852 . . . . 0.0 112.277 -168.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.8 mmt -94.8 37.99 1.13 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.86 166.77 14.87 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 125.907 1.717 . . . . 0.0 109.974 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.2 t -75.96 -14.12 60.24 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.935 174.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.43 -50.63 15.22 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.988 1.267 . . . . 0.0 111.193 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -53.47 -59.95 3.93 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.197 1.399 . . . . 0.0 108.84 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -60.51 -15.15 24.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.139 0.976 . . . . 0.0 113.426 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -20.77 62.17 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.404 -0.81 . . . . 0.0 111.102 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.61 32.13 25.42 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.814 1.197 . . . . 0.0 112.333 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt-85 -139.55 -65.25 0.48 Allowed 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.81 141.2 48.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.694 0.679 . . . . 0.0 110.009 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -135.5 155.12 78.67 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.48 1.112 . . . . 0.0 109.619 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.82 140.1 90.6 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.471 2.114 . . . . 0.0 110.745 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.88 86.19 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 117.939 -1.478 . . . . 0.0 114.727 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.56 129.11 39.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.988 1.894 . . . . 0.0 107.738 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.94 133.01 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.74 148.27 24.81 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.106 1.362 . . . . 0.0 107.743 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.08 -53.73 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.48 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -129.65 147.83 51.48 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.858 0.863 . . . . 0.0 109.097 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.9 t -139.77 124.79 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 64.13 4.06 1.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.527 1.531 . . . . 0.0 113.878 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.33 -14.01 12.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.009 1.766 . . . . 0.0 112.592 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.47 133.72 20.12 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 119.267 1.534 . . . . 0.0 108.878 -167.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.46 108.85 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.766 2.977 . . . . 0.0 109.689 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.03 -6.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.634 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.29 108.67 3.29 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.629 -1.294 . . . . 0.0 110.111 -166.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.43 14.1 69.19 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.904 0.764 . . . . 0.0 113.294 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.618 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 37.1 mmtt -82.07 -161.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.285 1.434 . . . . 0.0 108.234 162.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -113.06 172.16 7.11 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.336 1.055 . . . . 0.0 110.676 171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -45.51 -55.28 6.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.747 2.019 . . . . 0.0 111.399 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.49 -35.34 67.88 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.533 -0.729 . . . . 0.0 112.338 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.618 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 32.2 t80 -49.52 -51.6 35.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.345 0.593 . . . . 0.0 109.611 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.73 -39.11 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.503 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm -58.65 -37.24 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.025 1.284 . . . . 0.0 110.522 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.68 -44.36 93.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.254 1.421 . . . . 0.0 110.196 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.81 -51.6 66.43 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.382 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.7 mmm -52.97 -39.7 63.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.103 0.865 . . . . 0.0 111.422 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.4 -34.95 74.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.948 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.97 -36.99 24.67 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.575 1.08 . . . . 0.0 112.922 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.674 1.125 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.74 71.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.395 -1.441 . . . . 0.0 112.97 171.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -78.53 -36.16 45.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 110.682 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -62.16 -15.32 45.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.954 1.302 . . . . 0.0 111.239 162.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 3.13 77.11 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.077 1.322 . . . . 0.0 112.453 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -160.85 151.76 18.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.136 1.468 . . . . 0.0 107.178 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.35 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -84.48 133.12 34.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 16.7 mt -131.18 103.53 6.54 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.5 m -85.5 124.44 32.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.23 171.39 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 126.04 1.736 . . . . 0.0 107.965 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -153.04 166.76 31.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 121.22 -0.925 . . . . 0.0 110.239 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 141.76 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.434 160.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 155.04 29.84 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.737 0.815 . . . . 0.0 111.129 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.0 p -137.95 158.57 33.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.66 1.184 . . . . 0.0 109.315 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tp -161.52 160.61 29.3 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.811 2.044 . . . . 0.0 106.381 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 t -148.38 133.77 18.57 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.94 -167.27 32.64 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.472 -0.627 . . . . 0.0 112.129 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.02 155.58 42.85 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.861 2.374 . . . . 0.0 110.138 166.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 m -76.13 -25.03 54.97 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m 50.13 -153.13 0.15 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.079 1.352 . . . . 0.0 110.541 -166.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.383 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 164.398 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -119.69 75.99 1.11 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.745 1.273 . . . . 0.0 107.822 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.1 m -83.79 160.47 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 164.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.21 174.45 33.37 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 m -140.47 -52.55 0.49 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.0 m -150.63 156.24 40.96 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.34 -28.34 0.12 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 119.052 -0.86 . . . . 0.0 114.09 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -124.64 168.15 13.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.978 1.889 . . . . 0.0 109.496 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -122.19 131.79 54.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.35 139.89 32.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 163.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.76 116.79 20.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 10.7 p30 -80.89 153.18 27.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.214 0.916 . . . . 0.0 110.011 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.57 108.36 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -96.87 106.8 19.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.64 130.03 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.707 0.765 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -93.44 150.1 20.71 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.999 0.92 . . . . 0.0 109.527 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.482 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 30.1 ttt85 -122.83 85.84 2.49 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.847 -1.158 . . . . 0.0 109.245 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.0 mtp -141.82 -3.17 1.14 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -135.31 -88.24 0.35 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -77.03 -31.22 56.17 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.74 -158.29 44.74 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.456 1.025 . . . . 0.0 111.124 -167.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.2 m-85 -102.56 97.24 7.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.297 0.549 . . . . 0.0 112.071 -163.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.62 60.99 4.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.905 1.241 . . . . 0.0 112.898 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.0 p90 -141.58 158.45 43.82 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.526 1.163 . . . . 0.0 109.398 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -112.17 167.73 10.18 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.66 1.584 . . . . 0.0 108.169 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.4 130.29 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -143.25 -178.36 5.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.152 2.181 . . . . 0.0 108.678 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.91 -170.34 29.1 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.607 -1.308 . . . . 0.0 110.345 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.63 91.18 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 121.747 -0.854 . . . . 0.0 111.346 -172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -67.3 -35.11 78.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.959 0.88 . . . . 0.0 111.07 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -120.45 160.29 44.51 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 125.059 1.344 . . . . 0.0 108.39 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.48 57.89 5.3 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.511 3.474 . . . . 0.0 110.393 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.08 42.75 0.06 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.313 1.435 . . . . 0.0 110.476 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -124.88 168.12 14.21 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.46 1.904 . . . . 0.0 110.632 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -72.36 138.34 29.91 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.784 2.322 . . . . 0.0 108.979 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.1 mt -107.13 99.6 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 170.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.8 mt -95.29 136.55 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.955 2.502 . . . . 0.0 109.505 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm -49.47 127.46 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.23 -27.38 73.78 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.79 -1.005 . . . . 0.0 113.823 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 159.58 133.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.468 3.507 . . . . 0.0 106.339 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.41 148.69 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 119.907 1.231 . . . . 0.0 108.437 166.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mm -81.86 118.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -49.58 76.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 122.603 1.192 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 mmt -85.9 54.52 3.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.79 158.08 29.32 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.205 0.892 . . . . 0.0 111.848 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 m -63.07 -6.86 4.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.56 -48.19 14.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 120.961 1.71 . . . . 0.0 110.005 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.5 -53.15 61.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.71 1.204 . . . . 0.0 109.25 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -63.45 -18.64 63.96 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.364 1.066 . . . . 0.0 112.913 -171.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -17.35 62.69 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 110.817 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 18.4 73.7 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.468 1.032 . . . . 0.0 111.988 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -129.47 -70.69 0.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 112.493 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.27 146.29 50.72 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.09 143.2 46.21 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 124.041 0.936 . . . . 0.0 110.592 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.25 136.02 36.03 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 161.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.33 67.13 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 117.609 -1.662 . . . . 0.0 111.956 -168.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -76.54 134.13 39.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.425 2.112 . . . . 0.0 108.299 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -87.19 128.48 35.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.944 2.098 . . . . 0.0 107.777 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -78.03 162.99 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.222 1.809 . . . . 0.0 111.478 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.62 -55.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.604 1.962 . . . . 0.0 108.704 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.1 149.12 51.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.446 1.098 . . . . 0.0 109.25 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -137.64 122.9 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t0 57.23 17.5 3.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.325 1.85 . . . . 0.0 113.541 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.04 -11.07 48.51 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.17 1.843 . . . . 0.0 113.312 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.67 130.26 24.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 119.407 1.604 . . . . 0.0 107.671 -174.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.0 125.82 10.71 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.299 2.666 . . . . 0.0 108.245 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.73 -4.84 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.733 0.813 . . . . 0.0 111.81 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 124.94 22.32 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.66 -0.65 . . . . 0.0 110.318 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 1.11 79.67 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.189 0.899 . . . . 0.0 113.958 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -88.28 171.5 10.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 119.616 1.708 . . . . 0.0 108.738 172.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.6 p -90.62 168.55 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.531 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -44.64 -47.89 10.5 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.103 1.761 . . . . 0.0 111.53 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -52.92 -36.81 60.12 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.596 1.158 . . . . 0.0 113.408 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.97 -49.92 65.15 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.406 0.683 . . . . 0.0 109.295 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.01 -38.03 79.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 C-N-CA 125.092 1.357 . . . . 0.0 110.772 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.59 -40.84 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.483 1.038 . . . . 0.0 109.819 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.06 91.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.205 0.602 . . . . 0.0 110.867 172.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -53.93 45.26 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.626 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.2 mmm -55.03 -37.0 66.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.049 0.841 . . . . 0.0 111.428 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -61.97 -38.71 89.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 117.565 -1.207 . . . . 0.0 111.918 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -70.41 -48.24 57.03 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.697 1.135 . . . . 0.0 111.289 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -42.09 80.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.975 1.31 . . . . 0.0 111.362 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.78 67.19 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.117 -0.99 . . . . 0.0 113.031 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -84.36 -36.15 22.7 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.612 1.096 . . . . 0.0 110.94 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -53.09 -34.04 54.83 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.71 61.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.737 1.161 . . . . 0.0 112.219 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -160.43 173.07 16.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.344 2.258 . . . . 0.0 107.251 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -148.21 127.89 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -80.94 127.04 32.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 161.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.414 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.4 mt -116.48 97.19 5.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 86.1 m -83.89 115.08 22.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.17 171.15 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.844 1.658 . . . . 0.0 108.275 174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -152.87 151.0 29.89 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 119.46 -2.025 . . . . 0.0 112.402 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -140.69 129.61 23.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.677 0.791 . . . . 0.0 109.447 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 134.73 57.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.704 2.002 . . . . 0.0 111.243 169.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.09 136.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 126.483 1.913 . . . . 0.0 108.211 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.53 176.83 12.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 p -157.55 105.85 2.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.38 114.08 4.17 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.45 -21.16 30.68 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.68 1.74 . . . . 0.0 111.223 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t 61.41 -161.36 0.29 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.929 0.892 . . . . 0.0 108.606 -162.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 p -78.43 178.74 7.48 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 163.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 143.433 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.61 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -156.44 106.19 2.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.552 1.541 . . . . 0.0 107.234 -169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -83.31 93.6 7.76 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 49.41 84.03 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.014 1.292 . . . . 0.0 114.479 164.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t 56.09 -120.42 1.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.593 -1.194 . . . . 0.0 108.912 -163.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p -144.34 85.58 1.79 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.558 1.543 . . . . 0.0 109.527 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.15 -114.9 0.35 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -58.51 157.39 9.04 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.289 0.544 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -124.91 137.13 54.29 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.699 1.2 . . . . 0.0 108.931 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -93.71 154.47 17.78 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.736 1.214 . . . . 0.0 107.861 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mp -139.6 131.77 28.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.951 2.1 . . . . 0.0 106.701 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.56 133.05 33.85 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.334 1.054 . . . . 0.0 109.816 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -129.95 106.59 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.84 118.26 36.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.6 148.31 32.45 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.135 0.974 . . . . 0.0 109.5 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -86.82 164.41 16.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 164.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -117.57 95.48 4.97 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 164.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 ttt -143.77 -13.01 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.111 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.63 -108.41 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -65.24 -31.14 72.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.064 1.302 . . . . 0.0 113.016 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 93.66 0.58 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.624 1.107 . . . . 0.0 112.539 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 43.49 71.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 113.54 169.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.45 54.12 4.3 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.785 -1.197 . . . . 0.0 114.98 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -121.32 175.92 5.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.845 1.322 . . . . 0.0 109.409 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.12 165.21 26.6 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 167.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.6 130.62 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -171.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.17 146.39 27.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.422 1.089 . . . . 0.0 108.088 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.51 177.87 19.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.859 -2.096 . . . . 0.0 107.859 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.58 37.05 84.63 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 121.514 -0.992 . . . . 0.0 111.705 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.75 -36.42 67.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.596 1.198 . . . . 0.0 110.481 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -137.73 160.48 64.74 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.984 2.114 . . . . 0.0 107.766 -170.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.97 72.36 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.406 3.404 . . . . 0.0 110.537 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.14 -9.96 0.06 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 127.549 2.5 . . . . 0.0 111.826 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -72.98 158.21 87.5 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.834 1.317 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.45 137.73 31.23 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.77 2.314 . . . . 0.0 109.125 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -110.11 93.55 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.59 155.94 18.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.068 0.937 . . . . 0.0 110.36 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.83 107.54 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.11 -41.11 71.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.79 175.7 12.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.394 1.878 . . . . 0.0 107.575 168.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.43 148.99 29.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 mm -89.12 112.86 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.13 7.63 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.777 1.231 . . . . 0.0 113.548 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.7 mtm -90.04 -0.79 57.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 153.01 45.83 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -62.49 -6.93 3.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.69 29.16 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.539 1.518 . . . . 0.0 112.188 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.09 -52.26 50.4 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.947 0.794 . . . . 0.0 109.813 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -13.3 15.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 168.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.66 -17.73 62.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.246 1.385 . . . . 0.0 110.987 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.34 32.81 41.62 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.336 166.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -133.6 -66.34 0.65 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.343 1.572 . . . . 0.0 111.414 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.69 144.68 54.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.556 1.142 . . . . 0.0 111.489 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -130.94 151.7 79.38 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.749 1.219 . . . . 0.0 109.312 164.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -51.89 142.66 42.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.324 2.016 . . . . 0.0 110.694 163.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.18 64.24 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.954 -0.915 . . . . 0.0 113.798 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.61 134.23 53.9 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.697 1.749 . . . . 0.0 106.423 165.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.91 123.16 33.0 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.01 140.91 47.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.599 1.16 . . . . 0.0 109.022 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.8 -52.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 124.653 1.181 . . . . 0.0 108.825 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -130.03 146.74 51.72 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.17 124.41 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.17 14.44 6.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.056 1.742 . . . . 0.0 112.224 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.28 68.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.901 1.715 . . . . 0.0 112.517 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.63 126.12 35.17 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.717 1.607 . . . . 0.0 108.102 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.91 118.26 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.208 2.605 . . . . 0.0 109.209 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.74 -9.11 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.81 6.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.871 1.269 . . . . 0.0 109.71 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.46 3.77 61.14 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.553 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 21.4 mmtt -107.18 178.64 4.49 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.591 1.957 . . . . 0.0 108.728 174.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -95.22 -179.93 4.97 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.207 -0.308 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -49.91 -54.83 17.2 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.498 1.119 . . . . 0.0 110.924 169.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -26.83 68.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.73 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 64.9 t80 -46.54 -54.07 10.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.719 0.771 . . . . 0.0 110.608 169.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.04 -36.53 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.473 1.509 . . . . 0.0 110.082 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.6 mm -57.53 -41.02 78.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 119.126 0.876 . . . . 0.0 110.149 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.522 0.729 . . . . 0.0 111.359 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.96 -51.66 13.15 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.058 0.943 . . . . 0.0 110.828 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.6 mmm -55.09 -38.1 67.67 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.406 1.083 . . . . 0.0 110.867 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -60.79 2.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.809 1.644 . . . . 0.0 110.17 173.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -54.82 -51.08 66.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.512 1.125 . . . . 0.0 111.259 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.92 78.48 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.028 0.931 . . . . 0.0 111.534 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.4 66.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.773 -1.204 . . . . 0.0 112.194 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtt-85 -69.97 -49.91 47.04 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.207 1.367 . . . . 0.0 109.636 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -54.53 -38.21 66.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.769 0.827 . . . . 0.0 110.313 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.62 42.34 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.064 0.84 . . . . 0.0 111.858 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -151.36 166.76 30.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.802 1.301 . . . . 0.0 108.368 167.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.01 165.3 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -126.83 144.53 50.94 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 164.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.3 mt -138.11 97.39 3.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 103.061 -2.941 . . . . 0.0 103.061 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -86.4 112.98 21.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.35 165.92 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.478 0.711 . . . . 0.0 109.52 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -153.08 162.61 41.12 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.605 -1.309 . . . . 0.0 111.962 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -150.32 147.35 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.697 1.199 . . . . 0.0 109.991 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -51.07 146.15 6.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.687 1.195 . . . . 0.0 111.358 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.83 147.91 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.277 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.08 -170.15 3.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.447 1.499 . . . . 0.0 108.613 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 m -136.94 167.78 20.83 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.665 1.586 . . . . 0.0 106.995 155.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.25 80.83 0.12 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 169.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.25 -12.98 37.87 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.658 3.572 . . . . 0.0 114.244 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 m -73.02 102.52 3.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 160.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.0 121.18 3.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.455 1.502 . . . . 0.0 110.629 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.348 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 168.626 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.825 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 m -127.89 -9.46 5.48 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.23 1.412 . . . . 0.0 114.075 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t 54.67 -173.17 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.968 0.907 . . . . 0.0 110.338 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.7 134.96 5.09 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.53 129.93 39.46 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.134 1.374 . . . . 0.0 109.104 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 t -153.02 127.82 9.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.11 -24.92 1.05 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 127.081 2.277 . . . . 0.0 115.606 154.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -137.64 161.67 35.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.039 1.736 . . . . 0.0 107.466 168.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.13 138.31 54.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 169.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.15 145.8 28.2 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 158.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.39 121.76 33.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.015 2.126 . . . . 0.0 106.721 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 135.2 35.65 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.898 1.279 . . . . 0.0 109.348 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.91 107.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.56 0.695 . . . . 0.0 109.446 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.02 120.77 40.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 108.776 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -123.22 124.06 42.17 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.047 1.339 . . . . 0.0 108.94 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -74.44 153.18 39.3 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.784 169.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -102.94 114.55 28.93 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -69.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -73.79 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.614 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -126.11 1.92 7.2 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -148.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.21 57.48 8.41 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 123.946 0.784 . . . . 0.0 112.368 167.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.74 80.79 0.05 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.6 2.36 . . . . 0.0 113.006 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.0 75.64 1.1 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.281 0.943 . . . . 0.0 112.798 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -127.95 175.55 8.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.141 2.176 . . . . 0.0 106.187 159.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -123.02 162.46 22.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 157.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.27 127.28 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -134.4 -177.29 4.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 107.329 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.34 -156.26 48.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -170.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.63 -105.31 0.71 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -164.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.92 -52.81 0.25 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 129.308 3.043 . . . . 0.0 110.29 -167.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -100.39 160.87 25.8 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 110.861 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 96.11 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.408 3.406 . . . . 0.0 111.563 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.33 19.24 30.86 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 118.372 -1.238 . . . . 0.0 113.067 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -66.11 162.06 50.34 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.708 1.254 . . . . 0.0 109.387 164.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.4 132.66 21.12 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.673 2.249 . . . . 0.0 109.226 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.84 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -87.17 144.42 26.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 110.495 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.91 108.35 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.2 -44.31 51.62 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 127.487 2.47 . . . . 0.0 112.248 -177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.76 160.97 29.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.589 0.756 . . . . 0.0 109.618 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.18 115.68 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 161.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -66.89 121.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -21.64 60.56 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -127.95 33.12 4.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.636 1.574 . . . . 0.0 108.353 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 176.65 17.64 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.831 1.205 . . . . 0.0 111.735 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -61.67 -25.71 67.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.534 0.733 . . . . 0.0 112.756 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -53.96 14.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.849 0.749 . . . . 0.0 109.501 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.86 -46.54 78.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.472 1.109 . . . . 0.0 111.735 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -28.39 65.53 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -72.49 -39.7 67.48 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.756 0.822 . . . . 0.0 110.21 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.2 35.9 19.46 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.992 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -124.2 -67.51 0.92 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.01 0.905 . . . . 0.0 110.725 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.47 137.48 48.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.85 149.41 62.71 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 110.253 174.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -57.6 132.1 48.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.338 2.025 . . . . 0.0 110.38 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 7.38 87.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 117.897 -1.502 . . . . 0.0 113.617 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.08 142.94 58.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.141 1.97 . . . . 0.0 108.271 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.16 125.84 35.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.123 -0.985 . . . . 0.0 108.673 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.19 154.37 26.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 109.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.6 -51.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 108.798 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.82 148.8 52.58 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.121 0.968 . . . . 0.0 109.705 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.92 105.54 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t70 54.63 22.95 4.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.295 1.838 . . . . 0.0 113.189 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.02 -13.63 57.41 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.973 2.225 . . . . 0.0 113.027 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' CG2' ' HH ' ' A' ' 74' ' ' TYR . 4.3 mp -88.43 125.56 63.13 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.114 1.457 . . . . 0.0 107.798 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -73.5 131.0 15.6 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.635 2.89 . . . . 0.0 109.425 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.43 -8.6 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 123.957 0.903 . . . . 0.0 111.633 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.94 57.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.755 -0.59 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.93 7.57 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.372 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 25.3 mmtt -95.88 -177.14 3.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.405 1.602 . . . . 0.0 110.155 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -109.99 175.77 5.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.757 2.023 . . . . 0.0 110.739 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -53.86 -57.09 12.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 109.135 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -45.85 -45.86 15.33 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 112.061 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 50.0 t80 -49.77 -40.24 40.58 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.682 0.614 . . . . 0.0 111.412 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.38 -41.6 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 110.757 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.45 -41.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.026 0.83 . . . . 0.0 109.608 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -23.97 64.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.756 1.622 . . . . 0.0 112.126 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.18 -45.12 16.83 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 123.681 0.792 . . . . 0.0 110.258 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mmm -56.87 -34.94 68.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.917 0.78 . . . . 0.0 111.878 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.87 -42.9 85.52 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.117 0.967 . . . . 0.0 111.51 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -45.35 74.07 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.469 0.707 . . . . 0.0 110.699 174.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.73 71.48 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.764 -1.21 . . . . 0.0 112.245 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.95 74.74 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.609 -0.682 . . . . 0.0 111.046 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -69.09 -36.82 77.98 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.194 0.998 . . . . 0.0 112.343 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -68.61 -12.22 61.06 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.565 0.62 . . . . 0.0 112.014 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.62 7.3 87.21 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.511 1.053 . . . . 0.0 112.936 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.6 169.11 10.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 120.843 -1.386 . . . . 0.0 107.586 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.85 159.7 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -122.12 145.07 48.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mt -138.11 99.34 3.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -84.58 114.02 21.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.28 170.69 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 166.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -151.27 164.21 37.13 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.051 -1.655 . . . . 0.0 109.885 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.36 133.57 15.27 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.537 1.135 . . . . 0.0 108.586 168.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 150.55 39.01 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.571 0.748 . . . . 0.0 109.178 163.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.22 142.95 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.426 0.69 . . . . 0.0 110.751 -170.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 tt -148.21 -71.48 0.21 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 m 52.0 46.38 26.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.088 1.355 . . . . 0.0 113.104 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.39 178.29 21.12 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.68 99.69 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.798 2.998 . . . . 0.0 109.584 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.4 t -65.96 137.52 57.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 168.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.6 p -147.65 166.55 27.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.989 2.116 . . . . 0.0 108.215 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 116.442 -2.31 . . . . 0.0 111.343 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.452 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 82.89 131.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.47 179.91 8.72 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.16 0.981 . . . . 0.0 110.694 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.58 -172.07 22.67 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -164.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.4 m -74.9 -44.58 48.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.485 1.143 . . . . 0.0 113.326 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m 53.5 167.59 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.676 0.671 . . . . 0.0 111.592 -153.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.58 -84.28 0.26 Allowed Glycine 0 C--N 1.334 0.467 0 O-C-N 119.755 -1.841 . . . . 0.0 111.913 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -67.35 153.64 43.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.314 1.057 . . . . 0.0 108.827 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.68 143.09 47.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.109 1.364 . . . . 0.0 107.74 171.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.74 141.95 29.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 169.3 9.1 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.345 2.258 . . . . 0.0 107.186 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 128.13 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.856 1.662 . . . . 0.0 107.014 172.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.05 136.99 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -128.13 127.57 43.25 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 108.165 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.93 155.05 45.92 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.299 1.04 . . . . 0.0 109.374 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -105.29 165.86 10.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.102 0.953 . . . . 0.0 111.398 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -125.49 93.35 3.83 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 124.861 1.264 . . . . 0.0 109.211 174.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.9 mtp -144.34 -63.28 0.37 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -66.43 -69.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.835 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -114.76 -31.08 6.26 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . 78.18 85.71 0.5 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -164.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 72.97 -153.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.754 0.914 . . . . 0.0 108.697 167.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.9 55.14 0.02 OUTLIER Glycine 0 C--O 1.227 -0.312 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -143.36 172.87 12.17 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -141.35 142.27 33.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.023 0.929 . . . . 0.0 109.439 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 135.47 57.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.272 2.7 pp -148.98 -178.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.306 2.242 . . . . 0.0 108.644 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.7 -145.92 46.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.48 30.55 34.12 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 118.0 0.9 . . . . 0.0 111.598 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -90.82 -7.08 53.31 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 112.082 -163.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -129.7 155.59 80.13 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 126.891 2.076 . . . . 0.0 106.828 165.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.96 92.11 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 124.66 3.573 . . . . 0.0 108.161 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.91 -12.42 1.91 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.627 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -79.23 159.43 72.79 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 119.433 1.617 . . . . 0.0 112.192 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.42 147.01 51.59 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.222 1.948 . . . . 0.0 108.764 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -116.77 92.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.88 130.66 44.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.814 1.646 . . . . 0.0 109.16 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 mm -54.81 110.42 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.04 -43.58 81.13 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.442 -0.786 . . . . 0.0 111.738 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 139.89 14.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.43 147.15 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 159.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.12 110.61 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.25 -34.72 61.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 123.105 1.431 . . . . 0.0 112.009 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 33.1 mmt -95.91 20.8 9.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.591 1.156 . . . . 0.0 110.506 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 176.11 21.54 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.202 0.906 . . . . 0.0 111.552 -165.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -20.68 64.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.225 -0.893 . . . . 0.0 113.09 -160.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.52 -63.74 1.01 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.005 0.82 . . . . 0.0 109.743 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.61 -43.58 80.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.094 0.958 . . . . 0.0 110.751 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -70.62 -18.99 62.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.908 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.21 -22.6 33.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.616 1.553 . . . . 0.0 111.371 168.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.97 14.03 65.44 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.371 159.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.45 -43.81 4.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.381 1.591 . . . . 0.0 113.968 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.19 155.76 27.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -135.6 153.47 77.59 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.511 . . . . 0.0 110.586 155.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.58 112.95 3.35 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.817 1.678 . . . . 0.0 110.633 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.15 -13.09 5.76 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.232 2.348 . . . . 0.0 110.977 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.37 131.38 48.06 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 122.28 28.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 120.05 1.295 . . . . 0.0 107.697 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.2 153.52 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 109.788 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 t -130.07 -45.58 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.122 1.369 . . . . 0.0 109.511 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.37 149.23 51.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.352 1.061 . . . . 0.0 109.636 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.4 t -137.39 122.72 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 53.58 14.28 0.58 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.33 2.652 . . . . 0.0 113.555 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.7 30.92 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.447 2.451 . . . . 0.0 113.367 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -94.49 130.37 33.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 120.586 2.193 . . . . 0.0 106.895 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -71.91 111.01 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.958 2.439 . . . . 0.0 108.567 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -72.83 -8.25 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.335 0.654 . . . . 0.0 110.96 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.65 120.42 9.44 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.12 -9.2 70.53 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.284 1.421 . . . . 0.0 114.909 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -83.03 173.59 11.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.067 -1.255 . . . . 0.0 109.098 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.1 p -93.83 169.86 9.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -51.34 -46.62 62.72 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.454 1.102 . . . . 0.0 112.052 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 -59.22 -33.18 70.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.905 0.775 . . . . 0.0 112.56 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -48.1 -48.02 33.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.914 0.886 . . . . 0.0 109.554 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.62 -35.5 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.456 -0.778 . . . . 0.0 110.816 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.56 -35.21 69.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 120.91 -1.119 . . . . 0.0 110.321 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.43 -42.39 87.77 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.471 1.108 . . . . 0.0 109.82 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -47.13 85.49 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 111.491 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -27.83 45.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.733 0.813 . . . . 0.0 110.493 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -45.08 63.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.567 0.621 . . . . 0.0 110.63 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -63.3 -46.86 84.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 111.329 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.456 1.102 . . . . 0.0 110.79 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.74 -24.19 67.57 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.114 -0.991 . . . . 0.0 112.791 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -59.45 2.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 169.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -56.84 -39.33 74.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 124.622 1.201 . . . . 0.0 109.715 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 9.3 16.74 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.352 0.977 . . . . 0.0 112.692 170.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -149.48 175.83 11.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.5 128.46 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 156.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 139.32 31.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 161.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 41.4 mt -135.51 111.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.8 m -95.49 115.57 27.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.1 173.84 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 165.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -150.86 160.72 43.7 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 120.392 -1.442 . . . . 0.0 110.195 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -155.34 144.46 20.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 160.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.24 148.6 51.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.538 2.335 . . . . 0.0 109.887 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 55.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.484 -1.689 . . . . 0.0 106.669 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.8 tp 64.15 166.19 0.15 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.959 2.104 . . . . 0.0 112.889 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -88.53 -174.88 4.76 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.604 1.962 . . . . 0.0 109.537 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.29 178.34 17.86 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 167.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -74.75 59.97 5.12 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.701 2.934 . . . . 0.0 110.396 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -152.43 146.88 25.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.963 1.305 . . . . 0.0 107.807 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.5 m -141.39 -6.3 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.809 0 CA-C-O 117.556 -1.691 . . . . 0.0 110.727 -174.282 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.794 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 p -158.87 -93.39 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.513 0.656 . . . . 0.0 110.374 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -91.91 156.57 17.38 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.512 1.925 . . . . 0.0 110.201 -171.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.43 126.17 2.22 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.8 m 54.57 27.75 8.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -52.63 129.26 28.79 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 168.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.75 -99.54 0.12 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-O 118.774 -1.014 . . . . 0.0 110.82 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.406 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 24.7 p90 -62.39 147.64 47.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.054 0.927 . . . . 0.0 109.256 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -106.71 131.15 54.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.01 159.54 21.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 158.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.32 121.67 11.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 173.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.98 135.76 36.46 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.3 t -126.15 107.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -95.59 127.77 41.9 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -121.35 124.16 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.963 0.905 . . . . 0.0 109.881 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -71.95 144.38 48.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -101.47 103.94 14.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.0 mtm -142.91 -53.16 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.04 -105.23 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.399 1.079 . . . . 0.0 110.713 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -69.91 -21.74 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.436 1.471 . . . . 0.0 112.139 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 67.17 2.13 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.19 100.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.485 2.314 . . . . 0.0 111.369 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.06 53.42 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.605 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -134.59 170.69 15.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.469 1.634 . . . . 0.0 110.034 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.97 151.73 48.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.71 2.404 . . . . 0.0 109.134 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.69 152.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.682 1.193 . . . . 0.0 107.809 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 -179.16 6.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.413 1.485 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.36 -142.82 43.31 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.81 20.72 62.38 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.937 0.78 . . . . 0.0 112.028 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.76 -45.96 87.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.242 1.417 . . . . 0.0 110.021 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -108.77 155.17 41.14 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.91 93.8 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.892 3.728 . . . . 0.0 109.528 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.34 2.87 2.55 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.82 1.2 . . . . 0.0 112.739 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -77.71 167.98 31.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.452 1.126 . . . . 0.0 109.824 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.57 131.7 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.304 2.67 . . . . 0.0 110.211 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.81 105.76 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.8 mt -101.68 162.8 12.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.851 1.66 . . . . 0.0 112.436 177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.8 mm -65.79 121.5 14.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.22 -60.87 5.58 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 122.968 0.318 . . . . 0.0 112.633 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.43 114.78 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.9 2.08 . . . . 0.0 106.952 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.3 149.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.85 116.0 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.99 -29.74 44.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.312 1.845 . . . . 0.0 115.135 -165.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.4 mmt -135.12 10.72 3.56 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.455 1.102 . . . . 0.0 111.795 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.8 172.41 54.05 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -57.88 -11.86 2.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.19 -52.69 6.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.141 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.0 -43.66 73.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.184 1.356 . . . . 0.0 110.414 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -55.79 -28.63 57.09 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.84 -17.43 28.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.395 1.078 . . . . 0.0 111.978 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.54 23.74 67.14 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -122.44 -14.11 7.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.978 1.889 . . . . 0.0 114.31 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.14 168.8 12.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.294 0.952 . . . . 0.0 108.636 166.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.85 18.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.133 1.373 . . . . 0.0 107.838 158.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.44 123.77 11.59 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.894 2.396 . . . . 0.0 109.164 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.9 34.93 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.052 0.834 . . . . 0.0 113.288 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -64.39 153.83 37.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 118.643 1.221 . . . . 0.0 109.507 152.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -104.58 116.64 32.43 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.821 2.048 . . . . 0.0 108.276 166.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.22 136.83 37.87 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.32 2.248 . . . . 0.0 108.755 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.98 -52.95 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 123.596 0.758 . . . . 0.0 110.276 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -134.59 145.17 48.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.81 124.83 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 107.322 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.43 21.15 1.14 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.613 2.365 . . . . 0.0 112.09 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.48 -10.78 70.87 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.82 2.153 . . . . 0.0 113.788 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.77 133.19 38.26 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 119.575 1.687 . . . . 0.0 107.625 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -72.01 133.94 22.46 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.024 2.483 . . . . 0.0 108.295 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.5 m -99.07 -7.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.229 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.75 133.72 47.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.82 -9.04 25.87 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.7 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 69.7 mmtt -85.96 171.8 11.18 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.935 1.868 . . . . 0.0 108.723 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.8 p -92.3 172.97 8.06 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.137 0.575 . . . . 0.0 110.362 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -49.7 -56.07 11.53 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.717 1.207 . . . . 0.0 109.485 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -50.56 -41.77 54.56 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.62 1.568 . . . . 0.0 112.929 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 41.0 t80 -51.63 -47.14 63.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.753 0.787 . . . . 0.0 110.266 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 t -73.13 -34.35 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.791 0.836 . . . . 0.0 110.465 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -62.44 -35.44 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.878 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.5 -43.88 97.73 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.788 1.235 . . . . 0.0 110.105 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -53.88 46.15 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.625 0.77 . . . . 0.0 111.669 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.7 mmm -58.59 -35.22 72.07 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.235 0.614 . . . . 0.0 111.082 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -59.5 -45.14 92.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.482 -0.77 . . . . 0.0 111.2 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.62 -51.08 66.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.808 0.843 . . . . 0.0 111.683 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.77 71.82 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 111.678 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.22 78.5 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.036 -1.04 . . . . 0.0 111.288 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -72.14 -42.87 65.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.391 0.996 . . . . 0.0 111.183 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -55.35 -33.51 63.45 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.364 1.065 . . . . 0.0 110.227 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.63 10.64 65.01 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.182 0.896 . . . . 0.0 112.228 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -164.66 168.86 17.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.751 2.02 . . . . 0.0 107.053 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.38 159.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.36 88.97 2.35 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.632 1.173 . . . . 0.0 109.294 -170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.9 97.95 8.49 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -83.55 127.07 33.45 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.423 ' HB ' ' CG ' ' A' ' 57' ' ' ASP . 17.2 m -125.99 158.47 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 126.038 1.735 . . . . 0.0 107.051 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.406 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 11.6 ptt180 -151.3 161.32 42.93 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.674 -0.641 . . . . 0.0 111.085 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.21 146.36 22.71 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 145.52 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.0 0.92 . . . . 0.0 110.411 166.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.2 t -103.87 140.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mp -137.8 150.99 47.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 p -166.94 73.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.275 1.03 . . . . 0.0 108.371 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 150.84 97.06 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.355 -1.247 . . . . 0.0 111.63 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.16 135.45 31.91 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.439 2.093 . . . . 0.0 108.237 165.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 t 169.93 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 128.76 2.824 . . . . 0.0 104.136 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 t -143.44 -175.57 4.6 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.239 1.816 . . . . 0.0 106.977 157.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.234 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.598 -169.252 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.96 0 CA-C-O 118.886 -0.952 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -68.82 111.26 4.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.119 1.459 . . . . 0.0 108.568 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 t -157.83 164.1 37.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.997 1.319 . . . . 0.0 107.726 168.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -25.63 -92.35 0.01 OUTLIER Glycine 0 CA--C 1.524 0.628 0 C-N-CA 129.428 3.394 . . . . 0.0 115.032 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 t -160.83 173.48 15.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 m -134.53 84.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.39 -3.91 0.05 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 114.66 0.624 . . . . 0.0 114.66 -168.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -102.52 -174.05 2.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 121.023 -1.28 . . . . 0.0 107.587 158.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -135.82 137.33 41.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 159.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -83.45 152.46 24.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 164.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.41 163.21 19.09 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -124.98 121.37 34.24 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.207 1.803 . . . . 0.0 107.706 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.9 t -121.59 109.1 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -78.18 144.52 36.28 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 mt -140.05 128.21 22.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.182 0.993 . . . . 0.0 108.8 166.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -72.95 160.06 32.71 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.741 0.416 . . . . 0.0 111.669 171.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.506 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 8.5 ttt-85 -141.5 89.65 2.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.287 1.435 . . . . 0.0 107.439 166.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mtm -154.27 -41.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 109.22 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -72.78 -163.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 142.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -64.73 8.32 0.12 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -148.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 174.2 50.22 Favored Glycine 0 N--CA 1.45 -0.398 0 O-C-N 120.672 -1.267 . . . . 0.0 112.287 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -65.99 160.83 22.76 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.57 72.32 0.29 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -143.31 171.87 13.52 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 171.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -132.18 158.67 41.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.126 1.371 . . . . 0.0 107.774 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.75 121.38 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.81 -177.23 3.08 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.474 2.31 . . . . 0.0 107.716 -168.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.49 -144.39 49.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.04 19.96 47.4 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.124 0.868 . . . . 0.0 112.904 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -26.28 68.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.011 0.925 . . . . 0.0 111.204 -168.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -140.39 160.25 60.28 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 126.114 1.766 . . . . 0.0 109.056 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.76 112.65 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 173.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.07 35.89 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.923 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.91 155.61 91.36 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.662 1.731 . . . . 0.0 108.466 166.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.63 152.41 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.517 2.811 . . . . 0.0 110.371 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.8 mt -117.78 93.98 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 165.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -81.36 152.85 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.25 139.3 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 159.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.7 -56.79 1.39 Allowed Glycine 0 C--O 1.226 -0.372 0 O-C-N 121.492 -0.755 . . . . 0.0 111.639 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.84 145.76 36.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.42 123.78 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.61 110.62 7.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -171.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.8 149.16 11.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.269 0.98 . . . . 0.0 110.483 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.5 mmt 66.47 -6.75 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.988 2.115 . . . . 0.0 114.564 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -151.63 5.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.847 1.689 . . . . 0.0 111.416 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -66.5 -63.77 1.0 Allowed 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.918 -1.342 . . . . 0.0 110.725 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -45.26 94.55 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -157.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.52 -45.92 90.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.234 1.014 . . . . 0.0 111.535 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.9 -39.64 95.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.686 1.595 . . . . 0.0 112.616 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -36.89 83.45 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 110.368 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.2 15.32 65.26 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 125.486 1.517 . . . . 0.0 113.24 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -98.59 -32.85 11.22 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.574 1.549 . . . . 0.0 109.604 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.48 146.7 32.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.05 146.87 48.33 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.843 164.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -69.24 112.41 2.98 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.894 2.396 . . . . 0.0 110.674 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.14 5.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.709 1.623 . . . . 0.0 112.268 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.84 140.88 57.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 122.5 32.61 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.989 1.268 . . . . 0.0 108.583 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.06 156.83 38.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.102 0.961 . . . . 0.0 111.202 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.14 -53.01 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.902 1.681 . . . . 0.0 108.933 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.4 148.25 51.3 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.528 1.131 . . . . 0.0 109.618 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 64' ' ' GLY . 96.0 t -142.84 126.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.721 1.608 . . . . 0.0 107.019 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.11 -3.83 0.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.921 2.088 . . . . 0.0 112.708 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 125.58 -16.96 6.96 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.841 3.115 . . . . 0.0 111.914 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.27 134.87 20.96 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.868 1.334 . . . . 0.0 108.648 -167.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.16 118.83 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.382 2.722 . . . . 0.0 109.883 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -80.3 -7.3 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 111.023 173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 118.29 8.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 109.992 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.97 -10.01 70.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.657 1.122 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -78.55 -172.53 2.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 108.712 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -100.63 171.89 7.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.685 1.194 . . . . 0.0 109.402 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -50.81 -53.65 30.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.389 1.476 . . . . 0.0 109.844 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.75 -24.26 67.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -51.71 -48.92 63.37 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.854 0.835 . . . . 0.0 110.21 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.7 t -71.65 -37.18 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.572 1.149 . . . . 0.0 110.126 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.02 -28.35 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.204 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -45.48 72.54 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.476 1.51 . . . . 0.0 110.415 169.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -49.62 76.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.191 0.596 . . . . 0.0 110.775 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.0 mmm -57.74 -19.88 30.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.942 0.497 . . . . 0.0 112.331 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -47.85 21.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.373 0.988 . . . . 0.0 111.103 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.43 -47.04 85.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 119.016 0.825 . . . . 0.0 111.111 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.35 -38.02 73.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.689 0.796 . . . . 0.0 111.713 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.78 -14.25 62.91 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 113.805 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -81.7 -43.74 18.07 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.033 1.288 . . . . 0.0 109.764 165.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -63.28 -17.35 62.42 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.747 1.219 . . . . 0.0 112.016 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.31 69.01 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.037 1.303 . . . . 0.0 112.406 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -157.31 168.7 26.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.031 1.732 . . . . 0.0 106.872 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.06 163.49 26.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -121.88 140.42 52.43 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 166.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.4 mt -137.01 106.67 6.17 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 m -97.31 112.58 24.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.44 164.77 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.65 151.75 32.97 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.567 -1.333 . . . . 0.0 110.839 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -151.02 136.05 17.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.58 133.54 16.62 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 166.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.8 t -84.31 162.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 170.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.47 -41.36 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.923 0.889 . . . . 0.0 109.689 169.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m 41.39 48.66 3.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.16 1.784 . . . . 0.0 110.556 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.06 -165.81 13.25 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 127.197 2.332 . . . . 0.0 110.067 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -62.62 160.89 30.34 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.904 1.736 . . . . 0.0 110.726 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.8 -177.77 6.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.795 1.238 . . . . 0.0 110.206 -165.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -146.93 160.43 42.34 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.223 0.609 . . . . 0.0 109.722 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 -170.032 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.839 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -131.87 108.53 9.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m 63.57 172.43 0.17 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 0.0 112.754 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.06 162.83 54.52 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.29 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -148.24 161.0 42.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.519 1.128 . . . . 0.0 109.154 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -178.75 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.533 2.333 . . . . 0.0 109.336 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.69 -109.01 0.11 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -59.95 130.6 47.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.156 0.979 . . . . 0.0 108.984 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -97.0 147.3 24.14 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 112.918 -1.946 . . . . 0.0 106.253 164.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.02 154.19 23.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 160.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.06 118.08 23.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.51 130.44 39.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -135.08 107.15 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.26 128.27 41.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.76 165.46 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 109.409 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -127.35 145.75 50.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -98.94 101.48 12.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tpt -144.7 -63.51 0.36 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.28 -85.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.809 0.844 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -95.51 -31.02 13.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.919 0.327 . . . . 0.0 111.803 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.68 71.66 1.27 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.26 83.28 0.17 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.9 1.68 . . . . 0.0 111.155 168.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.39 59.44 2.83 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.893 0.759 . . . . 0.0 112.878 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.35 175.05 9.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.082 1.353 . . . . 0.0 109.613 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -129.57 166.91 18.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.99 1.316 . . . . 0.0 108.563 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.05 122.69 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.0 mt -140.36 -176.5 4.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 108.593 -173.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.27 -151.47 52.11 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -168.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.96 33.35 20.9 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 117.427 0.613 . . . . 0.0 111.578 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.63 -17.09 62.28 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.332 -1.099 . . . . 0.0 110.62 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -132.4 160.32 68.63 Favored Pre-proline 0 C--O 1.239 0.539 0 C-N-CA 126.715 2.006 . . . . 0.0 107.694 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.3 79.39 3.35 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.105 3.203 . . . . 0.0 109.153 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.09 51.38 0.27 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 125.697 1.618 . . . . 0.0 109.296 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -118.47 159.3 44.32 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.761 1.624 . . . . 0.0 107.506 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 144.34 47.89 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.788 1.659 . . . . 0.0 109.018 -170.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 7.2 mt -105.37 79.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 124.189 1.947 . . . . 0.0 107.329 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.34 124.37 31.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.316 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 mm -47.15 129.06 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.12 -0.81 89.67 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.902 2.668 . . . . 0.0 116.787 -166.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 127.35 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 C-N-CA 132.36 4.264 . . . . 0.0 108.824 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.2 t -77.41 149.89 5.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.74 117.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.36 -35.67 70.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -163.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.6 mtm -131.33 114.64 15.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.02 -177.84 38.08 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 m -51.84 -45.32 63.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.84 72.32 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.369 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.11 -41.4 99.34 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.916 0.486 . . . . 0.0 110.287 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -59.58 -46.53 88.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.227 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -21.22 66.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.434 0.561 . . . . 0.0 110.59 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 0.32 30.6 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.33 1.443 . . . . 0.0 113.673 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -99.35 -21.52 15.99 Favored 'General case' 0 C--O 1.228 -0.059 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.056 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.6 mt -95.92 145.97 24.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.309 1.413 . . . . 0.0 108.147 172.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -140.22 -179.06 0.92 Allowed Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.926 1.691 . . . . 0.0 109.949 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -94.94 138.41 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 111.702 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 -3.69 59.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 125.867 1.698 . . . . 0.0 111.771 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.43 139.96 46.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.11 132.66 42.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.011 2.124 . . . . 0.0 106.878 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.14 152.18 23.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 109.369 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.01 -50.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 108.742 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -127.74 152.37 47.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.929 . . . . 0.0 110.011 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.13 123.72 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 106.81 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t0 55.6 19.21 3.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.591 2.356 . . . . 0.0 113.319 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.11 -16.03 27.78 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.862 2.172 . . . . 0.0 113.702 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.18 131.88 22.63 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 118.778 1.289 . . . . 0.0 108.433 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -72.27 111.65 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.651 2.901 . . . . 0.0 109.004 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.67 -4.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.981 0.913 . . . . 0.0 112.007 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.3 126.29 27.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 109.54 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.86 -7.47 81.68 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.301 0.953 . . . . 0.0 112.91 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -91.99 175.95 6.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.145 1.473 . . . . 0.0 108.974 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -95.09 167.89 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.76 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -48.78 -44.38 38.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 110.646 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -57.62 -35.72 70.84 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.631 0.772 . . . . 0.0 113.075 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -56.14 -44.14 78.91 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.27 -38.55 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.965 0.906 . . . . 0.0 110.406 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -56.97 -40.61 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 120.093 1.315 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -70.73 -33.4 70.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.747 0.248 . . . . 0.0 111.574 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.17 -46.77 72.96 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.663 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.4 mmm -63.54 -33.15 74.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.195 0.907 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.06 -45.25 75.31 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.175 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -49.66 64.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.856 0.862 . . . . 0.0 111.422 176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.35 66.85 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 110.539 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 -23.44 64.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.019 -1.051 . . . . 0.0 113.327 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -93.47 -31.37 14.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.207 1.003 . . . . 0.0 110.846 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -57.71 -25.2 60.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.329 0.652 . . . . 0.0 110.519 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.88 5.35 90.14 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 121.432 -0.792 . . . . 0.0 111.926 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -149.75 174.04 13.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.372 1.869 . . . . 0.0 107.195 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.48 147.84 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 160.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -115.71 108.83 16.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 24.7 mt -99.29 140.95 32.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -120.56 114.78 22.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.55 171.36 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -148.67 162.2 40.2 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.512 -1.367 . . . . 0.0 109.24 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -155.06 120.57 5.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 109.75 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 147.31 52.01 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.378 1.471 . . . . 0.0 110.213 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.78 164.95 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.52 160.44 34.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.841 3.256 . . . . 0.0 106.822 168.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.1 t -148.9 141.77 24.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.97 -122.55 1.11 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.981 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.03 -173.8 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.365 2.71 . . . . 0.0 111.028 173.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -151.03 -33.82 0.15 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.039 0.936 . . . . 0.0 112.876 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.8 m -146.86 152.39 38.64 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.838 -1.164 . . . . 0.0 108.679 161.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.751 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -170.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.576 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m 69.4 -48.01 0.6 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.145 2.578 . . . . 0.0 114.458 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.0 m 55.68 -176.47 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.023 1.729 . . . . 0.0 113.967 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.69 110.02 3.46 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 m 28.83 75.8 0.03 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.042 2.537 . . . . 0.0 111.994 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 m -55.8 150.23 13.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.16 -95.58 0.01 OUTLIER Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 124.127 0.87 . . . . 0.0 112.075 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 2.5 p90 -51.88 135.76 29.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.81 0.814 . . . . 0.0 108.9 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 133.26 33.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 167.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.26 152.99 24.91 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 158.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -136.42 162.71 32.3 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.53 2.332 . . . . 0.0 107.511 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.52 116.93 22.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.314 1.054 . . . . 0.0 110.559 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.91 136.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 168.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -129.05 107.46 9.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 123.8 46.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -75.21 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -124.72 99.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 167.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.1 ptp -132.37 6.41 4.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.641 0.776 . . . . 0.0 110.687 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.2 -110.9 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -64.58 -30.42 71.44 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.551 1.069 . . . . 0.0 112.028 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.22 82.87 0.61 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 67.23 -171.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.148 1.379 . . . . 0.0 110.167 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.58 45.88 0.21 Allowed Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -139.58 152.05 46.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -108.6 167.16 10.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.703 2.401 . . . . 0.0 108.538 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.67 135.41 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 120.542 -1.349 . . . . 0.0 107.733 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -138.64 -176.82 4.61 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 128.563 2.745 . . . . 0.0 106.815 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.48 -159.91 41.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.67 24.8 54.25 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.719 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -64.33 -28.11 69.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.579 1.19 . . . . 0.0 110.714 -171.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -135.09 160.67 67.4 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 126.936 2.094 . . . . 0.0 108.03 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.32 35.18 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.752 1 C-N-CA 125.372 4.048 . . . . 0.0 113.603 -166.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.86 20.51 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.997 1.761 . . . . 0.0 111.528 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -89.7 154.07 47.96 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 118.92 1.36 . . . . 0.0 111.123 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.84 135.14 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.916 3.078 . . . . 0.0 109.286 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.2 92.51 2.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 mt -85.15 134.87 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.494 -0.754 . . . . 0.0 111.28 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.5 mm -54.04 112.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.696 1.998 . . . . 0.0 105.728 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.1 -74.86 0.3 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.713 1.625 . . . . 0.0 113.216 -170.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.92 119.27 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.631 1.973 . . . . 0.0 106.756 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.61 149.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.49 113.25 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.13 -23.75 56.2 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.156 1.382 . . . . 0.0 114.588 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.1 mmt -110.95 -0.05 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.23 -178.1 22.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.899 1.238 . . . . 0.0 111.181 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -66.14 -8.34 23.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.25 -40.45 18.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.086 1.766 . . . . 0.0 111.332 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.7 -53.04 24.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.447 1.099 . . . . 0.0 110.428 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -55.32 -29.18 57.77 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.54 -21.94 65.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.766 0.826 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.16 52.65 51.23 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.982 1.277 . . . . 0.0 111.022 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.78 -78.75 0.28 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.1 mt -69.13 142.05 54.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.054 0.843 . . . . 0.0 110.813 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -119.59 154.22 54.49 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.934 0.894 . . . . 0.0 108.978 159.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 142.89 34.83 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.85 1.7 . . . . 0.0 110.07 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.43 88.46 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.963 -0.91 . . . . 0.0 113.533 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -71.19 141.13 50.67 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 169.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.45 128.82 36.63 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.006 -1.059 . . . . 0.0 109.4 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.72 153.47 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.396 1.878 . . . . 0.0 110.923 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.94 -37.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.005 1.722 . . . . 0.0 109.516 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 66' ' ' PRO . 70.2 m-85 -137.18 151.92 49.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.084 0.953 . . . . 0.0 110.388 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.5 t -147.31 134.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 127.036 2.134 . . . . 0.0 106.954 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t0 58.83 17.03 4.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.299 1.44 . . . . 0.0 111.029 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.8 0.82 88.85 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.732 2.11 . . . . 0.0 114.066 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mm -94.78 136.03 23.31 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 127.036 2.134 . . . . 0.0 108.098 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 18.0 Cg_endo -74.07 145.59 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.358 2.039 . . . . 0.0 109.189 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.02 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.077 0.551 . . . . 0.0 112.379 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.8 102.14 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.041 -0.412 . . . . 0.0 110.239 -165.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.48 -3.8 50.53 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.529 1.061 . . . . 0.0 113.718 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 57.3 mmtt -78.83 -179.98 6.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.052 -1.264 . . . . 0.0 108.023 158.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.7 p -111.85 175.52 5.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.21 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -40.8 -64.24 0.56 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 109.792 170.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -55.43 -38.75 69.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.239 0.616 . . . . 0.0 112.577 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 9.1 t80 -55.01 -48.04 73.88 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.441 0.564 . . . . 0.0 109.488 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.12 -44.06 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.353 -1.308 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mm -57.16 -37.54 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.507 1.503 . . . . 0.0 109.785 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -54.52 46.02 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.053 0.941 . . . . 0.0 110.91 170.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.03 -35.04 77.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.268 0.627 . . . . 0.0 112.154 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -30.48 23.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.335 1.454 . . . . 0.0 109.388 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.9 -30.87 71.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.195 0.998 . . . . 0.0 111.339 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -51.04 59.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 173.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.18 74.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.456 1.103 . . . . 0.0 111.394 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -23.34 15.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.533 -1.354 . . . . 0.0 112.464 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -94.17 -21.73 18.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.926 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -61.92 -35.87 79.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.193 1.361 . . . . 0.0 110.696 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.47 -0.72 49.77 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.529 -0.732 . . . . 0.0 112.724 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -151.81 167.84 26.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.76 2.024 . . . . 0.0 106.672 165.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.02 122.13 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 162.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.53 128.16 33.27 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.7 mt -130.8 128.41 40.66 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.4 m -112.06 122.53 48.01 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -111.09 164.81 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.442 1.097 . . . . 0.0 109.339 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -152.21 146.78 25.71 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.596 -1.315 . . . . 0.0 110.954 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -148.82 126.88 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.834 0.454 . . . . 0.0 110.204 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.9 123.17 17.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.197 0.999 . . . . 0.0 112.361 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.5 p -93.08 165.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.207 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.41 -62.49 0.09 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 37.89 74.73 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.531 2.732 . . . . 0.0 112.364 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 170.98 44.13 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.53 162.6 41.32 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.097 2.532 . . . . 0.0 112.445 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 t -141.93 -35.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 112.485 -172.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.7 m -163.63 160.62 23.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.204 1.366 . . . . 0.0 108.68 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 CA-C-O 116.74 -2.144 . . . . 0.0 108.067 178.775 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.809 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m 81.2 -55.23 0.29 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 127.178 2.191 . . . . 0.0 112.485 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.4 m -77.28 68.17 3.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.368 1.867 . . . . 0.0 110.049 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.77 150.1 25.47 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.488 1.518 . . . . 0.0 112.002 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -84.66 93.95 8.52 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.5 m -68.79 78.51 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.693 0.797 . . . . 0.0 110.007 167.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.5 -94.43 0.24 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 121.141 -0.974 . . . . 0.0 110.758 169.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -53.9 126.56 22.78 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 124.386 0.698 . . . . 0.0 109.605 -164.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.61 117.27 26.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -83.95 141.06 31.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 116.72 15.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.52 143.06 36.93 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.819 1.648 . . . . 0.0 109.176 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.59 108.72 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 126.248 1.819 . . . . 0.0 106.743 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.3 130.45 35.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -120.9 123.91 43.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.253 0.933 . . . . 0.0 109.276 164.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -74.42 158.58 33.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.185 165.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 51.9 ttt-85 -131.24 102.31 5.93 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 125.793 1.637 . . . . 0.0 107.11 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 ptp -155.66 8.77 0.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -136.75 -76.54 0.42 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.638 -1.288 . . . . 0.0 108.41 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.47 -7.7 12.83 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.66 1.584 . . . . 0.0 111.919 170.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.14 -179.95 41.43 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.159 0.885 . . . . 0.0 111.807 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.1 m-85 -62.48 147.08 49.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.61 51.15 0.87 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -134.7 153.51 51.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -110.97 163.93 13.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.666 1.987 . . . . 0.0 107.316 168.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.46 150.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.155 1.382 . . . . 0.0 108.642 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -134.59 -177.29 4.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.856 2.062 . . . . 0.0 108.549 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.12 -140.51 37.88 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.03 23.92 8.0 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 127.956 2.693 . . . . 0.0 112.922 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.37 -25.38 65.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.031 -0.688 . . . . 0.0 110.342 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -121.84 155.9 59.86 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 123.507 0.723 . . . . 0.0 110.145 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.07 133.09 29.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.112 1.874 . . . . 0.0 108.684 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.43 19.32 74.36 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.935 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -72.59 162.38 74.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.603 1.201 . . . . 0.0 110.34 168.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -71.09 119.27 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.289 1.993 . . . . 0.0 109.571 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -90.45 97.74 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -83.73 151.77 25.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 mm -55.83 122.23 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.21 -62.7 4.24 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 128.96 4.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.762 0.825 . . . . 0.0 108.799 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.79 128.0 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.5 mm -68.21 132.93 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.278 1.431 . . . . 0.0 108.611 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.82 65.77 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.756 1.223 . . . . 0.0 113.855 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.7 mtt -126.79 54.98 1.57 Allowed 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 169.45 12.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -6.99 20.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.325 -1.321 . . . . 0.0 114.08 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.54 -56.4 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 120.03 1.286 . . . . 0.0 110.507 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.61 -45.99 91.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.429 0.559 . . . . 0.0 110.562 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -18.94 48.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.96 -17.67 20.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.962 1.305 . . . . 0.0 111.835 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.71 45.38 53.05 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.955 -1.091 . . . . 0.0 113.869 165.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -133.37 -48.51 0.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.765 0.783 . . . . 0.0 111.436 166.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 mt -74.04 148.15 42.23 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.609 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -139.77 148.5 55.79 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 125.167 1.387 . . . . 0.0 112.327 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.94 92.59 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.816 3.011 . . . . 0.0 112.464 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.87 -13.61 1.51 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.202 1.858 . . . . 0.0 113.029 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.32 154.12 28.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.957 1.379 . . . . 0.0 109.694 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.32 131.78 42.49 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.81 155.83 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.11 0.964 . . . . 0.0 110.453 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.88 -51.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 125.071 1.348 . . . . 0.0 109.332 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.401 ' CE1' ' HB3' ' A' ' 66' ' ' PRO . 96.5 m-85 -132.65 146.72 52.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.8 116.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t0 57.99 25.04 11.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.586 1.555 . . . . 0.0 111.522 -166.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.44 0.77 59.11 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.503 1.049 . . . . 0.0 112.815 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 mm -86.27 127.62 60.63 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 119.798 1.799 . . . . 0.0 106.507 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HB3' ' CE1' ' A' ' 61' ' ' TYR . 23.6 Cg_endo -69.82 128.36 15.86 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.503 2.802 . . . . 0.0 109.257 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -92.16 -3.65 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.708 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 149.11 48.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.203 0.91 . . . . 0.0 108.848 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.25 -28.12 0.33 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.017 1.294 . . . . 0.0 114.57 -172.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -74.71 173.72 10.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.054 1.342 . . . . 0.0 109.434 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -103.92 -177.36 3.35 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.726 1.61 . . . . 0.0 109.47 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.86 -55.01 40.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.254 1.822 . . . . 0.0 110.443 172.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -56.13 -35.27 66.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.382 0.992 . . . . 0.0 112.422 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -47.04 -50.34 19.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.261 0.625 . . . . 0.0 111.165 171.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.59 -35.78 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.453 1.101 . . . . 0.0 110.338 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.37 -27.86 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 119.935 1.243 . . . . 0.0 110.379 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.12 -41.28 74.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.354 -1.466 . . . . 0.0 110.686 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.98 -31.28 72.09 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.894 -1.129 . . . . 0.0 112.229 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.77 -35.02 77.93 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.024 1.33 . . . . 0.0 109.61 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.3 -60.33 3.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.486 0.714 . . . . 0.0 109.944 171.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -56.9 -49.37 75.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.351 1.061 . . . . 0.0 112.379 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.94 79.42 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 111.721 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.22 64.76 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.035 -1.04 . . . . 0.0 112.337 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -81.44 -42.59 20.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 110.428 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.07 -20.2 62.3 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.049 0.939 . . . . 0.0 110.708 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.87 11.61 76.37 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.129 0.871 . . . . 0.0 111.996 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.21 167.85 11.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.953 1.701 . . . . 0.0 107.046 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.29 150.77 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -105.29 126.09 51.71 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.65 99.27 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.4 m -87.49 116.69 25.78 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.86 169.85 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.436 1.095 . . . . 0.0 109.005 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -153.25 167.97 27.54 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.527 -1.358 . . . . 0.0 110.858 172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.492 HH11 ' CB ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -150.14 149.11 29.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.164 161.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -53.13 156.03 2.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.56 1.171 . . . . 0.0 111.615 161.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.5 146.69 18.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.26 -40.23 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.577 0.351 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m 68.21 1.9 3.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 155.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.28 118.79 1.49 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.06 163.28 36.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 120.864 2.332 . . . . 0.0 109.605 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 t -141.83 166.14 25.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 163.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.35 109.1 4.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -144.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m -142.44 144.74 33.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.746 1.218 . . . . 0.0 108.197 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 46.94 75.77 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.544 1.937 . . . . 0.0 111.491 -176.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.47 -177.01 5.13 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.174 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t -49.65 103.57 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.571 1.548 . . . . 0.0 111.431 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -133.02 58.33 1.77 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.224 1.81 . . . . 0.0 108.946 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.67 -21.14 47.68 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.473 -1.239 . . . . 0.0 115.083 157.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.52 162.86 17.3 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 108.519 166.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 130.45 52.6 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.83 138.18 33.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 162.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.84 134.56 53.57 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.765 2.026 . . . . 0.0 107.251 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -92.08 132.44 36.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.4 t -130.12 108.82 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.588 1.555 . . . . 0.0 106.977 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -86.4 126.89 34.69 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 168.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -117.61 123.14 45.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.187 0.903 . . . . 0.0 109.041 164.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -78.74 161.44 26.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 111.055 172.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 38.8 ttt-85 -139.88 93.62 2.67 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.741 1.216 . . . . 0.0 110.48 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.7 mtp -142.29 -8.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 161.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -131.22 -105.65 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -164.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 m -65.6 -23.45 66.83 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.08 -1.013 . . . . 0.0 112.285 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.44 -179.94 7.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.704 1.138 . . . . 0.0 111.729 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 3.1 m-85 -63.5 123.52 18.98 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.16 -1.2 . . . . 0.0 110.632 -165.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.75 53.42 0.59 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 124.148 0.88 . . . . 0.0 111.133 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -142.2 167.87 21.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.441 1.121 . . . . 0.0 108.66 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -123.43 162.36 22.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.801 2.04 . . . . 0.0 107.503 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.98 151.73 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.17 2.188 . . . . 0.0 106.99 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.0 mt -149.03 -177.31 5.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.476 2.31 . . . . 0.0 107.806 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.59 56.0 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.232 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -11.0 59.74 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.906 1.853 . . . . 0.0 112.415 -170.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -132.1 160.34 68.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 127.225 2.21 . . . . 0.0 107.369 168.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.94 69.56 7.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.961 3.774 . . . . 0.0 110.058 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.1 7.12 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.27 1.414 . . . . 0.0 112.599 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.54 160.84 39.88 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.62 1.71 . . . . 0.0 109.76 159.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.86 140.87 51.98 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.669 1.58 . . . . 0.0 109.175 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -105.79 93.2 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.3 149.27 25.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.1 0.476 . . . . 0.0 110.339 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.79 121.33 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 158.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.49 -68.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 124.849 1.214 . . . . 0.0 110.081 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 144.55 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.729 1.612 . . . . 0.0 107.609 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.45 139.84 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 162.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mm -86.15 110.2 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.88 144.56 11.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.893 1.277 . . . . 0.0 111.076 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.0 mmt 47.09 69.99 0.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.105 1.762 . . . . 0.0 110.012 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.01 -179.94 44.97 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 m -57.71 -38.52 75.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.906 1.353 . . . . 0.0 114.64 -165.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 -44.43 50.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.872 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -42.49 65.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.212 1.005 . . . . 0.0 111.654 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -77.33 -21.42 53.43 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.089 -1.007 . . . . 0.0 112.296 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.74 -29.32 40.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.189 0.996 . . . . 0.0 110.524 171.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.36 -3.49 4.49 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.11 2.291 . . . . 0.0 114.524 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -90.33 -42.14 11.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.658 1.229 . . . . 0.0 111.695 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 mt -69.28 160.95 30.26 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.989 0.516 . . . . 0.0 109.643 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 155.61 72.4 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.679 1.191 . . . . 0.0 109.221 160.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.0 142.47 51.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.772 1.648 . . . . 0.0 108.838 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.26 -0.94 86.85 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.465 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.55 145.13 55.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.335 1.568 . . . . 0.0 107.433 166.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -93.71 133.57 36.93 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.746 1.157 . . . . 0.0 108.323 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -88.14 153.48 21.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.373 1.469 . . . . 0.0 110.173 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.0 -47.16 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.578 1.551 . . . . 0.0 109.426 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.21 150.31 48.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.879 1.672 . . . . 0.0 108.731 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 64' ' ' GLY . 69.5 t -145.44 118.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 69.85 -31.39 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.099 2.56 . . . . 0.0 112.427 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 157.63 -21.13 0.39 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 128.065 2.745 . . . . 0.0 110.485 171.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 mp -76.82 135.69 67.5 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 127.59 2.356 . . . . 0.0 107.457 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -72.92 151.49 50.72 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.425 2.083 . . . . 0.0 110.057 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.8 m -114.26 -7.77 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.26 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.23 102.83 2.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.68 2.13 30.65 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.855 1.216 . . . . 0.0 113.502 -174.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -98.17 173.23 7.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.875 1.837 . . . . 0.0 109.387 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -89.56 172.45 8.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.319 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -61.57 -46.4 90.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 111.137 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -62.61 -26.94 68.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.106 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -45.86 -48.87 15.87 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.268 1.027 . . . . 0.0 110.516 168.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.62 -36.16 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.442 1.097 . . . . 0.0 109.118 -169.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.14 -45.46 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.186 0.903 . . . . 0.0 109.783 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -70.35 -24.85 63.05 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -74.18 -46.71 40.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.477 0.711 . . . . 0.0 110.54 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 89.6 mmm -62.58 -24.58 67.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.926 1.239 . . . . 0.0 112.199 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.46 -50.82 72.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.934 167.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -50.45 56.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.291 1.836 . . . . 0.0 111.333 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.98 69.86 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.58 0.752 . . . . 0.0 111.264 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.31 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.629 -1.294 . . . . 0.0 112.15 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -69.26 -37.78 78.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.504 1.521 . . . . 0.0 111.187 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -62.78 -12.39 23.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.381 0.537 . . . . 0.0 112.14 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.44 9.68 85.88 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.282 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -170.76 166.38 7.89 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.355 1.862 . . . . 0.0 108.119 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 118.92 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -82.18 100.65 9.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt -87.06 145.73 26.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 169.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.2 m -123.44 118.99 28.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 165.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.17 169.5 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 124.097 0.873 . . . . 0.0 108.99 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -151.35 161.04 43.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.868 -1.145 . . . . 0.0 110.183 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.83 134.46 14.53 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.531 169.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 139.28 58.27 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.915 1.286 . . . . 0.0 111.829 169.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.46 57.2 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.484 1.513 . . . . 0.0 108.481 -169.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 tp 51.92 13.95 0.28 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.334 1.854 . . . . 0.0 115.863 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 t -66.33 149.25 50.65 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.397 -1.439 . . . . 0.0 107.904 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.87 103.54 0.67 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -67.97 173.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.362 1.375 . . . . 0.0 109.628 165.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -121.05 168.4 11.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 109.693 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -81.31 -21.16 39.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.477 0.711 . . . . 0.0 110.648 163.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 174.34 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m -120.68 100.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.798 2.039 . . . . 0.0 106.861 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 p -141.56 166.37 24.92 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.643 1.977 . . . . 0.0 106.122 158.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.67 166.83 30.82 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.541 1.067 . . . . 0.0 111.323 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -77.26 149.73 35.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.888 -0.772 . . . . 0.0 109.004 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -132.16 116.61 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -66.65 2.34 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 125.749 1.642 . . . . 0.0 113.105 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -65.44 153.45 41.31 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 117.76 0.78 . . . . 0.0 108.98 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -112.59 145.22 40.73 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 170.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.16 158.58 21.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 164.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -129.09 138.96 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.433 1.893 . . . . 0.0 106.925 177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.13 125.89 46.31 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 108.098 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.17 142.79 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.349 1.06 . . . . 0.0 108.677 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -130.18 125.52 35.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.56 165.07 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.927 0.785 . . . . 0.0 110.643 -174.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -132.99 159.98 38.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.811 0.845 . . . . 0.0 111.333 -174.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -126.03 85.07 2.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.828 1.251 . . . . 0.0 111.04 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.4 ttm -140.4 -17.2 0.91 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.258 0.623 . . . . 0.0 111.487 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -91.93 -128.33 0.1 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -67.23 -7.03 20.88 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.994 -1.066 . . . . 0.0 113.084 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.25 73.5 0.69 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -165.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 74.88 156.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.545 2.338 . . . . 0.0 111.718 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.28 36.62 2.75 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.914 0.768 . . . . 0.0 111.33 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -130.65 166.26 21.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.154 0.977 . . . . 0.0 108.973 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -123.05 164.96 17.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.54 1.936 . . . . 0.0 107.544 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.61 125.7 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -173.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt -132.29 -178.25 4.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.546 1.538 . . . . 0.0 108.312 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.58 -162.96 54.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -168.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.61 18.52 65.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.078 -1.401 . . . . 0.0 114.751 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.18 -60.43 3.34 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.107 1.453 . . . . 0.0 109.002 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.91 161.2 47.88 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 107.98 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.123 3.215 . . . . 0.0 109.422 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 -5.51 12.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.305 1.431 . . . . 0.0 113.382 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -63.43 163.8 17.91 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.429 1.491 . . . . 0.0 111.47 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.25 140.48 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.937 1.758 . . . . 0.0 109.558 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.74 106.61 21.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mt -99.88 153.72 18.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 mm -52.42 140.56 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 160.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.65 -124.01 0.83 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.21 116.68 29.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.797 2.039 . . . . 0.0 107.023 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.8 124.42 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.78 103.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.0 152.5 36.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.5 mtm 47.62 43.98 16.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.4 1.88 . . . . 0.0 111.198 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' A' ' 48' ' ' ASP . . . -143.89 178.75 21.74 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 125.677 1.608 . . . . 0.0 111.874 -167.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -70.15 -7.88 45.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -163.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.19 -53.44 3.79 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.332 1.053 . . . . 0.0 110.3 165.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -43.81 -47.35 8.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 112.696 175.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -60.16 -38.13 82.25 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.267 1.427 . . . . 0.0 113.119 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.54 -32.96 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 0.0 110.831 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 31.38 35.4 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.462 160.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -131.85 -45.64 0.95 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.006 1.403 . . . . 0.0 112.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.93 144.98 52.01 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.682 -0.636 . . . . 0.0 110.222 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -132.27 158.97 74.18 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 124.778 1.231 . . . . 0.0 108.656 161.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 145.85 85.23 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.221 1.947 . . . . 0.0 110.098 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.16 6.5 79.86 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.398 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -69.73 126.35 29.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.094 1.947 . . . . 0.0 107.569 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -73.8 124.74 26.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.534 0.607 . . . . 0.0 109.402 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.51 150.73 31.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.759 0.823 . . . . 0.0 109.906 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.81 -46.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.225 1.81 . . . . 0.0 109.108 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.17 145.85 51.75 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.177 0.991 . . . . 0.0 110.249 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.7 t -139.2 129.39 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.829 1.652 . . . . 0.0 107.11 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.11 18.06 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.763 2.425 . . . . 0.0 113.225 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -11.38 62.78 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.385 2.421 . . . . 0.0 112.836 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.31 132.88 34.38 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.866 1.666 . . . . 0.0 108.62 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -70.99 116.83 4.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.863 2.375 . . . . 0.0 109.59 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.92 -7.37 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.388 0.675 . . . . 0.0 111.625 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 114.46 2.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.197 1.399 . . . . 0.0 111.032 -171.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -14.9 56.11 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.428 1.49 . . . . 0.0 113.02 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 170.48 9.43 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.747 1.219 . . . . 0.0 110.634 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.1 p -85.72 171.67 11.43 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.63 0.772 . . . . 0.0 111.024 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -46.82 -54.28 10.18 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.81 1.644 . . . . 0.0 108.831 165.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 ttp-105 -55.62 -37.76 68.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.02 -44.04 74.25 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.495 0.589 . . . . 0.0 109.918 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.15 -41.35 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.917 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.56 -44.43 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.234 0.925 . . . . 0.0 110.451 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -45.36 95.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.901 1.28 . . . . 0.0 110.189 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.56 -45.84 71.05 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.713 0.688 . . . . 0.0 111.412 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.6 mmm -52.73 -36.52 57.78 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 0.0 110.275 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -18.67 60.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.241 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -85.11 -49.06 8.57 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.02 1.728 . . . . 0.0 109.216 172.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.39 40.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.447 1.099 . . . . 0.0 109.473 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.52 -36.45 23.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.483 1.113 . . . . 0.0 113.105 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 81' ' ' HIS . 2.0 mpt_? -68.36 -39.64 81.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -71.49 -13.83 61.93 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.784 1.234 . . . . 0.0 112.759 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.41 4.54 90.01 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 119.404 1.002 . . . . 0.0 113.876 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 6.1 pt20 -142.96 178.59 7.57 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.433 1.493 . . . . 0.0 109.246 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.09 128.58 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 162.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.18 139.92 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.8 mt -139.78 125.59 19.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.532 1.969 . . . . 0.0 107.374 -174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.13 115.11 25.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.6 m -99.5 167.99 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -144.81 152.79 40.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 120.523 -1.36 . . . . 0.0 108.857 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -151.5 143.39 23.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.087 1.355 . . . . 0.0 109.633 173.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 141.22 9.6 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.512 1.125 . . . . 0.0 110.263 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.8 155.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 166.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.21 130.5 11.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -66.04 -60.31 2.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.389 0.54 . . . . 0.0 111.783 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.82 39.46 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.541 -169.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.66 151.23 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.255 3.303 . . . . 0.0 112.98 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -159.51 176.75 11.69 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.539 1.135 . . . . 0.0 108.962 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.9 m -146.38 -162.95 1.63 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.331 1.452 . . . . 0.0 107.316 150.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.63 0 N-CA-C 103.16 -3.976 . . . . 0.0 103.16 -141.902 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.376 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -147.97 119.78 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 172.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m 62.28 172.58 0.13 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 112.151 -164.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.97 -102.99 0.83 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.611 1.1 . . . . 0.0 110.75 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.1 m -79.25 52.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.238 1.015 . . . . 0.0 110.917 170.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.0 m -59.12 140.36 55.93 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.86 -72.38 0.35 Allowed Glycine 0 C--N 1.33 0.201 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.037 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' CE2' ' HD2' ' A' ' 93' ' ' ARG . 36.0 p90 -70.45 161.53 30.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 119.06 1.43 . . . . 0.0 110.008 168.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 137.43 53.17 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.489 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -83.09 151.5 25.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.98 155.21 50.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.55 123.62 28.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.885 1.274 . . . . 0.0 108.538 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 86.1 t -101.91 151.01 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.734 2.014 . . . . 0.0 106.225 176.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -128.26 120.89 28.06 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.546 1.539 . . . . 0.0 108.615 166.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.85 123.51 44.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.05 20.52 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.902 0.319 . . . . 0.0 110.147 166.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.6 ttt180 -119.69 93.79 4.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.138 2.175 . . . . 0.0 105.718 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.29 -13.78 7.11 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.046 0.538 . . . . 0.0 110.69 170.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.86 -112.45 0.19 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -65.2 -18.69 65.51 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.96 -173.65 53.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.101 0.834 . . . . 0.0 112.39 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 4.1 m-85 -71.82 111.14 6.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.433 0.693 . . . . 0.0 110.11 -164.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.26 46.47 3.64 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.419 1.009 . . . . 0.0 114.241 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -135.1 163.39 30.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.222 1.511 . . . . 0.0 110.368 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -120.27 157.29 29.47 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.294 1.838 . . . . 0.0 107.876 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.62 135.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.93 -178.85 6.02 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.213 1.405 . . . . 0.0 107.463 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.71 -154.35 46.93 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.34 34.25 40.89 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.281 0.943 . . . . 0.0 112.402 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 -46.44 43.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -167.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.09 157.96 32.71 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.423 1.089 . . . . 0.0 108.537 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.69 96.04 0.82 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.723 2.949 . . . . 0.0 108.129 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.13 -24.56 2.06 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.942 1.734 . . . . 0.0 111.44 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -73.73 150.71 88.77 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 119.399 1.599 . . . . 0.0 112.753 -171.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.38 149.55 69.45 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.588 2.858 . . . . 0.0 109.377 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -113.45 88.72 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -93.3 125.98 38.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.9 mm -43.83 120.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.484 1.913 . . . . 0.0 106.87 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.96 -56.68 23.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 124.925 1.25 . . . . 0.0 111.709 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.58 153.48 31.48 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.1 t -112.96 112.79 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 118.89 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.981 1.712 . . . . 0.0 108.368 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.53 124.55 12.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.113 0.965 . . . . 0.0 110.536 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . 0.252 20.4 ptp 46.81 20.39 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.701 2.4 . . . . 0.0 115.283 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.74 -173.19 42.72 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -58.84 -39.06 80.13 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.217 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.07 -28.59 60.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 121.679 2.036 . . . . 0.0 111.973 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.56 -47.62 69.31 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.052 0.941 . . . . 0.0 109.241 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -60.51 -40.21 90.62 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.497 0.719 . . . . 0.0 111.177 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.16 -23.5 67.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.388 1.475 . . . . 0.0 111.929 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.82 72.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.214 1.388 . . . . 0.0 113.121 167.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -122.72 -13.2 7.97 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.147 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -119.99 151.3 39.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.907 1.23 . . . . 0.0 107.885 177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -132.35 149.21 72.51 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.671 164.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.44 134.92 40.47 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.678 1.585 . . . . 0.0 108.203 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.17 1.05 76.27 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.243 -1.309 . . . . 0.0 113.961 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.12 140.68 58.82 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.563 2.181 . . . . 0.0 107.354 161.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -85.96 128.24 34.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.549 1.522 . . . . 0.0 108.767 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.26 158.0 36.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.887 0.767 . . . . 0.0 110.175 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.86 -53.29 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.499 1.919 . . . . 0.0 107.708 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -132.59 148.46 52.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.845 1.258 . . . . 0.0 108.894 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 64' ' ' GLY . 53.1 t -137.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 63.43 -2.48 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.431 2.293 . . . . 0.0 112.222 -169.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 108.93 -3.3 31.8 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 127.361 2.41 . . . . 0.0 112.096 -172.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.3 125.31 50.55 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.73 127.02 14.01 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.136 2.557 . . . . 0.0 108.555 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.03 -2.94 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.836 0.854 . . . . 0.0 110.565 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.24 120.29 14.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.901 0.88 . . . . 0.0 110.687 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.89 -12.24 37.16 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.777 1.18 . . . . 0.0 112.75 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.42 177.35 8.57 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.08 1.352 . . . . 0.0 107.814 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -105.3 175.33 5.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.622 0.769 . . . . 0.0 110.431 -172.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -52.05 -48.61 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.781 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -55.37 -35.09 64.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.38 -50.3 62.71 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.43 -40.49 82.31 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 124.035 0.934 . . . . 0.0 110.909 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mm -50.66 -42.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.586 1.084 . . . . 0.0 111.231 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -39.2 70.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.705 0.402 . . . . 0.0 110.57 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -50.18 73.65 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 122.917 0.487 . . . . 0.0 110.616 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.31 -40.14 85.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.317 0.508 . . . . 0.0 110.944 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -32.35 73.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.41 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -70.73 -57.46 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.523 1.529 . . . . 0.0 111.133 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.42 69.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.103 0.961 . . . . 0.0 111.303 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.09 72.35 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.582 -1.324 . . . . 0.0 111.09 169.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -73.73 -35.92 65.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 117.389 -1.291 . . . . 0.0 111.704 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -56.52 -25.82 52.75 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.082 0.855 . . . . 0.0 110.031 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.44 9.2 86.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 123.936 0.779 . . . . 0.0 111.571 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -160.28 165.62 31.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.037 1.419 . . . . 0.0 109.279 170.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.33 127.32 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.17 139.13 35.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 160.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.71 105.66 6.57 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.8 m -91.04 121.19 32.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.01 170.17 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' HD2' ' CE2' ' A' ' 8' ' ' TYR . 31.2 ptt180 -150.83 166.24 31.12 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.307 -1.496 . . . . 0.0 108.818 167.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -155.12 146.76 23.2 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -61.5 163.39 6.92 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.871 1.269 . . . . 0.0 111.17 168.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 25.7 t -128.66 165.09 29.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.793 1.637 . . . . 0.0 109.552 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.489 ' HG ' ' H ' ' A' ' 98' ' ' SER . 14.0 tp -167.37 -169.4 1.23 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 129.856 3.262 . . . . 0.0 104.321 -175.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.489 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 2.7 m -63.4 173.76 1.48 Allowed 'General case' 0 C--O 1.244 0.802 0 O-C-N 120.398 -1.439 . . . . 0.0 109.678 152.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.03 -178.59 23.39 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.338 -0.851 . . . . 0.0 111.05 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.39 169.91 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.096 2.531 . . . . 0.0 110.362 171.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.9 m 73.06 82.47 0.13 Allowed 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.635 1.974 . . . . 0.0 109.604 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 m -134.96 175.11 9.88 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.972 2.109 . . . . 0.0 107.59 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -160.427 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.644 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.06 169.13 5.71 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.539 -0.977 . . . . 0.0 108.84 162.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -70.05 170.32 11.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.565 -0.709 . . . . 0.0 109.412 162.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.09 -157.68 30.26 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.47 101.88 10.28 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 170.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -69.87 155.85 39.94 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 144.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.3 6.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.397 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -119.93 171.29 8.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.446 1.623 . . . . 0.0 108.769 166.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -128.91 129.46 45.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.79 146.13 28.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.4 116.66 21.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.84 130.57 34.92 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.7 130.41 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.507 1.523 . . . . 0.0 107.29 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -126.46 122.12 34.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -169.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.63 123.38 43.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -75.04 158.28 33.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.384 0.612 . . . . 0.0 109.645 169.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.7 ttt85 -125.48 88.28 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 168.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 ptm -142.33 -12.81 0.81 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 173.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -132.83 -71.99 0.52 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.639 1.576 . . . . 0.0 107.657 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -119.34 0.06 11.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.35 -156.97 52.57 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.702 1.137 . . . . 0.0 112.452 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.8 m-85 -108.94 105.16 14.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.75 0.82 . . . . 0.0 110.158 -169.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.95 41.83 3.11 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.307 1.908 . . . . 0.0 114.296 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.32 150.54 52.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.632 1.716 . . . . 0.0 110.166 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.06 160.21 14.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.739 1.616 . . . . 0.0 108.952 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.79 138.34 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.76 163.12 38.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.205 2.202 . . . . 0.0 106.0 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.62 176.09 42.06 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.11 90.07 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 -149.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.8 -26.41 65.18 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.658 0.783 . . . . 0.0 110.437 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.64 160.53 46.04 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.95 53.01 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.688 3.592 . . . . 0.0 109.651 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.73 58.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -136.27 161.65 61.04 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 111.569 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -73.31 132.31 17.64 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.955 2.437 . . . . 0.0 109.409 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.65 108.1 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 mt -100.01 149.66 23.23 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 mm -49.55 118.28 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.6 -72.81 0.84 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -171.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.1 117.15 4.83 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.861 0.865 . . . . 0.0 109.024 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.267 0.6 OUTLIER -80.0 149.26 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 121.308 0.575 . . . . 0.0 109.451 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -80.82 107.59 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -54.22 146.36 15.4 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 mmt 64.0 -10.86 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.236 1.814 . . . . 0.0 112.72 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -73.88 169.39 53.68 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -60.78 -23.03 64.7 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.13 -45.19 42.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.782 1.628 . . . . 0.0 110.96 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.13 -51.45 69.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -64.24 -34.53 78.32 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.489 -0.757 . . . . 0.0 112.237 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.76 -29.59 70.23 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.287 0.948 . . . . 0.0 110.792 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.39 28.32 52.89 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.816 161.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -136.78 -18.5 1.39 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.432 1.116 . . . . 0.0 113.343 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -90.01 148.25 23.18 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -135.32 157.04 77.47 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 125.062 1.345 . . . . 0.0 107.643 157.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.8 149.71 86.53 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.443 1.429 . . . . 0.0 108.881 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.63 -2.63 72.18 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.623 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.6 136.82 56.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.934 1.867 . . . . 0.0 107.276 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -85.37 127.36 34.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.766 1.166 . . . . 0.0 109.581 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.09 153.58 30.05 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.228 1.011 . . . . 0.0 110.224 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.5 -46.51 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 126.165 1.786 . . . . 0.0 109.055 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.4 148.42 42.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.403 1.081 . . . . 0.0 110.553 -176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.0 t -145.49 131.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 107.849 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 61.29 14.01 5.32 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.205 1.402 . . . . 0.0 111.333 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.08 -5.73 75.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 127.112 2.292 . . . . 0.0 113.444 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -104.36 133.99 19.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 121.069 2.434 . . . . 0.0 109.381 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.61 120.92 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.313 2.675 . . . . 0.0 110.786 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.62 -2.27 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.754 1.222 . . . . 0.0 112.62 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.62 125.12 22.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.357 1.063 . . . . 0.0 110.274 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.47 -7.12 9.07 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.367 0.984 . . . . 0.0 114.535 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.593 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 14.6 mmtt -82.88 174.29 11.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.412 1.485 . . . . 0.0 108.778 167.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.8 p -111.82 175.48 5.41 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.616 0.766 . . . . 0.0 110.696 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -38.69 -62.89 0.56 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.044 1.338 . . . . 0.0 110.586 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 ttp-105 -56.42 -34.09 66.43 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.593 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 76.0 t80 -58.12 -44.43 87.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.315 0.578 . . . . 0.0 110.978 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.97 -31.75 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.232 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.92 -41.48 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.265 -1.522 . . . . 0.0 111.272 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.88 -52.04 67.13 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.511 1.524 . . . . 0.0 109.042 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -51.3 69.78 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.277 0.631 . . . . 0.0 111.141 -175.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.2 mmm -61.98 -21.67 65.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 112.497 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 -32.59 53.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.723 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -66.27 -47.39 73.84 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.318 0.963 . . . . 0.0 110.126 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.05 70.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.41 73.99 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.9 -1.75 . . . . 0.0 112.887 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -68.68 -49.88 55.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.29 -20.6 7.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.432 1.493 . . . . 0.0 112.213 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.15 71.27 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.338 1.923 . . . . 0.0 111.329 170.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -177.47 170.56 2.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.441 2.296 . . . . 0.0 107.223 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.11 149.92 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.31 137.22 45.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.44 106.83 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -97.09 111.41 23.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.61 173.45 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -151.36 164.87 35.71 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.741 -1.225 . . . . 0.0 109.514 170.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.2 146.76 25.02 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.959 1.304 . . . . 0.0 108.322 164.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 144.15 41.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.665 1.186 . . . . 0.0 110.632 170.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -97.43 151.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.896 1.278 . . . . 0.0 108.436 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.69 127.47 25.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.2 m -162.81 86.05 0.55 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.84 98.18 0.18 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.807 -1.552 . . . . 0.0 110.615 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.93 131.78 23.19 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.275 2.65 . . . . 0.0 110.062 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 m 60.83 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 112.653 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -150.37 167.48 26.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.465 1.106 . . . . 0.0 108.401 160.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.35 0 N-CA-C 105.581 -3.008 . . . . 0.0 105.581 -164.067 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.361 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m 75.67 158.98 0.21 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.355 1.862 . . . . 0.0 112.534 166.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 m -54.94 131.91 45.6 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.201 1.4 . . . . 0.0 111.871 -172.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.92 156.11 22.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.073 1.32 . . . . 0.0 110.481 168.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m 58.86 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.533 1.933 . . . . 0.0 111.874 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -55.16 143.6 26.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.004 0.522 . . . . 0.0 110.114 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.1 1.54 88.67 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.971 0.796 . . . . 0.0 112.992 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.53 167.72 19.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 135.37 52.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -84.28 145.14 28.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.71 116.83 21.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -102.56 111.09 23.24 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 107.766 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.95 150.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.369 1.868 . . . . 0.0 107.356 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -128.53 119.71 25.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.875 1.67 . . . . 0.0 111.59 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.7 mt -116.55 123.01 46.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -72.72 146.55 46.37 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 165.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.83 101.25 13.17 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 152.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.1 ptm -133.98 -9.75 2.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.057 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -138.04 -98.43 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.7 p -66.75 -20.41 65.95 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -162.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.78 73.62 0.66 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 54.74 93.7 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.187 2.595 . . . . 0.0 113.512 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.94 55.7 4.53 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.564 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -129.31 175.16 8.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.932 1.293 . . . . 0.0 108.311 167.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -137.74 153.54 49.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.011 1.324 . . . . 0.0 107.573 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.42 140.02 47.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.98 160.77 43.0 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.829 2.052 . . . . 0.0 105.662 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 -178.86 52.34 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.06 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.68 48.72 79.22 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 -143.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.98 -37.87 88.98 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.86 161.5 55.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.667 1.987 . . . . 0.0 108.904 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.39 53.98 4.95 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 125.208 3.938 . . . . 0.0 112.288 -163.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.57 0.95 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.552 2.025 . . . . 0.0 112.077 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -75.12 163.94 64.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.042 1.921 . . . . 0.0 111.398 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -74.5 143.49 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.025 2.483 . . . . 0.0 110.13 171.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.42 104.85 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -98.32 155.27 17.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -55.67 118.79 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 161.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.87 -56.35 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.24 155.3 42.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.292 1.037 . . . . 0.0 109.257 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 149.28 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 C-N-CA 127.425 2.29 . . . . 0.0 107.224 166.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.68 108.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.7 138.68 10.57 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.496 1.118 . . . . 0.0 110.146 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.8 mmt 59.8 0.95 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.043 2.137 . . . . 0.0 113.856 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.76 -175.99 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.783 1.659 . . . . 0.0 110.845 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -54.37 -35.85 63.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -164.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.85 -51.81 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.011 0.823 . . . . 0.0 110.438 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.55 -45.88 88.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.419 0.688 . . . . 0.0 110.687 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -60.21 -31.34 70.07 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.728 0.811 . . . . 0.0 113.028 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.85 -21.43 64.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.081 0.401 . . . . 0.0 111.728 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.58 45.99 86.78 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.446 1.022 . . . . 0.0 112.875 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -143.53 -47.63 0.29 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.379 1.471 . . . . 0.0 112.173 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.7 153.64 41.08 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.662 0.664 . . . . 0.0 109.489 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -142.36 155.63 64.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.211 1.004 . . . . 0.0 110.436 162.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -57.36 134.87 66.53 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.644 2.229 . . . . 0.0 108.957 167.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.4 7.09 69.98 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.44 0.543 . . . . 0.0 113.694 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -77.71 123.12 26.27 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 171.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -73.05 123.78 24.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.42 149.87 35.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.921 0.888 . . . . 0.0 109.253 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.11 -52.12 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -134.09 147.44 50.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.381 1.072 . . . . 0.0 109.464 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.8 t -145.51 123.32 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -171.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.14 -56.38 0.23 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.398 2.279 . . . . 0.0 109.107 -160.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.37 -7.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.694 2.093 . . . . 0.0 110.847 164.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mp -73.48 139.05 77.83 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 127.242 2.217 . . . . 0.0 107.442 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.57 127.76 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.099 2.532 . . . . 0.0 112.704 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.73 -9.14 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.711 0.804 . . . . 0.0 113.103 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.41 129.86 43.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.926 0.891 . . . . 0.0 110.525 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.49 -12.7 2.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.427 1.013 . . . . 0.0 115.456 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 69.0 mmtt -75.34 179.03 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.712 . . . . 0.0 108.134 169.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.5 p -115.52 171.34 7.79 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.768 -0.582 . . . . 0.0 110.043 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -34.58 -60.21 0.44 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.538 1.935 . . . . 0.0 112.142 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -53.33 -37.41 62.29 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.946 1.298 . . . . 0.0 113.111 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.466 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 49.6 t80 -52.14 -45.45 65.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.992 0.917 . . . . 0.0 110.01 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.82 -37.92 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 124.785 1.234 . . . . 0.0 110.188 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.22 -35.27 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 121.539 -0.725 . . . . 0.0 110.104 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.69 -39.85 95.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.676 0.79 . . . . 0.0 111.331 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.39 -37.4 68.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.106 0.962 . . . . 0.0 111.033 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -38.92 78.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.056 0.942 . . . . 0.0 109.604 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -43.8 97.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.682 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -46.9 72.02 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.303 0.956 . . . . 0.0 110.555 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.79 -34.61 69.8 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.156 0.582 . . . . 0.0 111.802 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.26 82.77 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.604 -0.685 . . . . 0.0 111.301 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.63 -41.34 65.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.332 1.053 . . . . 0.0 110.123 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -55.66 -24.27 32.96 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.554 1.541 . . . . 0.0 112.389 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.95 63.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.156 1.836 . . . . 0.0 113.039 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -171.51 160.74 6.04 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.365 1.583 . . . . 0.0 109.048 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.29 121.88 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.284 1.04 . . . . 0.0 109.253 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -80.42 132.51 35.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 162.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 43.3 mt -127.65 106.06 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 m -94.98 111.63 23.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -99.33 171.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -150.75 161.42 42.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 120.203 -1.561 . . . . 0.0 110.136 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.25 136.54 20.02 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.844 0.831 . . . . 0.0 111.049 165.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.07 126.97 31.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.558 2.743 . . . . 0.0 111.843 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.2 t -70.43 151.37 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 109.519 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.82 131.53 7.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.0 m -139.22 68.37 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.265 1.026 . . . . 0.0 108.648 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.86 175.3 6.95 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.945 1.259 . . . . 0.0 112.314 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -73.26 -52.94 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.4 p -174.88 98.3 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.22 1.008 . . . . 0.0 109.678 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.3 m 62.19 111.81 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.252 2.221 . . . . 0.0 113.429 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -170.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.507 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 m -153.58 113.57 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.783 1.633 . . . . 0.0 107.933 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -108.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 168.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.37 118.39 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 107.066 -2.414 . . . . 0.0 107.066 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m 175.66 162.4 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.542 1.537 . . . . 0.0 111.241 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.3 p -145.47 -175.18 4.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.3 1.84 . . . . 0.0 106.446 142.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.38 -161.34 29.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 144.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 p90 50.2 -176.43 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.77 1.228 . . . . 0.0 112.252 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -132.83 130.15 39.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.7 120.95 26.63 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 116.82 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.66 129.88 34.98 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.932 2.093 . . . . 0.0 109.07 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.14 148.84 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.509 1.523 . . . . 0.0 107.107 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -130.72 133.98 46.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 167.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.57 129.36 50.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 124.011 0.819 . . . . 0.0 110.482 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.35 163.19 24.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.899 0.857 . . . . 0.0 110.136 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -114.92 102.38 9.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 164.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.557 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 8.9 ptp -146.62 -62.4 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 18' ' ' MET . 1.8 tm-20 -66.46 -171.55 0.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.004 1.721 . . . . 0.0 108.998 151.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -64.87 11.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.073 2.949 . . . . 0.0 117.006 -152.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 78.66 0.83 Allowed Glycine 0 N--CA 1.45 -0.401 0 O-C-N 121.155 -0.966 . . . . 0.0 112.343 160.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.04 81.71 0.13 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.985 2.114 . . . . 0.0 111.907 171.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.59 58.99 3.77 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.017 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.75 167.52 20.39 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.902 1.351 . . . . 0.0 109.808 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -118.64 163.98 16.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.008 2.123 . . . . 0.0 106.85 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 128.71 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.517 1.927 . . . . 0.0 106.319 -175.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.8 161.77 35.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.625 0.726 . . . . 0.0 110.149 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.94 -160.24 34.75 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 28.58 60.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -150.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.28 -30.81 62.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.054 0.542 . . . . 0.0 110.318 -162.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -104.05 161.51 22.71 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.911 2.085 . . . . 0.0 107.948 163.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.69 100.43 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.849 3.033 . . . . 0.0 108.809 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.75 6.51 7.16 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.241 1.401 . . . . 0.0 114.18 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -82.82 157.13 67.17 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 119.339 1.57 . . . . 0.0 110.862 172.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.72 138.89 39.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.49 2.127 . . . . 0.0 110.514 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.9 mt -102.56 95.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.05 145.67 25.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.81 117.03 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.74 -52.65 47.04 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 125.289 1.423 . . . . 0.0 111.471 -168.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.19 156.64 22.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.232 3.013 . . . . 0.0 105.137 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.7 130.48 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 169.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.64 117.12 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.16 -31.02 63.0 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.0 mmt -127.72 33.5 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.31 170.58 17.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -62.03 -12.94 21.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.22 -51.26 13.75 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.165 1.348 . . . . 0.0 109.668 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.07 -45.87 86.39 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -54.67 -46.73 74.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.304 0.502 . . . . 0.0 112.007 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.28 -30.51 71.38 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.8 0.273 . . . . 0.0 111.196 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.47 -37.69 3.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 127.437 2.446 . . . . 0.0 112.436 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -65.37 -21.88 66.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.548 1.139 . . . . 0.0 113.774 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.5 132.89 33.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -125.87 157.19 69.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 124.442 1.097 . . . . 0.0 109.309 160.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.28 148.45 74.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.431 1.421 . . . . 0.0 109.45 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.43 -7.19 79.95 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.529 -1.15 . . . . 0.0 112.562 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.04 128.97 37.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.497 1.648 . . . . 0.0 106.798 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.55 125.02 30.67 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 120.81 -1.181 . . . . 0.0 109.12 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.13 145.51 37.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.405 1.082 . . . . 0.0 109.773 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -120.13 -54.21 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.081 2.152 . . . . 0.0 108.245 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -128.57 146.03 50.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.128 1.371 . . . . 0.0 108.97 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -140.04 121.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t0 53.7 16.22 0.95 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.163 1.785 . . . . 0.0 111.963 -168.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.99 69.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 127.455 2.455 . . . . 0.0 114.199 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.12 125.9 71.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 120.834 2.317 . . . . 0.0 106.269 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.14 117.3 5.03 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.055 2.503 . . . . 0.0 108.466 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.6 m -79.1 -6.33 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.723 0.809 . . . . 0.0 111.669 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 121.35 16.86 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.146 0.578 . . . . 0.0 110.373 -171.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.41 -9.39 75.66 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.902 1.239 . . . . 0.0 112.978 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 66.5 mmtt -74.93 -164.34 0.29 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.282 1.433 . . . . 0.0 108.13 166.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -120.86 170.02 9.88 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.685 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -38.46 -61.44 0.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.956 1.702 . . . . 0.0 109.414 165.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -42.99 -46.22 5.38 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 128.46 2.704 . . . . 0.0 112.645 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.411 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 42.3 t80 -58.83 -40.91 85.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 111.118 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -75.44 -32.23 25.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.372 -0.83 . . . . 0.0 109.225 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -60.35 -40.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.763 1.165 . . . . 0.0 109.763 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.15 -45.69 92.21 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 110.269 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -48.96 78.52 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.644 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.8 mmm -60.11 -33.36 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.239 0.927 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -61.92 -45.3 94.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.208 0.603 . . . . 0.0 110.044 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -58.96 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.224 1.41 . . . . 0.0 111.355 175.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.65 73.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.192 1.397 . . . . 0.0 110.581 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.74 63.76 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.961 -1.087 . . . . 0.0 111.003 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -70.43 -41.78 72.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.79 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.01 -10.31 9.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.981 2.113 . . . . 0.0 113.365 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.76 1.5 83.91 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.012 1.291 . . . . 0.0 113.269 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -159.71 -178.59 7.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.979 2.112 . . . . 0.0 108.043 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.58 131.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.77 1.628 . . . . 0.0 106.752 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.69 141.89 34.44 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 162.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -135.8 122.81 21.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -115.7 113.18 23.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.24 168.71 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.92 148.91 29.68 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 119.678 -1.889 . . . . 0.0 110.208 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -147.2 123.99 11.23 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.28 145.4 10.99 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.461 1.504 . . . . 0.0 111.373 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.34 122.18 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.2 -47.6 0.23 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.454 -171.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.8 m -162.02 163.93 28.54 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.775 2.03 . . . . 0.0 107.563 168.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.95 -96.57 1.5 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-O 117.77 -1.572 . . . . 0.0 111.7 -166.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.72 110.5 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.022 3.148 . . . . 0.0 109.725 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 m -87.39 64.02 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.177 0.991 . . . . 0.0 108.448 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.9 p -75.94 75.54 2.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.908 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 -171.26 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -86.21 -74.3 0.42 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.55 0.675 . . . . 0.0 109.476 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -75.99 65.86 2.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.428 1.491 . . . . 0.0 110.957 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.55 92.06 0.1 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.204 -0.935 . . . . 0.0 112.436 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.4 m -70.22 103.26 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 158.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m 39.22 67.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.05 2.14 . . . . 0.0 113.259 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.02 -86.66 1.17 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -59.66 160.42 7.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.712 0.292 . . . . 0.0 110.349 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -122.53 141.96 51.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.3 159.53 21.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 166.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.54 146.82 40.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.374 1.47 . . . . 0.0 107.39 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.42 139.01 38.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.281 1.833 . . . . 0.0 109.322 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.2 t -137.52 107.42 4.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -100.66 139.3 36.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.9 mt -134.83 149.99 50.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.767 0.827 . . . . 0.0 109.976 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -97.84 151.26 20.4 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 109.447 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 60.6 ttt-85 -125.92 76.89 1.63 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 0.0 108.835 177.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -143.61 13.48 1.74 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.232 0.613 . . . . 0.0 111.151 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -147.82 -121.58 0.06 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.362 1.865 . . . . 0.0 106.935 -175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -31.13 71.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.078 -1.639 . . . . 0.0 111.826 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.23 -177.28 39.73 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.86 155.29 40.78 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.9 0.88 . . . . 0.0 110.393 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.72 63.23 0.47 Allowed Glycine 0 C--N 1.337 0.639 0 C-N-CA 124.294 0.95 . . . . 0.0 111.902 -170.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -128.79 170.36 13.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.882 1.273 . . . . 0.0 109.098 172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -122.16 163.36 19.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 156.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.26 133.63 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.1 mt -142.85 121.73 12.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.52 179.51 15.76 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.21 29.93 76.53 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -167.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -66.47 -20.45 66.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.573 0.687 . . . . 0.0 110.166 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.57 155.32 80.44 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.914 1.686 . . . . 0.0 110.103 165.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.43 81.88 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.094 3.863 . . . . 0.0 115.165 -165.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.92 -12.75 1.92 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 124.974 1.273 . . . . 0.0 112.033 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -66.82 157.14 85.08 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 117.55 0.675 . . . . 0.0 110.529 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.69 113.04 3.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.733 2.289 . . . . 0.0 111.777 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.56 105.16 6.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.4 mt -93.43 158.48 15.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.421 1.088 . . . . 0.0 109.704 166.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.43 126.04 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 154.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.91 -77.88 0.18 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.35 144.9 29.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.636 1.175 . . . . 0.0 108.602 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 1.2 m -98.79 140.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 123.88 0.872 . . . . 0.0 110.14 169.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.83 111.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.64 -39.83 68.38 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.256 0.551 . . . . 0.0 112.053 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.6 mmt -106.12 44.42 1.05 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.002 0.921 . . . . 0.0 109.053 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.85 165.09 27.73 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.8 1.667 . . . . 0.0 109.643 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -69.11 -10.32 57.07 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 115.653 1.724 . . . . 0.0 115.653 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.05 56.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.092 1.315 . . . . 0.0 109.348 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.89 -43.5 92.71 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.141 0.9 . . . . 0.0 110.058 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -55.82 -43.04 76.57 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.242 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.33 -18.48 63.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.621 1.1 . . . . 0.0 112.643 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.26 54.64 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.448 1.023 . . . . 0.0 113.078 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -134.5 -38.46 0.83 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -74.16 170.16 16.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.777 1.171 . . . . 0.0 109.418 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.08 152.22 42.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.15 0.98 . . . . 0.0 109.445 156.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.94 120.08 6.79 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.11 2.54 . . . . 0.0 108.585 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.62 6.2 54.91 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.378 -1.235 . . . . 0.0 112.951 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.67 142.41 58.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.654 1.727 . . . . 0.0 108.383 159.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -86.72 125.8 34.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.312 1.045 . . . . 0.0 109.466 173.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.75 156.43 27.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.038 1.335 . . . . 0.0 110.809 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.39 -54.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.583 1.953 . . . . 0.0 111.693 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.61 143.87 49.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.508 1.523 . . . . 0.0 110.777 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 64' ' ' GLY . 41.3 t -133.46 111.99 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 72.32 -38.02 0.41 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.102 2.961 . . . . 0.0 111.25 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 62' ' ' VAL . . . 164.32 -3.55 0.06 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 130.617 3.961 . . . . 0.0 109.797 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 125.87 38.41 Favored Pre-proline 0 N--CA 1.439 -1.023 0 O-C-N 120.562 -1.552 . . . . 0.0 107.058 -168.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.19 141.03 67.48 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.903 1.735 . . . . 0.0 109.662 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -90.15 -9.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.234 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.72 117.87 5.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.152 0.981 . . . . 0.0 110.12 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.04 83.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.849 0.738 . . . . 0.0 114.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 74' ' ' TYR . 26.3 mmmt -87.01 -171.83 3.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.304 1.441 . . . . 0.0 107.495 167.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -130.58 -179.55 5.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.168 0.987 . . . . 0.0 109.893 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -53.82 -57.44 10.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.661 0.784 . . . . 0.0 111.057 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.75 70.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.276 0.944 . . . . 0.0 112.879 -171.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.443 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 58.2 t80 -46.78 -59.67 2.9 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.038 0.935 . . . . 0.0 109.819 167.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.97 -36.61 76.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 123.37 0.668 . . . . 0.0 109.286 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.35 -32.63 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.652 -1.28 . . . . 0.0 111.507 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.84 -33.86 66.43 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.156 -1.59 . . . . 0.0 110.904 168.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -32.81 66.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.108 0.963 . . . . 0.0 111.357 -173.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 62.3 mmm -58.58 -36.81 74.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.57 1.148 . . . . 0.0 111.279 166.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -73.04 -45.74 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.11 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -51.14 -55.55 17.24 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 125.257 1.423 . . . . 0.0 110.962 170.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.75 89.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.776 0.831 . . . . 0.0 111.058 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.0 -14.64 60.91 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.464 -1.397 . . . . 0.0 113.058 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -85.7 -36.67 20.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.83 1.195 . . . . 0.0 111.068 165.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -62.67 -15.85 54.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.85 21.03 79.18 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.935 1.731 . . . . 0.0 112.546 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -164.78 177.05 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.755 2.022 . . . . 0.0 106.811 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.0 p -154.58 160.16 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -141.76 91.09 2.33 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.68 0.792 . . . . 0.0 108.907 -170.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 21.3 mt -98.24 99.5 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.49 1.516 . . . . 0.0 107.815 -170.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -87.9 131.35 34.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.4 167.7 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.411 1.884 . . . . 0.0 108.211 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -152.39 151.85 31.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 121.031 -1.043 . . . . 0.0 110.292 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -145.02 134.82 23.56 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.478 0.711 . . . . 0.0 109.116 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 118.0 7.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 126.39 1.876 . . . . 0.0 111.112 170.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 35.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 127.562 2.345 . . . . 0.0 111.114 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.21 87.8 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.039 1.735 . . . . 0.0 111.418 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.1 p -138.79 155.31 48.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.115 1.366 . . . . 0.0 107.487 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 163.33 77.23 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.03 -36.19 49.91 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.771 2.981 . . . . 0.0 111.483 -173.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.27 94.9 2.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -79.85 41.61 0.51 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 161.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.237 0 N-CA-C 106.214 -2.754 . . . . 0.0 106.214 -164.367 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.76 0.314 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -116.0 139.91 49.79 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.9 152.31 24.61 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 164.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.38 127.84 34.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.18 149.53 27.87 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -139.24 107.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -76.07 143.43 41.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.12 131.24 32.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -82.19 153.63 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -108.25 87.35 2.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtm -143.88 -3.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.66 -64.14 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -126.29 -14.28 5.95 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.47 60.7 3.93 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 119.728 1.149 . . . . 0.0 112.382 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 85.5 93.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.608 2.363 . . . . 0.0 110.568 160.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.72 53.76 4.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.677 0.656 . . . . 0.0 112.325 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE1' HD11 ' A' ' 90' ' ' LEU . 31.2 p90 -130.44 173.51 10.77 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.373 1.086 . . . . 0.0 109.039 169.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -140.37 165.61 26.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.5 128.66 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -164.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -139.62 -177.13 4.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.526 1.93 . . . . 0.0 108.053 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.43 -146.67 36.2 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.57 31.97 52.94 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.186 0.993 . . . . 0.0 112.652 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.96 -30.92 56.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.083 -0.657 . . . . 0.0 112.145 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -114.85 158.9 39.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.73 91.09 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.245 2.63 . . . . 0.0 109.638 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.3 1.84 10.11 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.14 1.353 . . . . 0.0 114.17 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.5 159.88 56.34 Favored Pre-proline 0 C--O 1.239 0.54 0 CA-C-N 119.428 1.614 . . . . 0.0 109.237 163.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.82 145.35 56.51 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.654 2.236 . . . . 0.0 111.224 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.53 92.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -100.69 140.73 34.56 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.653 3.581 . . . . 0.0 109.543 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.81 109.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.653 1.581 . . . . 0.0 107.672 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.76 -46.55 31.16 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 127.661 2.553 . . . . 0.0 112.569 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 163.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.545 1.538 . . . . 0.0 107.424 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.59 131.9 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 161.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.11 107.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.34 132.01 47.03 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.753 0.658 . . . . 0.0 109.853 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.1 mtm 68.49 -5.94 0.88 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.537 1.935 . . . . 0.0 114.19 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.64 176.81 53.5 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.192 0.884 . . . . 0.0 111.811 -171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 32.1 t -60.48 -8.84 3.01 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.217 1.807 . . . . 0.0 115.018 -167.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.78 -46.62 6.19 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 120.137 1.335 . . . . 0.0 111.609 168.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -56.4 -40.1 74.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.477 1.511 . . . . 0.0 110.306 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 13.3 ptm180 -69.89 -22.0 63.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -22.57 55.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.174 0.897 . . . . 0.0 110.129 170.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.8 60.3 8.94 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 125.643 1.592 . . . . 0.0 110.79 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -146.68 2.29 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -135.56 151.0 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -129.22 149.87 73.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 125.097 1.359 . . . . 0.0 109.053 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.81 130.58 34.74 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.556 2.838 . . . . 0.0 111.317 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.62 88.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.066 -1.408 . . . . 0.0 113.671 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 127.81 33.64 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.172 1.486 . . . . 0.0 107.761 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 119.28 18.06 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.6 mt -63.83 164.4 10.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.878 1.671 . . . . 0.0 111.001 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.2 -52.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.203 1.401 . . . . 0.0 109.673 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.34 148.19 52.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.005 0.922 . . . . 0.0 108.553 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -137.0 113.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.58 5.23 0.44 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.876 2.47 . . . . 0.0 114.198 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.46 -5.94 6.67 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.947 2.689 . . . . 0.0 113.094 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.0 124.6 34.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 119.483 1.642 . . . . 0.0 107.747 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.65 114.71 4.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.42 3.413 . . . . 0.0 109.179 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.72 -7.46 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.75 1.22 . . . . 0.0 112.789 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.24 129.85 40.47 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.579 -0.701 . . . . 0.0 110.313 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.01 84.06 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.991 -0.443 . . . . 0.0 113.374 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -101.22 -166.95 1.36 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.604 1.561 . . . . 0.0 108.195 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -121.56 177.75 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.075 0.95 . . . . 0.0 110.892 -170.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -52.19 -56.27 15.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.616 0.766 . . . . 0.0 109.759 169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -55.69 -33.41 64.12 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.79 -50.93 62.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.816 0.846 . . . . 0.0 110.357 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.55 -38.19 78.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 124.947 1.299 . . . . 0.0 111.16 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.0 mm -56.53 -39.46 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.868 0.758 . . . . 0.0 109.224 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -37.77 85.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.944 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.37 -49.69 74.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.234 0.613 . . . . 0.0 111.047 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.46 -36.77 74.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 111.133 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.31 -14.51 56.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.263 1.025 . . . . 0.0 113.105 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.27 -49.29 5.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.15 1.38 . . . . 0.0 110.825 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.76 -41.33 73.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.126 0.97 . . . . 0.0 110.63 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.0 -22.02 65.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.311 -1.493 . . . . 0.0 113.152 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.62 -43.52 20.37 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.535 1.134 . . . . 0.0 109.517 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -54.91 -23.64 19.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.329 0.652 . . . . 0.0 110.975 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.73 13.76 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.475 1.036 . . . . 0.0 111.956 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.15 174.68 12.6 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.231 2.212 . . . . 0.0 106.751 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.47 164.68 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -129.21 133.01 47.36 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 166.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.444 HD11 ' CE1' ' A' ' 24' ' ' PHE . 18.1 mt -130.61 97.48 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.119 2.168 . . . . 0.0 105.386 -169.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.1 m -85.49 117.07 24.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.19 170.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 108.743 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -152.9 145.89 24.55 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 119.594 -1.942 . . . . 0.0 112.326 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.57 130.57 17.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.754 0.706 . . . . 0.0 110.252 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.363 0 C-N-CA 125.072 1.349 . . . . 0.0 109.721 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.3 p90 . . . . . 0 C--O 1.241 0.61 0 CA-C-O 121.138 0.494 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -91.65 136.09 33.4 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.52 155.83 23.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.736 1.273 . . . . 0.0 108.122 151.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.32 116.93 10.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.158 2.183 . . . . 0.0 106.62 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.48 134.44 34.64 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.516 1.127 . . . . 0.0 109.767 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.412 HG22 ' HE ' ' A' ' 52' ' ' ARG . 79.6 t -129.04 143.36 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 127.014 2.125 . . . . 0.0 107.979 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -129.13 103.17 6.82 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.464 -0.773 . . . . 0.0 110.548 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -103.48 131.8 50.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.857 0.837 . . . . 0.0 109.772 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -86.86 160.73 18.64 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.418 0.687 . . . . 0.0 110.639 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -121.83 86.79 2.64 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.991 0.917 . . . . 0.0 110.488 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 mtp -130.41 -9.94 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.697 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.69 -100.32 0.19 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -29.73 70.7 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.12 1.327 . . . . 0.0 110.709 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.73 73.73 0.84 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 69.58 -115.8 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.308 1.843 . . . . 0.0 109.167 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.32 40.55 0.25 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 120.846 1.657 . . . . 0.0 112.742 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -123.22 175.52 6.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.045 1.338 . . . . 0.0 108.508 168.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.59 167.11 21.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.54 121.69 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.837 1.199 . . . . 0.0 109.07 -162.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.7 mt -138.26 147.09 43.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.32 -163.3 12.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.6 28.15 64.78 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 118.29 1.045 . . . . 0.0 112.458 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.22 -37.88 86.62 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.427 -1.043 . . . . 0.0 110.233 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.53 160.99 30.94 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.417 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.77 46.91 2.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.705 3.603 . . . . 0.0 112.588 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.13 48.29 0.12 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 109.858 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -123.26 164.05 30.17 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.596 1.159 . . . . 0.0 110.759 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.6 143.89 27.73 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.477 2.785 . . . . 0.0 108.463 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.58 100.38 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.9 mt -87.95 151.01 23.12 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mm -57.56 112.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 162.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.12 -56.39 24.39 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 126.814 2.149 . . . . 0.0 111.763 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.58 167.86 28.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.571 1.949 . . . . 0.0 106.943 172.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.38 130.71 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 mm -79.93 115.39 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.46 -21.2 3.45 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.491 1.917 . . . . 0.0 115.085 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.7 mmt -122.28 7.06 9.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.73 1.612 . . . . 0.0 110.989 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.91 167.63 34.91 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 120.701 -1.249 . . . . 0.0 110.53 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.417 ' HA ' ' CG ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -61.94 -12.86 20.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.292 1.037 . . . . 0.0 112.613 175.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.79 -69.12 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.997 0.817 . . . . 0.0 110.128 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.15 -43.75 78.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.643 0.656 . . . . 0.0 111.931 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.417 ' CG ' ' HA ' ' A' ' 46' ' ' SER . 0.1 OUTLIER -65.97 -10.04 35.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.687 -1.149 . . . . 0.0 113.764 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.37 -46.51 15.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.807 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 37.28 4.37 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.849 1.214 . . . . 0.0 114.189 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 13' ' ' VAL . 50.6 mtp85 -127.3 -62.69 1.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.001 1.401 . . . . 0.0 112.635 -171.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.17 143.52 55.36 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.046 0.938 . . . . 0.0 110.424 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -126.11 153.11 74.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 123.803 0.841 . . . . 0.0 109.756 166.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.75 141.81 64.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.95 1.767 . . . . 0.0 109.344 164.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 -8.55 63.81 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-O 117.45 -1.75 . . . . 0.0 114.495 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.04 126.5 27.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.953 1.876 . . . . 0.0 107.166 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HG3' HD23 ' A' ' 37' ' ' LEU . 26.0 tt0 -79.69 121.13 24.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.13 153.02 36.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.639 1.176 . . . . 0.0 110.002 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 t -130.99 -50.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.463 1.505 . . . . 0.0 109.088 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.32 143.71 50.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.24 122.06 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t0 54.84 21.82 3.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.714 1.205 . . . . 0.0 112.207 -167.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.95 -5.97 82.45 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 117.713 -1.604 . . . . 0.0 113.921 -174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -92.11 128.88 43.59 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 120.928 2.364 . . . . 0.0 106.592 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.71 119.05 6.07 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.994 2.463 . . . . 0.0 109.509 -173.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.34 -4.99 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.272 1.429 . . . . 0.0 110.619 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.06 115.96 4.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.561 1.144 . . . . 0.0 109.554 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.05 -1.92 21.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.908 0.766 . . . . 0.0 113.987 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -80.94 164.96 22.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.616 2.208 . . . . 0.0 108.876 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.4 p -81.16 171.25 15.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.46 0.704 . . . . 0.0 110.577 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -53.23 -49.98 65.69 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.28 -1.513 . . . . 0.0 109.389 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.85 -28.23 69.34 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -48.98 -57.02 7.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.721 1.208 . . . . 0.0 109.779 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.8 -39.19 84.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.884 1.274 . . . . 0.0 110.435 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.42 -27.74 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.237 -0.914 . . . . 0.0 110.511 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -41.04 68.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.557 1.143 . . . . 0.0 111.219 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -52.03 67.44 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.836 0.854 . . . . 0.0 109.823 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 71.4 mmm -54.83 -39.13 68.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.036 0.835 . . . . 0.0 111.391 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -43.5 98.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.28 0.632 . . . . 0.0 110.801 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -49.0 64.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.847 1.259 . . . . 0.0 111.769 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.03 71.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.262 1.825 . . . . 0.0 110.275 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.99 76.9 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.378 -0.826 . . . . 0.0 111.913 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.46 -39.56 74.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.649 1.113 . . . . 0.0 110.917 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.02 -20.6 66.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.712 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.97 70.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.674 1.131 . . . . 0.0 112.522 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -163.72 162.15 23.84 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.441 1.496 . . . . 0.0 108.273 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.58 128.38 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -80.49 141.77 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 161.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.8 mt -135.4 105.13 6.11 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -100.52 116.32 32.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.2 m -105.16 167.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 107.946 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -149.38 153.59 37.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.698 -1.251 . . . . 0.0 111.582 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -144.32 132.29 21.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.268 1.027 . . . . 0.0 109.306 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.398 0 C-N-CA 124.699 1.2 . . . . 0.0 110.846 167.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 51.1 p90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 130.38 40.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.51 130.13 34.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 163.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.99 155.35 34.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.648 1.579 . . . . 0.0 108.217 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -133.43 132.02 40.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.941 0.896 . . . . 0.0 111.883 -171.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 t -124.45 108.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.96 1.304 . . . . 0.0 108.561 -174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -80.65 129.2 34.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.5 mt -123.38 123.39 40.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 157.82 36.95 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.174 0.589 . . . . 0.0 110.053 173.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -114.2 83.18 1.83 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.9 mtm -138.62 -9.6 1.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.598 0.635 . . . . 0.0 112.205 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -131.21 -102.5 0.28 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -74.58 -22.03 59.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.66 1.573 . . . . 0.0 114.347 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.03 77.42 0.5 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.879 1.218 . . . . 0.0 112.929 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 58.94 76.67 0.34 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 128.347 2.659 . . . . 0.0 112.214 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.52 70.54 2.64 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.755 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CE1' HD11 ' A' ' 90' ' ' LEU . 34.8 p90 -142.37 147.72 36.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.867 1.334 . . . . 0.0 108.532 167.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -93.51 163.21 13.66 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.921 1.288 . . . . 0.0 108.227 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.87 139.4 49.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.105 1.362 . . . . 0.0 107.578 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.11 -177.5 5.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 108.273 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.38 -161.02 50.87 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.347 -0.846 . . . . 0.0 111.159 -170.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.71 75.24 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.749 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.98 -12.49 60.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.661 1.73 . . . . 0.0 113.366 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 15.6 mt-10 -141.6 160.12 57.74 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.822 1.649 . . . . 0.0 108.817 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 31' ' ' GLU . 73.6 Cg_endo -72.12 105.92 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.129 2.552 . . . . 0.0 109.252 -168.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.07 30.86 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.661 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -66.67 162.25 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.44 1.62 . . . . 0.0 109.323 155.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.82 140.82 68.89 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.864 2.376 . . . . 0.0 109.013 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -116.04 83.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.06 142.27 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.906 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mm -61.2 126.94 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.41 -41.12 91.27 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.163 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 167.01 124.42 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.658 2.383 . . . . 0.0 107.768 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.47 150.03 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.536 1.134 . . . . 0.0 110.705 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -83.32 106.99 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.64 69.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -120.06 40.59 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.2 -178.03 31.85 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 125.817 1.675 . . . . 0.0 109.92 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -59.53 -28.36 67.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -57.04 4.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.126 1.33 . . . . 0.0 109.871 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.34 -38.25 88.75 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.928 0.87 . . . . 0.0 110.102 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.01 -8.87 52.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.346 1.058 . . . . 0.0 113.356 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.61 -17.38 36.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.393 1.452 . . . . 0.0 110.646 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.58 83.5 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.282 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -117.47 -54.52 2.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -166.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 161.28 30.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -140.65 146.02 42.84 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 121.498 -0.752 . . . . 0.0 110.166 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.24 132.3 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.788 2.325 . . . . 0.0 111.259 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.13 -2.32 78.77 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.732 1.158 . . . . 0.0 113.715 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.1 141.68 58.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.351 1.076 . . . . 0.0 108.777 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.94 121.01 28.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.24 155.02 37.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.956 0.903 . . . . 0.0 110.439 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -126.79 -55.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 109.443 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -128.66 147.98 50.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.155 0.982 . . . . 0.0 109.786 -174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.5 t -138.6 118.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 59.11 9.01 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.849 2.06 . . . . 0.0 114.111 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.14 -15.15 6.51 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.429 1.966 . . . . 0.0 112.898 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.89 129.87 23.41 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.386 1.593 . . . . 0.0 108.229 -169.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.4 112.65 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.381 2.721 . . . . 0.0 109.249 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 75' ' ' VAL . 19.5 m -74.18 -7.04 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.098 0.959 . . . . 0.0 111.051 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.3 114.5 3.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.075 1.35 . . . . 0.0 108.599 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.32 -5.42 60.84 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.919 0.771 . . . . 0.0 113.795 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 74' ' ' TYR . 49.3 mmtt -101.47 -172.71 2.21 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.052 1.341 . . . . 0.0 109.623 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 174.27 5.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.943 1.297 . . . . 0.0 110.389 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -49.42 -56.08 10.9 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.875 1.67 . . . . 0.0 110.331 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -52.92 -36.39 59.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 112.795 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 45.2 t80 -54.2 -48.69 70.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.501 0.72 . . . . 0.0 110.281 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 67' ' ' VAL . 5.5 t -70.29 -34.77 59.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 125.006 1.322 . . . . 0.0 110.211 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 mm -62.41 -37.9 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.211 0.914 . . . . 0.0 109.989 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.95 89.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.022 0.374 . . . . 0.0 110.551 173.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -64.23 -50.74 66.81 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.429 176.603 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.6 mmm -56.98 -36.23 70.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.949 0.795 . . . . 0.0 111.161 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.79 -43.5 90.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.219 0.607 . . . . 0.0 111.335 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -45.99 72.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.656 0.783 . . . . 0.0 111.407 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.87 78.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.42 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -32.89 63.97 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.838 -1.164 . . . . 0.0 111.895 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -78.95 -29.55 44.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.351 1.06 . . . . 0.0 112.202 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -66.79 -22.27 66.03 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.01 -0.431 . . . . 0.0 110.928 168.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.88 6.51 89.07 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.039 -1.038 . . . . 0.0 112.484 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.04 173.12 14.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.269 2.227 . . . . 0.0 107.113 168.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.14 157.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 160.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.56 131.66 53.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 24' ' ' PHE . 26.4 mt -126.68 98.17 5.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -170.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 53.5 m -87.72 117.42 26.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.1 m -100.92 173.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 125.599 1.56 . . . . 0.0 108.492 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 17.8 ptt85 -150.13 158.83 44.57 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.669 -1.269 . . . . 0.0 108.581 167.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.83 31.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.652 0.739 . . . . 0.0 110.928 164.44 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -88.38 123.64 33.15 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 110.95 18.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 160.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mp -101.12 148.3 25.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.26 159.63 15.23 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.312 -0.868 . . . . 0.0 110.242 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.44 137.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -126.16 124.87 41.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.296 0.953 . . . . 0.0 108.553 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.49 136.36 51.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.719 0.808 . . . . 0.0 110.153 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -89.73 154.93 19.55 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.111 0.964 . . . . 0.0 110.069 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -115.32 83.54 1.94 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtt -137.41 -34.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.576 -0.725 . . . . 0.0 110.987 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.23 -81.78 0.25 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -122.37 -3.1 8.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.2 78.08 1.13 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.96 0.8 . . . . 0.0 111.699 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 65.82 -133.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 52.69 0.01 OUTLIER Glycine 0 C--O 1.225 -0.453 0 CA-C-N 119.8 1.182 . . . . 0.0 110.454 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 90' ' ' LEU . 47.9 p90 -137.77 172.66 12.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.91 0.855 . . . . 0.0 108.832 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -130.66 163.52 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.862 1.665 . . . . 0.0 106.653 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.5 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -141.24 122.64 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -169.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 41.7 mt -139.96 179.08 6.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.605 1.562 . . . . 0.0 107.478 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.33 -166.29 48.45 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.06 30.92 71.3 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.559 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.78 -32.48 74.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.698 1.749 . . . . 0.0 110.233 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.12 153.76 48.49 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 123.33 0.652 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.16 90.45 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.519 3.479 . . . . 0.0 107.792 -175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.73 -3.79 5.02 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 117.96 -1.467 . . . . 0.0 113.167 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.44 159.23 85.26 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.73 1.765 . . . . 0.0 109.909 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.16 144.32 68.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.483 2.122 . . . . 0.0 109.804 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -114.68 92.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.9 160.15 15.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.448 1.899 . . . . 0.0 110.993 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm -65.82 119.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 167.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -57.05 -45.06 92.79 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.078 2.275 . . . . 0.0 112.542 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.51 170.17 4.95 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.962 2.105 . . . . 0.0 107.402 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.39 138.41 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 168.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -85.41 117.39 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.34 80.62 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.064 0.852 . . . . 0.0 112.277 -168.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.8 mmt -94.8 37.99 1.13 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.86 166.77 14.87 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 125.907 1.717 . . . . 0.0 109.974 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 21.2 t -75.96 -14.12 60.24 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.935 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.43 -50.63 15.22 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.988 1.267 . . . . 0.0 111.193 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -53.47 -59.95 3.93 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.197 1.399 . . . . 0.0 108.84 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 21.9 ptt180 -60.51 -15.15 24.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.139 0.976 . . . . 0.0 113.426 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -20.77 62.17 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.404 -0.81 . . . . 0.0 111.102 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.61 32.13 25.42 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.814 1.197 . . . . 0.0 112.333 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt-85 -139.55 -65.25 0.48 Allowed 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.81 141.2 48.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.694 0.679 . . . . 0.0 110.009 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -135.5 155.12 78.67 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.48 1.112 . . . . 0.0 109.619 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.82 140.1 90.6 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.471 2.114 . . . . 0.0 110.745 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.88 86.19 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 117.939 -1.478 . . . . 0.0 114.727 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.56 129.11 39.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.988 1.894 . . . . 0.0 107.738 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.94 133.01 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.74 148.27 24.81 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.106 1.362 . . . . 0.0 107.743 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.08 -53.73 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.48 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -129.65 147.83 51.48 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.858 0.863 . . . . 0.0 109.097 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.9 t -139.77 124.79 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 64.13 4.06 1.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.527 1.531 . . . . 0.0 113.878 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.33 -14.01 12.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.009 1.766 . . . . 0.0 112.592 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -106.47 133.72 20.12 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 119.267 1.534 . . . . 0.0 108.878 -167.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.46 108.85 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.766 2.977 . . . . 0.0 109.689 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.03 -6.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.634 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.29 108.67 3.29 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.629 -1.294 . . . . 0.0 110.111 -166.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.43 14.1 69.19 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.904 0.764 . . . . 0.0 113.294 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 37.1 mmtt -82.07 -161.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.285 1.434 . . . . 0.0 108.234 162.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -113.06 172.16 7.11 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.336 1.055 . . . . 0.0 110.676 171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -45.51 -55.28 6.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.747 2.019 . . . . 0.0 111.399 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.49 -35.34 67.88 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.533 -0.729 . . . . 0.0 112.338 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.628 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 32.2 t80 -49.52 -51.6 35.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.345 0.593 . . . . 0.0 109.611 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.73 -39.11 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.503 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm -58.65 -37.24 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.025 1.284 . . . . 0.0 110.522 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.68 -44.36 93.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.254 1.421 . . . . 0.0 110.196 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.81 -51.6 66.43 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.382 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.7 mmm -52.97 -39.7 63.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.103 0.865 . . . . 0.0 111.422 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.4 -34.95 74.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.948 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.97 -36.99 24.67 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.575 1.08 . . . . 0.0 112.922 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.674 1.125 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.74 71.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.395 -1.441 . . . . 0.0 112.97 171.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -78.53 -36.16 45.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 110.682 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -62.16 -15.32 45.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.954 1.302 . . . . 0.0 111.239 162.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 3.13 77.11 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.077 1.322 . . . . 0.0 112.453 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -160.85 151.76 18.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.136 1.468 . . . . 0.0 107.178 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.35 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -84.48 133.12 34.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 24' ' ' PHE . 16.7 mt -131.18 103.53 6.54 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.5 m -85.5 124.44 32.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.23 171.39 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 126.04 1.736 . . . . 0.0 107.965 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -153.04 166.76 31.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 121.22 -0.925 . . . . 0.0 110.239 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 141.76 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.434 160.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 123.737 0.815 . . . . 0.0 111.129 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 p90 . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -122.19 131.79 54.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.35 139.89 32.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 163.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.76 116.79 20.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 10.7 p30 -80.89 153.18 27.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.214 0.916 . . . . 0.0 110.011 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.57 108.36 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -96.87 106.8 19.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.64 130.03 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.707 0.765 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -93.44 150.1 20.71 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.999 0.92 . . . . 0.0 109.527 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 30.1 ttt85 -122.83 85.84 2.49 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.847 -1.158 . . . . 0.0 109.245 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.0 mtp -141.82 -3.17 1.14 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -135.31 -88.24 0.35 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -77.03 -31.22 56.17 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.74 -158.29 44.74 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.456 1.025 . . . . 0.0 111.124 -167.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.2 m-85 -102.56 97.24 7.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.297 0.549 . . . . 0.0 112.071 -163.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.62 60.99 4.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.905 1.241 . . . . 0.0 112.898 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.0 p90 -141.58 158.45 43.82 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.526 1.163 . . . . 0.0 109.398 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -112.17 167.73 10.18 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.66 1.584 . . . . 0.0 108.169 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.4 130.29 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -143.25 -178.36 5.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.152 2.181 . . . . 0.0 108.678 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.91 -170.34 29.1 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.607 -1.308 . . . . 0.0 110.345 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.63 91.18 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 121.747 -0.854 . . . . 0.0 111.346 -172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -67.3 -35.11 78.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.959 0.88 . . . . 0.0 111.07 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -120.45 160.29 44.51 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 125.059 1.344 . . . . 0.0 108.39 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.48 57.89 5.3 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.511 3.474 . . . . 0.0 110.393 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.08 42.75 0.06 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.313 1.435 . . . . 0.0 110.476 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -124.88 168.12 14.21 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.46 1.904 . . . . 0.0 110.632 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -72.36 138.34 29.91 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.784 2.322 . . . . 0.0 108.979 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.1 mt -107.13 99.6 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 170.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 58' ' ' GLU . 10.8 mt -95.29 136.55 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.955 2.502 . . . . 0.0 109.505 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm -49.47 127.46 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.23 -27.38 73.78 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.79 -1.005 . . . . 0.0 113.823 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 159.58 133.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.468 3.507 . . . . 0.0 106.339 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.41 148.69 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 119.907 1.231 . . . . 0.0 108.437 166.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mm -81.86 118.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -49.58 76.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 122.603 1.192 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 mmt -85.9 54.52 3.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.79 158.08 29.32 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.205 0.892 . . . . 0.0 111.848 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 m -63.07 -6.86 4.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.56 -48.19 14.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 120.961 1.71 . . . . 0.0 110.005 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.5 -53.15 61.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.71 1.204 . . . . 0.0 109.25 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -63.45 -18.64 63.96 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.364 1.066 . . . . 0.0 112.913 -171.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -17.35 62.69 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 110.817 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 18.4 73.7 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.468 1.032 . . . . 0.0 111.988 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -129.47 -70.69 0.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 112.493 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.27 146.29 50.72 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.09 143.2 46.21 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 124.041 0.936 . . . . 0.0 110.592 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.25 136.02 36.03 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 161.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.33 67.13 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 117.609 -1.662 . . . . 0.0 111.956 -168.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -76.54 134.13 39.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.425 2.112 . . . . 0.0 108.299 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.428 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.1 tt0 -87.19 128.48 35.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.944 2.098 . . . . 0.0 107.777 166.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -78.03 162.99 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.222 1.809 . . . . 0.0 111.478 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.62 -55.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.604 1.962 . . . . 0.0 108.704 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.1 149.12 51.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.446 1.098 . . . . 0.0 109.25 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -137.64 122.9 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t0 57.23 17.5 3.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.325 1.85 . . . . 0.0 113.541 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.04 -11.07 48.51 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.17 1.843 . . . . 0.0 113.312 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -101.67 130.26 24.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 119.407 1.604 . . . . 0.0 107.671 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.0 125.82 10.71 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.299 2.666 . . . . 0.0 108.245 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.73 -4.84 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.733 0.813 . . . . 0.0 111.81 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 124.94 22.32 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.66 -0.65 . . . . 0.0 110.318 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 1.11 79.67 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.189 0.899 . . . . 0.0 113.958 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -88.28 171.5 10.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 119.616 1.708 . . . . 0.0 108.738 172.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.6 p -90.62 168.55 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.531 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -44.64 -47.89 10.5 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.103 1.761 . . . . 0.0 111.53 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -52.92 -36.81 60.12 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.596 1.158 . . . . 0.0 113.408 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.97 -49.92 65.15 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.406 0.683 . . . . 0.0 109.295 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.01 -38.03 79.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 C-N-CA 125.092 1.357 . . . . 0.0 110.772 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.59 -40.84 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.483 1.038 . . . . 0.0 109.819 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.06 91.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.205 0.602 . . . . 0.0 110.867 172.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -53.93 45.26 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.626 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.2 mmm -55.03 -37.0 66.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.049 0.841 . . . . 0.0 111.428 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -61.97 -38.71 89.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 117.565 -1.207 . . . . 0.0 111.918 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -70.41 -48.24 57.03 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.697 1.135 . . . . 0.0 111.289 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -42.09 80.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.975 1.31 . . . . 0.0 111.362 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.78 67.19 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.117 -0.99 . . . . 0.0 113.031 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -84.36 -36.15 22.7 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.612 1.096 . . . . 0.0 110.94 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -53.09 -34.04 54.83 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.71 61.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.737 1.161 . . . . 0.0 112.219 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -160.43 173.07 16.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.344 2.258 . . . . 0.0 107.251 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -148.21 127.89 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -80.94 127.04 32.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 161.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.4 mt -116.48 97.19 5.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 86.1 m -83.89 115.08 22.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.17 171.15 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.844 1.658 . . . . 0.0 108.275 174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -152.87 151.0 29.89 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 119.46 -2.025 . . . . 0.0 112.402 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -140.69 129.61 23.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.677 0.791 . . . . 0.0 109.447 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.239 0.526 0 C-N-CA 126.704 2.002 . . . . 0.0 111.243 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 p90 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.475 0.178 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -124.91 137.13 54.29 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.699 1.2 . . . . 0.0 108.931 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -93.71 154.47 17.78 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.736 1.214 . . . . 0.0 107.861 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mp -139.6 131.77 28.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.951 2.1 . . . . 0.0 106.701 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.56 133.05 33.85 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.334 1.054 . . . . 0.0 109.816 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -129.95 106.59 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.84 118.26 36.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.6 148.31 32.45 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.135 0.974 . . . . 0.0 109.5 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -86.82 164.41 16.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 164.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -117.57 95.48 4.97 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 164.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 ttt -143.77 -13.01 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.111 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.63 -108.41 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -65.24 -31.14 72.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.064 1.302 . . . . 0.0 113.016 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 93.66 0.58 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.624 1.107 . . . . 0.0 112.539 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 43.49 71.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 113.54 169.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.45 54.12 4.3 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.785 -1.197 . . . . 0.0 114.98 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -121.32 175.92 5.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.845 1.322 . . . . 0.0 109.409 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.12 165.21 26.6 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 167.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.6 130.62 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -171.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.17 146.39 27.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.422 1.089 . . . . 0.0 108.088 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.51 177.87 19.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.859 -2.096 . . . . 0.0 107.859 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.58 37.05 84.63 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 121.514 -0.992 . . . . 0.0 111.705 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.75 -36.42 67.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.596 1.198 . . . . 0.0 110.481 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -137.73 160.48 64.74 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.984 2.114 . . . . 0.0 107.766 -170.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.97 72.36 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.406 3.404 . . . . 0.0 110.537 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.14 -9.96 0.06 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 127.549 2.5 . . . . 0.0 111.826 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -72.98 158.21 87.5 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.834 1.317 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.45 137.73 31.23 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.77 2.314 . . . . 0.0 109.125 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -110.11 93.55 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.59 155.94 18.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.068 0.937 . . . . 0.0 110.36 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.83 107.54 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.11 -41.11 71.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.79 175.7 12.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.394 1.878 . . . . 0.0 107.575 168.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.43 148.99 29.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 mm -89.12 112.86 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.13 7.63 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.777 1.231 . . . . 0.0 113.548 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.7 mtm -90.04 -0.79 57.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 153.01 45.83 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -62.49 -6.93 3.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.69 29.16 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.539 1.518 . . . . 0.0 112.188 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.09 -52.26 50.4 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.947 0.794 . . . . 0.0 109.813 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -13.3 15.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 168.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.66 -17.73 62.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.246 1.385 . . . . 0.0 110.987 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.34 32.81 41.62 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.336 166.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -133.6 -66.34 0.65 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.343 1.572 . . . . 0.0 111.414 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.69 144.68 54.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.556 1.142 . . . . 0.0 111.489 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -130.94 151.7 79.38 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.749 1.219 . . . . 0.0 109.312 164.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -51.89 142.66 42.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.324 2.016 . . . . 0.0 110.694 163.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.18 64.24 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.954 -0.915 . . . . 0.0 113.798 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.61 134.23 53.9 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.697 1.749 . . . . 0.0 106.423 165.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.91 123.16 33.0 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.01 140.91 47.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.599 1.16 . . . . 0.0 109.022 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.8 -52.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 124.653 1.181 . . . . 0.0 108.825 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -130.03 146.74 51.72 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.17 124.41 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.17 14.44 6.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.056 1.742 . . . . 0.0 112.224 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.28 68.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.901 1.715 . . . . 0.0 112.517 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.63 126.12 35.17 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.717 1.607 . . . . 0.0 108.102 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.91 118.26 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.208 2.605 . . . . 0.0 109.209 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.74 -9.11 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.81 6.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.871 1.269 . . . . 0.0 109.71 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.46 3.77 61.14 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.553 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 21.4 mmtt -107.18 178.64 4.49 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.591 1.957 . . . . 0.0 108.728 174.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -95.22 -179.93 4.97 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.207 -0.308 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -49.91 -54.83 17.2 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.498 1.119 . . . . 0.0 110.924 169.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -26.83 68.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.73 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.466 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 64.9 t80 -46.54 -54.07 10.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.719 0.771 . . . . 0.0 110.608 169.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.04 -36.53 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.473 1.509 . . . . 0.0 110.082 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.6 mm -57.53 -41.02 78.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 119.126 0.876 . . . . 0.0 110.149 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.522 0.729 . . . . 0.0 111.359 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.96 -51.66 13.15 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.058 0.943 . . . . 0.0 110.828 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.6 mmm -55.09 -38.1 67.67 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.406 1.083 . . . . 0.0 110.867 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -60.79 2.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.809 1.644 . . . . 0.0 110.17 173.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -54.82 -51.08 66.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.512 1.125 . . . . 0.0 111.259 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.92 78.48 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.028 0.931 . . . . 0.0 111.534 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.4 66.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.773 -1.204 . . . . 0.0 112.194 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtt-85 -69.97 -49.91 47.04 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.207 1.367 . . . . 0.0 109.636 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -54.53 -38.21 66.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.769 0.827 . . . . 0.0 110.313 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.62 42.34 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.064 0.84 . . . . 0.0 111.858 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -151.36 166.76 30.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.802 1.301 . . . . 0.0 108.368 167.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.01 165.3 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -126.83 144.53 50.94 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 164.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.3 mt -138.11 97.39 3.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 103.061 -2.941 . . . . 0.0 103.061 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -86.4 112.98 21.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.35 165.92 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.478 0.711 . . . . 0.0 109.52 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -153.08 162.61 41.12 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.605 -1.309 . . . . 0.0 111.962 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -150.32 147.35 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.697 1.199 . . . . 0.0 109.991 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt . . . . . 0 C--O 1.234 0.281 0 C-N-CA 124.687 1.195 . . . . 0.0 111.358 164.298 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.13 138.31 54.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 169.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.15 145.8 28.2 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 158.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.39 121.76 33.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.015 2.126 . . . . 0.0 106.721 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 135.2 35.65 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.898 1.279 . . . . 0.0 109.348 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.91 107.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.56 0.695 . . . . 0.0 109.446 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.02 120.77 40.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 108.776 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -123.22 124.06 42.17 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.047 1.339 . . . . 0.0 108.94 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -74.44 153.18 39.3 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.784 169.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -102.94 114.55 28.93 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -69.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -73.79 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.614 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -126.11 1.92 7.2 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -148.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.21 57.48 8.41 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 123.946 0.784 . . . . 0.0 112.368 167.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.74 80.79 0.05 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.6 2.36 . . . . 0.0 113.006 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.0 75.64 1.1 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.281 0.943 . . . . 0.0 112.798 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -127.95 175.55 8.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.141 2.176 . . . . 0.0 106.187 159.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -123.02 162.46 22.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 157.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.27 127.28 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 94.6 mt -134.4 -177.29 4.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 107.329 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.34 -156.26 48.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -170.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.63 -105.31 0.71 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -164.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.92 -52.81 0.25 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 129.308 3.043 . . . . 0.0 110.29 -167.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -100.39 160.87 25.8 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 110.861 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 96.11 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.408 3.406 . . . . 0.0 111.563 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.33 19.24 30.86 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 118.372 -1.238 . . . . 0.0 113.067 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -66.11 162.06 50.34 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.708 1.254 . . . . 0.0 109.387 164.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.4 132.66 21.12 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.673 2.249 . . . . 0.0 109.226 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.84 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -87.17 144.42 26.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 110.495 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.91 108.35 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -51.2 -44.31 51.62 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 127.487 2.47 . . . . 0.0 112.248 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.76 160.97 29.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.589 0.756 . . . . 0.0 109.618 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.18 115.68 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 161.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -66.89 121.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -21.64 60.56 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -127.95 33.12 4.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.636 1.574 . . . . 0.0 108.353 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 176.65 17.64 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.831 1.205 . . . . 0.0 111.735 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -61.67 -25.71 67.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.534 0.733 . . . . 0.0 112.756 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -53.96 14.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.849 0.749 . . . . 0.0 109.501 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.86 -46.54 78.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.472 1.109 . . . . 0.0 111.735 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -28.39 65.53 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -72.49 -39.7 67.48 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.756 0.822 . . . . 0.0 110.21 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.2 35.9 19.46 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.992 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 52' ' ' ARG . 14.9 mtp85 -124.2 -67.51 0.92 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.01 0.905 . . . . 0.0 110.725 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.47 137.48 48.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -124.85 149.41 62.71 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 110.253 174.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 54' ' ' HIS . 24.4 Cg_exo -57.6 132.1 48.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.338 2.025 . . . . 0.0 110.38 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 7.38 87.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 117.897 -1.502 . . . . 0.0 113.617 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.08 142.94 58.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.141 1.97 . . . . 0.0 108.271 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.16 125.84 35.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.123 -0.985 . . . . 0.0 108.673 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.19 154.37 26.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 109.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.6 -51.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 108.798 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.82 148.8 52.58 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.121 0.968 . . . . 0.0 109.705 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.92 105.54 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t70 54.63 22.95 4.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.295 1.838 . . . . 0.0 113.189 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.02 -13.63 57.41 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.973 2.225 . . . . 0.0 113.027 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.43 125.56 63.13 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.114 1.457 . . . . 0.0 107.798 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -73.5 131.0 15.6 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.635 2.89 . . . . 0.0 109.425 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.43 -8.6 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 123.957 0.903 . . . . 0.0 111.633 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.94 57.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.755 -0.59 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.93 7.57 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.372 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 25.3 mmtt -95.88 -177.14 3.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.405 1.602 . . . . 0.0 110.155 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -109.99 175.77 5.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.757 2.023 . . . . 0.0 110.739 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -53.86 -57.09 12.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 109.135 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -45.85 -45.86 15.33 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 112.061 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 50.0 t80 -49.77 -40.24 40.58 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.682 0.614 . . . . 0.0 111.412 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.38 -41.6 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 110.757 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.45 -41.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.026 0.83 . . . . 0.0 109.608 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -23.97 64.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.756 1.622 . . . . 0.0 112.126 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.18 -45.12 16.83 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 123.681 0.792 . . . . 0.0 110.258 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mmm -56.87 -34.94 68.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.917 0.78 . . . . 0.0 111.878 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.87 -42.9 85.52 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.117 0.967 . . . . 0.0 111.51 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -45.35 74.07 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.469 0.707 . . . . 0.0 110.699 174.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.73 71.48 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.764 -1.21 . . . . 0.0 112.245 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.95 74.74 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.609 -0.682 . . . . 0.0 111.046 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -69.09 -36.82 77.98 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.194 0.998 . . . . 0.0 112.343 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -68.61 -12.22 61.06 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.565 0.62 . . . . 0.0 112.014 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.62 7.3 87.21 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.511 1.053 . . . . 0.0 112.936 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.6 169.11 10.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 120.843 -1.386 . . . . 0.0 107.586 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.85 159.7 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -122.12 145.07 48.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mt -138.11 99.34 3.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -84.58 114.02 21.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.28 170.69 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 166.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -151.27 164.21 37.13 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.051 -1.655 . . . . 0.0 109.885 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.36 133.57 15.27 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.537 1.135 . . . . 0.0 108.586 168.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.204 0 C-N-CA 123.571 0.748 . . . . 0.0 109.178 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.4 p90 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -119.68 143.09 47.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.109 1.364 . . . . 0.0 107.74 171.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.74 141.95 29.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 169.3 9.1 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.345 2.258 . . . . 0.0 107.186 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 128.13 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.856 1.662 . . . . 0.0 107.014 172.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.05 136.99 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -128.13 127.57 43.25 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 108.165 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.93 155.05 45.92 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.299 1.04 . . . . 0.0 109.374 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -105.29 165.86 10.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.102 0.953 . . . . 0.0 111.398 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -125.49 93.35 3.83 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 124.861 1.264 . . . . 0.0 109.211 174.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.9 mtp -144.34 -63.28 0.37 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -66.43 -69.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.835 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -114.76 -31.08 6.26 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . 78.18 85.71 0.5 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -164.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD1' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER 72.97 -153.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.754 0.914 . . . . 0.0 108.697 167.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.9 55.14 0.02 OUTLIER Glycine 0 C--O 1.227 -0.312 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.448 ' CE2' HD11 ' A' ' 90' ' ' LEU . 38.0 p90 -143.36 172.87 12.17 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -141.35 142.27 33.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.023 0.929 . . . . 0.0 109.439 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 135.47 57.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 27' ' ' LEU 0.272 2.7 pp -148.98 -178.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.306 2.242 . . . . 0.0 108.644 -177.434 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.7 -145.92 46.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.48 30.55 34.12 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 118.0 0.9 . . . . 0.0 111.598 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -90.82 -7.08 53.31 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 112.082 -163.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -129.7 155.59 80.13 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 126.891 2.076 . . . . 0.0 106.828 165.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.96 92.11 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 124.66 3.573 . . . . 0.0 108.161 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.91 -12.42 1.91 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.627 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -79.23 159.43 72.79 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 119.433 1.617 . . . . 0.0 112.192 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.42 147.01 51.59 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.222 1.948 . . . . 0.0 108.764 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -116.77 92.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.88 130.66 44.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.814 1.646 . . . . 0.0 109.16 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 mm -54.81 110.42 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.04 -43.58 81.13 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.442 -0.786 . . . . 0.0 111.738 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 139.89 14.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.43 147.15 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 159.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.12 110.61 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.25 -34.72 61.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 123.105 1.431 . . . . 0.0 112.009 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 33.1 mmt -95.91 20.8 9.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.591 1.156 . . . . 0.0 110.506 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 176.11 21.54 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.202 0.906 . . . . 0.0 111.552 -165.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -20.68 64.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.225 -0.893 . . . . 0.0 113.09 -160.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.52 -63.74 1.01 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.005 0.82 . . . . 0.0 109.743 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.61 -43.58 80.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.094 0.958 . . . . 0.0 110.751 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -70.62 -18.99 62.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.908 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.21 -22.6 33.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.616 1.553 . . . . 0.0 111.371 168.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.97 14.03 65.44 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.371 159.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.45 -43.81 4.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.381 1.591 . . . . 0.0 113.968 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.19 155.76 27.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -135.6 153.47 77.59 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.511 . . . . 0.0 110.586 155.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.58 112.95 3.35 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.817 1.678 . . . . 0.0 110.633 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.15 -13.09 5.76 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.232 2.348 . . . . 0.0 110.977 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.37 131.38 48.06 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 122.28 28.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 120.05 1.295 . . . . 0.0 107.697 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.2 153.52 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 109.788 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 t -130.07 -45.58 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.122 1.369 . . . . 0.0 109.511 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.37 149.23 51.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.352 1.061 . . . . 0.0 109.636 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.4 t -137.39 122.72 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 53.58 14.28 0.58 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.33 2.652 . . . . 0.0 113.555 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.7 30.92 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.447 2.451 . . . . 0.0 113.367 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.6 mp -94.49 130.37 33.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 120.586 2.193 . . . . 0.0 106.895 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -71.91 111.01 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.958 2.439 . . . . 0.0 108.567 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -72.83 -8.25 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.335 0.654 . . . . 0.0 110.96 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.65 120.42 9.44 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.12 -9.2 70.53 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.284 1.421 . . . . 0.0 114.909 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -83.03 173.59 11.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.067 -1.255 . . . . 0.0 109.098 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.1 p -93.83 169.86 9.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -51.34 -46.62 62.72 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.454 1.102 . . . . 0.0 112.052 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 -59.22 -33.18 70.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.905 0.775 . . . . 0.0 112.56 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -48.1 -48.02 33.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.914 0.886 . . . . 0.0 109.554 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.62 -35.5 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.456 -0.778 . . . . 0.0 110.816 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.56 -35.21 69.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 120.91 -1.119 . . . . 0.0 110.321 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.43 -42.39 87.77 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.471 1.108 . . . . 0.0 109.82 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -47.13 85.49 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 111.491 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -27.83 45.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.733 0.813 . . . . 0.0 110.493 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -45.08 63.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.567 0.621 . . . . 0.0 110.63 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -63.3 -46.86 84.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 111.329 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.456 1.102 . . . . 0.0 110.79 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.74 -24.19 67.57 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.114 -0.991 . . . . 0.0 112.791 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -59.45 2.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 169.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -56.84 -39.33 74.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 124.622 1.201 . . . . 0.0 109.715 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 9.3 16.74 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.352 0.977 . . . . 0.0 112.692 170.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -149.48 175.83 11.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.416 HG12 ' CD1' ' A' ' 22' ' ' PHE . 10.0 p -143.5 128.46 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 156.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 139.32 31.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 161.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.448 HD11 ' CE2' ' A' ' 24' ' ' PHE . 41.4 mt -135.51 111.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.8 m -95.49 115.57 27.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.1 173.84 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 165.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -150.86 160.72 43.7 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 120.392 -1.442 . . . . 0.0 110.195 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -155.34 144.46 20.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 160.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 127.538 2.335 . . . . 0.0 109.887 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 24.7 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.542 0.687 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -106.71 131.15 54.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.01 159.54 21.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 158.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.32 121.67 11.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 173.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.98 135.76 36.46 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.3 t -126.15 107.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -95.59 127.77 41.9 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -121.35 124.16 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.963 0.905 . . . . 0.0 109.881 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -71.95 144.38 48.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -101.47 103.94 14.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.0 mtm -142.91 -53.16 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.04 -105.23 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.399 1.079 . . . . 0.0 110.713 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -69.91 -21.74 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.436 1.471 . . . . 0.0 112.139 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 67.17 2.13 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.19 100.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.485 2.314 . . . . 0.0 111.369 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.06 53.42 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.605 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -134.59 170.69 15.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.469 1.634 . . . . 0.0 110.034 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.97 151.73 48.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.71 2.404 . . . . 0.0 109.134 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.69 152.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.682 1.193 . . . . 0.0 107.809 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 -179.16 6.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.413 1.485 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.36 -142.82 43.31 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.81 20.72 62.38 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.937 0.78 . . . . 0.0 112.028 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.76 -45.96 87.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.242 1.417 . . . . 0.0 110.021 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -108.77 155.17 41.14 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.91 93.8 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.892 3.728 . . . . 0.0 109.528 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.34 2.87 2.55 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.82 1.2 . . . . 0.0 112.739 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -77.71 167.98 31.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.452 1.126 . . . . 0.0 109.824 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.57 131.7 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.304 2.67 . . . . 0.0 110.211 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.81 105.76 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD23 ' HG3' ' A' ' 58' ' ' GLU . 15.8 mt -101.68 162.8 12.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.851 1.66 . . . . 0.0 112.436 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.458 HG12 ' CG ' ' A' ' 57' ' ' ASP . 41.8 mm -65.79 121.5 14.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.22 -60.87 5.58 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 122.968 0.318 . . . . 0.0 112.633 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.43 114.78 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.9 2.08 . . . . 0.0 106.952 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.3 149.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.85 116.0 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.99 -29.74 44.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.312 1.845 . . . . 0.0 115.135 -165.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.4 mmt -135.12 10.72 3.56 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.455 1.102 . . . . 0.0 111.795 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.8 172.41 54.05 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -57.88 -11.86 2.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.19 -52.69 6.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.141 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.0 -43.66 73.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.184 1.356 . . . . 0.0 110.414 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -55.79 -28.63 57.09 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.84 -17.43 28.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.395 1.078 . . . . 0.0 111.978 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.54 23.74 67.14 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -122.44 -14.11 7.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.978 1.889 . . . . 0.0 114.31 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.14 168.8 12.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.294 0.952 . . . . 0.0 108.636 166.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.85 18.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.133 1.373 . . . . 0.0 107.838 158.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.44 123.77 11.59 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.894 2.396 . . . . 0.0 109.164 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.9 34.93 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.052 0.834 . . . . 0.0 113.288 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.478 ' OD2' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -64.39 153.83 37.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 118.643 1.221 . . . . 0.0 109.507 152.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.2 tt0 -104.58 116.64 32.43 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.821 2.048 . . . . 0.0 108.276 166.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.22 136.83 37.87 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.32 2.248 . . . . 0.0 108.755 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.98 -52.95 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 123.596 0.758 . . . . 0.0 110.276 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -134.59 145.17 48.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.81 124.83 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 107.322 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.43 21.15 1.14 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.613 2.365 . . . . 0.0 112.09 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.48 -10.78 70.87 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.82 2.153 . . . . 0.0 113.788 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.77 133.19 38.26 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 119.575 1.687 . . . . 0.0 107.625 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -72.01 133.94 22.46 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.024 2.483 . . . . 0.0 108.295 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG1' HG22 ' A' ' 75' ' ' VAL . 33.5 m -99.07 -7.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.229 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.75 133.72 47.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.82 -9.04 25.87 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.7 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 69.7 mmtt -85.96 171.8 11.18 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.935 1.868 . . . . 0.0 108.723 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.8 p -92.3 172.97 8.06 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.137 0.575 . . . . 0.0 110.362 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -49.7 -56.07 11.53 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.717 1.207 . . . . 0.0 109.485 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -50.56 -41.77 54.56 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.62 1.568 . . . . 0.0 112.929 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 41.0 t80 -51.63 -47.14 63.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.753 0.787 . . . . 0.0 110.266 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' CG1' ' A' ' 67' ' ' VAL . 7.3 t -73.13 -34.35 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.791 0.836 . . . . 0.0 110.465 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -62.44 -35.44 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.878 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.5 -43.88 97.73 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.788 1.235 . . . . 0.0 110.105 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -53.88 46.15 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.625 0.77 . . . . 0.0 111.669 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.7 mmm -58.59 -35.22 72.07 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.235 0.614 . . . . 0.0 111.082 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -59.5 -45.14 92.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.482 -0.77 . . . . 0.0 111.2 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.62 -51.08 66.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.808 0.843 . . . . 0.0 111.683 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.77 71.82 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 111.678 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.22 78.5 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.036 -1.04 . . . . 0.0 111.288 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -72.14 -42.87 65.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.391 0.996 . . . . 0.0 111.183 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -55.35 -33.51 63.45 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.364 1.065 . . . . 0.0 110.227 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.63 10.64 65.01 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.182 0.896 . . . . 0.0 112.228 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -164.66 168.86 17.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.751 2.02 . . . . 0.0 107.053 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.38 159.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.36 88.97 2.35 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.632 1.173 . . . . 0.0 109.294 -170.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.9 97.95 8.49 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -83.55 127.07 33.45 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.478 HG11 ' OD2' ' A' ' 57' ' ' ASP . 17.2 m -125.99 158.47 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 126.038 1.735 . . . . 0.0 107.051 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 11.6 ptt180 -151.3 161.32 42.93 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.674 -0.641 . . . . 0.0 111.085 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.21 146.36 22.71 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.446 0 C-N-CA 124.0 0.92 . . . . 0.0 110.411 166.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 32.4 p90 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -135.82 137.33 41.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 159.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -83.45 152.46 24.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 164.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.41 163.21 19.09 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -124.98 121.37 34.24 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.207 1.803 . . . . 0.0 107.706 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.9 t -121.59 109.1 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -78.18 144.52 36.28 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 mt -140.05 128.21 22.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.182 0.993 . . . . 0.0 108.8 166.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -72.95 160.06 32.71 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.741 0.416 . . . . 0.0 111.669 171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 8.5 ttt-85 -141.5 89.65 2.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.287 1.435 . . . . 0.0 107.439 166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mtm -154.27 -41.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 109.22 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -72.78 -163.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 142.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -64.73 8.32 0.12 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -148.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 174.2 50.22 Favored Glycine 0 N--CA 1.45 -0.398 0 O-C-N 120.672 -1.267 . . . . 0.0 112.287 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -65.99 160.83 22.76 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.57 72.32 0.29 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 90' ' ' LEU . 45.1 p90 -143.31 171.87 13.52 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 171.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -132.18 158.67 41.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.126 1.371 . . . . 0.0 107.774 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.75 121.38 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.81 -177.23 3.08 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.474 2.31 . . . . 0.0 107.716 -168.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.49 -144.39 49.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.04 19.96 47.4 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.124 0.868 . . . . 0.0 112.904 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -26.28 68.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.011 0.925 . . . . 0.0 111.204 -168.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -140.39 160.25 60.28 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 126.114 1.766 . . . . 0.0 109.056 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.76 112.65 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 173.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.07 35.89 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.923 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.91 155.61 91.36 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.662 1.731 . . . . 0.0 108.466 166.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.63 152.41 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.517 2.811 . . . . 0.0 110.371 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 75' ' ' VAL . 60.8 mt -117.78 93.98 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 165.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -81.36 152.85 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.25 139.3 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 159.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.7 -56.79 1.39 Allowed Glycine 0 C--O 1.226 -0.372 0 O-C-N 121.492 -0.755 . . . . 0.0 111.639 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.84 145.76 36.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.42 123.78 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.61 110.62 7.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -171.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.8 149.16 11.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.269 0.98 . . . . 0.0 110.483 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.5 mmt 66.47 -6.75 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.988 2.115 . . . . 0.0 114.564 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -151.63 5.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.847 1.689 . . . . 0.0 111.416 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -66.5 -63.77 1.0 Allowed 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.918 -1.342 . . . . 0.0 110.725 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -45.26 94.55 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -157.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.52 -45.92 90.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.234 1.014 . . . . 0.0 111.535 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.9 -39.64 95.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.686 1.595 . . . . 0.0 112.616 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -36.89 83.45 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 110.368 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.2 15.32 65.26 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 125.486 1.517 . . . . 0.0 113.24 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -98.59 -32.85 11.22 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.574 1.549 . . . . 0.0 109.604 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.48 146.7 32.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.05 146.87 48.33 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.843 164.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -69.24 112.41 2.98 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.894 2.396 . . . . 0.0 110.674 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.14 5.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.709 1.623 . . . . 0.0 112.268 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.84 140.88 57.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 122.5 32.61 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.989 1.268 . . . . 0.0 108.583 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.06 156.83 38.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.102 0.961 . . . . 0.0 111.202 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.14 -53.01 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.902 1.681 . . . . 0.0 108.933 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.4 148.25 51.3 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.528 1.131 . . . . 0.0 109.618 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.84 126.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.721 1.608 . . . . 0.0 107.019 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.11 -3.83 0.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.921 2.088 . . . . 0.0 112.708 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.58 -16.96 6.96 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.841 3.115 . . . . 0.0 111.914 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.27 134.87 20.96 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.868 1.334 . . . . 0.0 108.648 -167.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.16 118.83 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.382 2.722 . . . . 0.0 109.883 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.488 ' CG1' HG22 ' A' ' 75' ' ' VAL . 15.5 m -80.3 -7.3 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 111.023 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 118.29 8.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 109.992 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.97 -10.01 70.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.657 1.122 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -78.55 -172.53 2.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 108.712 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -100.63 171.89 7.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.685 1.194 . . . . 0.0 109.402 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -50.81 -53.65 30.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.389 1.476 . . . . 0.0 109.844 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.75 -24.26 67.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -51.71 -48.92 63.37 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.854 0.835 . . . . 0.0 110.21 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.488 HG22 ' CG1' ' A' ' 67' ' ' VAL . 4.7 t -71.65 -37.18 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.572 1.149 . . . . 0.0 110.126 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.02 -28.35 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.204 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -45.48 72.54 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.476 1.51 . . . . 0.0 110.415 169.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -49.62 76.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.191 0.596 . . . . 0.0 110.775 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.0 mmm -57.74 -19.88 30.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.942 0.497 . . . . 0.0 112.331 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -47.85 21.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.373 0.988 . . . . 0.0 111.103 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.43 -47.04 85.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 119.016 0.825 . . . . 0.0 111.111 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.35 -38.02 73.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.689 0.796 . . . . 0.0 111.713 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.78 -14.25 62.91 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 113.805 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -81.7 -43.74 18.07 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.033 1.288 . . . . 0.0 109.764 165.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -63.28 -17.35 62.42 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.747 1.219 . . . . 0.0 112.016 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.31 69.01 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.037 1.303 . . . . 0.0 112.406 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -157.31 168.7 26.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.031 1.732 . . . . 0.0 106.872 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.06 163.49 26.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -121.88 140.42 52.43 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 166.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 24' ' ' PHE . 13.4 mt -137.01 106.67 6.17 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 m -97.31 112.58 24.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.44 164.77 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.65 151.75 32.97 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.567 -1.333 . . . . 0.0 110.839 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -151.02 136.05 17.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 166.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 p90 . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 122.156 0.979 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -97.0 147.3 24.14 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 112.918 -1.946 . . . . 0.0 106.253 164.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.02 154.19 23.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 160.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.06 118.08 23.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.51 130.44 39.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 53' ' ' LEU . 98.6 t -135.08 107.15 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.26 128.27 41.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.76 165.46 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 109.409 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -127.35 145.75 50.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -98.94 101.48 12.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tpt -144.7 -63.51 0.36 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.28 -85.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.809 0.844 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -95.51 -31.02 13.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.919 0.327 . . . . 0.0 111.803 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.68 71.66 1.27 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.26 83.28 0.17 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.9 1.68 . . . . 0.0 111.155 168.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.39 59.44 2.83 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.893 0.759 . . . . 0.0 112.878 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.7 p90 -135.35 175.05 9.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.082 1.353 . . . . 0.0 109.613 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -129.57 166.91 18.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.99 1.316 . . . . 0.0 108.563 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.05 122.69 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 79.0 mt -140.36 -176.5 4.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 108.593 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.27 -151.47 52.11 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -168.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.96 33.35 20.9 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 117.427 0.613 . . . . 0.0 111.578 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.63 -17.09 62.28 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.332 -1.099 . . . . 0.0 110.62 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -132.4 160.32 68.63 Favored Pre-proline 0 C--O 1.239 0.539 0 C-N-CA 126.715 2.006 . . . . 0.0 107.694 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.3 79.39 3.35 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.105 3.203 . . . . 0.0 109.153 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.09 51.38 0.27 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 125.697 1.618 . . . . 0.0 109.296 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -118.47 159.3 44.32 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.761 1.624 . . . . 0.0 107.506 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 144.34 47.89 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.788 1.659 . . . . 0.0 109.018 -170.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 7.2 mt -105.37 79.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 124.189 1.947 . . . . 0.0 107.329 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.34 124.37 31.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.316 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 mm -47.15 129.06 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -84.12 -0.81 89.67 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.902 2.668 . . . . 0.0 116.787 -166.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 127.35 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 C-N-CA 132.36 4.264 . . . . 0.0 108.824 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.2 t -77.41 149.89 5.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.74 117.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.36 -35.67 70.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -163.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.6 mtm -131.33 114.64 15.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.02 -177.84 38.08 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 m -51.84 -45.32 63.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.84 72.32 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.369 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.11 -41.4 99.34 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.916 0.486 . . . . 0.0 110.287 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -59.58 -46.53 88.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.227 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -21.22 66.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.434 0.561 . . . . 0.0 110.59 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 0.32 30.6 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.33 1.443 . . . . 0.0 113.673 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -99.35 -21.52 15.99 Favored 'General case' 0 C--O 1.228 -0.059 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.056 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' HG ' HG11 ' A' ' 13' ' ' VAL . 5.6 mt -95.92 145.97 24.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.309 1.413 . . . . 0.0 108.147 172.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -140.22 -179.06 0.92 Allowed Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.926 1.691 . . . . 0.0 109.949 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -94.94 138.41 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 111.702 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 -3.69 59.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 125.867 1.698 . . . . 0.0 111.771 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.43 139.96 46.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.11 132.66 42.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.011 2.124 . . . . 0.0 106.878 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.14 152.18 23.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 109.369 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.01 -50.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 108.742 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -127.74 152.37 47.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.929 . . . . 0.0 110.011 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.13 123.72 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 106.81 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t0 55.6 19.21 3.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.591 2.356 . . . . 0.0 113.319 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.11 -16.03 27.78 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.862 2.172 . . . . 0.0 113.702 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.18 131.88 22.63 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 118.778 1.289 . . . . 0.0 108.433 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -72.27 111.65 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.651 2.901 . . . . 0.0 109.004 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.67 -4.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.981 0.913 . . . . 0.0 112.007 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.3 126.29 27.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 109.54 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.86 -7.47 81.68 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.301 0.953 . . . . 0.0 112.91 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -91.99 175.95 6.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.145 1.473 . . . . 0.0 108.974 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -95.09 167.89 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.76 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -48.78 -44.38 38.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 110.646 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -57.62 -35.72 70.84 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.631 0.772 . . . . 0.0 113.075 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -56.14 -44.14 78.91 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.27 -38.55 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.965 0.906 . . . . 0.0 110.406 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -56.97 -40.61 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 120.093 1.315 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -70.73 -33.4 70.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.747 0.248 . . . . 0.0 111.574 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.17 -46.77 72.96 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.663 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.4 mmm -63.54 -33.15 74.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.195 0.907 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.06 -45.25 75.31 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.175 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -49.66 64.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.856 0.862 . . . . 0.0 111.422 176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.35 66.85 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 110.539 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 -23.44 64.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.019 -1.051 . . . . 0.0 113.327 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -93.47 -31.37 14.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.207 1.003 . . . . 0.0 110.846 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -57.71 -25.2 60.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.329 0.652 . . . . 0.0 110.519 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.88 5.35 90.14 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 121.432 -0.792 . . . . 0.0 111.926 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -149.75 174.04 13.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.372 1.869 . . . . 0.0 107.195 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.48 147.84 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 160.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -115.71 108.83 16.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.7 mt -99.29 140.95 32.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -120.56 114.78 22.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.55 171.36 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -148.67 162.2 40.2 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.512 -1.367 . . . . 0.0 109.24 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -155.06 120.57 5.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 109.75 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.172 0 C-N-CA 125.378 1.471 . . . . 0.0 110.213 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 2.5 p90 . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 121.81 0.814 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 133.26 33.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 167.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.26 152.99 24.91 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 158.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -136.42 162.71 32.3 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.53 2.332 . . . . 0.0 107.511 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.52 116.93 22.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.314 1.054 . . . . 0.0 110.559 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.91 136.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 168.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -129.05 107.46 9.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 123.8 46.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -75.21 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -124.72 99.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 167.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.1 ptp -132.37 6.41 4.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.641 0.776 . . . . 0.0 110.687 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.2 -110.9 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -64.58 -30.42 71.44 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.551 1.069 . . . . 0.0 112.028 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.22 82.87 0.61 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 67.23 -171.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.148 1.379 . . . . 0.0 110.167 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.58 45.88 0.21 Allowed Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 90' ' ' LEU . 13.3 p90 -139.58 152.05 46.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -108.6 167.16 10.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.703 2.401 . . . . 0.0 108.538 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.67 135.41 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 120.542 -1.349 . . . . 0.0 107.733 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -138.64 -176.82 4.61 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 128.563 2.745 . . . . 0.0 106.815 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.48 -159.91 41.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.67 24.8 54.25 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.719 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -64.33 -28.11 69.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.579 1.19 . . . . 0.0 110.714 -171.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -135.09 160.67 67.4 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 126.936 2.094 . . . . 0.0 108.03 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.32 35.18 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.752 1 C-N-CA 125.372 4.048 . . . . 0.0 113.603 -166.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.86 20.51 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.997 1.761 . . . . 0.0 111.528 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -89.7 154.07 47.96 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 118.92 1.36 . . . . 0.0 111.123 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.84 135.14 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.916 3.078 . . . . 0.0 109.286 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.2 92.51 2.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 mt -85.15 134.87 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.494 -0.754 . . . . 0.0 111.28 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.5 mm -54.04 112.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.696 1.998 . . . . 0.0 105.728 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.1 -74.86 0.3 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.713 1.625 . . . . 0.0 113.216 -170.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.92 119.27 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.631 1.973 . . . . 0.0 106.756 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.61 149.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.49 113.25 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.13 -23.75 56.2 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.156 1.382 . . . . 0.0 114.588 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.1 mmt -110.95 -0.05 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.23 -178.1 22.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.899 1.238 . . . . 0.0 111.181 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -66.14 -8.34 23.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.25 -40.45 18.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.086 1.766 . . . . 0.0 111.332 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.7 -53.04 24.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.447 1.099 . . . . 0.0 110.428 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -55.32 -29.18 57.77 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.54 -21.94 65.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.766 0.826 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.16 52.65 51.23 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.982 1.277 . . . . 0.0 111.022 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.78 -78.75 0.28 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.1 mt -69.13 142.05 54.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.054 0.843 . . . . 0.0 110.813 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -119.59 154.22 54.49 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.934 0.894 . . . . 0.0 108.978 159.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 142.89 34.83 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.85 1.7 . . . . 0.0 110.07 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.43 88.46 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.963 -0.91 . . . . 0.0 113.533 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -71.19 141.13 50.67 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 169.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.45 128.82 36.63 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.006 -1.059 . . . . 0.0 109.4 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.72 153.47 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.396 1.878 . . . . 0.0 110.923 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.94 -37.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.005 1.722 . . . . 0.0 109.516 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 66' ' ' PRO . 70.2 m-85 -137.18 151.92 49.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.084 0.953 . . . . 0.0 110.388 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.5 t -147.31 134.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 127.036 2.134 . . . . 0.0 106.954 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t0 58.83 17.03 4.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.299 1.44 . . . . 0.0 111.029 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.8 0.82 88.85 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.732 2.11 . . . . 0.0 114.066 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mm -94.78 136.03 23.31 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 127.036 2.134 . . . . 0.0 108.098 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 18.0 Cg_endo -74.07 145.59 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.358 2.039 . . . . 0.0 109.189 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.02 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.077 0.551 . . . . 0.0 112.379 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.8 102.14 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.041 -0.412 . . . . 0.0 110.239 -165.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.48 -3.8 50.53 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.529 1.061 . . . . 0.0 113.718 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 57.3 mmtt -78.83 -179.98 6.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.052 -1.264 . . . . 0.0 108.023 158.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.7 p -111.85 175.52 5.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.21 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -40.8 -64.24 0.56 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 109.792 170.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -55.43 -38.75 69.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.239 0.616 . . . . 0.0 112.577 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 9.1 t80 -55.01 -48.04 73.88 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.441 0.564 . . . . 0.0 109.488 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.12 -44.06 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.353 -1.308 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mm -57.16 -37.54 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.507 1.503 . . . . 0.0 109.785 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -54.52 46.02 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.053 0.941 . . . . 0.0 110.91 170.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.03 -35.04 77.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.268 0.627 . . . . 0.0 112.154 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -30.48 23.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.335 1.454 . . . . 0.0 109.388 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.9 -30.87 71.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.195 0.998 . . . . 0.0 111.339 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -51.04 59.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 173.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.18 74.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.456 1.103 . . . . 0.0 111.394 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -23.34 15.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.533 -1.354 . . . . 0.0 112.464 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -94.17 -21.73 18.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.926 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -61.92 -35.87 79.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.193 1.361 . . . . 0.0 110.696 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.47 -0.72 49.77 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.529 -0.732 . . . . 0.0 112.724 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -151.81 167.84 26.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.76 2.024 . . . . 0.0 106.672 165.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.02 122.13 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 162.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.53 128.16 33.27 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 24' ' ' PHE . 14.7 mt -130.8 128.41 40.66 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.4 m -112.06 122.53 48.01 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -111.09 164.81 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.442 1.097 . . . . 0.0 109.339 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -152.21 146.78 25.71 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.596 -1.315 . . . . 0.0 110.954 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -148.82 126.88 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.834 0.454 . . . . 0.0 110.204 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 124.197 0.999 . . . . 0.0 112.361 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 25.5 p90 . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.61 117.27 26.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -83.95 141.06 31.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 116.72 15.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.52 143.06 36.93 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.819 1.648 . . . . 0.0 109.176 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.59 108.72 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 126.248 1.819 . . . . 0.0 106.743 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.3 130.45 35.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -120.9 123.91 43.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.253 0.933 . . . . 0.0 109.276 164.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -74.42 158.58 33.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.185 165.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 51.9 ttt-85 -131.24 102.31 5.93 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 125.793 1.637 . . . . 0.0 107.11 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 ptp -155.66 8.77 0.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -136.75 -76.54 0.42 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.638 -1.288 . . . . 0.0 108.41 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.47 -7.7 12.83 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.66 1.584 . . . . 0.0 111.919 170.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.14 -179.95 41.43 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.159 0.885 . . . . 0.0 111.807 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.1 m-85 -62.48 147.08 49.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.61 51.15 0.87 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -134.7 153.51 51.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -110.97 163.93 13.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.666 1.987 . . . . 0.0 107.316 168.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.401 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -136.46 150.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.155 1.382 . . . . 0.0 108.642 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -134.59 -177.29 4.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.856 2.062 . . . . 0.0 108.549 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.12 -140.51 37.88 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.03 23.92 8.0 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 127.956 2.693 . . . . 0.0 112.922 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.37 -25.38 65.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.031 -0.688 . . . . 0.0 110.342 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -121.84 155.9 59.86 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 123.507 0.723 . . . . 0.0 110.145 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.07 133.09 29.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.112 1.874 . . . . 0.0 108.684 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.43 19.32 74.36 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.935 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -72.59 162.38 74.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.603 1.201 . . . . 0.0 110.34 168.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -71.09 119.27 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.289 1.993 . . . . 0.0 109.571 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -90.45 97.74 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -83.73 151.77 25.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 mm -55.83 122.23 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -67.21 -62.7 4.24 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 128.96 4.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.762 0.825 . . . . 0.0 108.799 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.79 128.0 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.5 mm -68.21 132.93 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.278 1.431 . . . . 0.0 108.611 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.82 65.77 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.756 1.223 . . . . 0.0 113.855 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.7 mtt -126.79 54.98 1.57 Allowed 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 169.45 12.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -6.99 20.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.325 -1.321 . . . . 0.0 114.08 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.54 -56.4 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 120.03 1.286 . . . . 0.0 110.507 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.61 -45.99 91.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.429 0.559 . . . . 0.0 110.562 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -18.94 48.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.96 -17.67 20.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.962 1.305 . . . . 0.0 111.835 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.71 45.38 53.05 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.955 -1.091 . . . . 0.0 113.869 165.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -133.37 -48.51 0.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.765 0.783 . . . . 0.0 111.436 166.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 mt -74.04 148.15 42.23 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.609 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -139.77 148.5 55.79 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 125.167 1.387 . . . . 0.0 112.327 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.94 92.59 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.816 3.011 . . . . 0.0 112.464 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.87 -13.61 1.51 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.202 1.858 . . . . 0.0 113.029 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.32 154.12 28.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.957 1.379 . . . . 0.0 109.694 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.32 131.78 42.49 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.81 155.83 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.11 0.964 . . . . 0.0 110.453 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.88 -51.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 125.071 1.348 . . . . 0.0 109.332 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.65 146.72 52.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.8 116.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t0 57.99 25.04 11.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.586 1.555 . . . . 0.0 111.522 -166.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.44 0.77 59.11 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.503 1.049 . . . . 0.0 112.815 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 mm -86.27 127.62 60.63 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 119.798 1.799 . . . . 0.0 106.507 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -69.82 128.36 15.86 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.503 2.802 . . . . 0.0 109.257 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -92.16 -3.65 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.708 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 149.11 48.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.203 0.91 . . . . 0.0 108.848 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.25 -28.12 0.33 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.017 1.294 . . . . 0.0 114.57 -172.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -74.71 173.72 10.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.054 1.342 . . . . 0.0 109.434 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -103.92 -177.36 3.35 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.726 1.61 . . . . 0.0 109.47 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.86 -55.01 40.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.254 1.822 . . . . 0.0 110.443 172.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -56.13 -35.27 66.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.382 0.992 . . . . 0.0 112.422 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -47.04 -50.34 19.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.261 0.625 . . . . 0.0 111.165 171.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.59 -35.78 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.453 1.101 . . . . 0.0 110.338 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.37 -27.86 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 119.935 1.243 . . . . 0.0 110.379 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.12 -41.28 74.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.354 -1.466 . . . . 0.0 110.686 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.98 -31.28 72.09 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.894 -1.129 . . . . 0.0 112.229 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.77 -35.02 77.93 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.024 1.33 . . . . 0.0 109.61 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.3 -60.33 3.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.486 0.714 . . . . 0.0 109.944 171.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -56.9 -49.37 75.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.351 1.061 . . . . 0.0 112.379 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.94 79.42 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 111.721 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.22 64.76 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.035 -1.04 . . . . 0.0 112.337 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -81.44 -42.59 20.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 110.428 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.07 -20.2 62.3 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.049 0.939 . . . . 0.0 110.708 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.87 11.61 76.37 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.129 0.871 . . . . 0.0 111.996 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.21 167.85 11.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.953 1.701 . . . . 0.0 107.046 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.29 150.77 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -105.29 126.09 51.71 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.65 99.27 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.4 m -87.49 116.69 25.78 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.86 169.85 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.436 1.095 . . . . 0.0 109.005 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.416 ' HD2' ' CD1' ' A' ' 8' ' ' TYR . 15.9 ptt180 -153.25 167.97 27.54 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.527 -1.358 . . . . 0.0 110.858 172.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.511 HH11 ' CB ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -150.14 149.11 29.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.164 161.006 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 122.56 1.171 . . . . 0.0 111.615 161.212 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.0 p90 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 130.45 52.6 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.83 138.18 33.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 162.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.84 134.56 53.57 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.765 2.026 . . . . 0.0 107.251 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -92.08 132.44 36.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.482 HG11 ' HG ' ' A' ' 53' ' ' LEU . 65.4 t -130.12 108.82 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.588 1.555 . . . . 0.0 106.977 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -86.4 126.89 34.69 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 168.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -117.61 123.14 45.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.187 0.903 . . . . 0.0 109.041 164.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -78.74 161.44 26.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 111.055 172.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 38.8 ttt-85 -139.88 93.62 2.67 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.741 1.216 . . . . 0.0 110.48 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.7 mtp -142.29 -8.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 161.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -131.22 -105.65 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -164.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 m -65.6 -23.45 66.83 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.08 -1.013 . . . . 0.0 112.285 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.44 -179.94 7.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.704 1.138 . . . . 0.0 111.729 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 3.1 m-85 -63.5 123.52 18.98 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.16 -1.2 . . . . 0.0 110.632 -165.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.75 53.42 0.59 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 124.148 0.88 . . . . 0.0 111.133 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CE1' HD11 ' A' ' 90' ' ' LEU . 32.0 p90 -142.2 167.87 21.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.441 1.121 . . . . 0.0 108.66 172.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -123.43 162.36 22.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.801 2.04 . . . . 0.0 107.503 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.98 151.73 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.17 2.188 . . . . 0.0 106.99 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD12 ' HA2' ' A' ' 39' ' ' GLY . 97.0 mt -149.03 -177.31 5.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.476 2.31 . . . . 0.0 107.806 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.59 56.0 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.232 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -11.0 59.74 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.906 1.853 . . . . 0.0 112.415 -170.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -132.1 160.34 68.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 127.225 2.21 . . . . 0.0 107.369 168.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.94 69.56 7.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.961 3.774 . . . . 0.0 110.058 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.1 7.12 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.27 1.414 . . . . 0.0 112.599 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.54 160.84 39.88 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.62 1.71 . . . . 0.0 109.76 159.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.86 140.87 51.98 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.669 1.58 . . . . 0.0 109.175 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -105.79 93.2 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.3 149.27 25.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.1 0.476 . . . . 0.0 110.339 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.79 121.33 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 158.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 27' ' ' LEU . . . -64.49 -68.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 124.849 1.214 . . . . 0.0 110.081 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 144.55 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.729 1.612 . . . . 0.0 107.609 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.45 139.84 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 162.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mm -86.15 110.2 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.88 144.56 11.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.893 1.277 . . . . 0.0 111.076 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.0 mmt 47.09 69.99 0.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.105 1.762 . . . . 0.0 110.012 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.01 -179.94 44.97 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 m -57.71 -38.52 75.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.906 1.353 . . . . 0.0 114.64 -165.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 -44.43 50.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.872 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -42.49 65.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.212 1.005 . . . . 0.0 111.654 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -77.33 -21.42 53.43 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.089 -1.007 . . . . 0.0 112.296 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.74 -29.32 40.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.189 0.996 . . . . 0.0 110.524 171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.36 -3.49 4.49 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.11 2.291 . . . . 0.0 114.524 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -90.33 -42.14 11.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.658 1.229 . . . . 0.0 111.695 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 13' ' ' VAL . 7.5 mt -69.28 160.95 30.26 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.989 0.516 . . . . 0.0 109.643 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 155.61 72.4 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.679 1.191 . . . . 0.0 109.221 160.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.0 142.47 51.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.772 1.648 . . . . 0.0 108.838 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.26 -0.94 86.85 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.465 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.55 145.13 55.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.335 1.568 . . . . 0.0 107.433 166.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -93.71 133.57 36.93 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.746 1.157 . . . . 0.0 108.323 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -88.14 153.48 21.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.373 1.469 . . . . 0.0 110.173 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.0 -47.16 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.578 1.551 . . . . 0.0 109.426 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.21 150.31 48.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.879 1.672 . . . . 0.0 108.731 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -145.44 118.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 69.85 -31.39 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.099 2.56 . . . . 0.0 112.427 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.63 -21.13 0.39 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 128.065 2.745 . . . . 0.0 110.485 171.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 65' ' ' ILE . 4.5 mp -76.82 135.69 67.5 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 127.59 2.356 . . . . 0.0 107.457 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -72.92 151.49 50.72 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.425 2.083 . . . . 0.0 110.057 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.8 m -114.26 -7.77 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.26 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.23 102.83 2.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.68 2.13 30.65 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.855 1.216 . . . . 0.0 113.502 -174.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -98.17 173.23 7.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.875 1.837 . . . . 0.0 109.387 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -89.56 172.45 8.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.319 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -61.57 -46.4 90.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 111.137 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -62.61 -26.94 68.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.106 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -45.86 -48.87 15.87 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.268 1.027 . . . . 0.0 110.516 168.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.62 -36.16 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.442 1.097 . . . . 0.0 109.118 -169.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.14 -45.46 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.186 0.903 . . . . 0.0 109.783 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -70.35 -24.85 63.05 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -74.18 -46.71 40.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.477 0.711 . . . . 0.0 110.54 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 89.6 mmm -62.58 -24.58 67.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.926 1.239 . . . . 0.0 112.199 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.46 -50.82 72.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.934 167.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -50.45 56.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.291 1.836 . . . . 0.0 111.333 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.98 69.86 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.58 0.752 . . . . 0.0 111.264 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.31 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.629 -1.294 . . . . 0.0 112.15 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -69.26 -37.78 78.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.504 1.521 . . . . 0.0 111.187 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -62.78 -12.39 23.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.381 0.537 . . . . 0.0 112.14 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.44 9.68 85.88 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.282 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -170.76 166.38 7.89 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.355 1.862 . . . . 0.0 108.119 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 118.92 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -82.18 100.65 9.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CE1' ' A' ' 24' ' ' PHE . 29.2 mt -87.06 145.73 26.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.2 m -123.44 118.99 28.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 165.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.17 169.5 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 124.097 0.873 . . . . 0.0 108.99 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -151.35 161.04 43.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.868 -1.145 . . . . 0.0 110.183 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.83 134.46 14.53 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.531 169.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 124.915 1.286 . . . . 0.0 111.829 169.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.4 p90 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HE3' HD11 ' A' ' 11' ' ' LEU . 49.7 pttt -112.59 145.22 40.73 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 170.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.16 158.58 21.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 164.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.441 HD11 ' HE3' ' A' ' 9' ' ' LYS . 2.0 mm? -129.09 138.96 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.433 1.893 . . . . 0.0 106.925 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.13 125.89 46.31 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 108.098 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.17 142.79 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.349 1.06 . . . . 0.0 108.677 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -130.18 125.52 35.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -124.56 165.07 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.927 0.785 . . . . 0.0 110.643 -174.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -132.99 159.98 38.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.811 0.845 . . . . 0.0 111.333 -174.11 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -126.03 85.07 2.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.828 1.251 . . . . 0.0 111.04 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.4 ttm -140.4 -17.2 0.91 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.258 0.623 . . . . 0.0 111.487 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -91.93 -128.33 0.1 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -67.23 -7.03 20.88 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.994 -1.066 . . . . 0.0 113.084 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.25 73.5 0.69 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -165.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 74.88 156.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.545 2.338 . . . . 0.0 111.718 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.28 36.62 2.75 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.914 0.768 . . . . 0.0 111.33 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -130.65 166.26 21.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.154 0.977 . . . . 0.0 108.973 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -123.05 164.96 17.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.54 1.936 . . . . 0.0 107.544 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.61 125.7 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -173.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt -132.29 -178.25 4.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.546 1.538 . . . . 0.0 108.312 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.58 -162.96 54.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -168.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.61 18.52 65.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.078 -1.401 . . . . 0.0 114.751 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.18 -60.43 3.34 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.107 1.453 . . . . 0.0 109.002 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.91 161.2 47.88 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 107.98 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.123 3.215 . . . . 0.0 109.422 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 -5.51 12.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.305 1.431 . . . . 0.0 113.382 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -63.43 163.8 17.91 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.429 1.491 . . . . 0.0 111.47 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.25 140.48 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.937 1.758 . . . . 0.0 109.558 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.74 106.61 21.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.7 mt -99.88 153.72 18.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 mm -52.42 140.56 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 160.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.65 -124.01 0.83 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.21 116.68 29.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.797 2.039 . . . . 0.0 107.023 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.8 124.42 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.78 103.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.0 152.5 36.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.5 mtm 47.62 43.98 16.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.4 1.88 . . . . 0.0 111.198 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' ASP . . . -143.89 178.75 21.74 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 125.677 1.608 . . . . 0.0 111.874 -167.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -70.15 -7.88 45.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -163.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.19 -53.44 3.79 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.332 1.053 . . . . 0.0 110.3 165.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -43.81 -47.35 8.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 112.696 175.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -60.16 -38.13 82.25 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.267 1.427 . . . . 0.0 113.119 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.54 -32.96 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 0.0 110.831 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 31.38 35.4 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.462 160.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -131.85 -45.64 0.95 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.006 1.403 . . . . 0.0 112.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.93 144.98 52.01 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.682 -0.636 . . . . 0.0 110.222 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -132.27 158.97 74.18 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 124.778 1.231 . . . . 0.0 108.656 161.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 145.85 85.23 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.221 1.947 . . . . 0.0 110.098 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.16 6.5 79.86 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.398 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -69.73 126.35 29.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.094 1.947 . . . . 0.0 107.569 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HG3' HD23 ' A' ' 37' ' ' LEU . 21.7 tt0 -73.8 124.74 26.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.534 0.607 . . . . 0.0 109.402 -174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.51 150.73 31.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.759 0.823 . . . . 0.0 109.906 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.81 -46.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.225 1.81 . . . . 0.0 109.108 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.17 145.85 51.75 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.177 0.991 . . . . 0.0 110.249 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.7 t -139.2 129.39 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.829 1.652 . . . . 0.0 107.11 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.11 18.06 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.763 2.425 . . . . 0.0 113.225 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -11.38 62.78 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.385 2.421 . . . . 0.0 112.836 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.31 132.88 34.38 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.866 1.666 . . . . 0.0 108.62 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -70.99 116.83 4.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.863 2.375 . . . . 0.0 109.59 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.92 -7.37 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.388 0.675 . . . . 0.0 111.625 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 114.46 2.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.197 1.399 . . . . 0.0 111.032 -171.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -14.9 56.11 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.428 1.49 . . . . 0.0 113.02 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 170.48 9.43 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.747 1.219 . . . . 0.0 110.634 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.1 p -85.72 171.67 11.43 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.63 0.772 . . . . 0.0 111.024 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -46.82 -54.28 10.18 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.81 1.644 . . . . 0.0 108.831 165.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 ttp-105 -55.62 -37.76 68.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.02 -44.04 74.25 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.495 0.589 . . . . 0.0 109.918 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.15 -41.35 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.917 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.56 -44.43 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.234 0.925 . . . . 0.0 110.451 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -45.36 95.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.901 1.28 . . . . 0.0 110.189 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.56 -45.84 71.05 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.713 0.688 . . . . 0.0 111.412 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.6 mmm -52.73 -36.52 57.78 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 0.0 110.275 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -18.67 60.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.241 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -85.11 -49.06 8.57 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.02 1.728 . . . . 0.0 109.216 172.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.39 40.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.447 1.099 . . . . 0.0 109.473 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.52 -36.45 23.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.483 1.113 . . . . 0.0 113.105 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 81' ' ' HIS . 2.0 mpt_? -68.36 -39.64 81.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -71.49 -13.83 61.93 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.784 1.234 . . . . 0.0 112.759 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.41 4.54 90.01 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 119.404 1.002 . . . . 0.0 113.876 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 6.1 pt20 -142.96 178.59 7.57 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.433 1.493 . . . . 0.0 109.246 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.09 128.58 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 162.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.18 139.92 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 15' ' ' LEU . 5.8 mt -139.78 125.59 19.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.532 1.969 . . . . 0.0 107.374 -174.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.13 115.11 25.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.6 m -99.5 167.99 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -144.81 152.79 40.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 120.523 -1.36 . . . . 0.0 108.857 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -151.5 143.39 23.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.087 1.355 . . . . 0.0 109.633 173.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.513 0 C-N-CA 124.512 1.125 . . . . 0.0 110.263 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE2' ' HD2' ' A' ' 93' ' ' ARG . 36.0 p90 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.026 0.441 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 137.43 53.17 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.489 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -83.09 151.5 25.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.98 155.21 50.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.55 123.62 28.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.885 1.274 . . . . 0.0 108.538 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 52' ' ' ARG . 86.1 t -101.91 151.01 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.734 2.014 . . . . 0.0 106.225 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -128.26 120.89 28.06 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.546 1.539 . . . . 0.0 108.615 166.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.85 123.51 44.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.05 20.52 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.902 0.319 . . . . 0.0 110.147 166.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.6 ttt180 -119.69 93.79 4.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.138 2.175 . . . . 0.0 105.718 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.29 -13.78 7.11 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.046 0.538 . . . . 0.0 110.69 170.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.86 -112.45 0.19 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -65.2 -18.69 65.51 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.96 -173.65 53.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.101 0.834 . . . . 0.0 112.39 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 4.1 m-85 -71.82 111.14 6.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.433 0.693 . . . . 0.0 110.11 -164.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.26 46.47 3.64 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.419 1.009 . . . . 0.0 114.241 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -135.1 163.39 30.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.222 1.511 . . . . 0.0 110.368 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -120.27 157.29 29.47 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.294 1.838 . . . . 0.0 107.876 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.62 135.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.93 -178.85 6.02 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.213 1.405 . . . . 0.0 107.463 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.71 -154.35 46.93 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.34 34.25 40.89 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.281 0.943 . . . . 0.0 112.402 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 -46.44 43.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -167.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.09 157.96 32.71 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.423 1.089 . . . . 0.0 108.537 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.69 96.04 0.82 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.723 2.949 . . . . 0.0 108.129 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.13 -24.56 2.06 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.942 1.734 . . . . 0.0 111.44 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -73.73 150.71 88.77 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 119.399 1.599 . . . . 0.0 112.753 -171.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.38 149.55 69.45 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.588 2.858 . . . . 0.0 109.377 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -113.45 88.72 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.2 mt -93.3 125.98 38.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.9 mm -43.83 120.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.484 1.913 . . . . 0.0 106.87 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.96 -56.68 23.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 124.925 1.25 . . . . 0.0 111.709 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.58 153.48 31.48 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.1 t -112.96 112.79 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 118.89 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.981 1.712 . . . . 0.0 108.368 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.53 124.55 12.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.113 0.965 . . . . 0.0 110.536 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . 0.252 20.4 ptp 46.81 20.39 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.701 2.4 . . . . 0.0 115.283 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.74 -173.19 42.72 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -58.84 -39.06 80.13 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.217 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.07 -28.59 60.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 121.679 2.036 . . . . 0.0 111.973 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.56 -47.62 69.31 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.052 0.941 . . . . 0.0 109.241 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -60.51 -40.21 90.62 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.497 0.719 . . . . 0.0 111.177 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.16 -23.5 67.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.388 1.475 . . . . 0.0 111.929 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.82 72.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.214 1.388 . . . . 0.0 113.121 167.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 13' ' ' VAL . 1.9 mmp_? -122.72 -13.2 7.97 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.147 -163.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.449 ' HG ' HG21 ' A' ' 13' ' ' VAL . 17.5 mt -119.99 151.3 39.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.907 1.23 . . . . 0.0 107.885 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -132.35 149.21 72.51 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.671 164.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.44 134.92 40.47 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.678 1.585 . . . . 0.0 108.203 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.17 1.05 76.27 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.243 -1.309 . . . . 0.0 113.961 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.12 140.68 58.82 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.563 2.181 . . . . 0.0 107.354 161.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HG3' HD23 ' A' ' 37' ' ' LEU . 24.3 tt0 -85.96 128.24 34.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.549 1.522 . . . . 0.0 108.767 173.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.26 158.0 36.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.887 0.767 . . . . 0.0 110.175 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.86 -53.29 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.499 1.919 . . . . 0.0 107.708 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -132.59 148.46 52.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.845 1.258 . . . . 0.0 108.894 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 63.43 -2.48 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.431 2.293 . . . . 0.0 112.222 -169.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.3 31.8 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 127.361 2.41 . . . . 0.0 112.096 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.3 125.31 50.55 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.73 127.02 14.01 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.136 2.557 . . . . 0.0 108.555 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.03 -2.94 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.836 0.854 . . . . 0.0 110.565 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.24 120.29 14.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.901 0.88 . . . . 0.0 110.687 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.89 -12.24 37.16 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.777 1.18 . . . . 0.0 112.75 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.42 177.35 8.57 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.08 1.352 . . . . 0.0 107.814 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -105.3 175.33 5.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.622 0.769 . . . . 0.0 110.431 -172.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -52.05 -48.61 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.781 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -55.37 -35.09 64.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.38 -50.3 62.71 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.43 -40.49 82.31 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 124.035 0.934 . . . . 0.0 110.909 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mm -50.66 -42.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.586 1.084 . . . . 0.0 111.231 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -39.2 70.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.705 0.402 . . . . 0.0 110.57 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -50.18 73.65 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 122.917 0.487 . . . . 0.0 110.616 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.31 -40.14 85.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.317 0.508 . . . . 0.0 110.944 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -32.35 73.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.41 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -70.73 -57.46 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.523 1.529 . . . . 0.0 111.133 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.42 69.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.103 0.961 . . . . 0.0 111.303 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.09 72.35 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.582 -1.324 . . . . 0.0 111.09 169.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -73.73 -35.92 65.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 117.389 -1.291 . . . . 0.0 111.704 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -56.52 -25.82 52.75 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.082 0.855 . . . . 0.0 110.031 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.44 9.2 86.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 123.936 0.779 . . . . 0.0 111.571 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -160.28 165.62 31.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.037 1.419 . . . . 0.0 109.279 170.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.33 127.32 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.17 139.13 35.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 160.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.71 105.66 6.57 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.8 m -91.04 121.19 32.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.01 170.17 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' CE2' ' A' ' 8' ' ' TYR . 31.2 ptt180 -150.83 166.24 31.12 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.307 -1.496 . . . . 0.0 108.818 167.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -155.12 146.76 23.2 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? . . . . . 0 C--O 1.239 0.552 0 C-N-CA 124.871 1.269 . . . . 0.0 111.17 168.054 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -128.91 129.46 45.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.79 146.13 28.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.4 116.66 21.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.84 130.57 34.92 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 52' ' ' ARG . 61.4 t -133.7 130.41 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.507 1.523 . . . . 0.0 107.29 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -126.46 122.12 34.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -169.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.63 123.38 43.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -75.04 158.28 33.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.384 0.612 . . . . 0.0 109.645 169.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.7 ttt85 -125.48 88.28 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 168.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 ptm -142.33 -12.81 0.81 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 173.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -132.83 -71.99 0.52 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.639 1.576 . . . . 0.0 107.657 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -119.34 0.06 11.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.35 -156.97 52.57 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.702 1.137 . . . . 0.0 112.452 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.8 m-85 -108.94 105.16 14.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.75 0.82 . . . . 0.0 110.158 -169.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.95 41.83 3.11 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.307 1.908 . . . . 0.0 114.296 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.32 150.54 52.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.632 1.716 . . . . 0.0 110.166 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.06 160.21 14.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.739 1.616 . . . . 0.0 108.952 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.79 138.34 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.76 163.12 38.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.205 2.202 . . . . 0.0 106.0 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.62 176.09 42.06 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.11 90.07 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 -149.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.8 -26.41 65.18 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.658 0.783 . . . . 0.0 110.437 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.64 160.53 46.04 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.95 53.01 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.688 3.592 . . . . 0.0 109.651 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.73 58.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -136.27 161.65 61.04 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 111.569 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -73.31 132.31 17.64 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.955 2.437 . . . . 0.0 109.409 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.65 108.1 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 58' ' ' GLU . 5.3 mt -100.01 149.66 23.23 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 mm -49.55 118.28 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.6 -72.81 0.84 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -171.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.1 117.15 4.83 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.861 0.865 . . . . 0.0 109.024 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.267 0.6 OUTLIER -80.0 149.26 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 121.308 0.575 . . . . 0.0 109.451 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -80.82 107.59 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.22 146.36 15.4 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 mmt 64.0 -10.86 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.236 1.814 . . . . 0.0 112.72 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.88 169.39 53.68 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -60.78 -23.03 64.7 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.13 -45.19 42.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.782 1.628 . . . . 0.0 110.96 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.13 -51.45 69.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -64.24 -34.53 78.32 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.489 -0.757 . . . . 0.0 112.237 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.76 -29.59 70.23 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.287 0.948 . . . . 0.0 110.792 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.39 28.32 52.89 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.816 161.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 13' ' ' VAL . 60.1 mtp85 -136.78 -18.5 1.39 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.432 1.116 . . . . 0.0 113.343 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -90.01 148.25 23.18 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -135.32 157.04 77.47 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 125.062 1.345 . . . . 0.0 107.643 157.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.8 149.71 86.53 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.443 1.429 . . . . 0.0 108.881 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.63 -2.63 72.18 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.623 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.6 136.82 56.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.934 1.867 . . . . 0.0 107.276 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HG3' HD23 ' A' ' 37' ' ' LEU . 33.6 tt0 -85.37 127.36 34.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.766 1.166 . . . . 0.0 109.581 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.09 153.58 30.05 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.228 1.011 . . . . 0.0 110.224 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.5 -46.51 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 126.165 1.786 . . . . 0.0 109.055 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.4 148.42 42.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.403 1.081 . . . . 0.0 110.553 -176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.0 t -145.49 131.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 107.849 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 61.29 14.01 5.32 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.205 1.402 . . . . 0.0 111.333 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.08 -5.73 75.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 127.112 2.292 . . . . 0.0 113.444 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -104.36 133.99 19.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 121.069 2.434 . . . . 0.0 109.381 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.61 120.92 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.313 2.675 . . . . 0.0 110.786 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.62 -2.27 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.754 1.222 . . . . 0.0 112.62 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.62 125.12 22.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.357 1.063 . . . . 0.0 110.274 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.47 -7.12 9.07 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.367 0.984 . . . . 0.0 114.535 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 14.6 mmtt -82.88 174.29 11.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.412 1.485 . . . . 0.0 108.778 167.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.8 p -111.82 175.48 5.41 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.616 0.766 . . . . 0.0 110.696 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -38.69 -62.89 0.56 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.044 1.338 . . . . 0.0 110.586 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 ttp-105 -56.42 -34.09 66.43 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.595 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 76.0 t80 -58.12 -44.43 87.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.315 0.578 . . . . 0.0 110.978 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.97 -31.75 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.232 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.92 -41.48 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.265 -1.522 . . . . 0.0 111.272 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.88 -52.04 67.13 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.511 1.524 . . . . 0.0 109.042 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -51.3 69.78 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.277 0.631 . . . . 0.0 111.141 -175.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.2 mmm -61.98 -21.67 65.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 112.497 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 -32.59 53.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.723 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -66.27 -47.39 73.84 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.318 0.963 . . . . 0.0 110.126 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.05 70.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.41 73.99 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.9 -1.75 . . . . 0.0 112.887 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -68.68 -49.88 55.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.29 -20.6 7.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.432 1.493 . . . . 0.0 112.213 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.15 71.27 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.338 1.923 . . . . 0.0 111.329 170.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -177.47 170.56 2.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.441 2.296 . . . . 0.0 107.223 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.11 149.92 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.31 137.22 45.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.44 106.83 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -97.09 111.41 23.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.61 173.45 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -151.36 164.87 35.71 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.741 -1.225 . . . . 0.0 109.514 170.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.2 146.76 25.02 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.959 1.304 . . . . 0.0 108.322 164.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 C-N-CA 124.665 1.186 . . . . 0.0 110.632 170.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 135.37 52.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -84.28 145.14 28.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.71 116.83 21.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -102.56 111.09 23.24 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 107.766 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.95 150.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.369 1.868 . . . . 0.0 107.356 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -128.53 119.71 25.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.875 1.67 . . . . 0.0 111.59 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.7 mt -116.55 123.01 46.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -72.72 146.55 46.37 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 165.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.83 101.25 13.17 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 152.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.1 ptm -133.98 -9.75 2.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.057 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -138.04 -98.43 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.7 p -66.75 -20.41 65.95 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -162.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.78 73.62 0.66 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 54.74 93.7 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.187 2.595 . . . . 0.0 113.512 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.94 55.7 4.53 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.564 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 90' ' ' LEU . 33.9 p90 -129.31 175.16 8.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.932 1.293 . . . . 0.0 108.311 167.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -137.74 153.54 49.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.011 1.324 . . . . 0.0 107.573 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.42 140.02 47.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.98 160.77 43.0 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.829 2.052 . . . . 0.0 105.662 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 -178.86 52.34 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.06 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.68 48.72 79.22 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 -143.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.98 -37.87 88.98 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.86 161.5 55.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.667 1.987 . . . . 0.0 108.904 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.39 53.98 4.95 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 125.208 3.938 . . . . 0.0 112.288 -163.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.57 0.95 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.552 2.025 . . . . 0.0 112.077 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -75.12 163.94 64.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.042 1.921 . . . . 0.0 111.398 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -74.5 143.49 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.025 2.483 . . . . 0.0 110.13 171.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.42 104.85 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.6 mt -98.32 155.27 17.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -55.67 118.79 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 161.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.87 -56.35 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.24 155.3 42.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.292 1.037 . . . . 0.0 109.257 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 149.28 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 C-N-CA 127.425 2.29 . . . . 0.0 107.224 166.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.68 108.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.7 138.68 10.57 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.496 1.118 . . . . 0.0 110.146 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.8 mmt 59.8 0.95 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.043 2.137 . . . . 0.0 113.856 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.76 -175.99 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.783 1.659 . . . . 0.0 110.845 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -54.37 -35.85 63.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -164.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.85 -51.81 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.011 0.823 . . . . 0.0 110.438 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.55 -45.88 88.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.419 0.688 . . . . 0.0 110.687 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -60.21 -31.34 70.07 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.728 0.811 . . . . 0.0 113.028 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.85 -21.43 64.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.081 0.401 . . . . 0.0 111.728 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.58 45.99 86.78 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.446 1.022 . . . . 0.0 112.875 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -143.53 -47.63 0.29 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.379 1.471 . . . . 0.0 112.173 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.7 153.64 41.08 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.662 0.664 . . . . 0.0 109.489 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -142.36 155.63 64.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.211 1.004 . . . . 0.0 110.436 162.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -57.36 134.87 66.53 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.644 2.229 . . . . 0.0 108.957 167.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.4 7.09 69.98 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.44 0.543 . . . . 0.0 113.694 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -77.71 123.12 26.27 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 171.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG3' HD23 ' A' ' 37' ' ' LEU . 37.7 tt0 -73.05 123.78 24.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.42 149.87 35.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.921 0.888 . . . . 0.0 109.253 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.11 -52.12 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -134.09 147.44 50.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.381 1.072 . . . . 0.0 109.464 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.8 t -145.51 123.32 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -171.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.14 -56.38 0.23 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.398 2.279 . . . . 0.0 109.107 -160.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.37 -7.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.694 2.093 . . . . 0.0 110.847 164.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 65' ' ' ILE . 4.3 mp -73.48 139.05 77.83 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 127.242 2.217 . . . . 0.0 107.442 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.57 127.76 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.099 2.532 . . . . 0.0 112.704 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.73 -9.14 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.711 0.804 . . . . 0.0 113.103 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.41 129.86 43.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.926 0.891 . . . . 0.0 110.525 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.49 -12.7 2.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.427 1.013 . . . . 0.0 115.456 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 69.0 mmtt -75.34 179.03 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.712 . . . . 0.0 108.134 169.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.5 p -115.52 171.34 7.79 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.768 -0.582 . . . . 0.0 110.043 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -34.58 -60.21 0.44 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.538 1.935 . . . . 0.0 112.142 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -53.33 -37.41 62.29 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.946 1.298 . . . . 0.0 113.111 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 49.6 t80 -52.14 -45.45 65.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.992 0.917 . . . . 0.0 110.01 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.82 -37.92 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 124.785 1.234 . . . . 0.0 110.188 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.22 -35.27 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 121.539 -0.725 . . . . 0.0 110.104 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.69 -39.85 95.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.676 0.79 . . . . 0.0 111.331 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.39 -37.4 68.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.106 0.962 . . . . 0.0 111.033 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -38.92 78.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.056 0.942 . . . . 0.0 109.604 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -43.8 97.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.682 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -46.9 72.02 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.303 0.956 . . . . 0.0 110.555 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.79 -34.61 69.8 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.156 0.582 . . . . 0.0 111.802 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.26 82.77 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.604 -0.685 . . . . 0.0 111.301 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.63 -41.34 65.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.332 1.053 . . . . 0.0 110.123 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -55.66 -24.27 32.96 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.554 1.541 . . . . 0.0 112.389 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.95 63.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.156 1.836 . . . . 0.0 113.039 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -171.51 160.74 6.04 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.365 1.583 . . . . 0.0 109.048 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.29 121.88 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.284 1.04 . . . . 0.0 109.253 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -80.42 132.51 35.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 162.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 24' ' ' PHE . 43.3 mt -127.65 106.06 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 m -94.98 111.63 23.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -99.33 171.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -150.75 161.42 42.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 120.203 -1.561 . . . . 0.0 110.136 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.25 136.54 20.02 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.844 0.831 . . . . 0.0 111.049 165.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 C-N-CA 128.558 2.743 . . . . 0.0 111.843 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 p90 . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 122.405 1.098 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -132.83 130.15 39.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.7 120.95 26.63 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 116.82 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.66 129.88 34.98 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.932 2.093 . . . . 0.0 109.07 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.14 148.84 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.509 1.523 . . . . 0.0 107.107 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -130.72 133.98 46.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 167.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.57 129.36 50.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 124.011 0.819 . . . . 0.0 110.482 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.35 163.19 24.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.899 0.857 . . . . 0.0 110.136 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -114.92 102.38 9.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 164.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.616 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 8.9 ptp -146.62 -62.4 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.616 ' H ' ' HG3' ' A' ' 18' ' ' MET . 1.8 tm-20 -66.46 -171.55 0.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.004 1.721 . . . . 0.0 108.998 151.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -64.87 11.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.073 2.949 . . . . 0.0 117.006 -152.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 78.66 0.83 Allowed Glycine 0 N--CA 1.45 -0.401 0 O-C-N 121.155 -0.966 . . . . 0.0 112.343 160.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.04 81.71 0.13 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.985 2.114 . . . . 0.0 111.907 171.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.59 58.99 3.77 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.017 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.75 167.52 20.39 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.902 1.351 . . . . 0.0 109.808 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -118.64 163.98 16.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.008 2.123 . . . . 0.0 106.85 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 128.71 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.517 1.927 . . . . 0.0 106.319 -175.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.8 161.77 35.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.625 0.726 . . . . 0.0 110.149 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.94 -160.24 34.75 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 28.58 60.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -150.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.28 -30.81 62.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.054 0.542 . . . . 0.0 110.318 -162.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -104.05 161.51 22.71 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.911 2.085 . . . . 0.0 107.948 163.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.69 100.43 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.849 3.033 . . . . 0.0 108.809 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.75 6.51 7.16 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.241 1.401 . . . . 0.0 114.18 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -82.82 157.13 67.17 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 119.339 1.57 . . . . 0.0 110.862 172.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.72 138.89 39.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.49 2.127 . . . . 0.0 110.514 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.9 mt -102.56 95.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.05 145.67 25.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.81 117.03 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.74 -52.65 47.04 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 125.289 1.423 . . . . 0.0 111.471 -168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.19 156.64 22.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.232 3.013 . . . . 0.0 105.137 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.7 130.48 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 169.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.64 117.12 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.16 -31.02 63.0 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.0 mmt -127.72 33.5 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.31 170.58 17.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -62.03 -12.94 21.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.22 -51.26 13.75 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.165 1.348 . . . . 0.0 109.668 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.07 -45.87 86.39 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -54.67 -46.73 74.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.304 0.502 . . . . 0.0 112.007 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.28 -30.51 71.38 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.8 0.273 . . . . 0.0 111.196 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.47 -37.69 3.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 127.437 2.446 . . . . 0.0 112.436 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -65.37 -21.88 66.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.548 1.139 . . . . 0.0 113.774 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.5 132.89 33.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -125.87 157.19 69.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 124.442 1.097 . . . . 0.0 109.309 160.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.28 148.45 74.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.431 1.421 . . . . 0.0 109.45 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.43 -7.19 79.95 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.529 -1.15 . . . . 0.0 112.562 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.04 128.97 37.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.497 1.648 . . . . 0.0 106.798 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.55 125.02 30.67 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 120.81 -1.181 . . . . 0.0 109.12 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.13 145.51 37.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.405 1.082 . . . . 0.0 109.773 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -120.13 -54.21 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.081 2.152 . . . . 0.0 108.245 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -128.57 146.03 50.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.128 1.371 . . . . 0.0 108.97 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -140.04 121.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t0 53.7 16.22 0.95 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.163 1.785 . . . . 0.0 111.963 -168.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.99 69.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 127.455 2.455 . . . . 0.0 114.199 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.12 125.9 71.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 120.834 2.317 . . . . 0.0 106.269 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.14 117.3 5.03 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.055 2.503 . . . . 0.0 108.466 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' A' ' 75' ' ' VAL . 26.6 m -79.1 -6.33 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.723 0.809 . . . . 0.0 111.669 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 121.35 16.86 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.146 0.578 . . . . 0.0 110.373 -171.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.41 -9.39 75.66 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.902 1.239 . . . . 0.0 112.978 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 66.5 mmtt -74.93 -164.34 0.29 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.282 1.433 . . . . 0.0 108.13 166.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -120.86 170.02 9.88 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.685 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -38.46 -61.44 0.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.956 1.702 . . . . 0.0 109.414 165.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -42.99 -46.22 5.38 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 128.46 2.704 . . . . 0.0 112.645 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 42.3 t80 -58.83 -40.91 85.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 111.118 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' CG1' ' A' ' 67' ' ' VAL . 18.9 t -75.44 -32.23 25.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.372 -0.83 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -60.35 -40.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.763 1.165 . . . . 0.0 109.763 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.15 -45.69 92.21 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 110.269 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -48.96 78.52 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.644 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.8 mmm -60.11 -33.36 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.239 0.927 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -61.92 -45.3 94.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.208 0.603 . . . . 0.0 110.044 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -58.96 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.224 1.41 . . . . 0.0 111.355 175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.65 73.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.192 1.397 . . . . 0.0 110.581 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.74 63.76 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.961 -1.087 . . . . 0.0 111.003 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -70.43 -41.78 72.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.79 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.01 -10.31 9.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.981 2.113 . . . . 0.0 113.365 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.76 1.5 83.91 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.012 1.291 . . . . 0.0 113.269 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -159.71 -178.59 7.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.979 2.112 . . . . 0.0 108.043 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.58 131.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.77 1.628 . . . . 0.0 106.752 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.69 141.89 34.44 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 162.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -135.8 122.81 21.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -115.7 113.18 23.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.24 168.71 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.92 148.91 29.68 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 119.678 -1.889 . . . . 0.0 110.208 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -147.2 123.99 11.23 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.461 1.504 . . . . 0.0 111.373 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 30.9 p90 . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.712 0.292 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -122.53 141.96 51.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.3 159.53 21.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 166.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.54 146.82 40.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.374 1.47 . . . . 0.0 107.39 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.42 139.01 38.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.281 1.833 . . . . 0.0 109.322 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.2 t -137.52 107.42 4.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -100.66 139.3 36.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.9 mt -134.83 149.99 50.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.767 0.827 . . . . 0.0 109.976 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -97.84 151.26 20.4 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 109.447 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 60.6 ttt-85 -125.92 76.89 1.63 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 0.0 108.835 177.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -143.61 13.48 1.74 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.232 0.613 . . . . 0.0 111.151 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -147.82 -121.58 0.06 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.362 1.865 . . . . 0.0 106.935 -175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -31.13 71.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.078 -1.639 . . . . 0.0 111.826 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.23 -177.28 39.73 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.86 155.29 40.78 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.9 0.88 . . . . 0.0 110.393 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.72 63.23 0.47 Allowed Glycine 0 C--N 1.337 0.639 0 C-N-CA 124.294 0.95 . . . . 0.0 111.902 -170.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 90' ' ' LEU . 37.4 p90 -128.79 170.36 13.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.882 1.273 . . . . 0.0 109.098 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -122.16 163.36 19.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 156.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.26 133.63 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.1 mt -142.85 121.73 12.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.52 179.51 15.76 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.21 29.93 76.53 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -167.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -66.47 -20.45 66.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.573 0.687 . . . . 0.0 110.166 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.57 155.32 80.44 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.914 1.686 . . . . 0.0 110.103 165.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.43 81.88 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.094 3.863 . . . . 0.0 115.165 -165.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.92 -12.75 1.92 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 124.974 1.273 . . . . 0.0 112.033 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -66.82 157.14 85.08 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 117.55 0.675 . . . . 0.0 110.529 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.69 113.04 3.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.733 2.289 . . . . 0.0 111.777 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.56 105.16 6.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.4 mt -93.43 158.48 15.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.421 1.088 . . . . 0.0 109.704 166.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.43 126.04 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 154.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.91 -77.88 0.18 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.35 144.9 29.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.636 1.175 . . . . 0.0 108.602 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 1.2 m -98.79 140.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 123.88 0.872 . . . . 0.0 110.14 169.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.83 111.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.64 -39.83 68.38 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.256 0.551 . . . . 0.0 112.053 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.6 mmt -106.12 44.42 1.05 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.002 0.921 . . . . 0.0 109.053 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.85 165.09 27.73 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.8 1.667 . . . . 0.0 109.643 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -69.11 -10.32 57.07 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 115.653 1.724 . . . . 0.0 115.653 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.05 56.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.092 1.315 . . . . 0.0 109.348 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.89 -43.5 92.71 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.141 0.9 . . . . 0.0 110.058 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -55.82 -43.04 76.57 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.242 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.33 -18.48 63.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.621 1.1 . . . . 0.0 112.643 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.26 54.64 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.448 1.023 . . . . 0.0 113.078 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -134.5 -38.46 0.83 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -74.16 170.16 16.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.777 1.171 . . . . 0.0 109.418 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.08 152.22 42.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.15 0.98 . . . . 0.0 109.445 156.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.94 120.08 6.79 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.11 2.54 . . . . 0.0 108.585 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.62 6.2 54.91 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.378 -1.235 . . . . 0.0 112.951 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.67 142.41 58.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.654 1.727 . . . . 0.0 108.383 159.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' HD23 ' A' ' 37' ' ' LEU . 6.4 tt0 -86.72 125.8 34.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.312 1.045 . . . . 0.0 109.466 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.624 HD23 HG12 ' A' ' 92' ' ' VAL . 12.2 mt -79.75 156.43 27.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.038 1.335 . . . . 0.0 110.809 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.39 -54.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.583 1.953 . . . . 0.0 111.693 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.61 143.87 49.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.508 1.523 . . . . 0.0 110.777 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.46 111.99 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 72.32 -38.02 0.41 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.102 2.961 . . . . 0.0 111.25 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 65' ' ' ILE . . . 164.32 -3.55 0.06 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 130.617 3.961 . . . . 0.0 109.797 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -100.11 125.87 38.41 Favored Pre-proline 0 N--CA 1.439 -1.023 0 O-C-N 120.562 -1.552 . . . . 0.0 107.058 -168.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.19 141.03 67.48 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.903 1.735 . . . . 0.0 109.662 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -90.15 -9.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.234 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.72 117.87 5.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.152 0.981 . . . . 0.0 110.12 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.04 83.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.849 0.738 . . . . 0.0 114.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG3' ' CE2' ' A' ' 74' ' ' TYR . 26.3 mmmt -87.01 -171.83 3.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.304 1.441 . . . . 0.0 107.495 167.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -130.58 -179.55 5.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.168 0.987 . . . . 0.0 109.893 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -53.82 -57.44 10.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.661 0.784 . . . . 0.0 111.057 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.75 70.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.276 0.944 . . . . 0.0 112.879 -171.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 58.2 t80 -46.78 -59.67 2.9 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.038 0.935 . . . . 0.0 109.819 167.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.97 -36.61 76.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 123.37 0.668 . . . . 0.0 109.286 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.35 -32.63 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.652 -1.28 . . . . 0.0 111.507 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.84 -33.86 66.43 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.156 -1.59 . . . . 0.0 110.904 168.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -72.59 -32.81 66.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.108 0.963 . . . . 0.0 111.357 -173.149 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 62.3 mmm -58.58 -36.81 74.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.57 1.148 . . . . 0.0 111.279 166.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -73.04 -45.74 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.11 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -51.14 -55.55 17.24 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 125.257 1.423 . . . . 0.0 110.962 170.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -58.71 -42.75 89.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.776 0.831 . . . . 0.0 111.058 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.0 -14.64 60.91 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.464 -1.397 . . . . 0.0 113.058 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -85.7 -36.67 20.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.83 1.195 . . . . 0.0 111.068 165.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -62.67 -15.85 54.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.85 21.03 79.18 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.935 1.731 . . . . 0.0 112.546 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -164.78 177.05 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.755 2.022 . . . . 0.0 106.811 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 82' ' ' ALA . 5.0 p -154.58 160.16 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -141.76 91.09 2.33 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.68 0.792 . . . . 0.0 108.907 -170.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 24' ' ' PHE . 21.3 mt -98.24 99.5 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.49 1.516 . . . . 0.0 107.815 -170.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -87.9 131.35 34.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.624 HG12 HD23 ' A' ' 59' ' ' LEU . 33.2 m -120.4 167.7 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.411 1.884 . . . . 0.0 108.211 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -152.39 151.85 31.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 121.031 -1.043 . . . . 0.0 110.292 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -145.02 134.82 23.56 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.478 0.711 . . . . 0.0 109.116 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 C-N-CA 126.39 1.876 . . . . 0.0 111.112 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.717 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t 58.08 26.57 13.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.025 0.93 . . . . 0.0 112.187 -169.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 p -119.56 -25.7 5.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.445 1.098 . . . . 0.0 112.157 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.66 105.46 2.68 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -50.7 49.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.152 0.981 . . . . 0.0 111.037 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -147.66 132.51 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.76 -61.92 0.02 OUTLIER Glycine 0 C--O 1.224 -0.475 0 CA-C-O 118.14 -1.366 . . . . 0.0 110.837 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -125.27 155.71 39.73 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 120.509 2.155 . . . . 0.0 111.063 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -116.0 139.91 49.79 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.9 152.31 24.61 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 164.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.38 127.84 34.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.18 149.53 27.87 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -139.24 107.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -76.07 143.43 41.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.12 131.24 32.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -82.19 153.63 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -108.25 87.35 2.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtm -143.88 -3.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.66 -64.14 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -126.29 -14.28 5.95 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.47 60.7 3.93 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 119.728 1.149 . . . . 0.0 112.382 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 85.5 93.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.608 2.363 . . . . 0.0 110.568 160.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.72 53.76 4.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.677 0.656 . . . . 0.0 112.325 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE1' HD11 ' A' ' 90' ' ' LEU . 31.2 p90 -130.44 173.51 10.77 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.373 1.086 . . . . 0.0 109.039 169.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -140.37 165.61 26.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.5 128.66 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -164.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -139.62 -177.13 4.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.526 1.93 . . . . 0.0 108.053 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.43 -146.67 36.2 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.57 31.97 52.94 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.186 0.993 . . . . 0.0 112.652 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.96 -30.92 56.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.083 -0.657 . . . . 0.0 112.145 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -114.85 158.9 39.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.73 91.09 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.245 2.63 . . . . 0.0 109.638 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.3 1.84 10.11 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.14 1.353 . . . . 0.0 114.17 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.5 159.88 56.34 Favored Pre-proline 0 C--O 1.239 0.54 0 CA-C-N 119.428 1.614 . . . . 0.0 109.237 163.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.82 145.35 56.51 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.654 2.236 . . . . 0.0 111.224 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.53 92.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -100.69 140.73 34.56 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.653 3.581 . . . . 0.0 109.543 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.81 109.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.653 1.581 . . . . 0.0 107.672 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.76 -46.55 31.16 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 127.661 2.553 . . . . 0.0 112.569 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 163.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.545 1.538 . . . . 0.0 107.424 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.59 131.9 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 161.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.11 107.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.34 132.01 47.03 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.753 0.658 . . . . 0.0 109.853 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.1 mtm 68.49 -5.94 0.88 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.537 1.935 . . . . 0.0 114.19 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.64 176.81 53.5 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.192 0.884 . . . . 0.0 111.811 -171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 32.1 t -60.48 -8.84 3.01 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.217 1.807 . . . . 0.0 115.018 -167.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.78 -46.62 6.19 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 120.137 1.335 . . . . 0.0 111.609 168.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -56.4 -40.1 74.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.477 1.511 . . . . 0.0 110.306 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 13.3 ptm180 -69.89 -22.0 63.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -22.57 55.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.174 0.897 . . . . 0.0 110.129 170.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.8 60.3 8.94 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 125.643 1.592 . . . . 0.0 110.79 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -146.68 2.29 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -135.56 151.0 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -129.22 149.87 73.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 125.097 1.359 . . . . 0.0 109.053 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.81 130.58 34.74 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.556 2.838 . . . . 0.0 111.317 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.62 88.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.066 -1.408 . . . . 0.0 113.671 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 127.81 33.64 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.172 1.486 . . . . 0.0 107.761 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 119.28 18.06 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.6 mt -63.83 164.4 10.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.878 1.671 . . . . 0.0 111.001 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.2 -52.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.203 1.401 . . . . 0.0 109.673 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.34 148.19 52.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.005 0.922 . . . . 0.0 108.553 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -137.0 113.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.58 5.23 0.44 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.876 2.47 . . . . 0.0 114.198 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.46 -5.94 6.67 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.947 2.689 . . . . 0.0 113.094 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.0 124.6 34.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 119.483 1.642 . . . . 0.0 107.747 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.65 114.71 4.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.42 3.413 . . . . 0.0 109.179 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.72 -7.46 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.75 1.22 . . . . 0.0 112.789 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.24 129.85 40.47 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.579 -0.701 . . . . 0.0 110.313 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.01 84.06 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.991 -0.443 . . . . 0.0 113.374 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -101.22 -166.95 1.36 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.604 1.561 . . . . 0.0 108.195 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -121.56 177.75 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.075 0.95 . . . . 0.0 110.892 -170.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -52.19 -56.27 15.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.616 0.766 . . . . 0.0 109.759 169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -55.69 -33.41 64.12 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.79 -50.93 62.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.816 0.846 . . . . 0.0 110.357 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.55 -38.19 78.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 124.947 1.299 . . . . 0.0 111.16 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.0 mm -56.53 -39.46 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.868 0.758 . . . . 0.0 109.224 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -37.77 85.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.944 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.37 -49.69 74.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.234 0.613 . . . . 0.0 111.047 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.46 -36.77 74.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 111.133 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.31 -14.51 56.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.263 1.025 . . . . 0.0 113.105 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.27 -49.29 5.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.15 1.38 . . . . 0.0 110.825 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.76 -41.33 73.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.126 0.97 . . . . 0.0 110.63 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.0 -22.02 65.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.311 -1.493 . . . . 0.0 113.152 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.62 -43.52 20.37 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.535 1.134 . . . . 0.0 109.517 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -54.91 -23.64 19.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.329 0.652 . . . . 0.0 110.975 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.73 13.76 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.475 1.036 . . . . 0.0 111.956 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.15 174.68 12.6 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.231 2.212 . . . . 0.0 106.751 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.47 164.68 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -129.21 133.01 47.36 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 166.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.444 HD11 ' CE1' ' A' ' 24' ' ' PHE . 18.1 mt -130.61 97.48 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.119 2.168 . . . . 0.0 105.386 -169.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.1 m -85.49 117.07 24.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.19 170.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 108.743 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -152.9 145.89 24.55 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 119.594 -1.942 . . . . 0.0 112.326 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.57 130.57 17.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.754 0.706 . . . . 0.0 110.252 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.19 126.78 27.62 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.072 1.349 . . . . 0.0 109.721 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.82 118.61 23.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 127.254 2.221 . . . . 0.0 107.093 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.14 153.7 51.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.865 0.866 . . . . 0.0 109.352 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -157.97 158.58 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 129.7 3.2 . . . . 0.0 105.202 165.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 144.65 98.73 0.26 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.96 167.01 27.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.811 2.341 . . . . 0.0 111.079 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.6 m -158.0 -56.21 0.07 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.633 1.973 . . . . 0.0 107.902 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.22 158.24 43.96 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 108.196 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.802 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.712 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -86.65 160.62 18.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.613 0.72 . . . . 0.0 111.617 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -132.56 70.26 1.47 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.95 72.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -170.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.5 m -144.65 153.89 42.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 165.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m 48.68 75.83 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.836 0.854 . . . . 0.0 111.243 -171.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.49 -107.07 0.13 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 157.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -54.19 138.03 39.37 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 117.464 0.632 . . . . 0.0 111.657 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -91.65 136.09 33.4 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.52 155.83 23.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.736 1.273 . . . . 0.0 108.122 151.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.32 116.93 10.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.158 2.183 . . . . 0.0 106.62 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.48 134.44 34.64 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.516 1.127 . . . . 0.0 109.767 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.412 HG22 ' HE ' ' A' ' 52' ' ' ARG . 79.6 t -129.04 143.36 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 127.014 2.125 . . . . 0.0 107.979 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -129.13 103.17 6.82 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.464 -0.773 . . . . 0.0 110.548 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -103.48 131.8 50.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.857 0.837 . . . . 0.0 109.772 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -86.86 160.73 18.64 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.418 0.687 . . . . 0.0 110.639 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -121.83 86.79 2.64 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.991 0.917 . . . . 0.0 110.488 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 mtp -130.41 -9.94 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.697 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.69 -100.32 0.19 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -29.73 70.7 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.12 1.327 . . . . 0.0 110.709 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.73 73.73 0.84 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 69.58 -115.8 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.308 1.843 . . . . 0.0 109.167 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.32 40.55 0.25 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 120.846 1.657 . . . . 0.0 112.742 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -123.22 175.52 6.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.045 1.338 . . . . 0.0 108.508 168.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.59 167.11 21.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.54 121.69 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.837 1.199 . . . . 0.0 109.07 -162.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.7 mt -138.26 147.09 43.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.32 -163.3 12.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.6 28.15 64.78 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 118.29 1.045 . . . . 0.0 112.458 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.22 -37.88 86.62 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.427 -1.043 . . . . 0.0 110.233 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.53 160.99 30.94 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.417 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.77 46.91 2.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.705 3.603 . . . . 0.0 112.588 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.13 48.29 0.12 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 109.858 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -123.26 164.05 30.17 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.596 1.159 . . . . 0.0 110.759 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.6 143.89 27.73 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.477 2.785 . . . . 0.0 108.463 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.58 100.38 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.9 mt -87.95 151.01 23.12 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mm -57.56 112.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 162.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.12 -56.39 24.39 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 126.814 2.149 . . . . 0.0 111.763 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.58 167.86 28.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.571 1.949 . . . . 0.0 106.943 172.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.38 130.71 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 mm -79.93 115.39 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.46 -21.2 3.45 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.491 1.917 . . . . 0.0 115.085 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.7 mmt -122.28 7.06 9.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.73 1.612 . . . . 0.0 110.989 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.91 167.63 34.91 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 120.701 -1.249 . . . . 0.0 110.53 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.417 ' HA ' ' CG ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -61.94 -12.86 20.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.292 1.037 . . . . 0.0 112.613 175.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.79 -69.12 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.997 0.817 . . . . 0.0 110.128 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.15 -43.75 78.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.643 0.656 . . . . 0.0 111.931 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.417 ' CG ' ' HA ' ' A' ' 46' ' ' SER . 0.1 OUTLIER -65.97 -10.04 35.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.687 -1.149 . . . . 0.0 113.764 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.37 -46.51 15.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.807 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 37.28 4.37 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.849 1.214 . . . . 0.0 114.189 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 13' ' ' VAL . 50.6 mtp85 -127.3 -62.69 1.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.001 1.401 . . . . 0.0 112.635 -171.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.17 143.52 55.36 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.046 0.938 . . . . 0.0 110.424 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -126.11 153.11 74.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 123.803 0.841 . . . . 0.0 109.756 166.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.75 141.81 64.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.95 1.767 . . . . 0.0 109.344 164.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 -8.55 63.81 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-O 117.45 -1.75 . . . . 0.0 114.495 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.04 126.5 27.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.953 1.876 . . . . 0.0 107.166 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HG3' HD23 ' A' ' 37' ' ' LEU . 26.0 tt0 -79.69 121.13 24.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.13 153.02 36.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.639 1.176 . . . . 0.0 110.002 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 t -130.99 -50.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.463 1.505 . . . . 0.0 109.088 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.32 143.71 50.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.24 122.06 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t0 54.84 21.82 3.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.714 1.205 . . . . 0.0 112.207 -167.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.95 -5.97 82.45 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 117.713 -1.604 . . . . 0.0 113.921 -174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -92.11 128.88 43.59 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 120.928 2.364 . . . . 0.0 106.592 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.71 119.05 6.07 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.994 2.463 . . . . 0.0 109.509 -173.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.34 -4.99 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.272 1.429 . . . . 0.0 110.619 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.06 115.96 4.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.561 1.144 . . . . 0.0 109.554 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.05 -1.92 21.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.908 0.766 . . . . 0.0 113.987 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -80.94 164.96 22.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.616 2.208 . . . . 0.0 108.876 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.4 p -81.16 171.25 15.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.46 0.704 . . . . 0.0 110.577 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -53.23 -49.98 65.69 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.28 -1.513 . . . . 0.0 109.389 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.85 -28.23 69.34 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -48.98 -57.02 7.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.721 1.208 . . . . 0.0 109.779 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.8 -39.19 84.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.884 1.274 . . . . 0.0 110.435 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.42 -27.74 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.237 -0.914 . . . . 0.0 110.511 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -41.04 68.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.557 1.143 . . . . 0.0 111.219 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -52.03 67.44 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.836 0.854 . . . . 0.0 109.823 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 71.4 mmm -54.83 -39.13 68.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.036 0.835 . . . . 0.0 111.391 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -43.5 98.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.28 0.632 . . . . 0.0 110.801 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -49.0 64.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.847 1.259 . . . . 0.0 111.769 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.03 71.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.262 1.825 . . . . 0.0 110.275 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.99 76.9 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.378 -0.826 . . . . 0.0 111.913 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.46 -39.56 74.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.649 1.113 . . . . 0.0 110.917 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.02 -20.6 66.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.712 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.97 70.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.674 1.131 . . . . 0.0 112.522 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -163.72 162.15 23.84 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.441 1.496 . . . . 0.0 108.273 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.58 128.38 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -80.49 141.77 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 161.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.8 mt -135.4 105.13 6.11 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -100.52 116.32 32.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.2 m -105.16 167.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 107.946 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -149.38 153.59 37.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.698 -1.251 . . . . 0.0 111.582 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -144.32 132.29 21.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.268 1.027 . . . . 0.0 109.306 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 139.78 18.33 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.699 1.2 . . . . 0.0 110.846 167.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.49 165.56 18.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 125.65 1.58 . . . . 0.0 106.759 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.52 -175.63 4.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.588 1.155 . . . . 0.0 108.32 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.0 t -143.76 -54.83 0.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.369 0.668 . . . . 0.0 110.561 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.77 -175.74 23.03 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.58 140.61 93.91 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.89 2.394 . . . . 0.0 111.803 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.85 127.09 31.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.18 1.792 . . . . 0.0 106.487 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 160.57 41.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.39 0 N-CA-C 105.854 -2.899 . . . . 0.0 105.854 -176.533 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -98.05 -63.48 1.12 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.862 0.831 . . . . 0.0 109.461 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 m -143.4 167.66 21.66 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.642 0.777 . . . . 0.0 109.691 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.15 84.16 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 106.371 -2.692 . . . . 0.0 106.371 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -68.47 83.49 0.27 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.96 -83.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.939 . . . . 0.0 110.248 -167.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.62 -2.74 5.26 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.955 1.252 . . . . 0.0 114.755 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 51.1 p90 -133.23 144.41 49.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.152 1.476 . . . . 0.0 107.994 157.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 130.38 40.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.51 130.13 34.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 163.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.99 155.35 34.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.648 1.579 . . . . 0.0 108.217 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -133.43 132.02 40.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.941 0.896 . . . . 0.0 111.883 -171.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 t -124.45 108.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.96 1.304 . . . . 0.0 108.561 -174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -80.65 129.2 34.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.5 mt -123.38 123.39 40.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 157.82 36.95 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.174 0.589 . . . . 0.0 110.053 173.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -114.2 83.18 1.83 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.9 mtm -138.62 -9.6 1.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.598 0.635 . . . . 0.0 112.205 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -131.21 -102.5 0.28 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -74.58 -22.03 59.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.66 1.573 . . . . 0.0 114.347 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.03 77.42 0.5 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.879 1.218 . . . . 0.0 112.929 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 58.94 76.67 0.34 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 128.347 2.659 . . . . 0.0 112.214 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.52 70.54 2.64 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.755 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CE1' HD11 ' A' ' 90' ' ' LEU . 34.8 p90 -142.37 147.72 36.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.867 1.334 . . . . 0.0 108.532 167.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -93.51 163.21 13.66 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.921 1.288 . . . . 0.0 108.227 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.87 139.4 49.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.105 1.362 . . . . 0.0 107.578 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.11 -177.5 5.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 108.273 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.38 -161.02 50.87 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.347 -0.846 . . . . 0.0 111.159 -170.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.71 75.24 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.749 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.98 -12.49 60.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.661 1.73 . . . . 0.0 113.366 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 15.6 mt-10 -141.6 160.12 57.74 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.822 1.649 . . . . 0.0 108.817 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 31' ' ' GLU . 73.6 Cg_endo -72.12 105.92 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.129 2.552 . . . . 0.0 109.252 -168.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.07 30.86 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.661 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -66.67 162.25 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.44 1.62 . . . . 0.0 109.323 155.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.82 140.82 68.89 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.864 2.376 . . . . 0.0 109.013 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -116.04 83.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.06 142.27 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.906 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mm -61.2 126.94 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.41 -41.12 91.27 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.163 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 167.01 124.42 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.658 2.383 . . . . 0.0 107.768 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.47 150.03 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.536 1.134 . . . . 0.0 110.705 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -83.32 106.99 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.64 69.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -120.06 40.59 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.2 -178.03 31.85 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 125.817 1.675 . . . . 0.0 109.92 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -59.53 -28.36 67.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -57.04 4.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.126 1.33 . . . . 0.0 109.871 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.34 -38.25 88.75 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.928 0.87 . . . . 0.0 110.102 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.01 -8.87 52.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.346 1.058 . . . . 0.0 113.356 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.61 -17.38 36.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.393 1.452 . . . . 0.0 110.646 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.58 83.5 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.282 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -117.47 -54.52 2.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -166.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 161.28 30.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -140.65 146.02 42.84 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 121.498 -0.752 . . . . 0.0 110.166 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.24 132.3 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.788 2.325 . . . . 0.0 111.259 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.13 -2.32 78.77 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.732 1.158 . . . . 0.0 113.715 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.1 141.68 58.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.351 1.076 . . . . 0.0 108.777 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.94 121.01 28.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.24 155.02 37.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.956 0.903 . . . . 0.0 110.439 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -126.79 -55.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 109.443 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -128.66 147.98 50.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.155 0.982 . . . . 0.0 109.786 -174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.5 t -138.6 118.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 59.11 9.01 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.849 2.06 . . . . 0.0 114.111 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.14 -15.15 6.51 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.429 1.966 . . . . 0.0 112.898 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.89 129.87 23.41 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.386 1.593 . . . . 0.0 108.229 -169.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.4 112.65 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.381 2.721 . . . . 0.0 109.249 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 75' ' ' VAL . 19.5 m -74.18 -7.04 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.098 0.959 . . . . 0.0 111.051 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.3 114.5 3.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.075 1.35 . . . . 0.0 108.599 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.32 -5.42 60.84 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.919 0.771 . . . . 0.0 113.795 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 74' ' ' TYR . 49.3 mmtt -101.47 -172.71 2.21 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.052 1.341 . . . . 0.0 109.623 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 174.27 5.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.943 1.297 . . . . 0.0 110.389 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -49.42 -56.08 10.9 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.875 1.67 . . . . 0.0 110.331 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -52.92 -36.39 59.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 112.795 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 45.2 t80 -54.2 -48.69 70.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.501 0.72 . . . . 0.0 110.281 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 67' ' ' VAL . 5.5 t -70.29 -34.77 59.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 125.006 1.322 . . . . 0.0 110.211 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 mm -62.41 -37.9 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.211 0.914 . . . . 0.0 109.989 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.95 89.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.022 0.374 . . . . 0.0 110.551 173.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -64.23 -50.74 66.81 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.429 176.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.6 mmm -56.98 -36.23 70.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.949 0.795 . . . . 0.0 111.161 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.79 -43.5 90.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.219 0.607 . . . . 0.0 111.335 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -45.99 72.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.656 0.783 . . . . 0.0 111.407 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.87 78.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.42 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -32.89 63.97 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.838 -1.164 . . . . 0.0 111.895 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -78.95 -29.55 44.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.351 1.06 . . . . 0.0 112.202 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -66.79 -22.27 66.03 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.01 -0.431 . . . . 0.0 110.928 168.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.88 6.51 89.07 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.039 -1.038 . . . . 0.0 112.484 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.04 173.12 14.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.269 2.227 . . . . 0.0 107.113 168.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.14 157.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 160.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.56 131.66 53.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 24' ' ' PHE . 26.4 mt -126.68 98.17 5.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -170.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 53.5 m -87.72 117.42 26.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.1 m -100.92 173.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 125.599 1.56 . . . . 0.0 108.492 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 17.8 ptt85 -150.13 158.83 44.57 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.669 -1.269 . . . . 0.0 108.581 167.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.83 31.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -50.3 153.7 1.43 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.652 0.739 . . . . 0.0 110.928 164.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 143.35 36.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.615 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.79 -74.73 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 170.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -146.33 -179.11 6.52 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.191 0.996 . . . . 0.0 109.651 157.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.02 130.0 3.85 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.129 1.823 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.37 179.24 6.36 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.641 2.894 . . . . 0.0 111.329 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -90.92 -46.12 8.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 161.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 t 51.87 62.73 2.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.918 1.287 . . . . 0.0 109.208 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.534 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 -150.29 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -155.51 -43.14 0.08 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.788 1.635 . . . . 0.0 109.956 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -141.46 -72.23 0.34 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.589 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 101.41 0.19 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.4 172.63 3.85 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.883 0.841 . . . . 0.0 110.439 164.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -65.64 144.32 57.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.863 0.465 . . . . 0.0 111.783 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.52 -92.57 0.79 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 124.92 1.248 . . . . 0.0 110.72 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -56.82 126.64 27.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -167.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -88.38 123.64 33.15 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 110.95 18.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 160.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mp -101.12 148.3 25.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.26 159.63 15.23 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.312 -0.868 . . . . 0.0 110.242 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.44 137.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -126.16 124.87 41.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.296 0.953 . . . . 0.0 108.553 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.49 136.36 51.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.719 0.808 . . . . 0.0 110.153 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -89.73 154.93 19.55 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.111 0.964 . . . . 0.0 110.069 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -115.32 83.54 1.94 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtt -137.41 -34.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.576 -0.725 . . . . 0.0 110.987 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.23 -81.78 0.25 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -122.37 -3.1 8.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.2 78.08 1.13 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.96 0.8 . . . . 0.0 111.699 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 65.82 -133.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 52.69 0.01 OUTLIER Glycine 0 C--O 1.225 -0.453 0 CA-C-N 119.8 1.182 . . . . 0.0 110.454 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 90' ' ' LEU . 47.9 p90 -137.77 172.66 12.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.91 0.855 . . . . 0.0 108.832 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -130.66 163.52 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.862 1.665 . . . . 0.0 106.653 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.5 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -141.24 122.64 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -169.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 41.7 mt -139.96 179.08 6.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.605 1.562 . . . . 0.0 107.478 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.33 -166.29 48.45 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.06 30.92 71.3 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.559 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.78 -32.48 74.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.698 1.749 . . . . 0.0 110.233 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.12 153.76 48.49 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 123.33 0.652 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.16 90.45 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.519 3.479 . . . . 0.0 107.792 -175.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.73 -3.79 5.02 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 117.96 -1.467 . . . . 0.0 113.167 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.44 159.23 85.26 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.73 1.765 . . . . 0.0 109.909 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.16 144.32 68.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.483 2.122 . . . . 0.0 109.804 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -114.68 92.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.9 160.15 15.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.448 1.899 . . . . 0.0 110.993 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm -65.82 119.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 167.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -57.05 -45.06 92.79 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.078 2.275 . . . . 0.0 112.542 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.51 170.17 4.95 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.962 2.105 . . . . 0.0 107.402 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.39 138.41 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 168.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -85.41 117.39 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.34 80.62 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.064 0.852 . . . . 0.0 112.277 -168.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.8 mmt -94.8 37.99 1.13 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.86 166.77 14.87 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 125.907 1.717 . . . . 0.0 109.974 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 21.2 t -75.96 -14.12 60.24 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.935 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.43 -50.63 15.22 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.988 1.267 . . . . 0.0 111.193 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -53.47 -59.95 3.93 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.197 1.399 . . . . 0.0 108.84 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 21.9 ptt180 -60.51 -15.15 24.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.139 0.976 . . . . 0.0 113.426 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -20.77 62.17 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.404 -0.81 . . . . 0.0 111.102 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.61 32.13 25.42 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.814 1.197 . . . . 0.0 112.333 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt-85 -139.55 -65.25 0.48 Allowed 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.81 141.2 48.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.694 0.679 . . . . 0.0 110.009 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -135.5 155.12 78.67 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.48 1.112 . . . . 0.0 109.619 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.82 140.1 90.6 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.471 2.114 . . . . 0.0 110.745 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.88 86.19 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 117.939 -1.478 . . . . 0.0 114.727 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.56 129.11 39.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.988 1.894 . . . . 0.0 107.738 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.94 133.01 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.74 148.27 24.81 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.106 1.362 . . . . 0.0 107.743 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.08 -53.73 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.48 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -129.65 147.83 51.48 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.858 0.863 . . . . 0.0 109.097 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.9 t -139.77 124.79 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 64.13 4.06 1.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.527 1.531 . . . . 0.0 113.878 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.33 -14.01 12.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.009 1.766 . . . . 0.0 112.592 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -106.47 133.72 20.12 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 119.267 1.534 . . . . 0.0 108.878 -167.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.46 108.85 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.766 2.977 . . . . 0.0 109.689 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.03 -6.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.634 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.29 108.67 3.29 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.629 -1.294 . . . . 0.0 110.111 -166.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.43 14.1 69.19 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.904 0.764 . . . . 0.0 113.294 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 37.1 mmtt -82.07 -161.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.285 1.434 . . . . 0.0 108.234 162.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -113.06 172.16 7.11 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.336 1.055 . . . . 0.0 110.676 171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -45.51 -55.28 6.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.747 2.019 . . . . 0.0 111.399 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.49 -35.34 67.88 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.533 -0.729 . . . . 0.0 112.338 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 32.2 t80 -49.52 -51.6 35.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.345 0.593 . . . . 0.0 109.611 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.73 -39.11 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.503 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm -58.65 -37.24 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.025 1.284 . . . . 0.0 110.522 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.68 -44.36 93.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.254 1.421 . . . . 0.0 110.196 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.81 -51.6 66.43 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.382 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.7 mmm -52.97 -39.7 63.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.103 0.865 . . . . 0.0 111.422 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.4 -34.95 74.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.948 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.97 -36.99 24.67 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.575 1.08 . . . . 0.0 112.922 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.674 1.125 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.74 71.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.395 -1.441 . . . . 0.0 112.97 171.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -78.53 -36.16 45.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 110.682 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -62.16 -15.32 45.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.954 1.302 . . . . 0.0 111.239 162.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 3.13 77.11 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.077 1.322 . . . . 0.0 112.453 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -160.85 151.76 18.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.136 1.468 . . . . 0.0 107.178 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.35 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -84.48 133.12 34.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 24' ' ' PHE . 16.7 mt -131.18 103.53 6.54 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.5 m -85.5 124.44 32.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.23 171.39 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 126.04 1.736 . . . . 0.0 107.965 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -153.04 166.76 31.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 121.22 -0.925 . . . . 0.0 110.239 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 141.76 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.434 160.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 155.04 29.84 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.737 0.815 . . . . 0.0 111.129 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.0 p -137.95 158.57 33.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.66 1.184 . . . . 0.0 109.315 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tp -161.52 160.61 29.3 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.811 2.044 . . . . 0.0 106.381 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 t -148.38 133.77 18.57 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.94 -167.27 32.64 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.472 -0.627 . . . . 0.0 112.129 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.02 155.58 42.85 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.861 2.374 . . . . 0.0 110.138 166.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 m -76.13 -25.03 54.97 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m 50.13 -153.13 0.15 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.079 1.352 . . . . 0.0 110.541 -166.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.383 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 164.398 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -119.69 75.99 1.11 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.745 1.273 . . . . 0.0 107.822 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.1 m -83.79 160.47 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 164.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.21 174.45 33.37 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 m -140.47 -52.55 0.49 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.0 m -150.63 156.24 40.96 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.34 -28.34 0.12 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 119.052 -0.86 . . . . 0.0 114.09 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -124.64 168.15 13.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.978 1.889 . . . . 0.0 109.496 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -122.19 131.79 54.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.35 139.89 32.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 163.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.76 116.79 20.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 10.7 p30 -80.89 153.18 27.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.214 0.916 . . . . 0.0 110.011 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.57 108.36 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -96.87 106.8 19.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.64 130.03 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.707 0.765 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -93.44 150.1 20.71 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.999 0.92 . . . . 0.0 109.527 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 30.1 ttt85 -122.83 85.84 2.49 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.847 -1.158 . . . . 0.0 109.245 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.0 mtp -141.82 -3.17 1.14 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -135.31 -88.24 0.35 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -77.03 -31.22 56.17 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.74 -158.29 44.74 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.456 1.025 . . . . 0.0 111.124 -167.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.2 m-85 -102.56 97.24 7.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.297 0.549 . . . . 0.0 112.071 -163.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.62 60.99 4.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.905 1.241 . . . . 0.0 112.898 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.0 p90 -141.58 158.45 43.82 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.526 1.163 . . . . 0.0 109.398 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -112.17 167.73 10.18 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.66 1.584 . . . . 0.0 108.169 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.4 130.29 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -143.25 -178.36 5.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.152 2.181 . . . . 0.0 108.678 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.91 -170.34 29.1 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.607 -1.308 . . . . 0.0 110.345 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.63 91.18 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 121.747 -0.854 . . . . 0.0 111.346 -172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -67.3 -35.11 78.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.959 0.88 . . . . 0.0 111.07 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -120.45 160.29 44.51 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 125.059 1.344 . . . . 0.0 108.39 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.48 57.89 5.3 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.511 3.474 . . . . 0.0 110.393 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.08 42.75 0.06 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.313 1.435 . . . . 0.0 110.476 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -124.88 168.12 14.21 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.46 1.904 . . . . 0.0 110.632 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -72.36 138.34 29.91 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.784 2.322 . . . . 0.0 108.979 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.1 mt -107.13 99.6 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 170.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 58' ' ' GLU . 10.8 mt -95.29 136.55 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.955 2.502 . . . . 0.0 109.505 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm -49.47 127.46 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.23 -27.38 73.78 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.79 -1.005 . . . . 0.0 113.823 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 159.58 133.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.468 3.507 . . . . 0.0 106.339 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.41 148.69 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 119.907 1.231 . . . . 0.0 108.437 166.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mm -81.86 118.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -49.58 76.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 122.603 1.192 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 mmt -85.9 54.52 3.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.79 158.08 29.32 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.205 0.892 . . . . 0.0 111.848 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 m -63.07 -6.86 4.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.56 -48.19 14.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 120.961 1.71 . . . . 0.0 110.005 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.5 -53.15 61.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.71 1.204 . . . . 0.0 109.25 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -63.45 -18.64 63.96 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.364 1.066 . . . . 0.0 112.913 -171.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -17.35 62.69 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 110.817 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 18.4 73.7 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.468 1.032 . . . . 0.0 111.988 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -129.47 -70.69 0.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 112.493 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.27 146.29 50.72 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.09 143.2 46.21 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 124.041 0.936 . . . . 0.0 110.592 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.25 136.02 36.03 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 161.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.33 67.13 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 117.609 -1.662 . . . . 0.0 111.956 -168.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -76.54 134.13 39.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.425 2.112 . . . . 0.0 108.299 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.428 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.1 tt0 -87.19 128.48 35.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.944 2.098 . . . . 0.0 107.777 166.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -78.03 162.99 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.222 1.809 . . . . 0.0 111.478 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.62 -55.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.604 1.962 . . . . 0.0 108.704 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.1 149.12 51.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.446 1.098 . . . . 0.0 109.25 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -137.64 122.9 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t0 57.23 17.5 3.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.325 1.85 . . . . 0.0 113.541 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.04 -11.07 48.51 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.17 1.843 . . . . 0.0 113.312 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -101.67 130.26 24.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 119.407 1.604 . . . . 0.0 107.671 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.0 125.82 10.71 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.299 2.666 . . . . 0.0 108.245 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.73 -4.84 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.733 0.813 . . . . 0.0 111.81 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 124.94 22.32 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.66 -0.65 . . . . 0.0 110.318 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 1.11 79.67 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.189 0.899 . . . . 0.0 113.958 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -88.28 171.5 10.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 119.616 1.708 . . . . 0.0 108.738 172.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.6 p -90.62 168.55 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.531 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -44.64 -47.89 10.5 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.103 1.761 . . . . 0.0 111.53 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -52.92 -36.81 60.12 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.596 1.158 . . . . 0.0 113.408 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.97 -49.92 65.15 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.406 0.683 . . . . 0.0 109.295 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.01 -38.03 79.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 C-N-CA 125.092 1.357 . . . . 0.0 110.772 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.59 -40.84 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.483 1.038 . . . . 0.0 109.819 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.06 91.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.205 0.602 . . . . 0.0 110.867 172.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -53.93 45.26 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.626 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.2 mmm -55.03 -37.0 66.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.049 0.841 . . . . 0.0 111.428 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -61.97 -38.71 89.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 117.565 -1.207 . . . . 0.0 111.918 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -70.41 -48.24 57.03 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.697 1.135 . . . . 0.0 111.289 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -42.09 80.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.975 1.31 . . . . 0.0 111.362 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.78 67.19 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.117 -0.99 . . . . 0.0 113.031 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -84.36 -36.15 22.7 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.612 1.096 . . . . 0.0 110.94 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -53.09 -34.04 54.83 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.71 61.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.737 1.161 . . . . 0.0 112.219 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -160.43 173.07 16.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.344 2.258 . . . . 0.0 107.251 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -148.21 127.89 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -80.94 127.04 32.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 161.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.4 mt -116.48 97.19 5.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 86.1 m -83.89 115.08 22.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.17 171.15 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.844 1.658 . . . . 0.0 108.275 174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -152.87 151.0 29.89 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 119.46 -2.025 . . . . 0.0 112.402 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -140.69 129.61 23.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.677 0.791 . . . . 0.0 109.447 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 134.73 57.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.704 2.002 . . . . 0.0 111.243 169.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.09 136.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 126.483 1.913 . . . . 0.0 108.211 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.53 176.83 12.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 p -157.55 105.85 2.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.38 114.08 4.17 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.45 -21.16 30.68 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.68 1.74 . . . . 0.0 111.223 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t 61.41 -161.36 0.29 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.929 0.892 . . . . 0.0 108.606 -162.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 p -78.43 178.74 7.48 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 163.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 143.433 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.61 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -156.44 106.19 2.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.552 1.541 . . . . 0.0 107.234 -169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -83.31 93.6 7.76 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 49.41 84.03 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.014 1.292 . . . . 0.0 114.479 164.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t 56.09 -120.42 1.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.593 -1.194 . . . . 0.0 108.912 -163.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p -144.34 85.58 1.79 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.558 1.543 . . . . 0.0 109.527 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.15 -114.9 0.35 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -58.51 157.39 9.04 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.289 0.544 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -124.91 137.13 54.29 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.699 1.2 . . . . 0.0 108.931 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -93.71 154.47 17.78 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.736 1.214 . . . . 0.0 107.861 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mp -139.6 131.77 28.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.951 2.1 . . . . 0.0 106.701 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.56 133.05 33.85 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.334 1.054 . . . . 0.0 109.816 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -129.95 106.59 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.84 118.26 36.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.6 148.31 32.45 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.135 0.974 . . . . 0.0 109.5 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -86.82 164.41 16.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 164.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -117.57 95.48 4.97 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 164.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 ttt -143.77 -13.01 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.111 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.63 -108.41 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -65.24 -31.14 72.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.064 1.302 . . . . 0.0 113.016 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 93.66 0.58 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.624 1.107 . . . . 0.0 112.539 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 43.49 71.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 113.54 169.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.45 54.12 4.3 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.785 -1.197 . . . . 0.0 114.98 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -121.32 175.92 5.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.845 1.322 . . . . 0.0 109.409 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.12 165.21 26.6 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 167.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.6 130.62 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -171.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.17 146.39 27.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.422 1.089 . . . . 0.0 108.088 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.51 177.87 19.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.859 -2.096 . . . . 0.0 107.859 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.58 37.05 84.63 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 121.514 -0.992 . . . . 0.0 111.705 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.75 -36.42 67.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.596 1.198 . . . . 0.0 110.481 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -137.73 160.48 64.74 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.984 2.114 . . . . 0.0 107.766 -170.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.97 72.36 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.406 3.404 . . . . 0.0 110.537 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.14 -9.96 0.06 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 127.549 2.5 . . . . 0.0 111.826 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -72.98 158.21 87.5 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.834 1.317 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.45 137.73 31.23 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.77 2.314 . . . . 0.0 109.125 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -110.11 93.55 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.59 155.94 18.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.068 0.937 . . . . 0.0 110.36 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.83 107.54 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.11 -41.11 71.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.79 175.7 12.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.394 1.878 . . . . 0.0 107.575 168.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.43 148.99 29.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 mm -89.12 112.86 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.13 7.63 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.777 1.231 . . . . 0.0 113.548 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.7 mtm -90.04 -0.79 57.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 153.01 45.83 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -62.49 -6.93 3.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.69 29.16 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.539 1.518 . . . . 0.0 112.188 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.09 -52.26 50.4 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.947 0.794 . . . . 0.0 109.813 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -13.3 15.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 168.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.66 -17.73 62.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.246 1.385 . . . . 0.0 110.987 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.34 32.81 41.62 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.336 166.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -133.6 -66.34 0.65 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.343 1.572 . . . . 0.0 111.414 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.69 144.68 54.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.556 1.142 . . . . 0.0 111.489 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -130.94 151.7 79.38 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.749 1.219 . . . . 0.0 109.312 164.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -51.89 142.66 42.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.324 2.016 . . . . 0.0 110.694 163.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.18 64.24 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.954 -0.915 . . . . 0.0 113.798 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.61 134.23 53.9 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.697 1.749 . . . . 0.0 106.423 165.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.91 123.16 33.0 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.01 140.91 47.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.599 1.16 . . . . 0.0 109.022 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.8 -52.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 124.653 1.181 . . . . 0.0 108.825 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -130.03 146.74 51.72 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.17 124.41 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.17 14.44 6.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.056 1.742 . . . . 0.0 112.224 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.28 68.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.901 1.715 . . . . 0.0 112.517 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.63 126.12 35.17 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.717 1.607 . . . . 0.0 108.102 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.91 118.26 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.208 2.605 . . . . 0.0 109.209 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.74 -9.11 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.81 6.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.871 1.269 . . . . 0.0 109.71 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.46 3.77 61.14 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.553 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 21.4 mmtt -107.18 178.64 4.49 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.591 1.957 . . . . 0.0 108.728 174.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -95.22 -179.93 4.97 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.207 -0.308 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -49.91 -54.83 17.2 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.498 1.119 . . . . 0.0 110.924 169.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -26.83 68.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.73 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.466 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 64.9 t80 -46.54 -54.07 10.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.719 0.771 . . . . 0.0 110.608 169.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.04 -36.53 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.473 1.509 . . . . 0.0 110.082 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.6 mm -57.53 -41.02 78.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 119.126 0.876 . . . . 0.0 110.149 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.522 0.729 . . . . 0.0 111.359 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.96 -51.66 13.15 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.058 0.943 . . . . 0.0 110.828 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.6 mmm -55.09 -38.1 67.67 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.406 1.083 . . . . 0.0 110.867 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -60.79 2.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.809 1.644 . . . . 0.0 110.17 173.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -54.82 -51.08 66.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.512 1.125 . . . . 0.0 111.259 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.92 78.48 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.028 0.931 . . . . 0.0 111.534 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.4 66.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.773 -1.204 . . . . 0.0 112.194 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtt-85 -69.97 -49.91 47.04 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.207 1.367 . . . . 0.0 109.636 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -54.53 -38.21 66.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.769 0.827 . . . . 0.0 110.313 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.62 42.34 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.064 0.84 . . . . 0.0 111.858 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -151.36 166.76 30.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.802 1.301 . . . . 0.0 108.368 167.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.01 165.3 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -126.83 144.53 50.94 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 164.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.3 mt -138.11 97.39 3.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 103.061 -2.941 . . . . 0.0 103.061 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -86.4 112.98 21.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.35 165.92 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.478 0.711 . . . . 0.0 109.52 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -153.08 162.61 41.12 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.605 -1.309 . . . . 0.0 111.962 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -150.32 147.35 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.697 1.199 . . . . 0.0 109.991 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -51.07 146.15 6.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.687 1.195 . . . . 0.0 111.358 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.83 147.91 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.277 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.08 -170.15 3.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.447 1.499 . . . . 0.0 108.613 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 m -136.94 167.78 20.83 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.665 1.586 . . . . 0.0 106.995 155.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.25 80.83 0.12 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 169.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.25 -12.98 37.87 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.658 3.572 . . . . 0.0 114.244 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 m -73.02 102.52 3.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 160.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.0 121.18 3.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.455 1.502 . . . . 0.0 110.629 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.348 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 168.626 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.825 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 m -127.89 -9.46 5.48 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.23 1.412 . . . . 0.0 114.075 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t 54.67 -173.17 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.968 0.907 . . . . 0.0 110.338 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.7 134.96 5.09 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.53 129.93 39.46 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.134 1.374 . . . . 0.0 109.104 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 t -153.02 127.82 9.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.11 -24.92 1.05 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 127.081 2.277 . . . . 0.0 115.606 154.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -137.64 161.67 35.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.039 1.736 . . . . 0.0 107.466 168.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.13 138.31 54.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 169.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.15 145.8 28.2 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 158.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.39 121.76 33.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.015 2.126 . . . . 0.0 106.721 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 135.2 35.65 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.898 1.279 . . . . 0.0 109.348 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.91 107.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.56 0.695 . . . . 0.0 109.446 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.02 120.77 40.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 108.776 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -123.22 124.06 42.17 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.047 1.339 . . . . 0.0 108.94 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -74.44 153.18 39.3 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.784 169.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -102.94 114.55 28.93 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -69.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -73.79 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.614 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -126.11 1.92 7.2 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -148.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.21 57.48 8.41 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 123.946 0.784 . . . . 0.0 112.368 167.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.74 80.79 0.05 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.6 2.36 . . . . 0.0 113.006 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.0 75.64 1.1 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.281 0.943 . . . . 0.0 112.798 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -127.95 175.55 8.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.141 2.176 . . . . 0.0 106.187 159.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -123.02 162.46 22.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 157.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.27 127.28 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 94.6 mt -134.4 -177.29 4.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 107.329 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.34 -156.26 48.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -170.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.63 -105.31 0.71 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -164.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.92 -52.81 0.25 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 129.308 3.043 . . . . 0.0 110.29 -167.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -100.39 160.87 25.8 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 110.861 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 96.11 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.408 3.406 . . . . 0.0 111.563 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.33 19.24 30.86 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 118.372 -1.238 . . . . 0.0 113.067 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -66.11 162.06 50.34 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.708 1.254 . . . . 0.0 109.387 164.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.4 132.66 21.12 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.673 2.249 . . . . 0.0 109.226 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.84 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -87.17 144.42 26.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 110.495 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.91 108.35 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -51.2 -44.31 51.62 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 127.487 2.47 . . . . 0.0 112.248 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.76 160.97 29.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.589 0.756 . . . . 0.0 109.618 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.18 115.68 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 161.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -66.89 121.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -21.64 60.56 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -127.95 33.12 4.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.636 1.574 . . . . 0.0 108.353 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 176.65 17.64 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.831 1.205 . . . . 0.0 111.735 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -61.67 -25.71 67.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.534 0.733 . . . . 0.0 112.756 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -53.96 14.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.849 0.749 . . . . 0.0 109.501 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.86 -46.54 78.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.472 1.109 . . . . 0.0 111.735 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -28.39 65.53 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -72.49 -39.7 67.48 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.756 0.822 . . . . 0.0 110.21 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.2 35.9 19.46 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.992 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 52' ' ' ARG . 14.9 mtp85 -124.2 -67.51 0.92 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.01 0.905 . . . . 0.0 110.725 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.47 137.48 48.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -124.85 149.41 62.71 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 110.253 174.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 54' ' ' HIS . 24.4 Cg_exo -57.6 132.1 48.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.338 2.025 . . . . 0.0 110.38 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 7.38 87.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 117.897 -1.502 . . . . 0.0 113.617 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.08 142.94 58.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.141 1.97 . . . . 0.0 108.271 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.16 125.84 35.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.123 -0.985 . . . . 0.0 108.673 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.19 154.37 26.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 109.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.6 -51.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 108.798 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.82 148.8 52.58 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.121 0.968 . . . . 0.0 109.705 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.92 105.54 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t70 54.63 22.95 4.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.295 1.838 . . . . 0.0 113.189 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.02 -13.63 57.41 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.973 2.225 . . . . 0.0 113.027 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.43 125.56 63.13 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.114 1.457 . . . . 0.0 107.798 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -73.5 131.0 15.6 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.635 2.89 . . . . 0.0 109.425 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.43 -8.6 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 123.957 0.903 . . . . 0.0 111.633 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.94 57.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.755 -0.59 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.93 7.57 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.372 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 25.3 mmtt -95.88 -177.14 3.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.405 1.602 . . . . 0.0 110.155 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -109.99 175.77 5.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.757 2.023 . . . . 0.0 110.739 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -53.86 -57.09 12.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 109.135 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -45.85 -45.86 15.33 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 112.061 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 50.0 t80 -49.77 -40.24 40.58 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.682 0.614 . . . . 0.0 111.412 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.38 -41.6 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 110.757 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.45 -41.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.026 0.83 . . . . 0.0 109.608 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -23.97 64.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.756 1.622 . . . . 0.0 112.126 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.18 -45.12 16.83 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 123.681 0.792 . . . . 0.0 110.258 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mmm -56.87 -34.94 68.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.917 0.78 . . . . 0.0 111.878 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.87 -42.9 85.52 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.117 0.967 . . . . 0.0 111.51 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -45.35 74.07 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.469 0.707 . . . . 0.0 110.699 174.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.73 71.48 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.764 -1.21 . . . . 0.0 112.245 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.95 74.74 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.609 -0.682 . . . . 0.0 111.046 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -69.09 -36.82 77.98 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.194 0.998 . . . . 0.0 112.343 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -68.61 -12.22 61.06 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.565 0.62 . . . . 0.0 112.014 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.62 7.3 87.21 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.511 1.053 . . . . 0.0 112.936 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.6 169.11 10.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 120.843 -1.386 . . . . 0.0 107.586 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.85 159.7 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -122.12 145.07 48.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mt -138.11 99.34 3.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -84.58 114.02 21.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.28 170.69 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 166.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -151.27 164.21 37.13 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.051 -1.655 . . . . 0.0 109.885 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.36 133.57 15.27 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.537 1.135 . . . . 0.0 108.586 168.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 150.55 39.01 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.571 0.748 . . . . 0.0 109.178 163.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.22 142.95 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.426 0.69 . . . . 0.0 110.751 -170.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 tt -148.21 -71.48 0.21 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 m 52.0 46.38 26.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.088 1.355 . . . . 0.0 113.104 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.39 178.29 21.12 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.68 99.69 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.798 2.998 . . . . 0.0 109.584 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.4 t -65.96 137.52 57.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 168.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.6 p -147.65 166.55 27.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.989 2.116 . . . . 0.0 108.215 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 116.442 -2.31 . . . . 0.0 111.343 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.452 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 82.89 131.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.47 179.91 8.72 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.16 0.981 . . . . 0.0 110.694 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.58 -172.07 22.67 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -164.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.4 m -74.9 -44.58 48.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.485 1.143 . . . . 0.0 113.326 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m 53.5 167.59 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.676 0.671 . . . . 0.0 111.592 -153.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.58 -84.28 0.26 Allowed Glycine 0 C--N 1.334 0.467 0 O-C-N 119.755 -1.841 . . . . 0.0 111.913 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -67.35 153.64 43.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.314 1.057 . . . . 0.0 108.827 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -119.68 143.09 47.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.109 1.364 . . . . 0.0 107.74 171.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.74 141.95 29.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 169.3 9.1 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.345 2.258 . . . . 0.0 107.186 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 128.13 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.856 1.662 . . . . 0.0 107.014 172.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.05 136.99 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -128.13 127.57 43.25 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 108.165 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.93 155.05 45.92 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.299 1.04 . . . . 0.0 109.374 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -105.29 165.86 10.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.102 0.953 . . . . 0.0 111.398 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -125.49 93.35 3.83 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 124.861 1.264 . . . . 0.0 109.211 174.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.9 mtp -144.34 -63.28 0.37 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -66.43 -69.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.835 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -114.76 -31.08 6.26 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . 78.18 85.71 0.5 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -164.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD1' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER 72.97 -153.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.754 0.914 . . . . 0.0 108.697 167.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.9 55.14 0.02 OUTLIER Glycine 0 C--O 1.227 -0.312 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.448 ' CE2' HD11 ' A' ' 90' ' ' LEU . 38.0 p90 -143.36 172.87 12.17 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -141.35 142.27 33.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.023 0.929 . . . . 0.0 109.439 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 135.47 57.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 27' ' ' LEU 0.272 2.7 pp -148.98 -178.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.306 2.242 . . . . 0.0 108.644 -177.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.7 -145.92 46.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.48 30.55 34.12 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 118.0 0.9 . . . . 0.0 111.598 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -90.82 -7.08 53.31 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 112.082 -163.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -129.7 155.59 80.13 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 126.891 2.076 . . . . 0.0 106.828 165.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.96 92.11 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 124.66 3.573 . . . . 0.0 108.161 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.91 -12.42 1.91 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.627 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -79.23 159.43 72.79 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 119.433 1.617 . . . . 0.0 112.192 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.42 147.01 51.59 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.222 1.948 . . . . 0.0 108.764 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -116.77 92.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.88 130.66 44.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.814 1.646 . . . . 0.0 109.16 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 mm -54.81 110.42 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.04 -43.58 81.13 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.442 -0.786 . . . . 0.0 111.738 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 139.89 14.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.43 147.15 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 159.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.12 110.61 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.25 -34.72 61.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 123.105 1.431 . . . . 0.0 112.009 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 33.1 mmt -95.91 20.8 9.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.591 1.156 . . . . 0.0 110.506 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 176.11 21.54 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.202 0.906 . . . . 0.0 111.552 -165.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -20.68 64.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.225 -0.893 . . . . 0.0 113.09 -160.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.52 -63.74 1.01 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.005 0.82 . . . . 0.0 109.743 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.61 -43.58 80.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.094 0.958 . . . . 0.0 110.751 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -70.62 -18.99 62.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.908 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.21 -22.6 33.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.616 1.553 . . . . 0.0 111.371 168.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.97 14.03 65.44 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.371 159.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.45 -43.81 4.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.381 1.591 . . . . 0.0 113.968 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.19 155.76 27.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -135.6 153.47 77.59 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.511 . . . . 0.0 110.586 155.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.58 112.95 3.35 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.817 1.678 . . . . 0.0 110.633 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.15 -13.09 5.76 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.232 2.348 . . . . 0.0 110.977 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.37 131.38 48.06 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 122.28 28.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 120.05 1.295 . . . . 0.0 107.697 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.2 153.52 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 109.788 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 t -130.07 -45.58 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.122 1.369 . . . . 0.0 109.511 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.37 149.23 51.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.352 1.061 . . . . 0.0 109.636 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.4 t -137.39 122.72 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 53.58 14.28 0.58 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.33 2.652 . . . . 0.0 113.555 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.7 30.92 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.447 2.451 . . . . 0.0 113.367 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.6 mp -94.49 130.37 33.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 120.586 2.193 . . . . 0.0 106.895 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -71.91 111.01 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.958 2.439 . . . . 0.0 108.567 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -72.83 -8.25 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.335 0.654 . . . . 0.0 110.96 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.65 120.42 9.44 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.12 -9.2 70.53 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.284 1.421 . . . . 0.0 114.909 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -83.03 173.59 11.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.067 -1.255 . . . . 0.0 109.098 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.1 p -93.83 169.86 9.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -51.34 -46.62 62.72 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.454 1.102 . . . . 0.0 112.052 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 -59.22 -33.18 70.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.905 0.775 . . . . 0.0 112.56 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -48.1 -48.02 33.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.914 0.886 . . . . 0.0 109.554 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.62 -35.5 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.456 -0.778 . . . . 0.0 110.816 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.56 -35.21 69.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 120.91 -1.119 . . . . 0.0 110.321 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.43 -42.39 87.77 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.471 1.108 . . . . 0.0 109.82 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -47.13 85.49 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 111.491 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -27.83 45.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.733 0.813 . . . . 0.0 110.493 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -45.08 63.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.567 0.621 . . . . 0.0 110.63 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -63.3 -46.86 84.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 111.329 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.456 1.102 . . . . 0.0 110.79 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.74 -24.19 67.57 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.114 -0.991 . . . . 0.0 112.791 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -59.45 2.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 169.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -56.84 -39.33 74.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 124.622 1.201 . . . . 0.0 109.715 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 9.3 16.74 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.352 0.977 . . . . 0.0 112.692 170.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -149.48 175.83 11.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.416 HG12 ' CD1' ' A' ' 22' ' ' PHE . 10.0 p -143.5 128.46 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 156.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 139.32 31.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 161.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.448 HD11 ' CE2' ' A' ' 24' ' ' PHE . 41.4 mt -135.51 111.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.8 m -95.49 115.57 27.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.1 173.84 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 165.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -150.86 160.72 43.7 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 120.392 -1.442 . . . . 0.0 110.195 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -155.34 144.46 20.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 160.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.24 148.6 51.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.538 2.335 . . . . 0.0 109.887 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 55.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.484 -1.689 . . . . 0.0 106.669 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.8 tp 64.15 166.19 0.15 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.959 2.104 . . . . 0.0 112.889 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -88.53 -174.88 4.76 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.604 1.962 . . . . 0.0 109.537 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.29 178.34 17.86 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 167.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -74.75 59.97 5.12 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.701 2.934 . . . . 0.0 110.396 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -152.43 146.88 25.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.963 1.305 . . . . 0.0 107.807 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.5 m -141.39 -6.3 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.809 0 CA-C-O 117.556 -1.691 . . . . 0.0 110.727 -174.282 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.794 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 p -158.87 -93.39 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.513 0.656 . . . . 0.0 110.374 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -91.91 156.57 17.38 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.512 1.925 . . . . 0.0 110.201 -171.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.43 126.17 2.22 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.8 m 54.57 27.75 8.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -52.63 129.26 28.79 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 168.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.75 -99.54 0.12 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-O 118.774 -1.014 . . . . 0.0 110.82 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 24.7 p90 -62.39 147.64 47.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.054 0.927 . . . . 0.0 109.256 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -106.71 131.15 54.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.01 159.54 21.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 158.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.32 121.67 11.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 173.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.98 135.76 36.46 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.3 t -126.15 107.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -95.59 127.77 41.9 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -121.35 124.16 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.963 0.905 . . . . 0.0 109.881 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -71.95 144.38 48.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -101.47 103.94 14.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.0 mtm -142.91 -53.16 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.04 -105.23 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.399 1.079 . . . . 0.0 110.713 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -69.91 -21.74 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.436 1.471 . . . . 0.0 112.139 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 67.17 2.13 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.19 100.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.485 2.314 . . . . 0.0 111.369 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.06 53.42 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.605 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -134.59 170.69 15.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.469 1.634 . . . . 0.0 110.034 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.97 151.73 48.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.71 2.404 . . . . 0.0 109.134 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.69 152.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.682 1.193 . . . . 0.0 107.809 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 -179.16 6.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.413 1.485 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.36 -142.82 43.31 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.81 20.72 62.38 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.937 0.78 . . . . 0.0 112.028 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.76 -45.96 87.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.242 1.417 . . . . 0.0 110.021 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -108.77 155.17 41.14 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.91 93.8 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.892 3.728 . . . . 0.0 109.528 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.34 2.87 2.55 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.82 1.2 . . . . 0.0 112.739 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -77.71 167.98 31.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.452 1.126 . . . . 0.0 109.824 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.57 131.7 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.304 2.67 . . . . 0.0 110.211 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.81 105.76 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD23 ' HG3' ' A' ' 58' ' ' GLU . 15.8 mt -101.68 162.8 12.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.851 1.66 . . . . 0.0 112.436 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.458 HG12 ' CG ' ' A' ' 57' ' ' ASP . 41.8 mm -65.79 121.5 14.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.22 -60.87 5.58 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 122.968 0.318 . . . . 0.0 112.633 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.43 114.78 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.9 2.08 . . . . 0.0 106.952 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.3 149.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.85 116.0 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.99 -29.74 44.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.312 1.845 . . . . 0.0 115.135 -165.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.4 mmt -135.12 10.72 3.56 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.455 1.102 . . . . 0.0 111.795 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.8 172.41 54.05 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -57.88 -11.86 2.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.19 -52.69 6.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.141 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.0 -43.66 73.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.184 1.356 . . . . 0.0 110.414 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -55.79 -28.63 57.09 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.84 -17.43 28.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.395 1.078 . . . . 0.0 111.978 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.54 23.74 67.14 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -122.44 -14.11 7.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.978 1.889 . . . . 0.0 114.31 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.14 168.8 12.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.294 0.952 . . . . 0.0 108.636 166.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.85 18.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.133 1.373 . . . . 0.0 107.838 158.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.44 123.77 11.59 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.894 2.396 . . . . 0.0 109.164 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.9 34.93 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.052 0.834 . . . . 0.0 113.288 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.478 ' OD2' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -64.39 153.83 37.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 118.643 1.221 . . . . 0.0 109.507 152.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.2 tt0 -104.58 116.64 32.43 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.821 2.048 . . . . 0.0 108.276 166.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.22 136.83 37.87 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.32 2.248 . . . . 0.0 108.755 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.98 -52.95 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 123.596 0.758 . . . . 0.0 110.276 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -134.59 145.17 48.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.81 124.83 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 107.322 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.43 21.15 1.14 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.613 2.365 . . . . 0.0 112.09 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.48 -10.78 70.87 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.82 2.153 . . . . 0.0 113.788 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.77 133.19 38.26 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 119.575 1.687 . . . . 0.0 107.625 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -72.01 133.94 22.46 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.024 2.483 . . . . 0.0 108.295 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG1' HG22 ' A' ' 75' ' ' VAL . 33.5 m -99.07 -7.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.229 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.75 133.72 47.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.82 -9.04 25.87 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.7 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 69.7 mmtt -85.96 171.8 11.18 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.935 1.868 . . . . 0.0 108.723 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.8 p -92.3 172.97 8.06 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.137 0.575 . . . . 0.0 110.362 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -49.7 -56.07 11.53 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.717 1.207 . . . . 0.0 109.485 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -50.56 -41.77 54.56 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.62 1.568 . . . . 0.0 112.929 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 41.0 t80 -51.63 -47.14 63.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.753 0.787 . . . . 0.0 110.266 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' CG1' ' A' ' 67' ' ' VAL . 7.3 t -73.13 -34.35 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.791 0.836 . . . . 0.0 110.465 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -62.44 -35.44 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.878 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.5 -43.88 97.73 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.788 1.235 . . . . 0.0 110.105 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -53.88 46.15 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.625 0.77 . . . . 0.0 111.669 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.7 mmm -58.59 -35.22 72.07 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.235 0.614 . . . . 0.0 111.082 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -59.5 -45.14 92.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.482 -0.77 . . . . 0.0 111.2 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.62 -51.08 66.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.808 0.843 . . . . 0.0 111.683 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.77 71.82 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 111.678 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.22 78.5 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.036 -1.04 . . . . 0.0 111.288 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -72.14 -42.87 65.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.391 0.996 . . . . 0.0 111.183 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -55.35 -33.51 63.45 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.364 1.065 . . . . 0.0 110.227 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.63 10.64 65.01 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.182 0.896 . . . . 0.0 112.228 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -164.66 168.86 17.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.751 2.02 . . . . 0.0 107.053 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.38 159.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.36 88.97 2.35 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.632 1.173 . . . . 0.0 109.294 -170.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.9 97.95 8.49 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -83.55 127.07 33.45 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.478 HG11 ' OD2' ' A' ' 57' ' ' ASP . 17.2 m -125.99 158.47 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 126.038 1.735 . . . . 0.0 107.051 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 11.6 ptt180 -151.3 161.32 42.93 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.674 -0.641 . . . . 0.0 111.085 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.21 146.36 22.71 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 145.52 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.0 0.92 . . . . 0.0 110.411 166.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.2 t -103.87 140.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mp -137.8 150.99 47.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 p -166.94 73.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.275 1.03 . . . . 0.0 108.371 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 150.84 97.06 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.355 -1.247 . . . . 0.0 111.63 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.16 135.45 31.91 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.439 2.093 . . . . 0.0 108.237 165.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 t 169.93 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 128.76 2.824 . . . . 0.0 104.136 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 t -143.44 -175.57 4.6 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.239 1.816 . . . . 0.0 106.977 157.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.234 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.598 -169.252 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.96 0 CA-C-O 118.886 -0.952 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -68.82 111.26 4.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.119 1.459 . . . . 0.0 108.568 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 t -157.83 164.1 37.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.997 1.319 . . . . 0.0 107.726 168.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -25.63 -92.35 0.01 OUTLIER Glycine 0 CA--C 1.524 0.628 0 C-N-CA 129.428 3.394 . . . . 0.0 115.032 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 t -160.83 173.48 15.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 m -134.53 84.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.39 -3.91 0.05 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 114.66 0.624 . . . . 0.0 114.66 -168.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 32.4 p90 -102.52 -174.05 2.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 121.023 -1.28 . . . . 0.0 107.587 158.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -135.82 137.33 41.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 159.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -83.45 152.46 24.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 164.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.41 163.21 19.09 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -124.98 121.37 34.24 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.207 1.803 . . . . 0.0 107.706 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.9 t -121.59 109.1 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -78.18 144.52 36.28 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 mt -140.05 128.21 22.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.182 0.993 . . . . 0.0 108.8 166.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -72.95 160.06 32.71 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.741 0.416 . . . . 0.0 111.669 171.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 8.5 ttt-85 -141.5 89.65 2.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.287 1.435 . . . . 0.0 107.439 166.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mtm -154.27 -41.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 109.22 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -72.78 -163.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 142.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -64.73 8.32 0.12 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -148.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 174.2 50.22 Favored Glycine 0 N--CA 1.45 -0.398 0 O-C-N 120.672 -1.267 . . . . 0.0 112.287 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -65.99 160.83 22.76 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.57 72.32 0.29 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 90' ' ' LEU . 45.1 p90 -143.31 171.87 13.52 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 171.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -132.18 158.67 41.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.126 1.371 . . . . 0.0 107.774 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.75 121.38 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.81 -177.23 3.08 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.474 2.31 . . . . 0.0 107.716 -168.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.49 -144.39 49.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.04 19.96 47.4 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.124 0.868 . . . . 0.0 112.904 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -26.28 68.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.011 0.925 . . . . 0.0 111.204 -168.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -140.39 160.25 60.28 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 126.114 1.766 . . . . 0.0 109.056 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.76 112.65 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 173.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.07 35.89 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.923 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.91 155.61 91.36 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.662 1.731 . . . . 0.0 108.466 166.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.63 152.41 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.517 2.811 . . . . 0.0 110.371 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 75' ' ' VAL . 60.8 mt -117.78 93.98 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 165.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -81.36 152.85 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.25 139.3 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 159.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.7 -56.79 1.39 Allowed Glycine 0 C--O 1.226 -0.372 0 O-C-N 121.492 -0.755 . . . . 0.0 111.639 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.84 145.76 36.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.42 123.78 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.61 110.62 7.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -171.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.8 149.16 11.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.269 0.98 . . . . 0.0 110.483 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.5 mmt 66.47 -6.75 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.988 2.115 . . . . 0.0 114.564 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -151.63 5.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.847 1.689 . . . . 0.0 111.416 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -66.5 -63.77 1.0 Allowed 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.918 -1.342 . . . . 0.0 110.725 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -45.26 94.55 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -157.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.52 -45.92 90.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.234 1.014 . . . . 0.0 111.535 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.9 -39.64 95.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.686 1.595 . . . . 0.0 112.616 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -36.89 83.45 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 110.368 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.2 15.32 65.26 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 125.486 1.517 . . . . 0.0 113.24 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -98.59 -32.85 11.22 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.574 1.549 . . . . 0.0 109.604 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.48 146.7 32.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.05 146.87 48.33 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.843 164.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -69.24 112.41 2.98 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.894 2.396 . . . . 0.0 110.674 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.14 5.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.709 1.623 . . . . 0.0 112.268 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.84 140.88 57.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 122.5 32.61 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.989 1.268 . . . . 0.0 108.583 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.06 156.83 38.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.102 0.961 . . . . 0.0 111.202 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.14 -53.01 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.902 1.681 . . . . 0.0 108.933 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.4 148.25 51.3 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.528 1.131 . . . . 0.0 109.618 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.84 126.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.721 1.608 . . . . 0.0 107.019 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.11 -3.83 0.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.921 2.088 . . . . 0.0 112.708 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.58 -16.96 6.96 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.841 3.115 . . . . 0.0 111.914 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.27 134.87 20.96 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.868 1.334 . . . . 0.0 108.648 -167.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.16 118.83 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.382 2.722 . . . . 0.0 109.883 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.488 ' CG1' HG22 ' A' ' 75' ' ' VAL . 15.5 m -80.3 -7.3 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 111.023 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 118.29 8.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 109.992 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.97 -10.01 70.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.657 1.122 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -78.55 -172.53 2.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 108.712 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -100.63 171.89 7.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.685 1.194 . . . . 0.0 109.402 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -50.81 -53.65 30.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.389 1.476 . . . . 0.0 109.844 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.75 -24.26 67.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -51.71 -48.92 63.37 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.854 0.835 . . . . 0.0 110.21 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.488 HG22 ' CG1' ' A' ' 67' ' ' VAL . 4.7 t -71.65 -37.18 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.572 1.149 . . . . 0.0 110.126 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.02 -28.35 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.204 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -45.48 72.54 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.476 1.51 . . . . 0.0 110.415 169.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -49.62 76.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.191 0.596 . . . . 0.0 110.775 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.0 mmm -57.74 -19.88 30.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.942 0.497 . . . . 0.0 112.331 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -47.85 21.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.373 0.988 . . . . 0.0 111.103 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.43 -47.04 85.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 119.016 0.825 . . . . 0.0 111.111 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.35 -38.02 73.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.689 0.796 . . . . 0.0 111.713 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.78 -14.25 62.91 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 113.805 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -81.7 -43.74 18.07 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.033 1.288 . . . . 0.0 109.764 165.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -63.28 -17.35 62.42 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.747 1.219 . . . . 0.0 112.016 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.31 69.01 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.037 1.303 . . . . 0.0 112.406 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -157.31 168.7 26.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.031 1.732 . . . . 0.0 106.872 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.06 163.49 26.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -121.88 140.42 52.43 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 166.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 24' ' ' PHE . 13.4 mt -137.01 106.67 6.17 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 m -97.31 112.58 24.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.44 164.77 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.65 151.75 32.97 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.567 -1.333 . . . . 0.0 110.839 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -151.02 136.05 17.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -48.58 133.54 16.62 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 166.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.8 t -84.31 162.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 170.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.47 -41.36 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.923 0.889 . . . . 0.0 109.689 169.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m 41.39 48.66 3.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.16 1.784 . . . . 0.0 110.556 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.06 -165.81 13.25 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 127.197 2.332 . . . . 0.0 110.067 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -62.62 160.89 30.34 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.904 1.736 . . . . 0.0 110.726 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.8 -177.77 6.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.795 1.238 . . . . 0.0 110.206 -165.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -146.93 160.43 42.34 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.223 0.609 . . . . 0.0 109.722 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 -170.032 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.839 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -131.87 108.53 9.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m 63.57 172.43 0.17 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 0.0 112.754 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.06 162.83 54.52 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.29 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -148.24 161.0 42.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.519 1.128 . . . . 0.0 109.154 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -178.75 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.533 2.333 . . . . 0.0 109.336 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.69 -109.01 0.11 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -59.95 130.6 47.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.156 0.979 . . . . 0.0 108.984 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -97.0 147.3 24.14 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 112.918 -1.946 . . . . 0.0 106.253 164.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.02 154.19 23.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 160.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.06 118.08 23.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.51 130.44 39.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 53' ' ' LEU . 98.6 t -135.08 107.15 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.26 128.27 41.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.76 165.46 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 109.409 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -127.35 145.75 50.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -98.94 101.48 12.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tpt -144.7 -63.51 0.36 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.28 -85.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.809 0.844 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -95.51 -31.02 13.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.919 0.327 . . . . 0.0 111.803 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.68 71.66 1.27 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.26 83.28 0.17 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.9 1.68 . . . . 0.0 111.155 168.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.39 59.44 2.83 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.893 0.759 . . . . 0.0 112.878 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.7 p90 -135.35 175.05 9.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.082 1.353 . . . . 0.0 109.613 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -129.57 166.91 18.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.99 1.316 . . . . 0.0 108.563 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.05 122.69 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 79.0 mt -140.36 -176.5 4.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 108.593 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.27 -151.47 52.11 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -168.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.96 33.35 20.9 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 117.427 0.613 . . . . 0.0 111.578 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.63 -17.09 62.28 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.332 -1.099 . . . . 0.0 110.62 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -132.4 160.32 68.63 Favored Pre-proline 0 C--O 1.239 0.539 0 C-N-CA 126.715 2.006 . . . . 0.0 107.694 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.3 79.39 3.35 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.105 3.203 . . . . 0.0 109.153 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.09 51.38 0.27 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 125.697 1.618 . . . . 0.0 109.296 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -118.47 159.3 44.32 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.761 1.624 . . . . 0.0 107.506 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 144.34 47.89 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.788 1.659 . . . . 0.0 109.018 -170.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 7.2 mt -105.37 79.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 124.189 1.947 . . . . 0.0 107.329 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.34 124.37 31.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.316 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 mm -47.15 129.06 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -84.12 -0.81 89.67 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.902 2.668 . . . . 0.0 116.787 -166.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 127.35 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 C-N-CA 132.36 4.264 . . . . 0.0 108.824 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.2 t -77.41 149.89 5.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.74 117.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.36 -35.67 70.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -163.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.6 mtm -131.33 114.64 15.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.02 -177.84 38.08 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 m -51.84 -45.32 63.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.84 72.32 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.369 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.11 -41.4 99.34 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.916 0.486 . . . . 0.0 110.287 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -59.58 -46.53 88.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.227 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -21.22 66.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.434 0.561 . . . . 0.0 110.59 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 0.32 30.6 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.33 1.443 . . . . 0.0 113.673 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -99.35 -21.52 15.99 Favored 'General case' 0 C--O 1.228 -0.059 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.056 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' HG ' HG11 ' A' ' 13' ' ' VAL . 5.6 mt -95.92 145.97 24.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.309 1.413 . . . . 0.0 108.147 172.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -140.22 -179.06 0.92 Allowed Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.926 1.691 . . . . 0.0 109.949 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -94.94 138.41 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 111.702 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 -3.69 59.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 125.867 1.698 . . . . 0.0 111.771 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.43 139.96 46.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.11 132.66 42.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.011 2.124 . . . . 0.0 106.878 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.14 152.18 23.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 109.369 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.01 -50.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 108.742 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -127.74 152.37 47.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.929 . . . . 0.0 110.011 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.13 123.72 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 106.81 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t0 55.6 19.21 3.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.591 2.356 . . . . 0.0 113.319 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.11 -16.03 27.78 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.862 2.172 . . . . 0.0 113.702 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.18 131.88 22.63 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 118.778 1.289 . . . . 0.0 108.433 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -72.27 111.65 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.651 2.901 . . . . 0.0 109.004 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.67 -4.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.981 0.913 . . . . 0.0 112.007 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.3 126.29 27.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 109.54 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.86 -7.47 81.68 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.301 0.953 . . . . 0.0 112.91 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -91.99 175.95 6.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.145 1.473 . . . . 0.0 108.974 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -95.09 167.89 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.76 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -48.78 -44.38 38.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 110.646 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -57.62 -35.72 70.84 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.631 0.772 . . . . 0.0 113.075 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -56.14 -44.14 78.91 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.27 -38.55 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.965 0.906 . . . . 0.0 110.406 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -56.97 -40.61 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 120.093 1.315 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -70.73 -33.4 70.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.747 0.248 . . . . 0.0 111.574 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.17 -46.77 72.96 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.663 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.4 mmm -63.54 -33.15 74.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.195 0.907 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.06 -45.25 75.31 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.175 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -49.66 64.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.856 0.862 . . . . 0.0 111.422 176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.35 66.85 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 110.539 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 -23.44 64.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.019 -1.051 . . . . 0.0 113.327 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -93.47 -31.37 14.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.207 1.003 . . . . 0.0 110.846 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -57.71 -25.2 60.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.329 0.652 . . . . 0.0 110.519 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.88 5.35 90.14 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 121.432 -0.792 . . . . 0.0 111.926 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -149.75 174.04 13.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.372 1.869 . . . . 0.0 107.195 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.48 147.84 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 160.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -115.71 108.83 16.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.7 mt -99.29 140.95 32.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -120.56 114.78 22.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.55 171.36 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -148.67 162.2 40.2 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.512 -1.367 . . . . 0.0 109.24 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -155.06 120.57 5.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 109.75 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 147.31 52.01 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.378 1.471 . . . . 0.0 110.213 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.78 164.95 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD13 ' H ' ' A' ' 98' ' ' SER . 0.2 OUTLIER -159.52 160.44 34.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.841 3.256 . . . . 0.0 106.822 168.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.448 ' H ' HD13 ' A' ' 97' ' ' LEU . 5.1 t -148.9 141.77 24.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.97 -122.55 1.11 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.981 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.03 -173.8 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.365 2.71 . . . . 0.0 111.028 173.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -151.03 -33.82 0.15 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.039 0.936 . . . . 0.0 112.876 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.8 m -146.86 152.39 38.64 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.838 -1.164 . . . . 0.0 108.679 161.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.751 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -170.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.576 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m 69.4 -48.01 0.6 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.145 2.578 . . . . 0.0 114.458 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.0 m 55.68 -176.47 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.023 1.729 . . . . 0.0 113.967 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.69 110.02 3.46 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 m 28.83 75.8 0.03 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.042 2.537 . . . . 0.0 111.994 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 m -55.8 150.23 13.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 96' ' ' VAL . . . -61.16 -95.58 0.01 OUTLIER Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 124.127 0.87 . . . . 0.0 112.075 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 2.5 p90 -51.88 135.76 29.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.81 0.814 . . . . 0.0 108.9 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 133.26 33.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 167.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.26 152.99 24.91 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 158.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -136.42 162.71 32.3 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.53 2.332 . . . . 0.0 107.511 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.52 116.93 22.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.314 1.054 . . . . 0.0 110.559 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.91 136.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 168.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -129.05 107.46 9.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 123.8 46.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -75.21 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -124.72 99.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 167.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.1 ptp -132.37 6.41 4.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.641 0.776 . . . . 0.0 110.687 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.2 -110.9 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -64.58 -30.42 71.44 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.551 1.069 . . . . 0.0 112.028 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.22 82.87 0.61 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 67.23 -171.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.148 1.379 . . . . 0.0 110.167 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.58 45.88 0.21 Allowed Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 90' ' ' LEU . 13.3 p90 -139.58 152.05 46.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -108.6 167.16 10.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.703 2.401 . . . . 0.0 108.538 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.67 135.41 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 120.542 -1.349 . . . . 0.0 107.733 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -138.64 -176.82 4.61 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 128.563 2.745 . . . . 0.0 106.815 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.48 -159.91 41.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.67 24.8 54.25 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.719 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -64.33 -28.11 69.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.579 1.19 . . . . 0.0 110.714 -171.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -135.09 160.67 67.4 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 126.936 2.094 . . . . 0.0 108.03 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.32 35.18 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.752 1 C-N-CA 125.372 4.048 . . . . 0.0 113.603 -166.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.86 20.51 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.997 1.761 . . . . 0.0 111.528 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -89.7 154.07 47.96 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 118.92 1.36 . . . . 0.0 111.123 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.84 135.14 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.916 3.078 . . . . 0.0 109.286 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.2 92.51 2.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 mt -85.15 134.87 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.494 -0.754 . . . . 0.0 111.28 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.5 mm -54.04 112.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.696 1.998 . . . . 0.0 105.728 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.1 -74.86 0.3 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.713 1.625 . . . . 0.0 113.216 -170.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.92 119.27 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.631 1.973 . . . . 0.0 106.756 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.61 149.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.49 113.25 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.13 -23.75 56.2 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.156 1.382 . . . . 0.0 114.588 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.1 mmt -110.95 -0.05 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.23 -178.1 22.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.899 1.238 . . . . 0.0 111.181 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -66.14 -8.34 23.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.25 -40.45 18.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.086 1.766 . . . . 0.0 111.332 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.7 -53.04 24.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.447 1.099 . . . . 0.0 110.428 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -55.32 -29.18 57.77 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.54 -21.94 65.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.766 0.826 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.16 52.65 51.23 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.982 1.277 . . . . 0.0 111.022 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.78 -78.75 0.28 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.1 mt -69.13 142.05 54.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.054 0.843 . . . . 0.0 110.813 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -119.59 154.22 54.49 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.934 0.894 . . . . 0.0 108.978 159.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 142.89 34.83 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.85 1.7 . . . . 0.0 110.07 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.43 88.46 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.963 -0.91 . . . . 0.0 113.533 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -71.19 141.13 50.67 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 169.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.45 128.82 36.63 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.006 -1.059 . . . . 0.0 109.4 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.72 153.47 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.396 1.878 . . . . 0.0 110.923 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.94 -37.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.005 1.722 . . . . 0.0 109.516 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 66' ' ' PRO . 70.2 m-85 -137.18 151.92 49.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.084 0.953 . . . . 0.0 110.388 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.5 t -147.31 134.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 127.036 2.134 . . . . 0.0 106.954 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t0 58.83 17.03 4.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.299 1.44 . . . . 0.0 111.029 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.8 0.82 88.85 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.732 2.11 . . . . 0.0 114.066 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mm -94.78 136.03 23.31 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 127.036 2.134 . . . . 0.0 108.098 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 18.0 Cg_endo -74.07 145.59 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.358 2.039 . . . . 0.0 109.189 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.02 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.077 0.551 . . . . 0.0 112.379 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.8 102.14 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.041 -0.412 . . . . 0.0 110.239 -165.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.48 -3.8 50.53 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.529 1.061 . . . . 0.0 113.718 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 57.3 mmtt -78.83 -179.98 6.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.052 -1.264 . . . . 0.0 108.023 158.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.7 p -111.85 175.52 5.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.21 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -40.8 -64.24 0.56 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 109.792 170.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -55.43 -38.75 69.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.239 0.616 . . . . 0.0 112.577 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 9.1 t80 -55.01 -48.04 73.88 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.441 0.564 . . . . 0.0 109.488 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.12 -44.06 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.353 -1.308 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mm -57.16 -37.54 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.507 1.503 . . . . 0.0 109.785 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -54.52 46.02 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.053 0.941 . . . . 0.0 110.91 170.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.03 -35.04 77.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.268 0.627 . . . . 0.0 112.154 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -30.48 23.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.335 1.454 . . . . 0.0 109.388 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.9 -30.87 71.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.195 0.998 . . . . 0.0 111.339 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -51.04 59.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 173.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.18 74.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.456 1.103 . . . . 0.0 111.394 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -23.34 15.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.533 -1.354 . . . . 0.0 112.464 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -94.17 -21.73 18.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.926 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -61.92 -35.87 79.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.193 1.361 . . . . 0.0 110.696 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.47 -0.72 49.77 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.529 -0.732 . . . . 0.0 112.724 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -151.81 167.84 26.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.76 2.024 . . . . 0.0 106.672 165.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.02 122.13 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 162.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.53 128.16 33.27 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 24' ' ' PHE . 14.7 mt -130.8 128.41 40.66 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.4 m -112.06 122.53 48.01 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -111.09 164.81 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.442 1.097 . . . . 0.0 109.339 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -152.21 146.78 25.71 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.596 -1.315 . . . . 0.0 110.954 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -148.82 126.88 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.834 0.454 . . . . 0.0 110.204 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.9 123.17 17.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.197 0.999 . . . . 0.0 112.361 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 7' ' ' GLY . 2.5 p -93.08 165.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.207 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.41 -62.49 0.09 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 37.89 74.73 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.531 2.732 . . . . 0.0 112.364 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 170.98 44.13 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.53 162.6 41.32 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.097 2.532 . . . . 0.0 112.445 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 t -141.93 -35.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 112.485 -172.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.7 m -163.63 160.62 23.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.204 1.366 . . . . 0.0 108.68 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 CA-C-O 116.74 -2.144 . . . . 0.0 108.067 178.775 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.809 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m 81.2 -55.23 0.29 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 127.178 2.191 . . . . 0.0 112.485 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.4 m -77.28 68.17 3.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.368 1.867 . . . . 0.0 110.049 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.77 150.1 25.47 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.488 1.518 . . . . 0.0 112.002 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -84.66 93.95 8.52 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.5 m -68.79 78.51 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.693 0.797 . . . . 0.0 110.007 167.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.5 -94.43 0.24 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 121.141 -0.974 . . . . 0.0 110.758 169.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 25.5 p90 -53.9 126.56 22.78 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 124.386 0.698 . . . . 0.0 109.605 -164.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.61 117.27 26.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -83.95 141.06 31.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 116.72 15.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.52 143.06 36.93 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.819 1.648 . . . . 0.0 109.176 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.59 108.72 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 126.248 1.819 . . . . 0.0 106.743 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.3 130.45 35.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -120.9 123.91 43.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.253 0.933 . . . . 0.0 109.276 164.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -74.42 158.58 33.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.185 165.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 51.9 ttt-85 -131.24 102.31 5.93 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 125.793 1.637 . . . . 0.0 107.11 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 ptp -155.66 8.77 0.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -136.75 -76.54 0.42 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.638 -1.288 . . . . 0.0 108.41 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.47 -7.7 12.83 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.66 1.584 . . . . 0.0 111.919 170.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.14 -179.95 41.43 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.159 0.885 . . . . 0.0 111.807 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.1 m-85 -62.48 147.08 49.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.61 51.15 0.87 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -134.7 153.51 51.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -110.97 163.93 13.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.666 1.987 . . . . 0.0 107.316 168.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.401 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -136.46 150.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.155 1.382 . . . . 0.0 108.642 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -134.59 -177.29 4.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.856 2.062 . . . . 0.0 108.549 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.12 -140.51 37.88 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.03 23.92 8.0 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 127.956 2.693 . . . . 0.0 112.922 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.37 -25.38 65.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.031 -0.688 . . . . 0.0 110.342 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -121.84 155.9 59.86 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 123.507 0.723 . . . . 0.0 110.145 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.07 133.09 29.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.112 1.874 . . . . 0.0 108.684 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.43 19.32 74.36 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.935 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -72.59 162.38 74.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.603 1.201 . . . . 0.0 110.34 168.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -71.09 119.27 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.289 1.993 . . . . 0.0 109.571 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -90.45 97.74 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -83.73 151.77 25.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 mm -55.83 122.23 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -67.21 -62.7 4.24 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 128.96 4.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.762 0.825 . . . . 0.0 108.799 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.79 128.0 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.5 mm -68.21 132.93 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.278 1.431 . . . . 0.0 108.611 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.82 65.77 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.756 1.223 . . . . 0.0 113.855 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.7 mtt -126.79 54.98 1.57 Allowed 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 169.45 12.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -6.99 20.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.325 -1.321 . . . . 0.0 114.08 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.54 -56.4 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 120.03 1.286 . . . . 0.0 110.507 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.61 -45.99 91.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.429 0.559 . . . . 0.0 110.562 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -18.94 48.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.96 -17.67 20.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.962 1.305 . . . . 0.0 111.835 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.71 45.38 53.05 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.955 -1.091 . . . . 0.0 113.869 165.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -133.37 -48.51 0.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.765 0.783 . . . . 0.0 111.436 166.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 mt -74.04 148.15 42.23 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.609 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -139.77 148.5 55.79 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 125.167 1.387 . . . . 0.0 112.327 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.94 92.59 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.816 3.011 . . . . 0.0 112.464 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.87 -13.61 1.51 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.202 1.858 . . . . 0.0 113.029 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.32 154.12 28.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.957 1.379 . . . . 0.0 109.694 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.32 131.78 42.49 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.81 155.83 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.11 0.964 . . . . 0.0 110.453 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.88 -51.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 125.071 1.348 . . . . 0.0 109.332 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.65 146.72 52.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.8 116.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t0 57.99 25.04 11.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.586 1.555 . . . . 0.0 111.522 -166.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.44 0.77 59.11 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.503 1.049 . . . . 0.0 112.815 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 mm -86.27 127.62 60.63 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 119.798 1.799 . . . . 0.0 106.507 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -69.82 128.36 15.86 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.503 2.802 . . . . 0.0 109.257 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -92.16 -3.65 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.708 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 149.11 48.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.203 0.91 . . . . 0.0 108.848 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.25 -28.12 0.33 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.017 1.294 . . . . 0.0 114.57 -172.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -74.71 173.72 10.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.054 1.342 . . . . 0.0 109.434 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -103.92 -177.36 3.35 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.726 1.61 . . . . 0.0 109.47 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.86 -55.01 40.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.254 1.822 . . . . 0.0 110.443 172.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -56.13 -35.27 66.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.382 0.992 . . . . 0.0 112.422 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -47.04 -50.34 19.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.261 0.625 . . . . 0.0 111.165 171.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.59 -35.78 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.453 1.101 . . . . 0.0 110.338 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.37 -27.86 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 119.935 1.243 . . . . 0.0 110.379 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.12 -41.28 74.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.354 -1.466 . . . . 0.0 110.686 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.98 -31.28 72.09 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.894 -1.129 . . . . 0.0 112.229 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.77 -35.02 77.93 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.024 1.33 . . . . 0.0 109.61 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.3 -60.33 3.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.486 0.714 . . . . 0.0 109.944 171.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -56.9 -49.37 75.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.351 1.061 . . . . 0.0 112.379 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.94 79.42 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 111.721 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.22 64.76 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.035 -1.04 . . . . 0.0 112.337 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -81.44 -42.59 20.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 110.428 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.07 -20.2 62.3 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.049 0.939 . . . . 0.0 110.708 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.87 11.61 76.37 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.129 0.871 . . . . 0.0 111.996 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.21 167.85 11.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.953 1.701 . . . . 0.0 107.046 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.29 150.77 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -105.29 126.09 51.71 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.65 99.27 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.4 m -87.49 116.69 25.78 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.86 169.85 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.436 1.095 . . . . 0.0 109.005 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.416 ' HD2' ' CD1' ' A' ' 8' ' ' TYR . 15.9 ptt180 -153.25 167.97 27.54 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.527 -1.358 . . . . 0.0 110.858 172.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.511 HH11 ' CB ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -150.14 149.11 29.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.164 161.006 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -53.13 156.03 2.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.56 1.171 . . . . 0.0 111.615 161.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.5 146.69 18.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.26 -40.23 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.577 0.351 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m 68.21 1.9 3.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 155.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.28 118.79 1.49 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.06 163.28 36.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 120.864 2.332 . . . . 0.0 109.605 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 t -141.83 166.14 25.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 163.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.35 109.1 4.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -144.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m -142.44 144.74 33.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.746 1.218 . . . . 0.0 108.197 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 46.94 75.77 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.544 1.937 . . . . 0.0 111.491 -176.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.47 -177.01 5.13 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.174 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t -49.65 103.57 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.571 1.548 . . . . 0.0 111.431 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -133.02 58.33 1.77 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.224 1.81 . . . . 0.0 108.946 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.67 -21.14 47.68 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.473 -1.239 . . . . 0.0 115.083 157.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.52 162.86 17.3 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 108.519 166.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 130.45 52.6 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.83 138.18 33.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 162.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.84 134.56 53.57 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.765 2.026 . . . . 0.0 107.251 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -92.08 132.44 36.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.482 HG11 ' HG ' ' A' ' 53' ' ' LEU . 65.4 t -130.12 108.82 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.588 1.555 . . . . 0.0 106.977 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -86.4 126.89 34.69 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 168.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -117.61 123.14 45.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.187 0.903 . . . . 0.0 109.041 164.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -78.74 161.44 26.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 111.055 172.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 38.8 ttt-85 -139.88 93.62 2.67 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.741 1.216 . . . . 0.0 110.48 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.7 mtp -142.29 -8.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 161.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -131.22 -105.65 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -164.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 m -65.6 -23.45 66.83 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.08 -1.013 . . . . 0.0 112.285 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.44 -179.94 7.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.704 1.138 . . . . 0.0 111.729 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 3.1 m-85 -63.5 123.52 18.98 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.16 -1.2 . . . . 0.0 110.632 -165.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.75 53.42 0.59 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 124.148 0.88 . . . . 0.0 111.133 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CE1' HD11 ' A' ' 90' ' ' LEU . 32.0 p90 -142.2 167.87 21.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.441 1.121 . . . . 0.0 108.66 172.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -123.43 162.36 22.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.801 2.04 . . . . 0.0 107.503 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.98 151.73 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.17 2.188 . . . . 0.0 106.99 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD12 ' HA2' ' A' ' 39' ' ' GLY . 97.0 mt -149.03 -177.31 5.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.476 2.31 . . . . 0.0 107.806 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.59 56.0 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.232 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -11.0 59.74 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.906 1.853 . . . . 0.0 112.415 -170.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -132.1 160.34 68.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 127.225 2.21 . . . . 0.0 107.369 168.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.94 69.56 7.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.961 3.774 . . . . 0.0 110.058 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.1 7.12 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.27 1.414 . . . . 0.0 112.599 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.54 160.84 39.88 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.62 1.71 . . . . 0.0 109.76 159.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.86 140.87 51.98 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.669 1.58 . . . . 0.0 109.175 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -105.79 93.2 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.3 149.27 25.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.1 0.476 . . . . 0.0 110.339 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.79 121.33 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 158.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 27' ' ' LEU . . . -64.49 -68.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 124.849 1.214 . . . . 0.0 110.081 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 144.55 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.729 1.612 . . . . 0.0 107.609 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.45 139.84 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 162.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mm -86.15 110.2 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.88 144.56 11.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.893 1.277 . . . . 0.0 111.076 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.0 mmt 47.09 69.99 0.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.105 1.762 . . . . 0.0 110.012 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.01 -179.94 44.97 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 m -57.71 -38.52 75.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.906 1.353 . . . . 0.0 114.64 -165.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 -44.43 50.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.872 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -42.49 65.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.212 1.005 . . . . 0.0 111.654 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -77.33 -21.42 53.43 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.089 -1.007 . . . . 0.0 112.296 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.74 -29.32 40.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.189 0.996 . . . . 0.0 110.524 171.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.36 -3.49 4.49 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.11 2.291 . . . . 0.0 114.524 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -90.33 -42.14 11.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.658 1.229 . . . . 0.0 111.695 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 13' ' ' VAL . 7.5 mt -69.28 160.95 30.26 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.989 0.516 . . . . 0.0 109.643 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 155.61 72.4 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.679 1.191 . . . . 0.0 109.221 160.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.0 142.47 51.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.772 1.648 . . . . 0.0 108.838 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.26 -0.94 86.85 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.465 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.55 145.13 55.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.335 1.568 . . . . 0.0 107.433 166.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -93.71 133.57 36.93 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.746 1.157 . . . . 0.0 108.323 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -88.14 153.48 21.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.373 1.469 . . . . 0.0 110.173 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.0 -47.16 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.578 1.551 . . . . 0.0 109.426 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.21 150.31 48.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.879 1.672 . . . . 0.0 108.731 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -145.44 118.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 69.85 -31.39 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.099 2.56 . . . . 0.0 112.427 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.63 -21.13 0.39 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 128.065 2.745 . . . . 0.0 110.485 171.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 65' ' ' ILE . 4.5 mp -76.82 135.69 67.5 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 127.59 2.356 . . . . 0.0 107.457 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -72.92 151.49 50.72 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.425 2.083 . . . . 0.0 110.057 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.8 m -114.26 -7.77 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.26 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.23 102.83 2.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.68 2.13 30.65 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.855 1.216 . . . . 0.0 113.502 -174.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -98.17 173.23 7.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.875 1.837 . . . . 0.0 109.387 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -89.56 172.45 8.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.319 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -61.57 -46.4 90.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 111.137 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -62.61 -26.94 68.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.106 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -45.86 -48.87 15.87 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.268 1.027 . . . . 0.0 110.516 168.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.62 -36.16 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.442 1.097 . . . . 0.0 109.118 -169.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.14 -45.46 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.186 0.903 . . . . 0.0 109.783 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -70.35 -24.85 63.05 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -74.18 -46.71 40.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.477 0.711 . . . . 0.0 110.54 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 89.6 mmm -62.58 -24.58 67.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.926 1.239 . . . . 0.0 112.199 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.46 -50.82 72.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.934 167.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -50.45 56.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.291 1.836 . . . . 0.0 111.333 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.98 69.86 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.58 0.752 . . . . 0.0 111.264 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.31 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.629 -1.294 . . . . 0.0 112.15 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -69.26 -37.78 78.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.504 1.521 . . . . 0.0 111.187 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -62.78 -12.39 23.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.381 0.537 . . . . 0.0 112.14 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.44 9.68 85.88 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.282 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -170.76 166.38 7.89 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.355 1.862 . . . . 0.0 108.119 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 118.92 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -82.18 100.65 9.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CE1' ' A' ' 24' ' ' PHE . 29.2 mt -87.06 145.73 26.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.2 m -123.44 118.99 28.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 165.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.17 169.5 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 124.097 0.873 . . . . 0.0 108.99 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -151.35 161.04 43.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.868 -1.145 . . . . 0.0 110.183 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.83 134.46 14.53 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.531 169.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 139.28 58.27 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.915 1.286 . . . . 0.0 111.829 169.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.46 57.2 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.484 1.513 . . . . 0.0 108.481 -169.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 tp 51.92 13.95 0.28 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.334 1.854 . . . . 0.0 115.863 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 t -66.33 149.25 50.65 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.397 -1.439 . . . . 0.0 107.904 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.87 103.54 0.67 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -67.97 173.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.362 1.375 . . . . 0.0 109.628 165.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -121.05 168.4 11.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 109.693 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -81.31 -21.16 39.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.477 0.711 . . . . 0.0 110.648 163.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 174.34 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m -120.68 100.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.798 2.039 . . . . 0.0 106.861 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 p -141.56 166.37 24.92 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.643 1.977 . . . . 0.0 106.122 158.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.67 166.83 30.82 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.541 1.067 . . . . 0.0 111.323 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -77.26 149.73 35.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.888 -0.772 . . . . 0.0 109.004 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -132.16 116.61 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -66.65 2.34 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 125.749 1.642 . . . . 0.0 113.105 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -65.44 153.45 41.31 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 117.76 0.78 . . . . 0.0 108.98 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HE3' HD11 ' A' ' 11' ' ' LEU . 49.7 pttt -112.59 145.22 40.73 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 170.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.16 158.58 21.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 164.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD11 ' HE3' ' A' ' 9' ' ' LYS . 2.0 mm? -129.09 138.96 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.433 1.893 . . . . 0.0 106.925 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.13 125.89 46.31 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 108.098 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.17 142.79 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.349 1.06 . . . . 0.0 108.677 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -130.18 125.52 35.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -124.56 165.07 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.927 0.785 . . . . 0.0 110.643 -174.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -132.99 159.98 38.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.811 0.845 . . . . 0.0 111.333 -174.11 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -126.03 85.07 2.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.828 1.251 . . . . 0.0 111.04 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.4 ttm -140.4 -17.2 0.91 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.258 0.623 . . . . 0.0 111.487 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -91.93 -128.33 0.1 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -67.23 -7.03 20.88 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.994 -1.066 . . . . 0.0 113.084 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.25 73.5 0.69 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -165.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 74.88 156.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.545 2.338 . . . . 0.0 111.718 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.28 36.62 2.75 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.914 0.768 . . . . 0.0 111.33 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -130.65 166.26 21.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.154 0.977 . . . . 0.0 108.973 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -123.05 164.96 17.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.54 1.936 . . . . 0.0 107.544 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.61 125.7 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -173.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt -132.29 -178.25 4.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.546 1.538 . . . . 0.0 108.312 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.58 -162.96 54.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -168.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.61 18.52 65.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.078 -1.401 . . . . 0.0 114.751 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.18 -60.43 3.34 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.107 1.453 . . . . 0.0 109.002 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.91 161.2 47.88 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 107.98 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.123 3.215 . . . . 0.0 109.422 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 -5.51 12.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.305 1.431 . . . . 0.0 113.382 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -63.43 163.8 17.91 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.429 1.491 . . . . 0.0 111.47 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.25 140.48 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.937 1.758 . . . . 0.0 109.558 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.74 106.61 21.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.7 mt -99.88 153.72 18.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 mm -52.42 140.56 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 160.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.65 -124.01 0.83 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.21 116.68 29.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.797 2.039 . . . . 0.0 107.023 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.8 124.42 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.78 103.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.0 152.5 36.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.5 mtm 47.62 43.98 16.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.4 1.88 . . . . 0.0 111.198 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' ASP . . . -143.89 178.75 21.74 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 125.677 1.608 . . . . 0.0 111.874 -167.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -70.15 -7.88 45.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -163.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.19 -53.44 3.79 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.332 1.053 . . . . 0.0 110.3 165.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -43.81 -47.35 8.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 112.696 175.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -60.16 -38.13 82.25 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.267 1.427 . . . . 0.0 113.119 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.54 -32.96 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 0.0 110.831 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 31.38 35.4 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.462 160.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -131.85 -45.64 0.95 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.006 1.403 . . . . 0.0 112.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.93 144.98 52.01 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.682 -0.636 . . . . 0.0 110.222 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -132.27 158.97 74.18 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 124.778 1.231 . . . . 0.0 108.656 161.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 145.85 85.23 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.221 1.947 . . . . 0.0 110.098 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.16 6.5 79.86 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.398 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -69.73 126.35 29.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.094 1.947 . . . . 0.0 107.569 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HG3' HD23 ' A' ' 37' ' ' LEU . 21.7 tt0 -73.8 124.74 26.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.534 0.607 . . . . 0.0 109.402 -174.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.51 150.73 31.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.759 0.823 . . . . 0.0 109.906 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.81 -46.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.225 1.81 . . . . 0.0 109.108 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.17 145.85 51.75 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.177 0.991 . . . . 0.0 110.249 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.7 t -139.2 129.39 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.829 1.652 . . . . 0.0 107.11 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.11 18.06 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.763 2.425 . . . . 0.0 113.225 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -11.38 62.78 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.385 2.421 . . . . 0.0 112.836 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.31 132.88 34.38 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.866 1.666 . . . . 0.0 108.62 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -70.99 116.83 4.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.863 2.375 . . . . 0.0 109.59 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.92 -7.37 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.388 0.675 . . . . 0.0 111.625 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 114.46 2.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.197 1.399 . . . . 0.0 111.032 -171.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -14.9 56.11 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.428 1.49 . . . . 0.0 113.02 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 170.48 9.43 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.747 1.219 . . . . 0.0 110.634 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.1 p -85.72 171.67 11.43 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.63 0.772 . . . . 0.0 111.024 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -46.82 -54.28 10.18 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.81 1.644 . . . . 0.0 108.831 165.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 ttp-105 -55.62 -37.76 68.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.02 -44.04 74.25 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.495 0.589 . . . . 0.0 109.918 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.15 -41.35 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.917 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.56 -44.43 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.234 0.925 . . . . 0.0 110.451 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -45.36 95.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.901 1.28 . . . . 0.0 110.189 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.56 -45.84 71.05 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.713 0.688 . . . . 0.0 111.412 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.6 mmm -52.73 -36.52 57.78 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 0.0 110.275 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -18.67 60.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.241 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -85.11 -49.06 8.57 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.02 1.728 . . . . 0.0 109.216 172.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.39 40.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.447 1.099 . . . . 0.0 109.473 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.52 -36.45 23.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.483 1.113 . . . . 0.0 113.105 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 81' ' ' HIS . 2.0 mpt_? -68.36 -39.64 81.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -71.49 -13.83 61.93 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.784 1.234 . . . . 0.0 112.759 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.41 4.54 90.01 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 119.404 1.002 . . . . 0.0 113.876 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 6.1 pt20 -142.96 178.59 7.57 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.433 1.493 . . . . 0.0 109.246 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.09 128.58 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 162.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.18 139.92 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 15' ' ' LEU . 5.8 mt -139.78 125.59 19.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.532 1.969 . . . . 0.0 107.374 -174.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.13 115.11 25.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.6 m -99.5 167.99 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -144.81 152.79 40.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 120.523 -1.36 . . . . 0.0 108.857 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -151.5 143.39 23.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.087 1.355 . . . . 0.0 109.633 173.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 141.22 9.6 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.512 1.125 . . . . 0.0 110.263 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.8 155.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 166.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.21 130.5 11.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -66.04 -60.31 2.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.389 0.54 . . . . 0.0 111.783 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.82 39.46 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.541 -169.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.66 151.23 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.255 3.303 . . . . 0.0 112.98 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -159.51 176.75 11.69 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.539 1.135 . . . . 0.0 108.962 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.9 m -146.38 -162.95 1.63 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.331 1.452 . . . . 0.0 107.316 150.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.63 0 N-CA-C 103.16 -3.976 . . . . 0.0 103.16 -141.902 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.376 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -147.97 119.78 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 172.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m 62.28 172.58 0.13 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 112.151 -164.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.97 -102.99 0.83 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.611 1.1 . . . . 0.0 110.75 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.1 m -79.25 52.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.238 1.015 . . . . 0.0 110.917 170.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.0 m -59.12 140.36 55.93 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.86 -72.38 0.35 Allowed Glycine 0 C--N 1.33 0.201 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.037 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE2' ' HD2' ' A' ' 93' ' ' ARG . 36.0 p90 -70.45 161.53 30.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 119.06 1.43 . . . . 0.0 110.008 168.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 137.43 53.17 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.489 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -83.09 151.5 25.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.98 155.21 50.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.55 123.62 28.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.885 1.274 . . . . 0.0 108.538 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 52' ' ' ARG . 86.1 t -101.91 151.01 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.734 2.014 . . . . 0.0 106.225 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -128.26 120.89 28.06 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.546 1.539 . . . . 0.0 108.615 166.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.85 123.51 44.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.05 20.52 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.902 0.319 . . . . 0.0 110.147 166.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.6 ttt180 -119.69 93.79 4.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.138 2.175 . . . . 0.0 105.718 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.29 -13.78 7.11 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.046 0.538 . . . . 0.0 110.69 170.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.86 -112.45 0.19 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -65.2 -18.69 65.51 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.96 -173.65 53.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.101 0.834 . . . . 0.0 112.39 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 4.1 m-85 -71.82 111.14 6.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.433 0.693 . . . . 0.0 110.11 -164.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.26 46.47 3.64 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.419 1.009 . . . . 0.0 114.241 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -135.1 163.39 30.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.222 1.511 . . . . 0.0 110.368 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -120.27 157.29 29.47 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.294 1.838 . . . . 0.0 107.876 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.62 135.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.93 -178.85 6.02 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.213 1.405 . . . . 0.0 107.463 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.71 -154.35 46.93 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.34 34.25 40.89 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.281 0.943 . . . . 0.0 112.402 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 -46.44 43.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -167.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.09 157.96 32.71 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.423 1.089 . . . . 0.0 108.537 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.69 96.04 0.82 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.723 2.949 . . . . 0.0 108.129 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.13 -24.56 2.06 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.942 1.734 . . . . 0.0 111.44 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -73.73 150.71 88.77 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 119.399 1.599 . . . . 0.0 112.753 -171.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.38 149.55 69.45 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.588 2.858 . . . . 0.0 109.377 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -113.45 88.72 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.2 mt -93.3 125.98 38.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.9 mm -43.83 120.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.484 1.913 . . . . 0.0 106.87 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.96 -56.68 23.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 124.925 1.25 . . . . 0.0 111.709 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.58 153.48 31.48 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.1 t -112.96 112.79 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 118.89 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.981 1.712 . . . . 0.0 108.368 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.53 124.55 12.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.113 0.965 . . . . 0.0 110.536 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . 0.252 20.4 ptp 46.81 20.39 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.701 2.4 . . . . 0.0 115.283 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.74 -173.19 42.72 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -58.84 -39.06 80.13 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.217 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.07 -28.59 60.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 121.679 2.036 . . . . 0.0 111.973 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.56 -47.62 69.31 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.052 0.941 . . . . 0.0 109.241 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -60.51 -40.21 90.62 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.497 0.719 . . . . 0.0 111.177 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.16 -23.5 67.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.388 1.475 . . . . 0.0 111.929 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.82 72.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.214 1.388 . . . . 0.0 113.121 167.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 13' ' ' VAL . 1.9 mmp_? -122.72 -13.2 7.97 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.147 -163.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' HG ' HG21 ' A' ' 13' ' ' VAL . 17.5 mt -119.99 151.3 39.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.907 1.23 . . . . 0.0 107.885 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -132.35 149.21 72.51 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.671 164.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.44 134.92 40.47 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.678 1.585 . . . . 0.0 108.203 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.17 1.05 76.27 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.243 -1.309 . . . . 0.0 113.961 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.12 140.68 58.82 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.563 2.181 . . . . 0.0 107.354 161.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HG3' HD23 ' A' ' 37' ' ' LEU . 24.3 tt0 -85.96 128.24 34.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.549 1.522 . . . . 0.0 108.767 173.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.26 158.0 36.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.887 0.767 . . . . 0.0 110.175 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.86 -53.29 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.499 1.919 . . . . 0.0 107.708 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -132.59 148.46 52.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.845 1.258 . . . . 0.0 108.894 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 63.43 -2.48 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.431 2.293 . . . . 0.0 112.222 -169.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.3 31.8 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 127.361 2.41 . . . . 0.0 112.096 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.3 125.31 50.55 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.73 127.02 14.01 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.136 2.557 . . . . 0.0 108.555 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.03 -2.94 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.836 0.854 . . . . 0.0 110.565 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.24 120.29 14.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.901 0.88 . . . . 0.0 110.687 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.89 -12.24 37.16 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.777 1.18 . . . . 0.0 112.75 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.42 177.35 8.57 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.08 1.352 . . . . 0.0 107.814 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -105.3 175.33 5.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.622 0.769 . . . . 0.0 110.431 -172.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -52.05 -48.61 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.781 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -55.37 -35.09 64.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.38 -50.3 62.71 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.43 -40.49 82.31 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 124.035 0.934 . . . . 0.0 110.909 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mm -50.66 -42.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.586 1.084 . . . . 0.0 111.231 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -39.2 70.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.705 0.402 . . . . 0.0 110.57 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -50.18 73.65 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 122.917 0.487 . . . . 0.0 110.616 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.31 -40.14 85.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.317 0.508 . . . . 0.0 110.944 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -32.35 73.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.41 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -70.73 -57.46 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.523 1.529 . . . . 0.0 111.133 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.42 69.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.103 0.961 . . . . 0.0 111.303 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.09 72.35 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.582 -1.324 . . . . 0.0 111.09 169.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -73.73 -35.92 65.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 117.389 -1.291 . . . . 0.0 111.704 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -56.52 -25.82 52.75 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.082 0.855 . . . . 0.0 110.031 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.44 9.2 86.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 123.936 0.779 . . . . 0.0 111.571 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -160.28 165.62 31.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.037 1.419 . . . . 0.0 109.279 170.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.33 127.32 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.17 139.13 35.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 160.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.71 105.66 6.57 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.8 m -91.04 121.19 32.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.01 170.17 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' CE2' ' A' ' 8' ' ' TYR . 31.2 ptt180 -150.83 166.24 31.12 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.307 -1.496 . . . . 0.0 108.818 167.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -155.12 146.76 23.2 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 96' ' ' VAL . 1.5 tmtm? -61.5 163.39 6.92 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.871 1.269 . . . . 0.0 111.17 168.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.437 ' H ' ' HD3' ' A' ' 95' ' ' LYS . 25.7 t -128.66 165.09 29.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.793 1.637 . . . . 0.0 109.552 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.0 tp -167.37 -169.4 1.23 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 129.856 3.262 . . . . 0.0 104.321 -175.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -63.4 173.76 1.48 Allowed 'General case' 0 C--O 1.244 0.802 0 O-C-N 120.398 -1.439 . . . . 0.0 109.678 152.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.03 -178.59 23.39 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.338 -0.851 . . . . 0.0 111.05 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.39 169.91 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.096 2.531 . . . . 0.0 110.362 171.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.9 m 73.06 82.47 0.13 Allowed 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.635 1.974 . . . . 0.0 109.604 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 m -134.96 175.11 9.88 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.972 2.109 . . . . 0.0 107.59 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -160.427 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.644 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.06 169.13 5.71 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.539 -0.977 . . . . 0.0 108.84 162.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -70.05 170.32 11.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.565 -0.709 . . . . 0.0 109.412 162.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.09 -157.68 30.26 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.47 101.88 10.28 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 170.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -69.87 155.85 39.94 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 144.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.3 6.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.397 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -119.93 171.29 8.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.446 1.623 . . . . 0.0 108.769 166.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -128.91 129.46 45.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.79 146.13 28.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.4 116.66 21.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.84 130.57 34.92 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 52' ' ' ARG . 61.4 t -133.7 130.41 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.507 1.523 . . . . 0.0 107.29 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -126.46 122.12 34.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -169.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.63 123.38 43.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -75.04 158.28 33.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.384 0.612 . . . . 0.0 109.645 169.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.7 ttt85 -125.48 88.28 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 168.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 ptm -142.33 -12.81 0.81 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 173.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -132.83 -71.99 0.52 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.639 1.576 . . . . 0.0 107.657 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -119.34 0.06 11.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.35 -156.97 52.57 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.702 1.137 . . . . 0.0 112.452 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.8 m-85 -108.94 105.16 14.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.75 0.82 . . . . 0.0 110.158 -169.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.95 41.83 3.11 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.307 1.908 . . . . 0.0 114.296 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.32 150.54 52.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.632 1.716 . . . . 0.0 110.166 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.06 160.21 14.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.739 1.616 . . . . 0.0 108.952 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.79 138.34 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.76 163.12 38.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.205 2.202 . . . . 0.0 106.0 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.62 176.09 42.06 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.11 90.07 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 -149.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.8 -26.41 65.18 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.658 0.783 . . . . 0.0 110.437 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.64 160.53 46.04 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.95 53.01 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.688 3.592 . . . . 0.0 109.651 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.73 58.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -136.27 161.65 61.04 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 111.569 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -73.31 132.31 17.64 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.955 2.437 . . . . 0.0 109.409 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.65 108.1 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 58' ' ' GLU . 5.3 mt -100.01 149.66 23.23 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 mm -49.55 118.28 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.6 -72.81 0.84 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -171.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.1 117.15 4.83 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.861 0.865 . . . . 0.0 109.024 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.267 0.6 OUTLIER -80.0 149.26 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 121.308 0.575 . . . . 0.0 109.451 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -80.82 107.59 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.22 146.36 15.4 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 mmt 64.0 -10.86 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.236 1.814 . . . . 0.0 112.72 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.88 169.39 53.68 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -60.78 -23.03 64.7 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.13 -45.19 42.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.782 1.628 . . . . 0.0 110.96 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.13 -51.45 69.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -64.24 -34.53 78.32 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.489 -0.757 . . . . 0.0 112.237 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.76 -29.59 70.23 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.287 0.948 . . . . 0.0 110.792 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.39 28.32 52.89 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.816 161.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 13' ' ' VAL . 60.1 mtp85 -136.78 -18.5 1.39 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.432 1.116 . . . . 0.0 113.343 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -90.01 148.25 23.18 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -135.32 157.04 77.47 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 125.062 1.345 . . . . 0.0 107.643 157.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.8 149.71 86.53 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.443 1.429 . . . . 0.0 108.881 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.63 -2.63 72.18 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.623 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.6 136.82 56.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.934 1.867 . . . . 0.0 107.276 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HG3' HD23 ' A' ' 37' ' ' LEU . 33.6 tt0 -85.37 127.36 34.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.766 1.166 . . . . 0.0 109.581 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.09 153.58 30.05 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.228 1.011 . . . . 0.0 110.224 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.5 -46.51 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 126.165 1.786 . . . . 0.0 109.055 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.4 148.42 42.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.403 1.081 . . . . 0.0 110.553 -176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.0 t -145.49 131.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 107.849 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 61.29 14.01 5.32 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.205 1.402 . . . . 0.0 111.333 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.08 -5.73 75.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 127.112 2.292 . . . . 0.0 113.444 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -104.36 133.99 19.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 121.069 2.434 . . . . 0.0 109.381 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.61 120.92 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.313 2.675 . . . . 0.0 110.786 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.62 -2.27 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.754 1.222 . . . . 0.0 112.62 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.62 125.12 22.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.357 1.063 . . . . 0.0 110.274 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.47 -7.12 9.07 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.367 0.984 . . . . 0.0 114.535 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 14.6 mmtt -82.88 174.29 11.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.412 1.485 . . . . 0.0 108.778 167.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.8 p -111.82 175.48 5.41 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.616 0.766 . . . . 0.0 110.696 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -38.69 -62.89 0.56 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.044 1.338 . . . . 0.0 110.586 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 ttp-105 -56.42 -34.09 66.43 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.595 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 76.0 t80 -58.12 -44.43 87.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.315 0.578 . . . . 0.0 110.978 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.97 -31.75 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.232 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.92 -41.48 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.265 -1.522 . . . . 0.0 111.272 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.88 -52.04 67.13 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.511 1.524 . . . . 0.0 109.042 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -51.3 69.78 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.277 0.631 . . . . 0.0 111.141 -175.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.2 mmm -61.98 -21.67 65.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 112.497 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 -32.59 53.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.723 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -66.27 -47.39 73.84 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.318 0.963 . . . . 0.0 110.126 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.05 70.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.41 73.99 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.9 -1.75 . . . . 0.0 112.887 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -68.68 -49.88 55.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.29 -20.6 7.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.432 1.493 . . . . 0.0 112.213 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.15 71.27 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.338 1.923 . . . . 0.0 111.329 170.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -177.47 170.56 2.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.441 2.296 . . . . 0.0 107.223 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.11 149.92 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.31 137.22 45.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.44 106.83 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -97.09 111.41 23.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.61 173.45 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -151.36 164.87 35.71 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.741 -1.225 . . . . 0.0 109.514 170.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.2 146.76 25.02 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.959 1.304 . . . . 0.0 108.322 164.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 144.15 41.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.665 1.186 . . . . 0.0 110.632 170.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -97.43 151.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.896 1.278 . . . . 0.0 108.436 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.69 127.47 25.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.2 m -162.81 86.05 0.55 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.84 98.18 0.18 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.807 -1.552 . . . . 0.0 110.615 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.93 131.78 23.19 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.275 2.65 . . . . 0.0 110.062 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 m 60.83 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 112.653 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -150.37 167.48 26.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.465 1.106 . . . . 0.0 108.401 160.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.35 0 N-CA-C 105.581 -3.008 . . . . 0.0 105.581 -164.067 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.361 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m 75.67 158.98 0.21 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.355 1.862 . . . . 0.0 112.534 166.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 m -54.94 131.91 45.6 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.201 1.4 . . . . 0.0 111.871 -172.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.92 156.11 22.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.073 1.32 . . . . 0.0 110.481 168.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m 58.86 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.533 1.933 . . . . 0.0 111.874 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -55.16 143.6 26.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.004 0.522 . . . . 0.0 110.114 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.1 1.54 88.67 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.971 0.796 . . . . 0.0 112.992 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.53 167.72 19.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 135.37 52.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -84.28 145.14 28.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.71 116.83 21.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -102.56 111.09 23.24 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 107.766 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.95 150.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.369 1.868 . . . . 0.0 107.356 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -128.53 119.71 25.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.875 1.67 . . . . 0.0 111.59 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.7 mt -116.55 123.01 46.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -72.72 146.55 46.37 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 165.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.83 101.25 13.17 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 152.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.1 ptm -133.98 -9.75 2.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.057 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -138.04 -98.43 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.7 p -66.75 -20.41 65.95 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -162.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.78 73.62 0.66 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 54.74 93.7 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.187 2.595 . . . . 0.0 113.512 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.94 55.7 4.53 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.564 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 90' ' ' LEU . 33.9 p90 -129.31 175.16 8.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.932 1.293 . . . . 0.0 108.311 167.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -137.74 153.54 49.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.011 1.324 . . . . 0.0 107.573 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.42 140.02 47.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.98 160.77 43.0 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.829 2.052 . . . . 0.0 105.662 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 -178.86 52.34 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.06 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.68 48.72 79.22 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 -143.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.98 -37.87 88.98 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.86 161.5 55.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.667 1.987 . . . . 0.0 108.904 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.39 53.98 4.95 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 125.208 3.938 . . . . 0.0 112.288 -163.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.57 0.95 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.552 2.025 . . . . 0.0 112.077 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -75.12 163.94 64.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.042 1.921 . . . . 0.0 111.398 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -74.5 143.49 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.025 2.483 . . . . 0.0 110.13 171.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.42 104.85 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.6 mt -98.32 155.27 17.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -55.67 118.79 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 161.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.87 -56.35 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.24 155.3 42.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.292 1.037 . . . . 0.0 109.257 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 149.28 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 C-N-CA 127.425 2.29 . . . . 0.0 107.224 166.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.68 108.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.7 138.68 10.57 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.496 1.118 . . . . 0.0 110.146 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.8 mmt 59.8 0.95 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.043 2.137 . . . . 0.0 113.856 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.76 -175.99 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.783 1.659 . . . . 0.0 110.845 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -54.37 -35.85 63.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -164.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.85 -51.81 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.011 0.823 . . . . 0.0 110.438 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.55 -45.88 88.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.419 0.688 . . . . 0.0 110.687 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -60.21 -31.34 70.07 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.728 0.811 . . . . 0.0 113.028 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.85 -21.43 64.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.081 0.401 . . . . 0.0 111.728 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.58 45.99 86.78 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.446 1.022 . . . . 0.0 112.875 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -143.53 -47.63 0.29 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.379 1.471 . . . . 0.0 112.173 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.7 153.64 41.08 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.662 0.664 . . . . 0.0 109.489 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -142.36 155.63 64.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.211 1.004 . . . . 0.0 110.436 162.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -57.36 134.87 66.53 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.644 2.229 . . . . 0.0 108.957 167.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.4 7.09 69.98 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.44 0.543 . . . . 0.0 113.694 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -77.71 123.12 26.27 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 171.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG3' HD23 ' A' ' 37' ' ' LEU . 37.7 tt0 -73.05 123.78 24.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.42 149.87 35.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.921 0.888 . . . . 0.0 109.253 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.11 -52.12 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -134.09 147.44 50.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.381 1.072 . . . . 0.0 109.464 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.8 t -145.51 123.32 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -171.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.14 -56.38 0.23 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.398 2.279 . . . . 0.0 109.107 -160.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.37 -7.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.694 2.093 . . . . 0.0 110.847 164.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.524 ' H ' HD12 ' A' ' 65' ' ' ILE . 4.3 mp -73.48 139.05 77.83 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 127.242 2.217 . . . . 0.0 107.442 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.57 127.76 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.099 2.532 . . . . 0.0 112.704 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.73 -9.14 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.711 0.804 . . . . 0.0 113.103 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.41 129.86 43.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.926 0.891 . . . . 0.0 110.525 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.49 -12.7 2.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.427 1.013 . . . . 0.0 115.456 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 69.0 mmtt -75.34 179.03 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.712 . . . . 0.0 108.134 169.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.5 p -115.52 171.34 7.79 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.768 -0.582 . . . . 0.0 110.043 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -34.58 -60.21 0.44 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.538 1.935 . . . . 0.0 112.142 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -53.33 -37.41 62.29 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.946 1.298 . . . . 0.0 113.111 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 49.6 t80 -52.14 -45.45 65.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.992 0.917 . . . . 0.0 110.01 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.82 -37.92 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 124.785 1.234 . . . . 0.0 110.188 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.22 -35.27 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 121.539 -0.725 . . . . 0.0 110.104 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.69 -39.85 95.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.676 0.79 . . . . 0.0 111.331 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.39 -37.4 68.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.106 0.962 . . . . 0.0 111.033 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -38.92 78.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.056 0.942 . . . . 0.0 109.604 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -43.8 97.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.682 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -46.9 72.02 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.303 0.956 . . . . 0.0 110.555 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.79 -34.61 69.8 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.156 0.582 . . . . 0.0 111.802 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.26 82.77 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.604 -0.685 . . . . 0.0 111.301 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.63 -41.34 65.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.332 1.053 . . . . 0.0 110.123 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -55.66 -24.27 32.96 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.554 1.541 . . . . 0.0 112.389 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.95 63.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.156 1.836 . . . . 0.0 113.039 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -171.51 160.74 6.04 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.365 1.583 . . . . 0.0 109.048 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.29 121.88 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.284 1.04 . . . . 0.0 109.253 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -80.42 132.51 35.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 162.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 24' ' ' PHE . 43.3 mt -127.65 106.06 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 m -94.98 111.63 23.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -99.33 171.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -150.75 161.42 42.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 120.203 -1.561 . . . . 0.0 110.136 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.25 136.54 20.02 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.844 0.831 . . . . 0.0 111.049 165.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.07 126.97 31.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.558 2.743 . . . . 0.0 111.843 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.2 t -70.43 151.37 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 109.519 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.82 131.53 7.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.0 m -139.22 68.37 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.265 1.026 . . . . 0.0 108.648 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.86 175.3 6.95 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.945 1.259 . . . . 0.0 112.314 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -73.26 -52.94 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.4 p -174.88 98.3 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.22 1.008 . . . . 0.0 109.678 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.3 m 62.19 111.81 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.252 2.221 . . . . 0.0 113.429 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -170.678 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.507 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 m -153.58 113.57 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.783 1.633 . . . . 0.0 107.933 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -108.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 168.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.37 118.39 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 107.066 -2.414 . . . . 0.0 107.066 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m 175.66 162.4 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.542 1.537 . . . . 0.0 111.241 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.3 p -145.47 -175.18 4.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.3 1.84 . . . . 0.0 106.446 142.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.38 -161.34 29.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 144.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 p90 50.2 -176.43 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.77 1.228 . . . . 0.0 112.252 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -132.83 130.15 39.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.7 120.95 26.63 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 116.82 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.66 129.88 34.98 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.932 2.093 . . . . 0.0 109.07 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.14 148.84 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.509 1.523 . . . . 0.0 107.107 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -130.72 133.98 46.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 167.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.57 129.36 50.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 124.011 0.819 . . . . 0.0 110.482 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.35 163.19 24.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.899 0.857 . . . . 0.0 110.136 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -114.92 102.38 9.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 164.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.616 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 8.9 ptp -146.62 -62.4 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.616 ' H ' ' HG3' ' A' ' 18' ' ' MET . 1.8 tm-20 -66.46 -171.55 0.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.004 1.721 . . . . 0.0 108.998 151.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -64.87 11.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.073 2.949 . . . . 0.0 117.006 -152.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 78.66 0.83 Allowed Glycine 0 N--CA 1.45 -0.401 0 O-C-N 121.155 -0.966 . . . . 0.0 112.343 160.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.04 81.71 0.13 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.985 2.114 . . . . 0.0 111.907 171.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.59 58.99 3.77 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.017 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.75 167.52 20.39 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.902 1.351 . . . . 0.0 109.808 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -118.64 163.98 16.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.008 2.123 . . . . 0.0 106.85 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 128.71 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.517 1.927 . . . . 0.0 106.319 -175.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.8 161.77 35.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.625 0.726 . . . . 0.0 110.149 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.94 -160.24 34.75 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 28.58 60.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -150.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.28 -30.81 62.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.054 0.542 . . . . 0.0 110.318 -162.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -104.05 161.51 22.71 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.911 2.085 . . . . 0.0 107.948 163.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.69 100.43 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.849 3.033 . . . . 0.0 108.809 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.75 6.51 7.16 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.241 1.401 . . . . 0.0 114.18 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -82.82 157.13 67.17 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 119.339 1.57 . . . . 0.0 110.862 172.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.72 138.89 39.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.49 2.127 . . . . 0.0 110.514 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.9 mt -102.56 95.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.05 145.67 25.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.81 117.03 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.74 -52.65 47.04 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 125.289 1.423 . . . . 0.0 111.471 -168.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.19 156.64 22.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.232 3.013 . . . . 0.0 105.137 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.7 130.48 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 169.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.64 117.12 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.16 -31.02 63.0 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.0 mmt -127.72 33.5 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.31 170.58 17.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -62.03 -12.94 21.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.22 -51.26 13.75 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.165 1.348 . . . . 0.0 109.668 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.07 -45.87 86.39 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -54.67 -46.73 74.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.304 0.502 . . . . 0.0 112.007 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.28 -30.51 71.38 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.8 0.273 . . . . 0.0 111.196 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.47 -37.69 3.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 127.437 2.446 . . . . 0.0 112.436 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -65.37 -21.88 66.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.548 1.139 . . . . 0.0 113.774 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.5 132.89 33.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -125.87 157.19 69.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 124.442 1.097 . . . . 0.0 109.309 160.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.28 148.45 74.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.431 1.421 . . . . 0.0 109.45 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.43 -7.19 79.95 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.529 -1.15 . . . . 0.0 112.562 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.04 128.97 37.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.497 1.648 . . . . 0.0 106.798 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.55 125.02 30.67 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 120.81 -1.181 . . . . 0.0 109.12 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.13 145.51 37.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.405 1.082 . . . . 0.0 109.773 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -120.13 -54.21 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.081 2.152 . . . . 0.0 108.245 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -128.57 146.03 50.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.128 1.371 . . . . 0.0 108.97 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -140.04 121.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t0 53.7 16.22 0.95 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.163 1.785 . . . . 0.0 111.963 -168.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.99 69.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 127.455 2.455 . . . . 0.0 114.199 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.12 125.9 71.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 120.834 2.317 . . . . 0.0 106.269 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.14 117.3 5.03 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.055 2.503 . . . . 0.0 108.466 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' A' ' 75' ' ' VAL . 26.6 m -79.1 -6.33 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.723 0.809 . . . . 0.0 111.669 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 121.35 16.86 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.146 0.578 . . . . 0.0 110.373 -171.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.41 -9.39 75.66 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.902 1.239 . . . . 0.0 112.978 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 66.5 mmtt -74.93 -164.34 0.29 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.282 1.433 . . . . 0.0 108.13 166.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -120.86 170.02 9.88 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.685 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -38.46 -61.44 0.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.956 1.702 . . . . 0.0 109.414 165.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -42.99 -46.22 5.38 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 128.46 2.704 . . . . 0.0 112.645 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 42.3 t80 -58.83 -40.91 85.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 111.118 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' CG1' ' A' ' 67' ' ' VAL . 18.9 t -75.44 -32.23 25.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.372 -0.83 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -60.35 -40.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.763 1.165 . . . . 0.0 109.763 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.15 -45.69 92.21 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 110.269 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -48.96 78.52 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.644 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.8 mmm -60.11 -33.36 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.239 0.927 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -61.92 -45.3 94.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.208 0.603 . . . . 0.0 110.044 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -58.96 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.224 1.41 . . . . 0.0 111.355 175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.65 73.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.192 1.397 . . . . 0.0 110.581 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.74 63.76 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.961 -1.087 . . . . 0.0 111.003 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -70.43 -41.78 72.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.79 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.01 -10.31 9.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.981 2.113 . . . . 0.0 113.365 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.76 1.5 83.91 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.012 1.291 . . . . 0.0 113.269 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -159.71 -178.59 7.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.979 2.112 . . . . 0.0 108.043 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.58 131.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.77 1.628 . . . . 0.0 106.752 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.69 141.89 34.44 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 162.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -135.8 122.81 21.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -115.7 113.18 23.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.24 168.71 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.92 148.91 29.68 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 119.678 -1.889 . . . . 0.0 110.208 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -147.2 123.99 11.23 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.28 145.4 10.99 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.461 1.504 . . . . 0.0 111.373 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.34 122.18 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.2 -47.6 0.23 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.454 -171.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.8 m -162.02 163.93 28.54 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.775 2.03 . . . . 0.0 107.563 168.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.95 -96.57 1.5 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-O 117.77 -1.572 . . . . 0.0 111.7 -166.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.72 110.5 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.022 3.148 . . . . 0.0 109.725 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 m -87.39 64.02 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.177 0.991 . . . . 0.0 108.448 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.9 p -75.94 75.54 2.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.908 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 -171.26 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -86.21 -74.3 0.42 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.55 0.675 . . . . 0.0 109.476 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -75.99 65.86 2.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.428 1.491 . . . . 0.0 110.957 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.55 92.06 0.1 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.204 -0.935 . . . . 0.0 112.436 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.4 m -70.22 103.26 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 158.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m 39.22 67.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.05 2.14 . . . . 0.0 113.259 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.02 -86.66 1.17 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 30.9 p90 -59.66 160.42 7.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.712 0.292 . . . . 0.0 110.349 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -122.53 141.96 51.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.3 159.53 21.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 166.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.54 146.82 40.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.374 1.47 . . . . 0.0 107.39 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.42 139.01 38.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.281 1.833 . . . . 0.0 109.322 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.2 t -137.52 107.42 4.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -100.66 139.3 36.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.9 mt -134.83 149.99 50.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.767 0.827 . . . . 0.0 109.976 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -97.84 151.26 20.4 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 109.447 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 60.6 ttt-85 -125.92 76.89 1.63 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 0.0 108.835 177.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -143.61 13.48 1.74 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.232 0.613 . . . . 0.0 111.151 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -147.82 -121.58 0.06 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.362 1.865 . . . . 0.0 106.935 -175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -31.13 71.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.078 -1.639 . . . . 0.0 111.826 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.23 -177.28 39.73 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.86 155.29 40.78 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.9 0.88 . . . . 0.0 110.393 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.72 63.23 0.47 Allowed Glycine 0 C--N 1.337 0.639 0 C-N-CA 124.294 0.95 . . . . 0.0 111.902 -170.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 90' ' ' LEU . 37.4 p90 -128.79 170.36 13.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.882 1.273 . . . . 0.0 109.098 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -122.16 163.36 19.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 156.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.26 133.63 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.1 mt -142.85 121.73 12.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.52 179.51 15.76 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.21 29.93 76.53 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -167.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -66.47 -20.45 66.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.573 0.687 . . . . 0.0 110.166 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.57 155.32 80.44 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.914 1.686 . . . . 0.0 110.103 165.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.43 81.88 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.094 3.863 . . . . 0.0 115.165 -165.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.92 -12.75 1.92 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 124.974 1.273 . . . . 0.0 112.033 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -66.82 157.14 85.08 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 117.55 0.675 . . . . 0.0 110.529 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.69 113.04 3.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.733 2.289 . . . . 0.0 111.777 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.56 105.16 6.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.4 mt -93.43 158.48 15.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.421 1.088 . . . . 0.0 109.704 166.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.43 126.04 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 154.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.91 -77.88 0.18 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.35 144.9 29.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.636 1.175 . . . . 0.0 108.602 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 1.2 m -98.79 140.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 123.88 0.872 . . . . 0.0 110.14 169.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.83 111.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.64 -39.83 68.38 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.256 0.551 . . . . 0.0 112.053 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.6 mmt -106.12 44.42 1.05 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.002 0.921 . . . . 0.0 109.053 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.85 165.09 27.73 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.8 1.667 . . . . 0.0 109.643 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -69.11 -10.32 57.07 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 115.653 1.724 . . . . 0.0 115.653 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.05 56.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.092 1.315 . . . . 0.0 109.348 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.89 -43.5 92.71 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.141 0.9 . . . . 0.0 110.058 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -55.82 -43.04 76.57 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.242 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.33 -18.48 63.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.621 1.1 . . . . 0.0 112.643 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.26 54.64 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.448 1.023 . . . . 0.0 113.078 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -134.5 -38.46 0.83 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -74.16 170.16 16.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.777 1.171 . . . . 0.0 109.418 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.08 152.22 42.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.15 0.98 . . . . 0.0 109.445 156.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.94 120.08 6.79 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.11 2.54 . . . . 0.0 108.585 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.62 6.2 54.91 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.378 -1.235 . . . . 0.0 112.951 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.67 142.41 58.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.654 1.727 . . . . 0.0 108.383 159.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' HD23 ' A' ' 37' ' ' LEU . 6.4 tt0 -86.72 125.8 34.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.312 1.045 . . . . 0.0 109.466 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.624 HD23 HG12 ' A' ' 92' ' ' VAL . 12.2 mt -79.75 156.43 27.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.038 1.335 . . . . 0.0 110.809 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.39 -54.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.583 1.953 . . . . 0.0 111.693 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.61 143.87 49.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.508 1.523 . . . . 0.0 110.777 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.46 111.99 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 72.32 -38.02 0.41 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.102 2.961 . . . . 0.0 111.25 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 65' ' ' ILE . . . 164.32 -3.55 0.06 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 130.617 3.961 . . . . 0.0 109.797 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -100.11 125.87 38.41 Favored Pre-proline 0 N--CA 1.439 -1.023 0 O-C-N 120.562 -1.552 . . . . 0.0 107.058 -168.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.19 141.03 67.48 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.903 1.735 . . . . 0.0 109.662 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -90.15 -9.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.234 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.72 117.87 5.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.152 0.981 . . . . 0.0 110.12 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.04 83.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.849 0.738 . . . . 0.0 114.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG3' ' CE2' ' A' ' 74' ' ' TYR . 26.3 mmmt -87.01 -171.83 3.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.304 1.441 . . . . 0.0 107.495 167.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -130.58 -179.55 5.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.168 0.987 . . . . 0.0 109.893 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -53.82 -57.44 10.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.661 0.784 . . . . 0.0 111.057 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.75 70.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.276 0.944 . . . . 0.0 112.879 -171.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 58.2 t80 -46.78 -59.67 2.9 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.038 0.935 . . . . 0.0 109.819 167.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.97 -36.61 76.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 123.37 0.668 . . . . 0.0 109.286 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.35 -32.63 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.652 -1.28 . . . . 0.0 111.507 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.84 -33.86 66.43 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.156 -1.59 . . . . 0.0 110.904 168.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -72.59 -32.81 66.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.108 0.963 . . . . 0.0 111.357 -173.149 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 62.3 mmm -58.58 -36.81 74.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.57 1.148 . . . . 0.0 111.279 166.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -73.04 -45.74 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.11 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -51.14 -55.55 17.24 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 125.257 1.423 . . . . 0.0 110.962 170.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -58.71 -42.75 89.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.776 0.831 . . . . 0.0 111.058 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.0 -14.64 60.91 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.464 -1.397 . . . . 0.0 113.058 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -85.7 -36.67 20.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.83 1.195 . . . . 0.0 111.068 165.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -62.67 -15.85 54.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.85 21.03 79.18 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.935 1.731 . . . . 0.0 112.546 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -164.78 177.05 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.755 2.022 . . . . 0.0 106.811 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 82' ' ' ALA . 5.0 p -154.58 160.16 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -141.76 91.09 2.33 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.68 0.792 . . . . 0.0 108.907 -170.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 24' ' ' PHE . 21.3 mt -98.24 99.5 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.49 1.516 . . . . 0.0 107.815 -170.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -87.9 131.35 34.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.624 HG12 HD23 ' A' ' 59' ' ' LEU . 33.2 m -120.4 167.7 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.411 1.884 . . . . 0.0 108.211 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -152.39 151.85 31.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 121.031 -1.043 . . . . 0.0 110.292 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -145.02 134.82 23.56 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.478 0.711 . . . . 0.0 109.116 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -63.1 118.0 7.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 126.39 1.876 . . . . 0.0 111.112 170.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 35.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 127.562 2.345 . . . . 0.0 111.114 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.21 87.8 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.039 1.735 . . . . 0.0 111.418 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.1 p -138.79 155.31 48.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.115 1.366 . . . . 0.0 107.487 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 163.33 77.23 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.03 -36.19 49.91 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.771 2.981 . . . . 0.0 111.483 -173.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.27 94.9 2.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -79.85 41.61 0.51 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 161.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.237 0 N-CA-C 106.214 -2.754 . . . . 0.0 106.214 -164.367 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.76 0.314 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -116.0 139.91 49.79 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.9 152.31 24.61 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 164.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.38 127.84 34.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.18 149.53 27.87 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -139.24 107.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -76.07 143.43 41.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.12 131.24 32.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -82.19 153.63 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -108.25 87.35 2.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtm -143.88 -3.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.66 -64.14 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -126.29 -14.28 5.95 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.47 60.7 3.93 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 119.728 1.149 . . . . 0.0 112.382 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 85.5 93.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.608 2.363 . . . . 0.0 110.568 160.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.72 53.76 4.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.677 0.656 . . . . 0.0 112.325 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE1' HD11 ' A' ' 90' ' ' LEU . 31.2 p90 -130.44 173.51 10.77 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.373 1.086 . . . . 0.0 109.039 169.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -140.37 165.61 26.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.5 128.66 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -164.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -139.62 -177.13 4.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.526 1.93 . . . . 0.0 108.053 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.43 -146.67 36.2 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.57 31.97 52.94 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.186 0.993 . . . . 0.0 112.652 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.96 -30.92 56.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.083 -0.657 . . . . 0.0 112.145 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -114.85 158.9 39.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.73 91.09 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.245 2.63 . . . . 0.0 109.638 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.3 1.84 10.11 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.14 1.353 . . . . 0.0 114.17 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.5 159.88 56.34 Favored Pre-proline 0 C--O 1.239 0.54 0 CA-C-N 119.428 1.614 . . . . 0.0 109.237 163.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.82 145.35 56.51 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.654 2.236 . . . . 0.0 111.224 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.53 92.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -100.69 140.73 34.56 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.653 3.581 . . . . 0.0 109.543 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.81 109.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.653 1.581 . . . . 0.0 107.672 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.76 -46.55 31.16 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 127.661 2.553 . . . . 0.0 112.569 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 163.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.545 1.538 . . . . 0.0 107.424 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.59 131.9 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 161.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.11 107.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.34 132.01 47.03 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.753 0.658 . . . . 0.0 109.853 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.1 mtm 68.49 -5.94 0.88 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.537 1.935 . . . . 0.0 114.19 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.64 176.81 53.5 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.192 0.884 . . . . 0.0 111.811 -171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 32.1 t -60.48 -8.84 3.01 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.217 1.807 . . . . 0.0 115.018 -167.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.78 -46.62 6.19 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 120.137 1.335 . . . . 0.0 111.609 168.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -56.4 -40.1 74.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.477 1.511 . . . . 0.0 110.306 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 13.3 ptm180 -69.89 -22.0 63.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -22.57 55.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.174 0.897 . . . . 0.0 110.129 170.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.8 60.3 8.94 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 125.643 1.592 . . . . 0.0 110.79 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -146.68 2.29 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -135.56 151.0 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -129.22 149.87 73.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 125.097 1.359 . . . . 0.0 109.053 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.81 130.58 34.74 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.556 2.838 . . . . 0.0 111.317 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.62 88.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.066 -1.408 . . . . 0.0 113.671 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 127.81 33.64 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.172 1.486 . . . . 0.0 107.761 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 119.28 18.06 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.6 mt -63.83 164.4 10.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.878 1.671 . . . . 0.0 111.001 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.2 -52.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.203 1.401 . . . . 0.0 109.673 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.34 148.19 52.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.005 0.922 . . . . 0.0 108.553 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -137.0 113.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.58 5.23 0.44 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.876 2.47 . . . . 0.0 114.198 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.46 -5.94 6.67 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.947 2.689 . . . . 0.0 113.094 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.0 124.6 34.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 119.483 1.642 . . . . 0.0 107.747 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.65 114.71 4.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.42 3.413 . . . . 0.0 109.179 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.72 -7.46 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.75 1.22 . . . . 0.0 112.789 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.24 129.85 40.47 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.579 -0.701 . . . . 0.0 110.313 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.01 84.06 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.991 -0.443 . . . . 0.0 113.374 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -101.22 -166.95 1.36 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.604 1.561 . . . . 0.0 108.195 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -121.56 177.75 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.075 0.95 . . . . 0.0 110.892 -170.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -52.19 -56.27 15.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.616 0.766 . . . . 0.0 109.759 169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -55.69 -33.41 64.12 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.79 -50.93 62.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.816 0.846 . . . . 0.0 110.357 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.55 -38.19 78.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 124.947 1.299 . . . . 0.0 111.16 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.0 mm -56.53 -39.46 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.868 0.758 . . . . 0.0 109.224 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -37.77 85.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.944 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.37 -49.69 74.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.234 0.613 . . . . 0.0 111.047 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.46 -36.77 74.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 111.133 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.31 -14.51 56.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.263 1.025 . . . . 0.0 113.105 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.27 -49.29 5.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.15 1.38 . . . . 0.0 110.825 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.76 -41.33 73.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.126 0.97 . . . . 0.0 110.63 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.0 -22.02 65.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.311 -1.493 . . . . 0.0 113.152 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.62 -43.52 20.37 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.535 1.134 . . . . 0.0 109.517 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -54.91 -23.64 19.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.329 0.652 . . . . 0.0 110.975 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.73 13.76 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.475 1.036 . . . . 0.0 111.956 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.15 174.68 12.6 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.231 2.212 . . . . 0.0 106.751 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.47 164.68 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -129.21 133.01 47.36 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 166.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.444 HD11 ' CE1' ' A' ' 24' ' ' PHE . 18.1 mt -130.61 97.48 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.119 2.168 . . . . 0.0 105.386 -169.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.1 m -85.49 117.07 24.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.19 170.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 108.743 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -152.9 145.89 24.55 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 119.594 -1.942 . . . . 0.0 112.326 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.57 130.57 17.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.754 0.706 . . . . 0.0 110.252 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.363 0 C-N-CA 125.072 1.349 . . . . 0.0 109.721 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.3 p90 . . . . . 0 C--O 1.241 0.61 0 CA-C-O 121.138 0.494 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -91.65 136.09 33.4 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.52 155.83 23.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.736 1.273 . . . . 0.0 108.122 151.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.32 116.93 10.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.158 2.183 . . . . 0.0 106.62 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.48 134.44 34.64 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.516 1.127 . . . . 0.0 109.767 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.412 HG22 ' HE ' ' A' ' 52' ' ' ARG . 79.6 t -129.04 143.36 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 127.014 2.125 . . . . 0.0 107.979 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -129.13 103.17 6.82 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.464 -0.773 . . . . 0.0 110.548 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -103.48 131.8 50.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.857 0.837 . . . . 0.0 109.772 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -86.86 160.73 18.64 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.418 0.687 . . . . 0.0 110.639 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -121.83 86.79 2.64 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.991 0.917 . . . . 0.0 110.488 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 mtp -130.41 -9.94 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.697 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.69 -100.32 0.19 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -29.73 70.7 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.12 1.327 . . . . 0.0 110.709 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.73 73.73 0.84 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 69.58 -115.8 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.308 1.843 . . . . 0.0 109.167 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.32 40.55 0.25 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 120.846 1.657 . . . . 0.0 112.742 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -123.22 175.52 6.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.045 1.338 . . . . 0.0 108.508 168.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.59 167.11 21.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.54 121.69 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.837 1.199 . . . . 0.0 109.07 -162.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.7 mt -138.26 147.09 43.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.32 -163.3 12.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.6 28.15 64.78 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 118.29 1.045 . . . . 0.0 112.458 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.22 -37.88 86.62 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.427 -1.043 . . . . 0.0 110.233 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.53 160.99 30.94 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.417 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.77 46.91 2.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.705 3.603 . . . . 0.0 112.588 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.13 48.29 0.12 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 109.858 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -123.26 164.05 30.17 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.596 1.159 . . . . 0.0 110.759 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.6 143.89 27.73 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.477 2.785 . . . . 0.0 108.463 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.58 100.38 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.9 mt -87.95 151.01 23.12 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mm -57.56 112.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 162.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.12 -56.39 24.39 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 126.814 2.149 . . . . 0.0 111.763 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.58 167.86 28.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.571 1.949 . . . . 0.0 106.943 172.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.38 130.71 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 mm -79.93 115.39 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.46 -21.2 3.45 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.491 1.917 . . . . 0.0 115.085 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.7 mmt -122.28 7.06 9.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.73 1.612 . . . . 0.0 110.989 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.91 167.63 34.91 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 120.701 -1.249 . . . . 0.0 110.53 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.417 ' HA ' ' CG ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -61.94 -12.86 20.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.292 1.037 . . . . 0.0 112.613 175.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.79 -69.12 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.997 0.817 . . . . 0.0 110.128 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.15 -43.75 78.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.643 0.656 . . . . 0.0 111.931 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.417 ' CG ' ' HA ' ' A' ' 46' ' ' SER . 0.1 OUTLIER -65.97 -10.04 35.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.687 -1.149 . . . . 0.0 113.764 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.37 -46.51 15.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.807 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 37.28 4.37 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.849 1.214 . . . . 0.0 114.189 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 13' ' ' VAL . 50.6 mtp85 -127.3 -62.69 1.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.001 1.401 . . . . 0.0 112.635 -171.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.17 143.52 55.36 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.046 0.938 . . . . 0.0 110.424 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -126.11 153.11 74.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 123.803 0.841 . . . . 0.0 109.756 166.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.75 141.81 64.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.95 1.767 . . . . 0.0 109.344 164.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 -8.55 63.81 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-O 117.45 -1.75 . . . . 0.0 114.495 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.04 126.5 27.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.953 1.876 . . . . 0.0 107.166 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HG3' HD23 ' A' ' 37' ' ' LEU . 26.0 tt0 -79.69 121.13 24.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.13 153.02 36.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.639 1.176 . . . . 0.0 110.002 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 t -130.99 -50.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.463 1.505 . . . . 0.0 109.088 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.32 143.71 50.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.24 122.06 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t0 54.84 21.82 3.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.714 1.205 . . . . 0.0 112.207 -167.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.95 -5.97 82.45 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 117.713 -1.604 . . . . 0.0 113.921 -174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -92.11 128.88 43.59 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 120.928 2.364 . . . . 0.0 106.592 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.71 119.05 6.07 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.994 2.463 . . . . 0.0 109.509 -173.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.34 -4.99 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.272 1.429 . . . . 0.0 110.619 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.06 115.96 4.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.561 1.144 . . . . 0.0 109.554 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.05 -1.92 21.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.908 0.766 . . . . 0.0 113.987 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -80.94 164.96 22.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.616 2.208 . . . . 0.0 108.876 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.4 p -81.16 171.25 15.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.46 0.704 . . . . 0.0 110.577 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -53.23 -49.98 65.69 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.28 -1.513 . . . . 0.0 109.389 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.85 -28.23 69.34 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -48.98 -57.02 7.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.721 1.208 . . . . 0.0 109.779 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.8 -39.19 84.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.884 1.274 . . . . 0.0 110.435 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.42 -27.74 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.237 -0.914 . . . . 0.0 110.511 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -41.04 68.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.557 1.143 . . . . 0.0 111.219 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -52.03 67.44 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.836 0.854 . . . . 0.0 109.823 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 71.4 mmm -54.83 -39.13 68.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.036 0.835 . . . . 0.0 111.391 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -43.5 98.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.28 0.632 . . . . 0.0 110.801 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -49.0 64.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.847 1.259 . . . . 0.0 111.769 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.03 71.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.262 1.825 . . . . 0.0 110.275 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.99 76.9 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.378 -0.826 . . . . 0.0 111.913 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.46 -39.56 74.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.649 1.113 . . . . 0.0 110.917 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.02 -20.6 66.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.712 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.97 70.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.674 1.131 . . . . 0.0 112.522 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -163.72 162.15 23.84 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.441 1.496 . . . . 0.0 108.273 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.58 128.38 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -80.49 141.77 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 161.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.8 mt -135.4 105.13 6.11 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -100.52 116.32 32.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.2 m -105.16 167.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 107.946 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -149.38 153.59 37.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.698 -1.251 . . . . 0.0 111.582 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -144.32 132.29 21.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.268 1.027 . . . . 0.0 109.306 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.398 0 C-N-CA 124.699 1.2 . . . . 0.0 110.846 167.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 51.1 p90 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 130.38 40.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.51 130.13 34.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 163.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.99 155.35 34.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.648 1.579 . . . . 0.0 108.217 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -133.43 132.02 40.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.941 0.896 . . . . 0.0 111.883 -171.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 t -124.45 108.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.96 1.304 . . . . 0.0 108.561 -174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -80.65 129.2 34.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.5 mt -123.38 123.39 40.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 157.82 36.95 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.174 0.589 . . . . 0.0 110.053 173.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -114.2 83.18 1.83 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.9 mtm -138.62 -9.6 1.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.598 0.635 . . . . 0.0 112.205 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -131.21 -102.5 0.28 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -74.58 -22.03 59.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.66 1.573 . . . . 0.0 114.347 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.03 77.42 0.5 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.879 1.218 . . . . 0.0 112.929 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 58.94 76.67 0.34 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 128.347 2.659 . . . . 0.0 112.214 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.52 70.54 2.64 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.755 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CE1' HD11 ' A' ' 90' ' ' LEU . 34.8 p90 -142.37 147.72 36.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.867 1.334 . . . . 0.0 108.532 167.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -93.51 163.21 13.66 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.921 1.288 . . . . 0.0 108.227 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.87 139.4 49.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.105 1.362 . . . . 0.0 107.578 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.11 -177.5 5.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 108.273 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.38 -161.02 50.87 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.347 -0.846 . . . . 0.0 111.159 -170.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.71 75.24 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.749 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.98 -12.49 60.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.661 1.73 . . . . 0.0 113.366 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 15.6 mt-10 -141.6 160.12 57.74 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.822 1.649 . . . . 0.0 108.817 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 31' ' ' GLU . 73.6 Cg_endo -72.12 105.92 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.129 2.552 . . . . 0.0 109.252 -168.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.07 30.86 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.661 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -66.67 162.25 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.44 1.62 . . . . 0.0 109.323 155.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.82 140.82 68.89 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.864 2.376 . . . . 0.0 109.013 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -116.04 83.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.06 142.27 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.906 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mm -61.2 126.94 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.41 -41.12 91.27 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.163 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 167.01 124.42 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.658 2.383 . . . . 0.0 107.768 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.47 150.03 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.536 1.134 . . . . 0.0 110.705 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -83.32 106.99 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.64 69.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -120.06 40.59 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.2 -178.03 31.85 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 125.817 1.675 . . . . 0.0 109.92 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -59.53 -28.36 67.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -57.04 4.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.126 1.33 . . . . 0.0 109.871 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.34 -38.25 88.75 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.928 0.87 . . . . 0.0 110.102 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.01 -8.87 52.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.346 1.058 . . . . 0.0 113.356 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.61 -17.38 36.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.393 1.452 . . . . 0.0 110.646 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.58 83.5 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.282 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -117.47 -54.52 2.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -166.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 161.28 30.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -140.65 146.02 42.84 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 121.498 -0.752 . . . . 0.0 110.166 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.24 132.3 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.788 2.325 . . . . 0.0 111.259 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.13 -2.32 78.77 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.732 1.158 . . . . 0.0 113.715 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.1 141.68 58.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.351 1.076 . . . . 0.0 108.777 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.94 121.01 28.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.24 155.02 37.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.956 0.903 . . . . 0.0 110.439 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -126.79 -55.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 109.443 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -128.66 147.98 50.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.155 0.982 . . . . 0.0 109.786 -174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.5 t -138.6 118.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 59.11 9.01 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.849 2.06 . . . . 0.0 114.111 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.14 -15.15 6.51 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.429 1.966 . . . . 0.0 112.898 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.89 129.87 23.41 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.386 1.593 . . . . 0.0 108.229 -169.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.4 112.65 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.381 2.721 . . . . 0.0 109.249 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 75' ' ' VAL . 19.5 m -74.18 -7.04 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.098 0.959 . . . . 0.0 111.051 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.3 114.5 3.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.075 1.35 . . . . 0.0 108.599 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.32 -5.42 60.84 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.919 0.771 . . . . 0.0 113.795 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 74' ' ' TYR . 49.3 mmtt -101.47 -172.71 2.21 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.052 1.341 . . . . 0.0 109.623 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 174.27 5.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.943 1.297 . . . . 0.0 110.389 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -49.42 -56.08 10.9 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.875 1.67 . . . . 0.0 110.331 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -52.92 -36.39 59.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 112.795 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 45.2 t80 -54.2 -48.69 70.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.501 0.72 . . . . 0.0 110.281 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 67' ' ' VAL . 5.5 t -70.29 -34.77 59.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 125.006 1.322 . . . . 0.0 110.211 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 mm -62.41 -37.9 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.211 0.914 . . . . 0.0 109.989 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.95 89.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.022 0.374 . . . . 0.0 110.551 173.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -64.23 -50.74 66.81 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.429 176.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.6 mmm -56.98 -36.23 70.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.949 0.795 . . . . 0.0 111.161 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.79 -43.5 90.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.219 0.607 . . . . 0.0 111.335 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -45.99 72.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.656 0.783 . . . . 0.0 111.407 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.87 78.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.42 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -32.89 63.97 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.838 -1.164 . . . . 0.0 111.895 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -78.95 -29.55 44.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.351 1.06 . . . . 0.0 112.202 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -66.79 -22.27 66.03 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.01 -0.431 . . . . 0.0 110.928 168.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.88 6.51 89.07 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.039 -1.038 . . . . 0.0 112.484 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.04 173.12 14.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.269 2.227 . . . . 0.0 107.113 168.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.14 157.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 160.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.56 131.66 53.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 24' ' ' PHE . 26.4 mt -126.68 98.17 5.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -170.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 53.5 m -87.72 117.42 26.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.1 m -100.92 173.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 125.599 1.56 . . . . 0.0 108.492 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 17.8 ptt85 -150.13 158.83 44.57 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.669 -1.269 . . . . 0.0 108.581 167.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.83 31.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mttp . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.652 0.739 . . . . 0.0 110.928 164.44 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -88.38 123.64 33.15 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 110.95 18.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 160.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mp -101.12 148.3 25.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.26 159.63 15.23 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.312 -0.868 . . . . 0.0 110.242 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.44 137.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -126.16 124.87 41.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.296 0.953 . . . . 0.0 108.553 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.49 136.36 51.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.719 0.808 . . . . 0.0 110.153 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -89.73 154.93 19.55 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.111 0.964 . . . . 0.0 110.069 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -115.32 83.54 1.94 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtt -137.41 -34.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.576 -0.725 . . . . 0.0 110.987 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.23 -81.78 0.25 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -122.37 -3.1 8.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.2 78.08 1.13 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.96 0.8 . . . . 0.0 111.699 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 65.82 -133.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 52.69 0.01 OUTLIER Glycine 0 C--O 1.225 -0.453 0 CA-C-N 119.8 1.182 . . . . 0.0 110.454 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 90' ' ' LEU . 47.9 p90 -137.77 172.66 12.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.91 0.855 . . . . 0.0 108.832 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -130.66 163.52 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.862 1.665 . . . . 0.0 106.653 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.5 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -141.24 122.64 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -169.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 41.7 mt -139.96 179.08 6.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.605 1.562 . . . . 0.0 107.478 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.33 -166.29 48.45 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.06 30.92 71.3 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.559 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.78 -32.48 74.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.698 1.749 . . . . 0.0 110.233 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.12 153.76 48.49 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 123.33 0.652 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.16 90.45 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.519 3.479 . . . . 0.0 107.792 -175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.73 -3.79 5.02 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 117.96 -1.467 . . . . 0.0 113.167 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.44 159.23 85.26 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.73 1.765 . . . . 0.0 109.909 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.16 144.32 68.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.483 2.122 . . . . 0.0 109.804 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -114.68 92.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.9 160.15 15.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.448 1.899 . . . . 0.0 110.993 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm -65.82 119.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 167.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -57.05 -45.06 92.79 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.078 2.275 . . . . 0.0 112.542 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.51 170.17 4.95 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.962 2.105 . . . . 0.0 107.402 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.39 138.41 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 168.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -85.41 117.39 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.34 80.62 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.064 0.852 . . . . 0.0 112.277 -168.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.8 mmt -94.8 37.99 1.13 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.86 166.77 14.87 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 125.907 1.717 . . . . 0.0 109.974 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 21.2 t -75.96 -14.12 60.24 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.935 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.43 -50.63 15.22 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.988 1.267 . . . . 0.0 111.193 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -53.47 -59.95 3.93 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.197 1.399 . . . . 0.0 108.84 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 21.9 ptt180 -60.51 -15.15 24.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.139 0.976 . . . . 0.0 113.426 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -20.77 62.17 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.404 -0.81 . . . . 0.0 111.102 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.61 32.13 25.42 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.814 1.197 . . . . 0.0 112.333 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt-85 -139.55 -65.25 0.48 Allowed 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.81 141.2 48.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.694 0.679 . . . . 0.0 110.009 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -135.5 155.12 78.67 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.48 1.112 . . . . 0.0 109.619 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.82 140.1 90.6 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.471 2.114 . . . . 0.0 110.745 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.88 86.19 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 117.939 -1.478 . . . . 0.0 114.727 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.56 129.11 39.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.988 1.894 . . . . 0.0 107.738 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.94 133.01 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.74 148.27 24.81 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.106 1.362 . . . . 0.0 107.743 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.08 -53.73 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.48 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -129.65 147.83 51.48 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.858 0.863 . . . . 0.0 109.097 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.9 t -139.77 124.79 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 64.13 4.06 1.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.527 1.531 . . . . 0.0 113.878 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.33 -14.01 12.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.009 1.766 . . . . 0.0 112.592 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -106.47 133.72 20.12 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 119.267 1.534 . . . . 0.0 108.878 -167.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.46 108.85 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.766 2.977 . . . . 0.0 109.689 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.03 -6.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.634 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.29 108.67 3.29 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.629 -1.294 . . . . 0.0 110.111 -166.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.43 14.1 69.19 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.904 0.764 . . . . 0.0 113.294 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 37.1 mmtt -82.07 -161.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.285 1.434 . . . . 0.0 108.234 162.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -113.06 172.16 7.11 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.336 1.055 . . . . 0.0 110.676 171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -45.51 -55.28 6.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.747 2.019 . . . . 0.0 111.399 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.49 -35.34 67.88 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.533 -0.729 . . . . 0.0 112.338 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.628 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 32.2 t80 -49.52 -51.6 35.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.345 0.593 . . . . 0.0 109.611 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.73 -39.11 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.503 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm -58.65 -37.24 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.025 1.284 . . . . 0.0 110.522 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.68 -44.36 93.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.254 1.421 . . . . 0.0 110.196 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.81 -51.6 66.43 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.382 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.7 mmm -52.97 -39.7 63.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.103 0.865 . . . . 0.0 111.422 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.4 -34.95 74.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.948 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.97 -36.99 24.67 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.575 1.08 . . . . 0.0 112.922 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.674 1.125 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.74 71.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.395 -1.441 . . . . 0.0 112.97 171.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -78.53 -36.16 45.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 110.682 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -62.16 -15.32 45.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.954 1.302 . . . . 0.0 111.239 162.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 3.13 77.11 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.077 1.322 . . . . 0.0 112.453 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -160.85 151.76 18.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.136 1.468 . . . . 0.0 107.178 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.35 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -84.48 133.12 34.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 24' ' ' PHE . 16.7 mt -131.18 103.53 6.54 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.5 m -85.5 124.44 32.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.23 171.39 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 126.04 1.736 . . . . 0.0 107.965 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -153.04 166.76 31.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 121.22 -0.925 . . . . 0.0 110.239 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 141.76 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.434 160.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 C-N-CA 123.737 0.815 . . . . 0.0 111.129 169.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 p90 . . . . . 0 N--CA 1.463 0.196 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -122.19 131.79 54.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.35 139.89 32.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 163.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.76 116.79 20.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 10.7 p30 -80.89 153.18 27.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.214 0.916 . . . . 0.0 110.011 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.57 108.36 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -96.87 106.8 19.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.64 130.03 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.707 0.765 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -93.44 150.1 20.71 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.999 0.92 . . . . 0.0 109.527 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 30.1 ttt85 -122.83 85.84 2.49 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.847 -1.158 . . . . 0.0 109.245 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.0 mtp -141.82 -3.17 1.14 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -135.31 -88.24 0.35 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -77.03 -31.22 56.17 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.74 -158.29 44.74 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.456 1.025 . . . . 0.0 111.124 -167.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.2 m-85 -102.56 97.24 7.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.297 0.549 . . . . 0.0 112.071 -163.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.62 60.99 4.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.905 1.241 . . . . 0.0 112.898 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.0 p90 -141.58 158.45 43.82 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.526 1.163 . . . . 0.0 109.398 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -112.17 167.73 10.18 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.66 1.584 . . . . 0.0 108.169 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.4 130.29 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -143.25 -178.36 5.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.152 2.181 . . . . 0.0 108.678 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.91 -170.34 29.1 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.607 -1.308 . . . . 0.0 110.345 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.63 91.18 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 121.747 -0.854 . . . . 0.0 111.346 -172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -67.3 -35.11 78.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.959 0.88 . . . . 0.0 111.07 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -120.45 160.29 44.51 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 125.059 1.344 . . . . 0.0 108.39 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.48 57.89 5.3 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.511 3.474 . . . . 0.0 110.393 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.08 42.75 0.06 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.313 1.435 . . . . 0.0 110.476 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -124.88 168.12 14.21 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.46 1.904 . . . . 0.0 110.632 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -72.36 138.34 29.91 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.784 2.322 . . . . 0.0 108.979 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.1 mt -107.13 99.6 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 170.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 58' ' ' GLU . 10.8 mt -95.29 136.55 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.955 2.502 . . . . 0.0 109.505 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm -49.47 127.46 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.23 -27.38 73.78 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.79 -1.005 . . . . 0.0 113.823 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 159.58 133.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.468 3.507 . . . . 0.0 106.339 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.41 148.69 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 119.907 1.231 . . . . 0.0 108.437 166.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mm -81.86 118.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -49.58 76.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 122.603 1.192 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 mmt -85.9 54.52 3.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.79 158.08 29.32 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.205 0.892 . . . . 0.0 111.848 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 m -63.07 -6.86 4.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.56 -48.19 14.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 120.961 1.71 . . . . 0.0 110.005 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.5 -53.15 61.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.71 1.204 . . . . 0.0 109.25 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -63.45 -18.64 63.96 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.364 1.066 . . . . 0.0 112.913 -171.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -17.35 62.69 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 110.817 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 18.4 73.7 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.468 1.032 . . . . 0.0 111.988 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -129.47 -70.69 0.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 112.493 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.27 146.29 50.72 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.09 143.2 46.21 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 124.041 0.936 . . . . 0.0 110.592 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.25 136.02 36.03 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 161.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.33 67.13 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 117.609 -1.662 . . . . 0.0 111.956 -168.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -76.54 134.13 39.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.425 2.112 . . . . 0.0 108.299 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.428 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.1 tt0 -87.19 128.48 35.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.944 2.098 . . . . 0.0 107.777 166.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -78.03 162.99 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.222 1.809 . . . . 0.0 111.478 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.62 -55.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.604 1.962 . . . . 0.0 108.704 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.1 149.12 51.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.446 1.098 . . . . 0.0 109.25 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -137.64 122.9 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t0 57.23 17.5 3.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.325 1.85 . . . . 0.0 113.541 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.04 -11.07 48.51 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.17 1.843 . . . . 0.0 113.312 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -101.67 130.26 24.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 119.407 1.604 . . . . 0.0 107.671 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.0 125.82 10.71 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.299 2.666 . . . . 0.0 108.245 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.73 -4.84 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.733 0.813 . . . . 0.0 111.81 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 124.94 22.32 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.66 -0.65 . . . . 0.0 110.318 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 1.11 79.67 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.189 0.899 . . . . 0.0 113.958 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -88.28 171.5 10.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 119.616 1.708 . . . . 0.0 108.738 172.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.6 p -90.62 168.55 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.531 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -44.64 -47.89 10.5 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.103 1.761 . . . . 0.0 111.53 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -52.92 -36.81 60.12 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.596 1.158 . . . . 0.0 113.408 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.97 -49.92 65.15 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.406 0.683 . . . . 0.0 109.295 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.01 -38.03 79.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 C-N-CA 125.092 1.357 . . . . 0.0 110.772 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.59 -40.84 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.483 1.038 . . . . 0.0 109.819 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.06 91.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.205 0.602 . . . . 0.0 110.867 172.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -53.93 45.26 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.626 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.2 mmm -55.03 -37.0 66.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.049 0.841 . . . . 0.0 111.428 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -61.97 -38.71 89.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 117.565 -1.207 . . . . 0.0 111.918 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -70.41 -48.24 57.03 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.697 1.135 . . . . 0.0 111.289 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -42.09 80.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.975 1.31 . . . . 0.0 111.362 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.78 67.19 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.117 -0.99 . . . . 0.0 113.031 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -84.36 -36.15 22.7 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.612 1.096 . . . . 0.0 110.94 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -53.09 -34.04 54.83 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.71 61.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.737 1.161 . . . . 0.0 112.219 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -160.43 173.07 16.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.344 2.258 . . . . 0.0 107.251 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -148.21 127.89 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -80.94 127.04 32.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 161.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.4 mt -116.48 97.19 5.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 86.1 m -83.89 115.08 22.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.17 171.15 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.844 1.658 . . . . 0.0 108.275 174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -152.87 151.0 29.89 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 119.46 -2.025 . . . . 0.0 112.402 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -140.69 129.61 23.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.677 0.791 . . . . 0.0 109.447 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.239 0.526 0 C-N-CA 126.704 2.002 . . . . 0.0 111.243 169.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 p90 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.475 0.178 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -124.91 137.13 54.29 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.699 1.2 . . . . 0.0 108.931 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -93.71 154.47 17.78 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.736 1.214 . . . . 0.0 107.861 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mp -139.6 131.77 28.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.951 2.1 . . . . 0.0 106.701 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.56 133.05 33.85 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.334 1.054 . . . . 0.0 109.816 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -129.95 106.59 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.84 118.26 36.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.6 148.31 32.45 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.135 0.974 . . . . 0.0 109.5 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -86.82 164.41 16.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 164.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -117.57 95.48 4.97 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 164.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 ttt -143.77 -13.01 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.111 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.63 -108.41 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -65.24 -31.14 72.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.064 1.302 . . . . 0.0 113.016 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 93.66 0.58 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.624 1.107 . . . . 0.0 112.539 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 43.49 71.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 113.54 169.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.45 54.12 4.3 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.785 -1.197 . . . . 0.0 114.98 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -121.32 175.92 5.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.845 1.322 . . . . 0.0 109.409 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.12 165.21 26.6 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 167.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.6 130.62 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -171.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.17 146.39 27.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.422 1.089 . . . . 0.0 108.088 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.51 177.87 19.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.859 -2.096 . . . . 0.0 107.859 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.58 37.05 84.63 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 121.514 -0.992 . . . . 0.0 111.705 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.75 -36.42 67.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.596 1.198 . . . . 0.0 110.481 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -137.73 160.48 64.74 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.984 2.114 . . . . 0.0 107.766 -170.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.97 72.36 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.406 3.404 . . . . 0.0 110.537 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.14 -9.96 0.06 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 127.549 2.5 . . . . 0.0 111.826 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -72.98 158.21 87.5 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.834 1.317 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.45 137.73 31.23 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.77 2.314 . . . . 0.0 109.125 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -110.11 93.55 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.59 155.94 18.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.068 0.937 . . . . 0.0 110.36 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.83 107.54 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.11 -41.11 71.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.79 175.7 12.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.394 1.878 . . . . 0.0 107.575 168.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.43 148.99 29.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 mm -89.12 112.86 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.13 7.63 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.777 1.231 . . . . 0.0 113.548 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.7 mtm -90.04 -0.79 57.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 153.01 45.83 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -62.49 -6.93 3.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.69 29.16 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.539 1.518 . . . . 0.0 112.188 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.09 -52.26 50.4 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.947 0.794 . . . . 0.0 109.813 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -13.3 15.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 168.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.66 -17.73 62.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.246 1.385 . . . . 0.0 110.987 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.34 32.81 41.62 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.336 166.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -133.6 -66.34 0.65 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.343 1.572 . . . . 0.0 111.414 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.69 144.68 54.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.556 1.142 . . . . 0.0 111.489 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -130.94 151.7 79.38 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.749 1.219 . . . . 0.0 109.312 164.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -51.89 142.66 42.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.324 2.016 . . . . 0.0 110.694 163.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.18 64.24 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.954 -0.915 . . . . 0.0 113.798 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.61 134.23 53.9 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.697 1.749 . . . . 0.0 106.423 165.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.91 123.16 33.0 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.01 140.91 47.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.599 1.16 . . . . 0.0 109.022 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.8 -52.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 124.653 1.181 . . . . 0.0 108.825 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -130.03 146.74 51.72 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.17 124.41 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.17 14.44 6.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.056 1.742 . . . . 0.0 112.224 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.28 68.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.901 1.715 . . . . 0.0 112.517 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.63 126.12 35.17 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.717 1.607 . . . . 0.0 108.102 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.91 118.26 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.208 2.605 . . . . 0.0 109.209 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.74 -9.11 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.81 6.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.871 1.269 . . . . 0.0 109.71 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.46 3.77 61.14 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.553 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 21.4 mmtt -107.18 178.64 4.49 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.591 1.957 . . . . 0.0 108.728 174.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -95.22 -179.93 4.97 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.207 -0.308 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -49.91 -54.83 17.2 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.498 1.119 . . . . 0.0 110.924 169.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -26.83 68.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.73 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.466 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 64.9 t80 -46.54 -54.07 10.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.719 0.771 . . . . 0.0 110.608 169.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.04 -36.53 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.473 1.509 . . . . 0.0 110.082 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.6 mm -57.53 -41.02 78.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 119.126 0.876 . . . . 0.0 110.149 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.522 0.729 . . . . 0.0 111.359 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.96 -51.66 13.15 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.058 0.943 . . . . 0.0 110.828 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.6 mmm -55.09 -38.1 67.67 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.406 1.083 . . . . 0.0 110.867 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -60.79 2.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.809 1.644 . . . . 0.0 110.17 173.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -54.82 -51.08 66.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.512 1.125 . . . . 0.0 111.259 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.92 78.48 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.028 0.931 . . . . 0.0 111.534 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.4 66.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.773 -1.204 . . . . 0.0 112.194 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtt-85 -69.97 -49.91 47.04 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.207 1.367 . . . . 0.0 109.636 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -54.53 -38.21 66.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.769 0.827 . . . . 0.0 110.313 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.62 42.34 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.064 0.84 . . . . 0.0 111.858 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -151.36 166.76 30.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.802 1.301 . . . . 0.0 108.368 167.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.01 165.3 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -126.83 144.53 50.94 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 164.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.3 mt -138.11 97.39 3.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 103.061 -2.941 . . . . 0.0 103.061 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -86.4 112.98 21.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.35 165.92 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.478 0.711 . . . . 0.0 109.52 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -153.08 162.61 41.12 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.605 -1.309 . . . . 0.0 111.962 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -150.32 147.35 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.697 1.199 . . . . 0.0 109.991 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt . . . . . 0 C--O 1.234 0.281 0 C-N-CA 124.687 1.195 . . . . 0.0 111.358 164.298 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.3 p90 . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.13 138.31 54.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 169.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.15 145.8 28.2 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 158.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.39 121.76 33.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.015 2.126 . . . . 0.0 106.721 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 135.2 35.65 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.898 1.279 . . . . 0.0 109.348 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.91 107.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.56 0.695 . . . . 0.0 109.446 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.02 120.77 40.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 108.776 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -123.22 124.06 42.17 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.047 1.339 . . . . 0.0 108.94 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -74.44 153.18 39.3 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.784 169.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -102.94 114.55 28.93 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -69.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -73.79 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.614 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -126.11 1.92 7.2 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -148.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.21 57.48 8.41 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 123.946 0.784 . . . . 0.0 112.368 167.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.74 80.79 0.05 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.6 2.36 . . . . 0.0 113.006 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.0 75.64 1.1 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.281 0.943 . . . . 0.0 112.798 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -127.95 175.55 8.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.141 2.176 . . . . 0.0 106.187 159.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -123.02 162.46 22.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 157.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.27 127.28 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 94.6 mt -134.4 -177.29 4.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 107.329 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.34 -156.26 48.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -170.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.63 -105.31 0.71 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -164.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.92 -52.81 0.25 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 129.308 3.043 . . . . 0.0 110.29 -167.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -100.39 160.87 25.8 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 110.861 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 96.11 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.408 3.406 . . . . 0.0 111.563 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.33 19.24 30.86 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 118.372 -1.238 . . . . 0.0 113.067 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -66.11 162.06 50.34 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.708 1.254 . . . . 0.0 109.387 164.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.4 132.66 21.12 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.673 2.249 . . . . 0.0 109.226 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.84 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -87.17 144.42 26.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 110.495 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.91 108.35 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -51.2 -44.31 51.62 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 127.487 2.47 . . . . 0.0 112.248 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.76 160.97 29.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.589 0.756 . . . . 0.0 109.618 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.18 115.68 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 161.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -66.89 121.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -21.64 60.56 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -127.95 33.12 4.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.636 1.574 . . . . 0.0 108.353 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 176.65 17.64 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.831 1.205 . . . . 0.0 111.735 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -61.67 -25.71 67.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.534 0.733 . . . . 0.0 112.756 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -53.96 14.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.849 0.749 . . . . 0.0 109.501 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.86 -46.54 78.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.472 1.109 . . . . 0.0 111.735 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -28.39 65.53 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -72.49 -39.7 67.48 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.756 0.822 . . . . 0.0 110.21 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.2 35.9 19.46 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.992 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 52' ' ' ARG . 14.9 mtp85 -124.2 -67.51 0.92 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.01 0.905 . . . . 0.0 110.725 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.47 137.48 48.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -124.85 149.41 62.71 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 110.253 174.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 54' ' ' HIS . 24.4 Cg_exo -57.6 132.1 48.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.338 2.025 . . . . 0.0 110.38 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 7.38 87.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 117.897 -1.502 . . . . 0.0 113.617 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.08 142.94 58.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.141 1.97 . . . . 0.0 108.271 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.16 125.84 35.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.123 -0.985 . . . . 0.0 108.673 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.19 154.37 26.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 109.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.6 -51.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 108.798 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.82 148.8 52.58 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.121 0.968 . . . . 0.0 109.705 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.92 105.54 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t70 54.63 22.95 4.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.295 1.838 . . . . 0.0 113.189 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.02 -13.63 57.41 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.973 2.225 . . . . 0.0 113.027 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.43 125.56 63.13 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.114 1.457 . . . . 0.0 107.798 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -73.5 131.0 15.6 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.635 2.89 . . . . 0.0 109.425 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.43 -8.6 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 123.957 0.903 . . . . 0.0 111.633 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.94 57.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.755 -0.59 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.93 7.57 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.372 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 25.3 mmtt -95.88 -177.14 3.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.405 1.602 . . . . 0.0 110.155 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -109.99 175.77 5.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.757 2.023 . . . . 0.0 110.739 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -53.86 -57.09 12.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 109.135 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -45.85 -45.86 15.33 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 112.061 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 50.0 t80 -49.77 -40.24 40.58 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.682 0.614 . . . . 0.0 111.412 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.38 -41.6 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 110.757 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.45 -41.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.026 0.83 . . . . 0.0 109.608 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -23.97 64.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.756 1.622 . . . . 0.0 112.126 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.18 -45.12 16.83 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 123.681 0.792 . . . . 0.0 110.258 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mmm -56.87 -34.94 68.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.917 0.78 . . . . 0.0 111.878 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.87 -42.9 85.52 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.117 0.967 . . . . 0.0 111.51 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -45.35 74.07 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.469 0.707 . . . . 0.0 110.699 174.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.73 71.48 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.764 -1.21 . . . . 0.0 112.245 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.95 74.74 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.609 -0.682 . . . . 0.0 111.046 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -69.09 -36.82 77.98 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.194 0.998 . . . . 0.0 112.343 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -68.61 -12.22 61.06 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.565 0.62 . . . . 0.0 112.014 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.62 7.3 87.21 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.511 1.053 . . . . 0.0 112.936 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.6 169.11 10.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 120.843 -1.386 . . . . 0.0 107.586 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.85 159.7 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -122.12 145.07 48.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mt -138.11 99.34 3.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -84.58 114.02 21.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.28 170.69 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 166.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -151.27 164.21 37.13 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.051 -1.655 . . . . 0.0 109.885 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.36 133.57 15.27 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.537 1.135 . . . . 0.0 108.586 168.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.204 0 C-N-CA 123.571 0.748 . . . . 0.0 109.178 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.4 p90 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -119.68 143.09 47.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.109 1.364 . . . . 0.0 107.74 171.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.74 141.95 29.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 169.3 9.1 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.345 2.258 . . . . 0.0 107.186 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 128.13 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.856 1.662 . . . . 0.0 107.014 172.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.05 136.99 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -128.13 127.57 43.25 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 108.165 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.93 155.05 45.92 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.299 1.04 . . . . 0.0 109.374 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -105.29 165.86 10.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.102 0.953 . . . . 0.0 111.398 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -125.49 93.35 3.83 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 124.861 1.264 . . . . 0.0 109.211 174.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.9 mtp -144.34 -63.28 0.37 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -66.43 -69.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.835 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -114.76 -31.08 6.26 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . 78.18 85.71 0.5 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -164.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD1' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER 72.97 -153.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.754 0.914 . . . . 0.0 108.697 167.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.9 55.14 0.02 OUTLIER Glycine 0 C--O 1.227 -0.312 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.448 ' CE2' HD11 ' A' ' 90' ' ' LEU . 38.0 p90 -143.36 172.87 12.17 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -141.35 142.27 33.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.023 0.929 . . . . 0.0 109.439 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 135.47 57.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.517 HD12 ' C ' ' A' ' 27' ' ' LEU 0.272 2.7 pp -148.98 -178.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.306 2.242 . . . . 0.0 108.644 -177.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.7 -145.92 46.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.48 30.55 34.12 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 118.0 0.9 . . . . 0.0 111.598 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -90.82 -7.08 53.31 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 112.082 -163.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -129.7 155.59 80.13 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 126.891 2.076 . . . . 0.0 106.828 165.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.96 92.11 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 124.66 3.573 . . . . 0.0 108.161 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.91 -12.42 1.91 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.627 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -79.23 159.43 72.79 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 119.433 1.617 . . . . 0.0 112.192 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.42 147.01 51.59 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.222 1.948 . . . . 0.0 108.764 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -116.77 92.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.88 130.66 44.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.814 1.646 . . . . 0.0 109.16 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 mm -54.81 110.42 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.04 -43.58 81.13 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.442 -0.786 . . . . 0.0 111.738 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 139.89 14.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.43 147.15 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 159.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.12 110.61 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.25 -34.72 61.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 123.105 1.431 . . . . 0.0 112.009 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 33.1 mmt -95.91 20.8 9.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.591 1.156 . . . . 0.0 110.506 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 176.11 21.54 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.202 0.906 . . . . 0.0 111.552 -165.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -20.68 64.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.225 -0.893 . . . . 0.0 113.09 -160.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.52 -63.74 1.01 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.005 0.82 . . . . 0.0 109.743 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.61 -43.58 80.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.094 0.958 . . . . 0.0 110.751 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -70.62 -18.99 62.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.908 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.21 -22.6 33.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.616 1.553 . . . . 0.0 111.371 168.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.97 14.03 65.44 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.371 159.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.45 -43.81 4.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.381 1.591 . . . . 0.0 113.968 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.19 155.76 27.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -135.6 153.47 77.59 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.511 . . . . 0.0 110.586 155.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.58 112.95 3.35 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.817 1.678 . . . . 0.0 110.633 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.15 -13.09 5.76 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.232 2.348 . . . . 0.0 110.977 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.37 131.38 48.06 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 122.28 28.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 120.05 1.295 . . . . 0.0 107.697 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.2 153.52 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 109.788 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 t -130.07 -45.58 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.122 1.369 . . . . 0.0 109.511 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.37 149.23 51.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.352 1.061 . . . . 0.0 109.636 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.4 t -137.39 122.72 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 53.58 14.28 0.58 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.33 2.652 . . . . 0.0 113.555 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.7 30.92 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.447 2.451 . . . . 0.0 113.367 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.6 mp -94.49 130.37 33.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 120.586 2.193 . . . . 0.0 106.895 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -71.91 111.01 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.958 2.439 . . . . 0.0 108.567 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -72.83 -8.25 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.335 0.654 . . . . 0.0 110.96 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.65 120.42 9.44 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.12 -9.2 70.53 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.284 1.421 . . . . 0.0 114.909 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -83.03 173.59 11.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.067 -1.255 . . . . 0.0 109.098 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.1 p -93.83 169.86 9.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -51.34 -46.62 62.72 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.454 1.102 . . . . 0.0 112.052 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 -59.22 -33.18 70.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.905 0.775 . . . . 0.0 112.56 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -48.1 -48.02 33.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.914 0.886 . . . . 0.0 109.554 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.62 -35.5 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.456 -0.778 . . . . 0.0 110.816 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.56 -35.21 69.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 120.91 -1.119 . . . . 0.0 110.321 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.43 -42.39 87.77 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.471 1.108 . . . . 0.0 109.82 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -47.13 85.49 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 111.491 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -27.83 45.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.733 0.813 . . . . 0.0 110.493 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -45.08 63.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.567 0.621 . . . . 0.0 110.63 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -63.3 -46.86 84.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 111.329 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.456 1.102 . . . . 0.0 110.79 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.74 -24.19 67.57 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.114 -0.991 . . . . 0.0 112.791 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -59.45 2.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 169.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -56.84 -39.33 74.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 124.622 1.201 . . . . 0.0 109.715 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 9.3 16.74 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.352 0.977 . . . . 0.0 112.692 170.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -149.48 175.83 11.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.416 HG12 ' CD1' ' A' ' 22' ' ' PHE . 10.0 p -143.5 128.46 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 156.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 139.32 31.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 161.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.448 HD11 ' CE2' ' A' ' 24' ' ' PHE . 41.4 mt -135.51 111.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.8 m -95.49 115.57 27.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.1 173.84 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 165.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -150.86 160.72 43.7 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 120.392 -1.442 . . . . 0.0 110.195 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -155.34 144.46 20.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 160.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 C-N-CA 127.538 2.335 . . . . 0.0 109.887 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 24.7 p90 . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.542 0.687 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -106.71 131.15 54.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.01 159.54 21.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 158.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.32 121.67 11.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 173.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.98 135.76 36.46 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.3 t -126.15 107.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -95.59 127.77 41.9 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -121.35 124.16 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.963 0.905 . . . . 0.0 109.881 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -71.95 144.38 48.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -101.47 103.94 14.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.0 mtm -142.91 -53.16 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.04 -105.23 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.399 1.079 . . . . 0.0 110.713 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -69.91 -21.74 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.436 1.471 . . . . 0.0 112.139 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 67.17 2.13 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.19 100.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.485 2.314 . . . . 0.0 111.369 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.06 53.42 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.605 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -134.59 170.69 15.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.469 1.634 . . . . 0.0 110.034 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.97 151.73 48.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.71 2.404 . . . . 0.0 109.134 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.69 152.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.682 1.193 . . . . 0.0 107.809 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 -179.16 6.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.413 1.485 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.36 -142.82 43.31 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.81 20.72 62.38 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.937 0.78 . . . . 0.0 112.028 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.76 -45.96 87.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.242 1.417 . . . . 0.0 110.021 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -108.77 155.17 41.14 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.91 93.8 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.892 3.728 . . . . 0.0 109.528 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.34 2.87 2.55 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.82 1.2 . . . . 0.0 112.739 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -77.71 167.98 31.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.452 1.126 . . . . 0.0 109.824 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.57 131.7 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.304 2.67 . . . . 0.0 110.211 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.81 105.76 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.438 HD23 ' HG3' ' A' ' 58' ' ' GLU . 15.8 mt -101.68 162.8 12.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.851 1.66 . . . . 0.0 112.436 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.458 HG12 ' CG ' ' A' ' 57' ' ' ASP . 41.8 mm -65.79 121.5 14.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.22 -60.87 5.58 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 122.968 0.318 . . . . 0.0 112.633 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.43 114.78 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.9 2.08 . . . . 0.0 106.952 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.3 149.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.85 116.0 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.99 -29.74 44.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.312 1.845 . . . . 0.0 115.135 -165.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.4 mmt -135.12 10.72 3.56 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.455 1.102 . . . . 0.0 111.795 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.8 172.41 54.05 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -57.88 -11.86 2.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.19 -52.69 6.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.141 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.0 -43.66 73.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.184 1.356 . . . . 0.0 110.414 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -55.79 -28.63 57.09 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.84 -17.43 28.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.395 1.078 . . . . 0.0 111.978 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.54 23.74 67.14 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -122.44 -14.11 7.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.978 1.889 . . . . 0.0 114.31 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.14 168.8 12.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.294 0.952 . . . . 0.0 108.636 166.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.85 18.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.133 1.373 . . . . 0.0 107.838 158.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.44 123.77 11.59 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.894 2.396 . . . . 0.0 109.164 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.9 34.93 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.052 0.834 . . . . 0.0 113.288 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.478 ' OD2' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -64.39 153.83 37.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 118.643 1.221 . . . . 0.0 109.507 152.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.2 tt0 -104.58 116.64 32.43 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.821 2.048 . . . . 0.0 108.276 166.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.22 136.83 37.87 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.32 2.248 . . . . 0.0 108.755 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.98 -52.95 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 123.596 0.758 . . . . 0.0 110.276 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -134.59 145.17 48.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.81 124.83 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 107.322 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.43 21.15 1.14 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.613 2.365 . . . . 0.0 112.09 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.48 -10.78 70.87 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.82 2.153 . . . . 0.0 113.788 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.77 133.19 38.26 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 119.575 1.687 . . . . 0.0 107.625 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -72.01 133.94 22.46 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.024 2.483 . . . . 0.0 108.295 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG1' HG22 ' A' ' 75' ' ' VAL . 33.5 m -99.07 -7.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.229 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.75 133.72 47.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.82 -9.04 25.87 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.7 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 69.7 mmtt -85.96 171.8 11.18 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.935 1.868 . . . . 0.0 108.723 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.8 p -92.3 172.97 8.06 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.137 0.575 . . . . 0.0 110.362 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -49.7 -56.07 11.53 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.717 1.207 . . . . 0.0 109.485 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -50.56 -41.77 54.56 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.62 1.568 . . . . 0.0 112.929 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 41.0 t80 -51.63 -47.14 63.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.753 0.787 . . . . 0.0 110.266 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' CG1' ' A' ' 67' ' ' VAL . 7.3 t -73.13 -34.35 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.791 0.836 . . . . 0.0 110.465 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -62.44 -35.44 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.878 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.5 -43.88 97.73 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.788 1.235 . . . . 0.0 110.105 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -53.88 46.15 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.625 0.77 . . . . 0.0 111.669 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.7 mmm -58.59 -35.22 72.07 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.235 0.614 . . . . 0.0 111.082 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -59.5 -45.14 92.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.482 -0.77 . . . . 0.0 111.2 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.62 -51.08 66.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.808 0.843 . . . . 0.0 111.683 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.77 71.82 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 111.678 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.22 78.5 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.036 -1.04 . . . . 0.0 111.288 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -72.14 -42.87 65.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.391 0.996 . . . . 0.0 111.183 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -55.35 -33.51 63.45 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.364 1.065 . . . . 0.0 110.227 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.63 10.64 65.01 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.182 0.896 . . . . 0.0 112.228 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -164.66 168.86 17.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.751 2.02 . . . . 0.0 107.053 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.38 159.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.36 88.97 2.35 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.632 1.173 . . . . 0.0 109.294 -170.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.9 97.95 8.49 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -83.55 127.07 33.45 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.478 HG11 ' OD2' ' A' ' 57' ' ' ASP . 17.2 m -125.99 158.47 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 126.038 1.735 . . . . 0.0 107.051 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 11.6 ptt180 -151.3 161.32 42.93 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.674 -0.641 . . . . 0.0 111.085 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.21 146.36 22.71 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.446 0 C-N-CA 124.0 0.92 . . . . 0.0 110.411 166.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 32.4 p90 . . . . . 0 CA--C 1.51 -0.593 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -135.82 137.33 41.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 159.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -83.45 152.46 24.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 164.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.41 163.21 19.09 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -124.98 121.37 34.24 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.207 1.803 . . . . 0.0 107.706 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.9 t -121.59 109.1 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -78.18 144.52 36.28 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 mt -140.05 128.21 22.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.182 0.993 . . . . 0.0 108.8 166.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -72.95 160.06 32.71 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.741 0.416 . . . . 0.0 111.669 171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 8.5 ttt-85 -141.5 89.65 2.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.287 1.435 . . . . 0.0 107.439 166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mtm -154.27 -41.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 109.22 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -72.78 -163.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 142.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -64.73 8.32 0.12 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -148.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 174.2 50.22 Favored Glycine 0 N--CA 1.45 -0.398 0 O-C-N 120.672 -1.267 . . . . 0.0 112.287 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -65.99 160.83 22.76 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.57 72.32 0.29 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 90' ' ' LEU . 45.1 p90 -143.31 171.87 13.52 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 171.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -132.18 158.67 41.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.126 1.371 . . . . 0.0 107.774 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.75 121.38 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.81 -177.23 3.08 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.474 2.31 . . . . 0.0 107.716 -168.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.49 -144.39 49.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.04 19.96 47.4 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.124 0.868 . . . . 0.0 112.904 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -26.28 68.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.011 0.925 . . . . 0.0 111.204 -168.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -140.39 160.25 60.28 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 126.114 1.766 . . . . 0.0 109.056 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.76 112.65 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 173.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.07 35.89 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.923 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.91 155.61 91.36 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.662 1.731 . . . . 0.0 108.466 166.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.63 152.41 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.517 2.811 . . . . 0.0 110.371 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 75' ' ' VAL . 60.8 mt -117.78 93.98 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 165.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -81.36 152.85 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.25 139.3 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 159.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.7 -56.79 1.39 Allowed Glycine 0 C--O 1.226 -0.372 0 O-C-N 121.492 -0.755 . . . . 0.0 111.639 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.84 145.76 36.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.42 123.78 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.61 110.62 7.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -171.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.8 149.16 11.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.269 0.98 . . . . 0.0 110.483 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.5 mmt 66.47 -6.75 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.988 2.115 . . . . 0.0 114.564 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -151.63 5.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.847 1.689 . . . . 0.0 111.416 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -66.5 -63.77 1.0 Allowed 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.918 -1.342 . . . . 0.0 110.725 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -45.26 94.55 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -157.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.52 -45.92 90.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.234 1.014 . . . . 0.0 111.535 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.9 -39.64 95.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.686 1.595 . . . . 0.0 112.616 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -36.89 83.45 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 110.368 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.2 15.32 65.26 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 125.486 1.517 . . . . 0.0 113.24 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -98.59 -32.85 11.22 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.574 1.549 . . . . 0.0 109.604 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.48 146.7 32.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.05 146.87 48.33 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.843 164.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -69.24 112.41 2.98 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.894 2.396 . . . . 0.0 110.674 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.14 5.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.709 1.623 . . . . 0.0 112.268 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.84 140.88 57.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 122.5 32.61 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.989 1.268 . . . . 0.0 108.583 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.06 156.83 38.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.102 0.961 . . . . 0.0 111.202 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.14 -53.01 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.902 1.681 . . . . 0.0 108.933 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.4 148.25 51.3 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.528 1.131 . . . . 0.0 109.618 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.84 126.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.721 1.608 . . . . 0.0 107.019 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.11 -3.83 0.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.921 2.088 . . . . 0.0 112.708 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.58 -16.96 6.96 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.841 3.115 . . . . 0.0 111.914 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.27 134.87 20.96 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.868 1.334 . . . . 0.0 108.648 -167.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.16 118.83 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.382 2.722 . . . . 0.0 109.883 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.488 ' CG1' HG22 ' A' ' 75' ' ' VAL . 15.5 m -80.3 -7.3 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 111.023 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 118.29 8.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 109.992 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.97 -10.01 70.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.657 1.122 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -78.55 -172.53 2.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 108.712 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -100.63 171.89 7.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.685 1.194 . . . . 0.0 109.402 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -50.81 -53.65 30.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.389 1.476 . . . . 0.0 109.844 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.75 -24.26 67.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -51.71 -48.92 63.37 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.854 0.835 . . . . 0.0 110.21 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.488 HG22 ' CG1' ' A' ' 67' ' ' VAL . 4.7 t -71.65 -37.18 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.572 1.149 . . . . 0.0 110.126 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.02 -28.35 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.204 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -45.48 72.54 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.476 1.51 . . . . 0.0 110.415 169.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -49.62 76.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.191 0.596 . . . . 0.0 110.775 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.0 mmm -57.74 -19.88 30.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.942 0.497 . . . . 0.0 112.331 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -47.85 21.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.373 0.988 . . . . 0.0 111.103 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.43 -47.04 85.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 119.016 0.825 . . . . 0.0 111.111 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.35 -38.02 73.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.689 0.796 . . . . 0.0 111.713 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.78 -14.25 62.91 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 113.805 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -81.7 -43.74 18.07 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.033 1.288 . . . . 0.0 109.764 165.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -63.28 -17.35 62.42 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.747 1.219 . . . . 0.0 112.016 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.31 69.01 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.037 1.303 . . . . 0.0 112.406 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -157.31 168.7 26.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.031 1.732 . . . . 0.0 106.872 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.06 163.49 26.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -121.88 140.42 52.43 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 166.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 24' ' ' PHE . 13.4 mt -137.01 106.67 6.17 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 m -97.31 112.58 24.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.44 164.77 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.65 151.75 32.97 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.567 -1.333 . . . . 0.0 110.839 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -151.02 136.05 17.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.511 -0.519 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 166.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 p90 . . . . . 0 N--CA 1.444 -0.76 0 CA-C-O 122.156 0.979 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -97.0 147.3 24.14 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 112.918 -1.946 . . . . 0.0 106.253 164.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.02 154.19 23.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 160.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.06 118.08 23.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.51 130.44 39.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 53' ' ' LEU . 98.6 t -135.08 107.15 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.26 128.27 41.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.76 165.46 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 109.409 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -127.35 145.75 50.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -98.94 101.48 12.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tpt -144.7 -63.51 0.36 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.28 -85.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.809 0.844 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -95.51 -31.02 13.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.919 0.327 . . . . 0.0 111.803 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.68 71.66 1.27 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.26 83.28 0.17 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.9 1.68 . . . . 0.0 111.155 168.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.39 59.44 2.83 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.893 0.759 . . . . 0.0 112.878 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.7 p90 -135.35 175.05 9.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.082 1.353 . . . . 0.0 109.613 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -129.57 166.91 18.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.99 1.316 . . . . 0.0 108.563 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.05 122.69 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 79.0 mt -140.36 -176.5 4.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 108.593 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.27 -151.47 52.11 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -168.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.96 33.35 20.9 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 117.427 0.613 . . . . 0.0 111.578 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.63 -17.09 62.28 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.332 -1.099 . . . . 0.0 110.62 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -132.4 160.32 68.63 Favored Pre-proline 0 C--O 1.239 0.539 0 C-N-CA 126.715 2.006 . . . . 0.0 107.694 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.3 79.39 3.35 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.105 3.203 . . . . 0.0 109.153 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.09 51.38 0.27 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 125.697 1.618 . . . . 0.0 109.296 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -118.47 159.3 44.32 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.761 1.624 . . . . 0.0 107.506 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 144.34 47.89 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.788 1.659 . . . . 0.0 109.018 -170.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 7.2 mt -105.37 79.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 124.189 1.947 . . . . 0.0 107.329 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.34 124.37 31.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.316 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 mm -47.15 129.06 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -84.12 -0.81 89.67 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.902 2.668 . . . . 0.0 116.787 -166.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 127.35 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 C-N-CA 132.36 4.264 . . . . 0.0 108.824 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.2 t -77.41 149.89 5.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.74 117.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.36 -35.67 70.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -163.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.6 mtm -131.33 114.64 15.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.02 -177.84 38.08 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 m -51.84 -45.32 63.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.84 72.32 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.369 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.11 -41.4 99.34 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.916 0.486 . . . . 0.0 110.287 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -59.58 -46.53 88.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.227 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -21.22 66.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.434 0.561 . . . . 0.0 110.59 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 0.32 30.6 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.33 1.443 . . . . 0.0 113.673 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -99.35 -21.52 15.99 Favored 'General case' 0 C--O 1.228 -0.059 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.056 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.49 ' HG ' HG11 ' A' ' 13' ' ' VAL . 5.6 mt -95.92 145.97 24.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.309 1.413 . . . . 0.0 108.147 172.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -140.22 -179.06 0.92 Allowed Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.926 1.691 . . . . 0.0 109.949 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -94.94 138.41 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 111.702 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 -3.69 59.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 125.867 1.698 . . . . 0.0 111.771 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.43 139.96 46.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.11 132.66 42.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.011 2.124 . . . . 0.0 106.878 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.14 152.18 23.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 109.369 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.01 -50.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 108.742 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -127.74 152.37 47.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.929 . . . . 0.0 110.011 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.13 123.72 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 106.81 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t0 55.6 19.21 3.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.591 2.356 . . . . 0.0 113.319 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.11 -16.03 27.78 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.862 2.172 . . . . 0.0 113.702 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.18 131.88 22.63 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 118.778 1.289 . . . . 0.0 108.433 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -72.27 111.65 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.651 2.901 . . . . 0.0 109.004 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.67 -4.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.981 0.913 . . . . 0.0 112.007 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.3 126.29 27.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 109.54 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.86 -7.47 81.68 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.301 0.953 . . . . 0.0 112.91 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -91.99 175.95 6.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.145 1.473 . . . . 0.0 108.974 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -95.09 167.89 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.76 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -48.78 -44.38 38.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 110.646 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -57.62 -35.72 70.84 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.631 0.772 . . . . 0.0 113.075 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -56.14 -44.14 78.91 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.27 -38.55 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.965 0.906 . . . . 0.0 110.406 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -56.97 -40.61 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 120.093 1.315 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -70.73 -33.4 70.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.747 0.248 . . . . 0.0 111.574 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.17 -46.77 72.96 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.663 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.4 mmm -63.54 -33.15 74.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.195 0.907 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.06 -45.25 75.31 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.175 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -49.66 64.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.856 0.862 . . . . 0.0 111.422 176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.35 66.85 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 110.539 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 -23.44 64.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.019 -1.051 . . . . 0.0 113.327 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -93.47 -31.37 14.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.207 1.003 . . . . 0.0 110.846 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -57.71 -25.2 60.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.329 0.652 . . . . 0.0 110.519 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.88 5.35 90.14 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 121.432 -0.792 . . . . 0.0 111.926 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -149.75 174.04 13.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.372 1.869 . . . . 0.0 107.195 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.48 147.84 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 160.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -115.71 108.83 16.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.7 mt -99.29 140.95 32.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -120.56 114.78 22.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.55 171.36 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -148.67 162.2 40.2 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.512 -1.367 . . . . 0.0 109.24 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -155.06 120.57 5.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 109.75 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.172 0 C-N-CA 125.378 1.471 . . . . 0.0 110.213 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 2.5 p90 . . . . . 0 N--CA 1.441 -0.878 0 CA-C-O 121.81 0.814 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 133.26 33.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 167.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.26 152.99 24.91 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 158.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -136.42 162.71 32.3 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.53 2.332 . . . . 0.0 107.511 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.52 116.93 22.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.314 1.054 . . . . 0.0 110.559 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.91 136.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 168.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -129.05 107.46 9.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 123.8 46.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -75.21 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -124.72 99.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 167.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.1 ptp -132.37 6.41 4.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.641 0.776 . . . . 0.0 110.687 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.2 -110.9 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -64.58 -30.42 71.44 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.551 1.069 . . . . 0.0 112.028 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.22 82.87 0.61 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 67.23 -171.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.148 1.379 . . . . 0.0 110.167 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.58 45.88 0.21 Allowed Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 90' ' ' LEU . 13.3 p90 -139.58 152.05 46.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -108.6 167.16 10.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.703 2.401 . . . . 0.0 108.538 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.67 135.41 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 120.542 -1.349 . . . . 0.0 107.733 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -138.64 -176.82 4.61 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 128.563 2.745 . . . . 0.0 106.815 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.48 -159.91 41.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.67 24.8 54.25 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.719 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -64.33 -28.11 69.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.579 1.19 . . . . 0.0 110.714 -171.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -135.09 160.67 67.4 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 126.936 2.094 . . . . 0.0 108.03 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.32 35.18 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.752 1 C-N-CA 125.372 4.048 . . . . 0.0 113.603 -166.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.86 20.51 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.997 1.761 . . . . 0.0 111.528 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -89.7 154.07 47.96 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 118.92 1.36 . . . . 0.0 111.123 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.84 135.14 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.916 3.078 . . . . 0.0 109.286 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.2 92.51 2.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 mt -85.15 134.87 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.494 -0.754 . . . . 0.0 111.28 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.5 mm -54.04 112.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.696 1.998 . . . . 0.0 105.728 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.1 -74.86 0.3 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.713 1.625 . . . . 0.0 113.216 -170.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.92 119.27 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.631 1.973 . . . . 0.0 106.756 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.61 149.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.49 113.25 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.13 -23.75 56.2 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.156 1.382 . . . . 0.0 114.588 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.1 mmt -110.95 -0.05 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.23 -178.1 22.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.899 1.238 . . . . 0.0 111.181 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -66.14 -8.34 23.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.25 -40.45 18.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.086 1.766 . . . . 0.0 111.332 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.7 -53.04 24.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.447 1.099 . . . . 0.0 110.428 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -55.32 -29.18 57.77 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.54 -21.94 65.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.766 0.826 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.16 52.65 51.23 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.982 1.277 . . . . 0.0 111.022 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.78 -78.75 0.28 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.1 mt -69.13 142.05 54.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.054 0.843 . . . . 0.0 110.813 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -119.59 154.22 54.49 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.934 0.894 . . . . 0.0 108.978 159.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 142.89 34.83 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.85 1.7 . . . . 0.0 110.07 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.43 88.46 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.963 -0.91 . . . . 0.0 113.533 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -71.19 141.13 50.67 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 169.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.45 128.82 36.63 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.006 -1.059 . . . . 0.0 109.4 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.72 153.47 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.396 1.878 . . . . 0.0 110.923 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.94 -37.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.005 1.722 . . . . 0.0 109.516 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 66' ' ' PRO . 70.2 m-85 -137.18 151.92 49.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.084 0.953 . . . . 0.0 110.388 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.5 t -147.31 134.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 127.036 2.134 . . . . 0.0 106.954 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t0 58.83 17.03 4.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.299 1.44 . . . . 0.0 111.029 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.8 0.82 88.85 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.732 2.11 . . . . 0.0 114.066 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mm -94.78 136.03 23.31 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 127.036 2.134 . . . . 0.0 108.098 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 18.0 Cg_endo -74.07 145.59 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.358 2.039 . . . . 0.0 109.189 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.02 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.077 0.551 . . . . 0.0 112.379 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.8 102.14 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.041 -0.412 . . . . 0.0 110.239 -165.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.48 -3.8 50.53 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.529 1.061 . . . . 0.0 113.718 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 57.3 mmtt -78.83 -179.98 6.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.052 -1.264 . . . . 0.0 108.023 158.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.7 p -111.85 175.52 5.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.21 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -40.8 -64.24 0.56 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 109.792 170.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -55.43 -38.75 69.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.239 0.616 . . . . 0.0 112.577 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 9.1 t80 -55.01 -48.04 73.88 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.441 0.564 . . . . 0.0 109.488 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.12 -44.06 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.353 -1.308 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mm -57.16 -37.54 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.507 1.503 . . . . 0.0 109.785 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -54.52 46.02 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.053 0.941 . . . . 0.0 110.91 170.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.03 -35.04 77.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.268 0.627 . . . . 0.0 112.154 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -30.48 23.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.335 1.454 . . . . 0.0 109.388 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.9 -30.87 71.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.195 0.998 . . . . 0.0 111.339 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -51.04 59.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 173.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.18 74.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.456 1.103 . . . . 0.0 111.394 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -23.34 15.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.533 -1.354 . . . . 0.0 112.464 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -94.17 -21.73 18.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.926 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -61.92 -35.87 79.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.193 1.361 . . . . 0.0 110.696 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.47 -0.72 49.77 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.529 -0.732 . . . . 0.0 112.724 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -151.81 167.84 26.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.76 2.024 . . . . 0.0 106.672 165.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.02 122.13 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 162.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.53 128.16 33.27 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 24' ' ' PHE . 14.7 mt -130.8 128.41 40.66 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.4 m -112.06 122.53 48.01 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -111.09 164.81 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.442 1.097 . . . . 0.0 109.339 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -152.21 146.78 25.71 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.596 -1.315 . . . . 0.0 110.954 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -148.82 126.88 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.834 0.454 . . . . 0.0 110.204 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.273 0 C-N-CA 124.197 0.999 . . . . 0.0 112.361 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 25.5 p90 . . . . . 0 C--O 1.234 0.279 0 CA-C-O 121.295 0.569 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.61 117.27 26.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -83.95 141.06 31.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 116.72 15.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.52 143.06 36.93 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.819 1.648 . . . . 0.0 109.176 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.59 108.72 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 126.248 1.819 . . . . 0.0 106.743 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.3 130.45 35.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -120.9 123.91 43.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.253 0.933 . . . . 0.0 109.276 164.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -74.42 158.58 33.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.185 165.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 51.9 ttt-85 -131.24 102.31 5.93 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 125.793 1.637 . . . . 0.0 107.11 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 ptp -155.66 8.77 0.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -136.75 -76.54 0.42 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.638 -1.288 . . . . 0.0 108.41 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.47 -7.7 12.83 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.66 1.584 . . . . 0.0 111.919 170.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.14 -179.95 41.43 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.159 0.885 . . . . 0.0 111.807 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.1 m-85 -62.48 147.08 49.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.61 51.15 0.87 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -134.7 153.51 51.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -110.97 163.93 13.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.666 1.987 . . . . 0.0 107.316 168.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.401 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -136.46 150.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.155 1.382 . . . . 0.0 108.642 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -134.59 -177.29 4.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.856 2.062 . . . . 0.0 108.549 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.12 -140.51 37.88 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.03 23.92 8.0 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 127.956 2.693 . . . . 0.0 112.922 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.37 -25.38 65.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.031 -0.688 . . . . 0.0 110.342 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -121.84 155.9 59.86 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 123.507 0.723 . . . . 0.0 110.145 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.07 133.09 29.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.112 1.874 . . . . 0.0 108.684 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.43 19.32 74.36 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.935 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -72.59 162.38 74.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.603 1.201 . . . . 0.0 110.34 168.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -71.09 119.27 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.289 1.993 . . . . 0.0 109.571 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -90.45 97.74 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -83.73 151.77 25.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 mm -55.83 122.23 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -67.21 -62.7 4.24 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 128.96 4.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.762 0.825 . . . . 0.0 108.799 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.79 128.0 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.5 mm -68.21 132.93 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.278 1.431 . . . . 0.0 108.611 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.82 65.77 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.756 1.223 . . . . 0.0 113.855 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.7 mtt -126.79 54.98 1.57 Allowed 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 169.45 12.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -6.99 20.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.325 -1.321 . . . . 0.0 114.08 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.54 -56.4 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 120.03 1.286 . . . . 0.0 110.507 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.61 -45.99 91.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.429 0.559 . . . . 0.0 110.562 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -18.94 48.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.96 -17.67 20.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.962 1.305 . . . . 0.0 111.835 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.71 45.38 53.05 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.955 -1.091 . . . . 0.0 113.869 165.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -133.37 -48.51 0.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.765 0.783 . . . . 0.0 111.436 166.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 mt -74.04 148.15 42.23 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.609 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -139.77 148.5 55.79 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 125.167 1.387 . . . . 0.0 112.327 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.94 92.59 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.816 3.011 . . . . 0.0 112.464 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.87 -13.61 1.51 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.202 1.858 . . . . 0.0 113.029 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.32 154.12 28.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.957 1.379 . . . . 0.0 109.694 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.32 131.78 42.49 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.81 155.83 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.11 0.964 . . . . 0.0 110.453 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.88 -51.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 125.071 1.348 . . . . 0.0 109.332 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.65 146.72 52.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.8 116.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t0 57.99 25.04 11.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.586 1.555 . . . . 0.0 111.522 -166.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.44 0.77 59.11 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.503 1.049 . . . . 0.0 112.815 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 mm -86.27 127.62 60.63 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 119.798 1.799 . . . . 0.0 106.507 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -69.82 128.36 15.86 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.503 2.802 . . . . 0.0 109.257 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -92.16 -3.65 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.708 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 149.11 48.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.203 0.91 . . . . 0.0 108.848 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.25 -28.12 0.33 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.017 1.294 . . . . 0.0 114.57 -172.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -74.71 173.72 10.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.054 1.342 . . . . 0.0 109.434 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -103.92 -177.36 3.35 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.726 1.61 . . . . 0.0 109.47 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.86 -55.01 40.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.254 1.822 . . . . 0.0 110.443 172.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -56.13 -35.27 66.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.382 0.992 . . . . 0.0 112.422 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -47.04 -50.34 19.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.261 0.625 . . . . 0.0 111.165 171.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.59 -35.78 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.453 1.101 . . . . 0.0 110.338 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.37 -27.86 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 119.935 1.243 . . . . 0.0 110.379 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.12 -41.28 74.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.354 -1.466 . . . . 0.0 110.686 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.98 -31.28 72.09 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.894 -1.129 . . . . 0.0 112.229 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.77 -35.02 77.93 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.024 1.33 . . . . 0.0 109.61 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.3 -60.33 3.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.486 0.714 . . . . 0.0 109.944 171.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -56.9 -49.37 75.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.351 1.061 . . . . 0.0 112.379 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.94 79.42 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 111.721 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.22 64.76 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.035 -1.04 . . . . 0.0 112.337 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -81.44 -42.59 20.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 110.428 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.07 -20.2 62.3 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.049 0.939 . . . . 0.0 110.708 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.87 11.61 76.37 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.129 0.871 . . . . 0.0 111.996 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.21 167.85 11.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.953 1.701 . . . . 0.0 107.046 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.29 150.77 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -105.29 126.09 51.71 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.65 99.27 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.4 m -87.49 116.69 25.78 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.86 169.85 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.436 1.095 . . . . 0.0 109.005 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.416 ' HD2' ' CD1' ' A' ' 8' ' ' TYR . 15.9 ptt180 -153.25 167.97 27.54 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.527 -1.358 . . . . 0.0 110.858 172.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.511 HH11 ' CB ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -150.14 149.11 29.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.164 161.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 122.56 1.171 . . . . 0.0 111.615 161.212 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.0 p90 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 130.45 52.6 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.83 138.18 33.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 162.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.84 134.56 53.57 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.765 2.026 . . . . 0.0 107.251 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -92.08 132.44 36.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.482 HG11 ' HG ' ' A' ' 53' ' ' LEU . 65.4 t -130.12 108.82 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.588 1.555 . . . . 0.0 106.977 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -86.4 126.89 34.69 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 168.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -117.61 123.14 45.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.187 0.903 . . . . 0.0 109.041 164.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -78.74 161.44 26.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 111.055 172.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 38.8 ttt-85 -139.88 93.62 2.67 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.741 1.216 . . . . 0.0 110.48 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.7 mtp -142.29 -8.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 161.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -131.22 -105.65 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -164.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 m -65.6 -23.45 66.83 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.08 -1.013 . . . . 0.0 112.285 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.44 -179.94 7.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.704 1.138 . . . . 0.0 111.729 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 3.1 m-85 -63.5 123.52 18.98 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.16 -1.2 . . . . 0.0 110.632 -165.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.75 53.42 0.59 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 124.148 0.88 . . . . 0.0 111.133 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CE1' HD11 ' A' ' 90' ' ' LEU . 32.0 p90 -142.2 167.87 21.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.441 1.121 . . . . 0.0 108.66 172.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -123.43 162.36 22.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.801 2.04 . . . . 0.0 107.503 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.98 151.73 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.17 2.188 . . . . 0.0 106.99 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.419 HD12 ' HA2' ' A' ' 39' ' ' GLY . 97.0 mt -149.03 -177.31 5.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.476 2.31 . . . . 0.0 107.806 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.59 56.0 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.232 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -11.0 59.74 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.906 1.853 . . . . 0.0 112.415 -170.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -132.1 160.34 68.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 127.225 2.21 . . . . 0.0 107.369 168.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.94 69.56 7.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.961 3.774 . . . . 0.0 110.058 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.1 7.12 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.27 1.414 . . . . 0.0 112.599 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.54 160.84 39.88 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.62 1.71 . . . . 0.0 109.76 159.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.86 140.87 51.98 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.669 1.58 . . . . 0.0 109.175 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -105.79 93.2 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.3 149.27 25.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.1 0.476 . . . . 0.0 110.339 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.79 121.33 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 158.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 27' ' ' LEU . . . -64.49 -68.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 124.849 1.214 . . . . 0.0 110.081 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 144.55 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.729 1.612 . . . . 0.0 107.609 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.45 139.84 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 162.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mm -86.15 110.2 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.88 144.56 11.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.893 1.277 . . . . 0.0 111.076 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.0 mmt 47.09 69.99 0.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.105 1.762 . . . . 0.0 110.012 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.01 -179.94 44.97 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 m -57.71 -38.52 75.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.906 1.353 . . . . 0.0 114.64 -165.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 -44.43 50.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.872 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -42.49 65.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.212 1.005 . . . . 0.0 111.654 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -77.33 -21.42 53.43 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.089 -1.007 . . . . 0.0 112.296 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.74 -29.32 40.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.189 0.996 . . . . 0.0 110.524 171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.36 -3.49 4.49 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.11 2.291 . . . . 0.0 114.524 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -90.33 -42.14 11.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.658 1.229 . . . . 0.0 111.695 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 13' ' ' VAL . 7.5 mt -69.28 160.95 30.26 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.989 0.516 . . . . 0.0 109.643 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 155.61 72.4 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.679 1.191 . . . . 0.0 109.221 160.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.0 142.47 51.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.772 1.648 . . . . 0.0 108.838 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.26 -0.94 86.85 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.465 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.55 145.13 55.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.335 1.568 . . . . 0.0 107.433 166.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -93.71 133.57 36.93 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.746 1.157 . . . . 0.0 108.323 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -88.14 153.48 21.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.373 1.469 . . . . 0.0 110.173 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.0 -47.16 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.578 1.551 . . . . 0.0 109.426 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.21 150.31 48.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.879 1.672 . . . . 0.0 108.731 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -145.44 118.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 69.85 -31.39 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.099 2.56 . . . . 0.0 112.427 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.63 -21.13 0.39 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 128.065 2.745 . . . . 0.0 110.485 171.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.521 HD12 ' H ' ' A' ' 65' ' ' ILE . 4.5 mp -76.82 135.69 67.5 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 127.59 2.356 . . . . 0.0 107.457 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -72.92 151.49 50.72 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.425 2.083 . . . . 0.0 110.057 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.8 m -114.26 -7.77 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.26 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.23 102.83 2.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.68 2.13 30.65 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.855 1.216 . . . . 0.0 113.502 -174.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -98.17 173.23 7.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.875 1.837 . . . . 0.0 109.387 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -89.56 172.45 8.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.319 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -61.57 -46.4 90.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 111.137 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -62.61 -26.94 68.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.106 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -45.86 -48.87 15.87 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.268 1.027 . . . . 0.0 110.516 168.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.62 -36.16 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.442 1.097 . . . . 0.0 109.118 -169.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.14 -45.46 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.186 0.903 . . . . 0.0 109.783 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -70.35 -24.85 63.05 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -74.18 -46.71 40.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.477 0.711 . . . . 0.0 110.54 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 89.6 mmm -62.58 -24.58 67.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.926 1.239 . . . . 0.0 112.199 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.46 -50.82 72.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.934 167.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -50.45 56.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.291 1.836 . . . . 0.0 111.333 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.98 69.86 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.58 0.752 . . . . 0.0 111.264 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.31 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.629 -1.294 . . . . 0.0 112.15 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -69.26 -37.78 78.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.504 1.521 . . . . 0.0 111.187 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -62.78 -12.39 23.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.381 0.537 . . . . 0.0 112.14 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.44 9.68 85.88 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.282 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -170.76 166.38 7.89 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.355 1.862 . . . . 0.0 108.119 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 118.92 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -82.18 100.65 9.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CE1' ' A' ' 24' ' ' PHE . 29.2 mt -87.06 145.73 26.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.2 m -123.44 118.99 28.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 165.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.17 169.5 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 124.097 0.873 . . . . 0.0 108.99 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -151.35 161.04 43.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.868 -1.145 . . . . 0.0 110.183 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.83 134.46 14.53 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.531 169.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.443 -0.815 0 C-N-CA 124.915 1.286 . . . . 0.0 111.829 169.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.4 p90 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HE3' HD11 ' A' ' 11' ' ' LEU . 49.7 pttt -112.59 145.22 40.73 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 170.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.16 158.58 21.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 164.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.441 HD11 ' HE3' ' A' ' 9' ' ' LYS . 2.0 mm? -129.09 138.96 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.433 1.893 . . . . 0.0 106.925 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.13 125.89 46.31 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 108.098 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.17 142.79 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.349 1.06 . . . . 0.0 108.677 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -130.18 125.52 35.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -124.56 165.07 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.927 0.785 . . . . 0.0 110.643 -174.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -132.99 159.98 38.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.811 0.845 . . . . 0.0 111.333 -174.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -126.03 85.07 2.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.828 1.251 . . . . 0.0 111.04 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.4 ttm -140.4 -17.2 0.91 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.258 0.623 . . . . 0.0 111.487 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -91.93 -128.33 0.1 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -67.23 -7.03 20.88 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.994 -1.066 . . . . 0.0 113.084 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.25 73.5 0.69 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -165.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 74.88 156.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.545 2.338 . . . . 0.0 111.718 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.28 36.62 2.75 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.914 0.768 . . . . 0.0 111.33 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -130.65 166.26 21.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.154 0.977 . . . . 0.0 108.973 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -123.05 164.96 17.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.54 1.936 . . . . 0.0 107.544 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.61 125.7 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -173.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt -132.29 -178.25 4.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.546 1.538 . . . . 0.0 108.312 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.58 -162.96 54.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -168.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.61 18.52 65.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.078 -1.401 . . . . 0.0 114.751 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.18 -60.43 3.34 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.107 1.453 . . . . 0.0 109.002 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.91 161.2 47.88 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 107.98 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.123 3.215 . . . . 0.0 109.422 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 -5.51 12.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.305 1.431 . . . . 0.0 113.382 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -63.43 163.8 17.91 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.429 1.491 . . . . 0.0 111.47 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.25 140.48 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.937 1.758 . . . . 0.0 109.558 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.74 106.61 21.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.7 mt -99.88 153.72 18.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 mm -52.42 140.56 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 160.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.65 -124.01 0.83 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.21 116.68 29.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.797 2.039 . . . . 0.0 107.023 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.8 124.42 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.78 103.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.0 152.5 36.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.5 mtm 47.62 43.98 16.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.4 1.88 . . . . 0.0 111.198 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' ASP . . . -143.89 178.75 21.74 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 125.677 1.608 . . . . 0.0 111.874 -167.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -70.15 -7.88 45.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -163.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.19 -53.44 3.79 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.332 1.053 . . . . 0.0 110.3 165.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -43.81 -47.35 8.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 112.696 175.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -60.16 -38.13 82.25 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.267 1.427 . . . . 0.0 113.119 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.54 -32.96 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 0.0 110.831 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 31.38 35.4 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.462 160.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -131.85 -45.64 0.95 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.006 1.403 . . . . 0.0 112.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.93 144.98 52.01 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.682 -0.636 . . . . 0.0 110.222 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -132.27 158.97 74.18 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 124.778 1.231 . . . . 0.0 108.656 161.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 145.85 85.23 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.221 1.947 . . . . 0.0 110.098 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.16 6.5 79.86 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.398 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -69.73 126.35 29.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.094 1.947 . . . . 0.0 107.569 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HG3' HD23 ' A' ' 37' ' ' LEU . 21.7 tt0 -73.8 124.74 26.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.534 0.607 . . . . 0.0 109.402 -174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.51 150.73 31.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.759 0.823 . . . . 0.0 109.906 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.81 -46.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.225 1.81 . . . . 0.0 109.108 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.17 145.85 51.75 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.177 0.991 . . . . 0.0 110.249 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.7 t -139.2 129.39 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.829 1.652 . . . . 0.0 107.11 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.11 18.06 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.763 2.425 . . . . 0.0 113.225 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -11.38 62.78 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.385 2.421 . . . . 0.0 112.836 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.31 132.88 34.38 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.866 1.666 . . . . 0.0 108.62 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -70.99 116.83 4.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.863 2.375 . . . . 0.0 109.59 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.92 -7.37 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.388 0.675 . . . . 0.0 111.625 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 114.46 2.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.197 1.399 . . . . 0.0 111.032 -171.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -14.9 56.11 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.428 1.49 . . . . 0.0 113.02 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 170.48 9.43 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.747 1.219 . . . . 0.0 110.634 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.1 p -85.72 171.67 11.43 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.63 0.772 . . . . 0.0 111.024 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -46.82 -54.28 10.18 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.81 1.644 . . . . 0.0 108.831 165.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 ttp-105 -55.62 -37.76 68.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.02 -44.04 74.25 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.495 0.589 . . . . 0.0 109.918 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.15 -41.35 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.917 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.56 -44.43 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.234 0.925 . . . . 0.0 110.451 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -45.36 95.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.901 1.28 . . . . 0.0 110.189 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.56 -45.84 71.05 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.713 0.688 . . . . 0.0 111.412 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.6 mmm -52.73 -36.52 57.78 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 0.0 110.275 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -18.67 60.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.241 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -85.11 -49.06 8.57 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.02 1.728 . . . . 0.0 109.216 172.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.39 40.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.447 1.099 . . . . 0.0 109.473 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.52 -36.45 23.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.483 1.113 . . . . 0.0 113.105 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 81' ' ' HIS . 2.0 mpt_? -68.36 -39.64 81.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -71.49 -13.83 61.93 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.784 1.234 . . . . 0.0 112.759 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.41 4.54 90.01 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 119.404 1.002 . . . . 0.0 113.876 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 6.1 pt20 -142.96 178.59 7.57 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.433 1.493 . . . . 0.0 109.246 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.09 128.58 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 162.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.18 139.92 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 15' ' ' LEU . 5.8 mt -139.78 125.59 19.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.532 1.969 . . . . 0.0 107.374 -174.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.13 115.11 25.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.6 m -99.5 167.99 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -144.81 152.79 40.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 120.523 -1.36 . . . . 0.0 108.857 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -151.5 143.39 23.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.087 1.355 . . . . 0.0 109.633 173.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.513 0 C-N-CA 124.512 1.125 . . . . 0.0 110.263 169.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE2' ' HD2' ' A' ' 93' ' ' ARG . 36.0 p90 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.026 0.441 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 137.43 53.17 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.489 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -83.09 151.5 25.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.98 155.21 50.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.55 123.62 28.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.885 1.274 . . . . 0.0 108.538 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 52' ' ' ARG . 86.1 t -101.91 151.01 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.734 2.014 . . . . 0.0 106.225 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -128.26 120.89 28.06 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.546 1.539 . . . . 0.0 108.615 166.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.85 123.51 44.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.05 20.52 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.902 0.319 . . . . 0.0 110.147 166.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.6 ttt180 -119.69 93.79 4.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.138 2.175 . . . . 0.0 105.718 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.29 -13.78 7.11 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.046 0.538 . . . . 0.0 110.69 170.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.86 -112.45 0.19 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -65.2 -18.69 65.51 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.96 -173.65 53.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.101 0.834 . . . . 0.0 112.39 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 4.1 m-85 -71.82 111.14 6.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.433 0.693 . . . . 0.0 110.11 -164.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.26 46.47 3.64 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.419 1.009 . . . . 0.0 114.241 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -135.1 163.39 30.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.222 1.511 . . . . 0.0 110.368 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -120.27 157.29 29.47 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.294 1.838 . . . . 0.0 107.876 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.62 135.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.93 -178.85 6.02 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.213 1.405 . . . . 0.0 107.463 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.71 -154.35 46.93 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.34 34.25 40.89 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.281 0.943 . . . . 0.0 112.402 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 -46.44 43.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -167.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.09 157.96 32.71 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.423 1.089 . . . . 0.0 108.537 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.69 96.04 0.82 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.723 2.949 . . . . 0.0 108.129 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.13 -24.56 2.06 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.942 1.734 . . . . 0.0 111.44 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -73.73 150.71 88.77 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 119.399 1.599 . . . . 0.0 112.753 -171.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.38 149.55 69.45 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.588 2.858 . . . . 0.0 109.377 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -113.45 88.72 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.2 mt -93.3 125.98 38.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.9 mm -43.83 120.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.484 1.913 . . . . 0.0 106.87 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.96 -56.68 23.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 124.925 1.25 . . . . 0.0 111.709 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.58 153.48 31.48 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.1 t -112.96 112.79 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 118.89 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.981 1.712 . . . . 0.0 108.368 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.53 124.55 12.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.113 0.965 . . . . 0.0 110.536 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . 0.252 20.4 ptp 46.81 20.39 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.701 2.4 . . . . 0.0 115.283 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.74 -173.19 42.72 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -58.84 -39.06 80.13 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.217 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.07 -28.59 60.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 121.679 2.036 . . . . 0.0 111.973 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.56 -47.62 69.31 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.052 0.941 . . . . 0.0 109.241 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -60.51 -40.21 90.62 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.497 0.719 . . . . 0.0 111.177 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.16 -23.5 67.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.388 1.475 . . . . 0.0 111.929 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.82 72.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.214 1.388 . . . . 0.0 113.121 167.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 13' ' ' VAL . 1.9 mmp_? -122.72 -13.2 7.97 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.147 -163.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.449 ' HG ' HG21 ' A' ' 13' ' ' VAL . 17.5 mt -119.99 151.3 39.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.907 1.23 . . . . 0.0 107.885 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -132.35 149.21 72.51 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.671 164.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.44 134.92 40.47 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.678 1.585 . . . . 0.0 108.203 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.17 1.05 76.27 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.243 -1.309 . . . . 0.0 113.961 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.12 140.68 58.82 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.563 2.181 . . . . 0.0 107.354 161.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HG3' HD23 ' A' ' 37' ' ' LEU . 24.3 tt0 -85.96 128.24 34.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.549 1.522 . . . . 0.0 108.767 173.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.26 158.0 36.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.887 0.767 . . . . 0.0 110.175 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.86 -53.29 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.499 1.919 . . . . 0.0 107.708 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -132.59 148.46 52.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.845 1.258 . . . . 0.0 108.894 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 63.43 -2.48 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.431 2.293 . . . . 0.0 112.222 -169.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.3 31.8 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 127.361 2.41 . . . . 0.0 112.096 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.3 125.31 50.55 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.73 127.02 14.01 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.136 2.557 . . . . 0.0 108.555 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.03 -2.94 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.836 0.854 . . . . 0.0 110.565 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.24 120.29 14.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.901 0.88 . . . . 0.0 110.687 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.89 -12.24 37.16 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.777 1.18 . . . . 0.0 112.75 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.42 177.35 8.57 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.08 1.352 . . . . 0.0 107.814 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -105.3 175.33 5.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.622 0.769 . . . . 0.0 110.431 -172.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -52.05 -48.61 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.781 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -55.37 -35.09 64.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.38 -50.3 62.71 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.43 -40.49 82.31 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 124.035 0.934 . . . . 0.0 110.909 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mm -50.66 -42.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.586 1.084 . . . . 0.0 111.231 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -39.2 70.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.705 0.402 . . . . 0.0 110.57 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -50.18 73.65 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 122.917 0.487 . . . . 0.0 110.616 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.31 -40.14 85.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.317 0.508 . . . . 0.0 110.944 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -32.35 73.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.41 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -70.73 -57.46 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.523 1.529 . . . . 0.0 111.133 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.42 69.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.103 0.961 . . . . 0.0 111.303 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.09 72.35 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.582 -1.324 . . . . 0.0 111.09 169.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -73.73 -35.92 65.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 117.389 -1.291 . . . . 0.0 111.704 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -56.52 -25.82 52.75 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.082 0.855 . . . . 0.0 110.031 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.44 9.2 86.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 123.936 0.779 . . . . 0.0 111.571 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -160.28 165.62 31.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.037 1.419 . . . . 0.0 109.279 170.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.33 127.32 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.17 139.13 35.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 160.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.71 105.66 6.57 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.8 m -91.04 121.19 32.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.01 170.17 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' CE2' ' A' ' 8' ' ' TYR . 31.2 ptt180 -150.83 166.24 31.12 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.307 -1.496 . . . . 0.0 108.818 167.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -155.12 146.76 23.2 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? . . . . . 0 C--O 1.239 0.552 0 C-N-CA 124.871 1.269 . . . . 0.0 111.17 168.054 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.0 p90 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -128.91 129.46 45.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.79 146.13 28.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.4 116.66 21.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.84 130.57 34.92 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 52' ' ' ARG . 61.4 t -133.7 130.41 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.507 1.523 . . . . 0.0 107.29 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -126.46 122.12 34.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -169.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.63 123.38 43.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -75.04 158.28 33.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.384 0.612 . . . . 0.0 109.645 169.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.7 ttt85 -125.48 88.28 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 168.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 ptm -142.33 -12.81 0.81 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 173.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -132.83 -71.99 0.52 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.639 1.576 . . . . 0.0 107.657 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -119.34 0.06 11.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.35 -156.97 52.57 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.702 1.137 . . . . 0.0 112.452 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.8 m-85 -108.94 105.16 14.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.75 0.82 . . . . 0.0 110.158 -169.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.95 41.83 3.11 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.307 1.908 . . . . 0.0 114.296 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.32 150.54 52.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.632 1.716 . . . . 0.0 110.166 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.06 160.21 14.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.739 1.616 . . . . 0.0 108.952 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.79 138.34 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.76 163.12 38.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.205 2.202 . . . . 0.0 106.0 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.62 176.09 42.06 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.11 90.07 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 -149.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.8 -26.41 65.18 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.658 0.783 . . . . 0.0 110.437 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.64 160.53 46.04 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.95 53.01 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.688 3.592 . . . . 0.0 109.651 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.73 58.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -136.27 161.65 61.04 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 111.569 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -73.31 132.31 17.64 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.955 2.437 . . . . 0.0 109.409 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.65 108.1 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 58' ' ' GLU . 5.3 mt -100.01 149.66 23.23 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 mm -49.55 118.28 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.6 -72.81 0.84 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -171.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.1 117.15 4.83 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.861 0.865 . . . . 0.0 109.024 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.267 0.6 OUTLIER -80.0 149.26 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 121.308 0.575 . . . . 0.0 109.451 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -80.82 107.59 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.22 146.36 15.4 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 mmt 64.0 -10.86 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.236 1.814 . . . . 0.0 112.72 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.88 169.39 53.68 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -60.78 -23.03 64.7 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.13 -45.19 42.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.782 1.628 . . . . 0.0 110.96 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.13 -51.45 69.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -64.24 -34.53 78.32 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.489 -0.757 . . . . 0.0 112.237 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.76 -29.59 70.23 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.287 0.948 . . . . 0.0 110.792 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.39 28.32 52.89 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.816 161.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 13' ' ' VAL . 60.1 mtp85 -136.78 -18.5 1.39 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.432 1.116 . . . . 0.0 113.343 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -90.01 148.25 23.18 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -135.32 157.04 77.47 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 125.062 1.345 . . . . 0.0 107.643 157.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.8 149.71 86.53 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.443 1.429 . . . . 0.0 108.881 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.63 -2.63 72.18 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.623 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.6 136.82 56.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.934 1.867 . . . . 0.0 107.276 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HG3' HD23 ' A' ' 37' ' ' LEU . 33.6 tt0 -85.37 127.36 34.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.766 1.166 . . . . 0.0 109.581 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.09 153.58 30.05 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.228 1.011 . . . . 0.0 110.224 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.5 -46.51 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 126.165 1.786 . . . . 0.0 109.055 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.4 148.42 42.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.403 1.081 . . . . 0.0 110.553 -176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.0 t -145.49 131.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 107.849 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 61.29 14.01 5.32 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.205 1.402 . . . . 0.0 111.333 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.08 -5.73 75.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 127.112 2.292 . . . . 0.0 113.444 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -104.36 133.99 19.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 121.069 2.434 . . . . 0.0 109.381 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.61 120.92 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.313 2.675 . . . . 0.0 110.786 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.62 -2.27 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.754 1.222 . . . . 0.0 112.62 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.62 125.12 22.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.357 1.063 . . . . 0.0 110.274 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.47 -7.12 9.07 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.367 0.984 . . . . 0.0 114.535 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 14.6 mmtt -82.88 174.29 11.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.412 1.485 . . . . 0.0 108.778 167.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.8 p -111.82 175.48 5.41 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.616 0.766 . . . . 0.0 110.696 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -38.69 -62.89 0.56 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.044 1.338 . . . . 0.0 110.586 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 ttp-105 -56.42 -34.09 66.43 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.595 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 76.0 t80 -58.12 -44.43 87.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.315 0.578 . . . . 0.0 110.978 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.97 -31.75 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.232 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.92 -41.48 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.265 -1.522 . . . . 0.0 111.272 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.88 -52.04 67.13 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.511 1.524 . . . . 0.0 109.042 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -51.3 69.78 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.277 0.631 . . . . 0.0 111.141 -175.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.2 mmm -61.98 -21.67 65.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 112.497 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 -32.59 53.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.723 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -66.27 -47.39 73.84 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.318 0.963 . . . . 0.0 110.126 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.05 70.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.41 73.99 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.9 -1.75 . . . . 0.0 112.887 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -68.68 -49.88 55.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.29 -20.6 7.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.432 1.493 . . . . 0.0 112.213 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.15 71.27 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.338 1.923 . . . . 0.0 111.329 170.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -177.47 170.56 2.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.441 2.296 . . . . 0.0 107.223 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.11 149.92 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.31 137.22 45.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.44 106.83 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -97.09 111.41 23.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.61 173.45 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -151.36 164.87 35.71 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.741 -1.225 . . . . 0.0 109.514 170.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.2 146.76 25.02 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.959 1.304 . . . . 0.0 108.322 164.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.325 0 C-N-CA 124.665 1.186 . . . . 0.0 110.632 170.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 135.37 52.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -84.28 145.14 28.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.71 116.83 21.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -102.56 111.09 23.24 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 107.766 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.95 150.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.369 1.868 . . . . 0.0 107.356 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -128.53 119.71 25.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.875 1.67 . . . . 0.0 111.59 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.7 mt -116.55 123.01 46.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -72.72 146.55 46.37 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 165.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.83 101.25 13.17 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 152.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.1 ptm -133.98 -9.75 2.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.057 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -138.04 -98.43 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.7 p -66.75 -20.41 65.95 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -162.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.78 73.62 0.66 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 54.74 93.7 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.187 2.595 . . . . 0.0 113.512 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.94 55.7 4.53 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.564 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 90' ' ' LEU . 33.9 p90 -129.31 175.16 8.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.932 1.293 . . . . 0.0 108.311 167.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -137.74 153.54 49.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.011 1.324 . . . . 0.0 107.573 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.42 140.02 47.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.98 160.77 43.0 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.829 2.052 . . . . 0.0 105.662 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 -178.86 52.34 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.06 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.68 48.72 79.22 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 -143.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.98 -37.87 88.98 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.86 161.5 55.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.667 1.987 . . . . 0.0 108.904 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.39 53.98 4.95 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 125.208 3.938 . . . . 0.0 112.288 -163.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.57 0.95 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.552 2.025 . . . . 0.0 112.077 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -75.12 163.94 64.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.042 1.921 . . . . 0.0 111.398 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -74.5 143.49 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.025 2.483 . . . . 0.0 110.13 171.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.42 104.85 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.6 mt -98.32 155.27 17.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -55.67 118.79 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 161.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.87 -56.35 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.24 155.3 42.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.292 1.037 . . . . 0.0 109.257 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 149.28 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 C-N-CA 127.425 2.29 . . . . 0.0 107.224 166.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.68 108.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.7 138.68 10.57 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.496 1.118 . . . . 0.0 110.146 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.8 mmt 59.8 0.95 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.043 2.137 . . . . 0.0 113.856 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.76 -175.99 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.783 1.659 . . . . 0.0 110.845 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -54.37 -35.85 63.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -164.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.85 -51.81 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.011 0.823 . . . . 0.0 110.438 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.55 -45.88 88.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.419 0.688 . . . . 0.0 110.687 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -60.21 -31.34 70.07 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.728 0.811 . . . . 0.0 113.028 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.85 -21.43 64.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.081 0.401 . . . . 0.0 111.728 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.58 45.99 86.78 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.446 1.022 . . . . 0.0 112.875 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -143.53 -47.63 0.29 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.379 1.471 . . . . 0.0 112.173 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.7 153.64 41.08 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.662 0.664 . . . . 0.0 109.489 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -142.36 155.63 64.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.211 1.004 . . . . 0.0 110.436 162.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -57.36 134.87 66.53 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.644 2.229 . . . . 0.0 108.957 167.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.4 7.09 69.98 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.44 0.543 . . . . 0.0 113.694 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -77.71 123.12 26.27 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 171.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG3' HD23 ' A' ' 37' ' ' LEU . 37.7 tt0 -73.05 123.78 24.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.42 149.87 35.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.921 0.888 . . . . 0.0 109.253 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.11 -52.12 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -134.09 147.44 50.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.381 1.072 . . . . 0.0 109.464 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.8 t -145.51 123.32 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -171.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.14 -56.38 0.23 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.398 2.279 . . . . 0.0 109.107 -160.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.37 -7.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.694 2.093 . . . . 0.0 110.847 164.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 65' ' ' ILE . 4.3 mp -73.48 139.05 77.83 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 127.242 2.217 . . . . 0.0 107.442 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.57 127.76 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.099 2.532 . . . . 0.0 112.704 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.73 -9.14 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.711 0.804 . . . . 0.0 113.103 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.41 129.86 43.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.926 0.891 . . . . 0.0 110.525 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.49 -12.7 2.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.427 1.013 . . . . 0.0 115.456 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 69.0 mmtt -75.34 179.03 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.712 . . . . 0.0 108.134 169.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.5 p -115.52 171.34 7.79 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.768 -0.582 . . . . 0.0 110.043 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -34.58 -60.21 0.44 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.538 1.935 . . . . 0.0 112.142 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -53.33 -37.41 62.29 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.946 1.298 . . . . 0.0 113.111 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 49.6 t80 -52.14 -45.45 65.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.992 0.917 . . . . 0.0 110.01 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.82 -37.92 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 124.785 1.234 . . . . 0.0 110.188 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.22 -35.27 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 121.539 -0.725 . . . . 0.0 110.104 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.69 -39.85 95.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.676 0.79 . . . . 0.0 111.331 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.39 -37.4 68.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.106 0.962 . . . . 0.0 111.033 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -38.92 78.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.056 0.942 . . . . 0.0 109.604 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -43.8 97.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.682 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -46.9 72.02 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.303 0.956 . . . . 0.0 110.555 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.79 -34.61 69.8 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.156 0.582 . . . . 0.0 111.802 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.26 82.77 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.604 -0.685 . . . . 0.0 111.301 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.63 -41.34 65.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.332 1.053 . . . . 0.0 110.123 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -55.66 -24.27 32.96 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.554 1.541 . . . . 0.0 112.389 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.95 63.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.156 1.836 . . . . 0.0 113.039 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -171.51 160.74 6.04 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.365 1.583 . . . . 0.0 109.048 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.29 121.88 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.284 1.04 . . . . 0.0 109.253 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -80.42 132.51 35.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 162.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 24' ' ' PHE . 43.3 mt -127.65 106.06 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 m -94.98 111.63 23.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -99.33 171.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -150.75 161.42 42.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 120.203 -1.561 . . . . 0.0 110.136 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.25 136.54 20.02 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.844 0.831 . . . . 0.0 111.049 165.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 C-N-CA 128.558 2.743 . . . . 0.0 111.843 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 p90 . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 122.405 1.098 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -132.83 130.15 39.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.7 120.95 26.63 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 116.82 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.66 129.88 34.98 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.932 2.093 . . . . 0.0 109.07 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.14 148.84 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.509 1.523 . . . . 0.0 107.107 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -130.72 133.98 46.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 167.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.57 129.36 50.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 124.011 0.819 . . . . 0.0 110.482 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.35 163.19 24.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.899 0.857 . . . . 0.0 110.136 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -114.92 102.38 9.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 164.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.616 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 8.9 ptp -146.62 -62.4 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.616 ' H ' ' HG3' ' A' ' 18' ' ' MET . 1.8 tm-20 -66.46 -171.55 0.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.004 1.721 . . . . 0.0 108.998 151.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -64.87 11.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.073 2.949 . . . . 0.0 117.006 -152.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 78.66 0.83 Allowed Glycine 0 N--CA 1.45 -0.401 0 O-C-N 121.155 -0.966 . . . . 0.0 112.343 160.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.04 81.71 0.13 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.985 2.114 . . . . 0.0 111.907 171.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.59 58.99 3.77 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.017 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.75 167.52 20.39 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.902 1.351 . . . . 0.0 109.808 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -118.64 163.98 16.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.008 2.123 . . . . 0.0 106.85 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 128.71 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.517 1.927 . . . . 0.0 106.319 -175.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.8 161.77 35.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.625 0.726 . . . . 0.0 110.149 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.94 -160.24 34.75 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 28.58 60.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -150.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.28 -30.81 62.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.054 0.542 . . . . 0.0 110.318 -162.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -104.05 161.51 22.71 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.911 2.085 . . . . 0.0 107.948 163.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.69 100.43 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.849 3.033 . . . . 0.0 108.809 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.75 6.51 7.16 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.241 1.401 . . . . 0.0 114.18 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -82.82 157.13 67.17 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 119.339 1.57 . . . . 0.0 110.862 172.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.72 138.89 39.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.49 2.127 . . . . 0.0 110.514 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.9 mt -102.56 95.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.05 145.67 25.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.81 117.03 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.74 -52.65 47.04 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 125.289 1.423 . . . . 0.0 111.471 -168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.19 156.64 22.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.232 3.013 . . . . 0.0 105.137 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.7 130.48 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 169.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.64 117.12 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.16 -31.02 63.0 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.0 mmt -127.72 33.5 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.31 170.58 17.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -62.03 -12.94 21.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.22 -51.26 13.75 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.165 1.348 . . . . 0.0 109.668 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.07 -45.87 86.39 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -54.67 -46.73 74.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.304 0.502 . . . . 0.0 112.007 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.28 -30.51 71.38 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.8 0.273 . . . . 0.0 111.196 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.47 -37.69 3.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 127.437 2.446 . . . . 0.0 112.436 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -65.37 -21.88 66.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.548 1.139 . . . . 0.0 113.774 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.5 132.89 33.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -125.87 157.19 69.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 124.442 1.097 . . . . 0.0 109.309 160.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.28 148.45 74.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.431 1.421 . . . . 0.0 109.45 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.43 -7.19 79.95 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.529 -1.15 . . . . 0.0 112.562 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.04 128.97 37.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.497 1.648 . . . . 0.0 106.798 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.55 125.02 30.67 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 120.81 -1.181 . . . . 0.0 109.12 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.13 145.51 37.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.405 1.082 . . . . 0.0 109.773 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -120.13 -54.21 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.081 2.152 . . . . 0.0 108.245 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -128.57 146.03 50.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.128 1.371 . . . . 0.0 108.97 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -140.04 121.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t0 53.7 16.22 0.95 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.163 1.785 . . . . 0.0 111.963 -168.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.99 69.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 127.455 2.455 . . . . 0.0 114.199 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.12 125.9 71.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 120.834 2.317 . . . . 0.0 106.269 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.14 117.3 5.03 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.055 2.503 . . . . 0.0 108.466 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' A' ' 75' ' ' VAL . 26.6 m -79.1 -6.33 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.723 0.809 . . . . 0.0 111.669 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 121.35 16.86 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.146 0.578 . . . . 0.0 110.373 -171.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.41 -9.39 75.66 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.902 1.239 . . . . 0.0 112.978 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 66.5 mmtt -74.93 -164.34 0.29 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.282 1.433 . . . . 0.0 108.13 166.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -120.86 170.02 9.88 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.685 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -38.46 -61.44 0.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.956 1.702 . . . . 0.0 109.414 165.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -42.99 -46.22 5.38 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 128.46 2.704 . . . . 0.0 112.645 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 42.3 t80 -58.83 -40.91 85.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 111.118 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' CG1' ' A' ' 67' ' ' VAL . 18.9 t -75.44 -32.23 25.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.372 -0.83 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -60.35 -40.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.763 1.165 . . . . 0.0 109.763 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.15 -45.69 92.21 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 110.269 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -48.96 78.52 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.644 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.8 mmm -60.11 -33.36 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.239 0.927 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -61.92 -45.3 94.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.208 0.603 . . . . 0.0 110.044 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -58.96 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.224 1.41 . . . . 0.0 111.355 175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.65 73.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.192 1.397 . . . . 0.0 110.581 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.74 63.76 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.961 -1.087 . . . . 0.0 111.003 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -70.43 -41.78 72.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.79 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.01 -10.31 9.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.981 2.113 . . . . 0.0 113.365 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.76 1.5 83.91 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.012 1.291 . . . . 0.0 113.269 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -159.71 -178.59 7.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.979 2.112 . . . . 0.0 108.043 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.58 131.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.77 1.628 . . . . 0.0 106.752 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.69 141.89 34.44 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 162.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -135.8 122.81 21.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -115.7 113.18 23.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.24 168.71 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.92 148.91 29.68 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 119.678 -1.889 . . . . 0.0 110.208 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -147.2 123.99 11.23 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 C-N-CA 125.461 1.504 . . . . 0.0 111.373 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 30.9 p90 . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.712 0.292 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -122.53 141.96 51.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.3 159.53 21.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 166.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.54 146.82 40.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.374 1.47 . . . . 0.0 107.39 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.42 139.01 38.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.281 1.833 . . . . 0.0 109.322 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.2 t -137.52 107.42 4.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -100.66 139.3 36.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.9 mt -134.83 149.99 50.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.767 0.827 . . . . 0.0 109.976 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -97.84 151.26 20.4 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 109.447 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 60.6 ttt-85 -125.92 76.89 1.63 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 0.0 108.835 177.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -143.61 13.48 1.74 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.232 0.613 . . . . 0.0 111.151 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -147.82 -121.58 0.06 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.362 1.865 . . . . 0.0 106.935 -175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -31.13 71.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.078 -1.639 . . . . 0.0 111.826 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.23 -177.28 39.73 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.86 155.29 40.78 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.9 0.88 . . . . 0.0 110.393 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.72 63.23 0.47 Allowed Glycine 0 C--N 1.337 0.639 0 C-N-CA 124.294 0.95 . . . . 0.0 111.902 -170.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 90' ' ' LEU . 37.4 p90 -128.79 170.36 13.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.882 1.273 . . . . 0.0 109.098 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -122.16 163.36 19.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 156.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.26 133.63 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.1 mt -142.85 121.73 12.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.52 179.51 15.76 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.21 29.93 76.53 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -167.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -66.47 -20.45 66.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.573 0.687 . . . . 0.0 110.166 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.57 155.32 80.44 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.914 1.686 . . . . 0.0 110.103 165.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.43 81.88 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.094 3.863 . . . . 0.0 115.165 -165.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.92 -12.75 1.92 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 124.974 1.273 . . . . 0.0 112.033 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -66.82 157.14 85.08 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 117.55 0.675 . . . . 0.0 110.529 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.69 113.04 3.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.733 2.289 . . . . 0.0 111.777 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.56 105.16 6.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.4 mt -93.43 158.48 15.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.421 1.088 . . . . 0.0 109.704 166.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.43 126.04 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 154.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.91 -77.88 0.18 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.35 144.9 29.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.636 1.175 . . . . 0.0 108.602 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 1.2 m -98.79 140.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 123.88 0.872 . . . . 0.0 110.14 169.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.83 111.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.64 -39.83 68.38 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.256 0.551 . . . . 0.0 112.053 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.6 mmt -106.12 44.42 1.05 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.002 0.921 . . . . 0.0 109.053 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.85 165.09 27.73 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.8 1.667 . . . . 0.0 109.643 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -69.11 -10.32 57.07 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 115.653 1.724 . . . . 0.0 115.653 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.05 56.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.092 1.315 . . . . 0.0 109.348 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.89 -43.5 92.71 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.141 0.9 . . . . 0.0 110.058 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -55.82 -43.04 76.57 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.242 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.33 -18.48 63.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.621 1.1 . . . . 0.0 112.643 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.26 54.64 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.448 1.023 . . . . 0.0 113.078 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -134.5 -38.46 0.83 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -74.16 170.16 16.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.777 1.171 . . . . 0.0 109.418 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.08 152.22 42.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.15 0.98 . . . . 0.0 109.445 156.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.94 120.08 6.79 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.11 2.54 . . . . 0.0 108.585 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.62 6.2 54.91 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.378 -1.235 . . . . 0.0 112.951 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.67 142.41 58.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.654 1.727 . . . . 0.0 108.383 159.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' HD23 ' A' ' 37' ' ' LEU . 6.4 tt0 -86.72 125.8 34.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.312 1.045 . . . . 0.0 109.466 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.624 HD23 HG12 ' A' ' 92' ' ' VAL . 12.2 mt -79.75 156.43 27.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.038 1.335 . . . . 0.0 110.809 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.39 -54.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.583 1.953 . . . . 0.0 111.693 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.61 143.87 49.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.508 1.523 . . . . 0.0 110.777 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.46 111.99 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 72.32 -38.02 0.41 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.102 2.961 . . . . 0.0 111.25 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 65' ' ' ILE . . . 164.32 -3.55 0.06 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 130.617 3.961 . . . . 0.0 109.797 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 65' ' ' ILE . 1.0 OUTLIER -100.11 125.87 38.41 Favored Pre-proline 0 N--CA 1.439 -1.023 0 O-C-N 120.562 -1.552 . . . . 0.0 107.058 -168.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.19 141.03 67.48 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.903 1.735 . . . . 0.0 109.662 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -90.15 -9.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.234 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.72 117.87 5.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.152 0.981 . . . . 0.0 110.12 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.04 83.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.849 0.738 . . . . 0.0 114.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG3' ' CE2' ' A' ' 74' ' ' TYR . 26.3 mmmt -87.01 -171.83 3.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.304 1.441 . . . . 0.0 107.495 167.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -130.58 -179.55 5.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.168 0.987 . . . . 0.0 109.893 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -53.82 -57.44 10.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.661 0.784 . . . . 0.0 111.057 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.75 70.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.276 0.944 . . . . 0.0 112.879 -171.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 58.2 t80 -46.78 -59.67 2.9 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.038 0.935 . . . . 0.0 109.819 167.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.97 -36.61 76.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 123.37 0.668 . . . . 0.0 109.286 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.35 -32.63 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.652 -1.28 . . . . 0.0 111.507 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.84 -33.86 66.43 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.156 -1.59 . . . . 0.0 110.904 168.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -72.59 -32.81 66.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.108 0.963 . . . . 0.0 111.357 -173.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 62.3 mmm -58.58 -36.81 74.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.57 1.148 . . . . 0.0 111.279 166.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -73.04 -45.74 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.11 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -51.14 -55.55 17.24 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 125.257 1.423 . . . . 0.0 110.962 170.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -58.71 -42.75 89.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.776 0.831 . . . . 0.0 111.058 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.0 -14.64 60.91 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.464 -1.397 . . . . 0.0 113.058 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -85.7 -36.67 20.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.83 1.195 . . . . 0.0 111.068 165.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -62.67 -15.85 54.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.85 21.03 79.18 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.935 1.731 . . . . 0.0 112.546 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -164.78 177.05 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.755 2.022 . . . . 0.0 106.811 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 82' ' ' ALA . 5.0 p -154.58 160.16 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -141.76 91.09 2.33 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.68 0.792 . . . . 0.0 108.907 -170.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 24' ' ' PHE . 21.3 mt -98.24 99.5 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.49 1.516 . . . . 0.0 107.815 -170.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -87.9 131.35 34.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.624 HG12 HD23 ' A' ' 59' ' ' LEU . 33.2 m -120.4 167.7 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.411 1.884 . . . . 0.0 108.211 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -152.39 151.85 31.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 121.031 -1.043 . . . . 0.0 110.292 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -145.02 134.82 23.56 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.478 0.711 . . . . 0.0 109.116 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.293 0 C-N-CA 126.39 1.876 . . . . 0.0 111.112 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.717 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t 58.08 26.57 13.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.025 0.93 . . . . 0.0 112.187 -169.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.6 p -119.56 -25.7 5.93 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.445 1.098 . . . . 0.0 112.157 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.66 105.46 2.68 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.62 -50.7 49.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.152 0.981 . . . . 0.0 111.037 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.3 t -147.66 132.51 18.03 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -163.76 -61.92 0.02 OUTLIER Glycine 0 C--O 1.224 -0.475 0 CA-C-O 118.14 -1.366 . . . . 0.0 110.837 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -125.27 155.71 39.73 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 120.509 2.155 . . . . 0.0 111.063 174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -116.0 139.91 49.79 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 170.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.9 152.31 24.61 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 164.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 mp -133.38 127.84 34.32 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.18 149.53 27.87 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 109.554 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -139.24 107.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -76.07 143.43 41.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 164.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.12 131.24 32.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 162.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -82.19 153.63 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.232 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -108.25 87.35 2.48 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.2 mtm -143.88 -3.51 0.88 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.66 -64.14 0.76 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -171.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.9 m -126.29 -14.28 5.95 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.47 60.7 3.93 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-N 119.728 1.149 . . . . 0.0 112.382 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 85.5 93.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.608 2.363 . . . . 0.0 110.568 160.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.72 53.76 4.58 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 123.677 0.656 . . . . 0.0 112.325 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' CE1' HD11 ' A' ' 90' ' ' LEU . 31.2 p90 -130.44 173.51 10.77 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.373 1.086 . . . . 0.0 109.039 169.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -140.37 165.61 26.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 170.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -140.5 128.66 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -164.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -139.62 -177.13 4.81 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.526 1.93 . . . . 0.0 108.053 -173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.43 -146.67 36.2 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 54.57 31.97 52.94 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 118.186 0.993 . . . . 0.0 112.652 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.96 -30.92 56.23 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.083 -0.657 . . . . 0.0 112.145 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -114.85 158.9 39.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.73 91.09 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.245 2.63 . . . . 0.0 109.638 -174.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.3 1.84 10.11 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.14 1.353 . . . . 0.0 114.17 -176.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -64.5 159.88 56.34 Favored Pre-proline 0 C--O 1.239 0.54 0 CA-C-N 119.428 1.614 . . . . 0.0 109.237 163.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -69.82 145.35 56.51 Favored 'Trans proline' 0 N--CA 1.445 -1.375 0 C-N-CA 122.654 2.236 . . . . 0.0 111.224 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.4 mt -120.53 92.88 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 mt -100.69 140.73 34.56 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.653 3.581 . . . . 0.0 109.543 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.81 109.59 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.653 1.581 . . . . 0.0 107.672 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.76 -46.55 31.16 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 127.661 2.553 . . . . 0.0 112.569 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.99 163.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.545 1.538 . . . . 0.0 107.424 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.59 131.9 57.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 161.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.11 107.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.34 132.01 47.03 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.753 0.658 . . . . 0.0 109.853 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 53.1 mtm 68.49 -5.94 0.88 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.537 1.935 . . . . 0.0 114.19 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.64 176.81 53.5 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 122.192 0.884 . . . . 0.0 111.811 -171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 32.1 t -60.48 -8.84 3.01 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.217 1.807 . . . . 0.0 115.018 -167.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.78 -46.62 6.19 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 120.137 1.335 . . . . 0.0 111.609 168.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -56.4 -40.1 74.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.477 1.511 . . . . 0.0 110.306 177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.48 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 13.3 ptm180 -69.89 -22.0 63.27 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 174.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -22.57 55.78 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.174 0.897 . . . . 0.0 110.129 170.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.8 60.3 8.94 Favored Glycine 0 C--N 1.342 0.877 0 C-N-CA 125.643 1.592 . . . . 0.0 110.79 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.8 mtm180 -146.68 2.29 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -174.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -135.56 151.0 49.88 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -129.22 149.87 73.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 125.097 1.359 . . . . 0.0 109.053 165.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.81 130.58 34.74 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.556 2.838 . . . . 0.0 111.317 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.62 88.18 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.066 -1.408 . . . . 0.0 113.671 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -60.25 127.81 33.64 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 119.172 1.486 . . . . 0.0 107.761 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 119.28 18.06 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 59' ' ' LEU . 5.6 mt -63.83 164.4 10.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.878 1.671 . . . . 0.0 111.001 173.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -137.2 -52.76 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 125.203 1.401 . . . . 0.0 109.673 169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.34 148.19 52.65 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 124.005 0.922 . . . . 0.0 108.553 -173.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 93.6 t -137.0 113.69 12.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 58.58 5.23 0.44 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.876 2.47 . . . . 0.0 114.198 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.46 -5.94 6.67 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 127.947 2.689 . . . . 0.0 113.094 176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.403 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.0 124.6 34.25 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-N 119.483 1.642 . . . . 0.0 107.747 -173.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -71.65 114.71 4.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 124.42 3.413 . . . . 0.0 109.179 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.72 -7.46 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.75 1.22 . . . . 0.0 112.789 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.24 129.85 40.47 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.579 -0.701 . . . . 0.0 110.313 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.4 -6.01 84.06 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.991 -0.443 . . . . 0.0 113.374 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -101.22 -166.95 1.36 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.604 1.561 . . . . 0.0 108.195 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.5 p -121.56 177.75 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.075 0.95 . . . . 0.0 110.892 -170.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -52.19 -56.27 15.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.616 0.766 . . . . 0.0 109.759 169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -55.69 -33.41 64.12 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -52.79 -50.93 62.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.816 0.846 . . . . 0.0 110.357 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.55 -38.19 78.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 C-N-CA 124.947 1.299 . . . . 0.0 111.16 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.0 mm -56.53 -39.46 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 118.868 0.758 . . . . 0.0 109.224 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -37.77 85.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.944 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.37 -49.69 74.56 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.234 0.613 . . . . 0.0 111.047 175.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 81.6 mmm -58.46 -36.77 74.19 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.87 0.468 . . . . 0.0 111.133 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.31 -14.51 56.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.263 1.025 . . . . 0.0 113.105 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -96.27 -49.29 5.27 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.15 1.38 . . . . 0.0 110.825 168.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.76 -41.33 73.86 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.126 0.97 . . . . 0.0 110.63 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.0 -22.02 65.34 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.311 -1.493 . . . . 0.0 113.152 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -80.62 -43.52 20.37 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.535 1.134 . . . . 0.0 109.517 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -54.91 -23.64 19.76 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.329 0.652 . . . . 0.0 110.975 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.73 13.76 79.19 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.475 1.036 . . . . 0.0 111.956 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.15 174.68 12.6 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.231 2.212 . . . . 0.0 106.751 171.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.47 164.68 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 170.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -129.21 133.01 47.36 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 166.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.444 HD11 ' CE1' ' A' ' 24' ' ' PHE . 18.1 mt -130.61 97.48 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.119 2.168 . . . . 0.0 105.386 -169.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.1 m -85.49 117.07 24.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.19 170.11 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.781 1.232 . . . . 0.0 108.743 172.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -152.9 145.89 24.55 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 119.594 -1.942 . . . . 0.0 112.326 176.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.57 130.57 17.27 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.754 0.706 . . . . 0.0 110.252 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.19 126.78 27.62 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.072 1.349 . . . . 0.0 109.721 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.7 t -76.82 118.61 23.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 127.254 2.221 . . . . 0.0 107.093 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.14 153.7 51.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.865 0.866 . . . . 0.0 109.352 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -157.97 158.58 35.21 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 129.7 3.2 . . . . 0.0 105.202 165.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 144.65 98.73 0.26 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.96 167.01 27.85 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.811 2.341 . . . . 0.0 111.079 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 72.6 m -158.0 -56.21 0.07 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.633 1.973 . . . . 0.0 107.902 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.22 158.24 43.96 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.34 1.456 . . . . 0.0 108.196 172.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.802 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.712 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.9 m -86.65 160.62 18.82 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.613 0.72 . . . . 0.0 111.617 -173.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -132.56 70.26 1.47 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 151.95 72.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -170.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.5 m -144.65 153.89 42.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 165.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m 48.68 75.83 0.13 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.836 0.854 . . . . 0.0 111.243 -171.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.49 -107.07 0.13 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 157.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -54.19 138.03 39.37 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 117.464 0.632 . . . . 0.0 111.657 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -91.65 136.09 33.4 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 167.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -83.52 155.83 23.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.736 1.273 . . . . 0.0 108.122 151.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.32 116.93 10.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 127.158 2.183 . . . . 0.0 106.62 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.48 134.44 34.64 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.516 1.127 . . . . 0.0 109.767 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.412 HG22 ' HE ' ' A' ' 52' ' ' ARG . 79.6 t -129.04 143.36 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 127.014 2.125 . . . . 0.0 107.979 174.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -129.13 103.17 6.82 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.464 -0.773 . . . . 0.0 110.548 -177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -103.48 131.8 50.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.857 0.837 . . . . 0.0 109.772 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -86.86 160.73 18.64 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.418 0.687 . . . . 0.0 110.639 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -121.83 86.79 2.64 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.991 0.917 . . . . 0.0 110.488 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 mtp -130.41 -9.94 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.697 169.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.69 -100.32 0.19 Allowed 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -170.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -29.73 70.7 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 120.12 1.327 . . . . 0.0 110.709 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.73 73.73 0.84 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 -167.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 69.58 -115.8 0.12 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.308 1.843 . . . . 0.0 109.167 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 130.32 40.55 0.25 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 120.846 1.657 . . . . 0.0 112.742 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -123.22 175.52 6.63 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.045 1.338 . . . . 0.0 108.508 168.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -135.59 167.11 21.71 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.54 121.69 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.837 1.199 . . . . 0.0 109.07 -162.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.7 mt -138.26 147.09 43.31 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.32 -163.3 12.55 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -169.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.6 28.15 64.78 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 118.29 1.045 . . . . 0.0 112.458 176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.22 -37.88 86.62 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 121.427 -1.043 . . . . 0.0 110.233 -174.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.53 160.99 30.94 Favored Pre-proline 0 N--CA 1.449 -0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.417 173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.77 46.91 2.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.705 3.603 . . . . 0.0 112.588 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -176.13 48.29 0.12 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.993 1.759 . . . . 0.0 109.858 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -123.26 164.05 30.17 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 124.596 1.159 . . . . 0.0 110.759 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -75.6 143.89 27.73 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.477 2.785 . . . . 0.0 108.463 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -116.58 100.38 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.9 mt -87.95 151.01 23.12 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.1 mm -57.56 112.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 162.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.12 -56.39 24.39 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 126.814 2.149 . . . . 0.0 111.763 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.58 167.86 28.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.571 1.949 . . . . 0.0 106.943 172.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.38 130.71 74.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 175.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.8 mm -79.93 115.39 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.46 -21.2 3.45 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.491 1.917 . . . . 0.0 115.085 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.7 mmt -122.28 7.06 9.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.73 1.612 . . . . 0.0 110.989 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.91 167.63 34.91 Favored Glycine 0 CA--C 1.524 0.61 0 O-C-N 120.701 -1.249 . . . . 0.0 110.53 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.417 ' HA ' ' CG ' ' A' ' 49' ' ' ARG . 0.3 OUTLIER -61.94 -12.86 20.34 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.292 1.037 . . . . 0.0 112.613 175.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.79 -69.12 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.997 0.817 . . . . 0.0 110.128 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.15 -43.75 78.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 118.643 0.656 . . . . 0.0 111.931 -172.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.417 ' CG ' ' HA ' ' A' ' 46' ' ' SER . 0.1 OUTLIER -65.97 -10.04 35.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.687 -1.149 . . . . 0.0 113.764 178.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.37 -46.51 15.93 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.412 1.46 . . . . 0.0 109.807 167.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.29 37.28 4.37 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.849 1.214 . . . . 0.0 114.189 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 13' ' ' VAL . 50.6 mtp85 -127.3 -62.69 1.08 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.001 1.401 . . . . 0.0 112.635 -171.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.17 143.52 55.36 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.046 0.938 . . . . 0.0 110.424 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -126.11 153.11 74.11 Favored Pre-proline 0 C--N 1.326 -0.456 0 C-N-CA 123.803 0.841 . . . . 0.0 109.756 166.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.75 141.81 64.03 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.95 1.767 . . . . 0.0 109.344 164.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.26 -8.55 63.81 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-O 117.45 -1.75 . . . . 0.0 114.495 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -63.04 126.5 27.55 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 119.953 1.876 . . . . 0.0 107.166 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HG3' HD23 ' A' ' 37' ' ' LEU . 26.0 tt0 -79.69 121.13 24.94 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.13 153.02 36.57 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.639 1.176 . . . . 0.0 110.002 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.6 t -130.99 -50.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.463 1.505 . . . . 0.0 109.088 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.32 143.71 50.06 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.24 122.06 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t0 54.84 21.82 3.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.714 1.205 . . . . 0.0 112.207 -167.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.95 -5.97 82.45 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 117.713 -1.604 . . . . 0.0 113.921 -174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -92.11 128.88 43.59 Favored Pre-proline 0 N--CA 1.451 -0.392 0 CA-C-N 120.928 2.364 . . . . 0.0 106.592 -175.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -68.71 119.05 6.07 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.994 2.463 . . . . 0.0 109.509 -173.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.34 -4.99 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 125.272 1.429 . . . . 0.0 110.619 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.06 115.96 4.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.561 1.144 . . . . 0.0 109.554 -172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.05 -1.92 21.69 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.908 0.766 . . . . 0.0 113.987 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -80.94 164.96 22.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 120.616 2.208 . . . . 0.0 108.876 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.4 p -81.16 171.25 15.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.46 0.704 . . . . 0.0 110.577 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -53.23 -49.98 65.69 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.28 -1.513 . . . . 0.0 109.389 169.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -61.85 -28.23 69.34 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -48.98 -57.02 7.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.721 1.208 . . . . 0.0 109.779 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.5 t -63.8 -39.19 84.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 124.884 1.274 . . . . 0.0 110.435 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.42 -27.74 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 121.237 -0.914 . . . . 0.0 110.511 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.02 -41.04 68.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.557 1.143 . . . . 0.0 111.219 170.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.74 -52.03 67.44 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.836 0.854 . . . . 0.0 109.823 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 71.4 mmm -54.83 -39.13 68.23 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.036 0.835 . . . . 0.0 111.391 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.69 -43.5 98.73 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.28 0.632 . . . . 0.0 110.801 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.99 -49.0 64.22 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.847 1.259 . . . . 0.0 111.769 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.97 -37.03 71.02 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.262 1.825 . . . . 0.0 110.275 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.41 -36.99 76.9 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.378 -0.826 . . . . 0.0 111.913 174.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -70.46 -39.56 74.21 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.649 1.113 . . . . 0.0 110.917 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -66.02 -20.6 66.24 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.712 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.97 70.72 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.674 1.131 . . . . 0.0 112.522 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -163.72 162.15 23.84 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 125.441 1.496 . . . . 0.0 108.273 -172.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.58 128.38 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -80.49 141.77 34.86 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 161.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 39.8 mt -135.4 105.13 6.11 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.9 m -100.52 116.32 32.19 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.2 m -105.16 167.39 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.902 1.281 . . . . 0.0 107.946 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 ptt85 -149.38 153.59 37.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.698 -1.251 . . . . 0.0 111.582 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -144.32 132.29 21.52 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.268 1.027 . . . . 0.0 109.306 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.29 139.78 18.33 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.699 1.2 . . . . 0.0 110.846 167.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.4 p -122.49 165.56 18.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 C-N-CA 125.65 1.58 . . . . 0.0 106.759 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.52 -175.63 4.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.588 1.155 . . . . 0.0 108.32 -175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.0 t -143.76 -54.83 0.37 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.369 0.668 . . . . 0.0 110.561 173.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.77 -175.74 23.03 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.58 140.61 93.91 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.89 2.394 . . . . 0.0 111.803 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.85 127.09 31.88 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.18 1.792 . . . . 0.0 106.487 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 160.57 41.31 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 165.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.39 0 N-CA-C 105.854 -2.899 . . . . 0.0 105.854 -176.533 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m -98.05 -63.48 1.12 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.862 0.831 . . . . 0.0 109.461 173.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 m -143.4 167.66 21.66 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 123.642 0.777 . . . . 0.0 109.691 171.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.15 84.16 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 106.371 -2.692 . . . . 0.0 106.371 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -68.47 83.49 0.27 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.96 -83.48 0.22 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.049 0.939 . . . . 0.0 110.248 -167.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -129.62 -2.74 5.26 Favored Glycine 0 C--N 1.34 0.768 0 CA-C-N 119.955 1.252 . . . . 0.0 114.755 -168.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.433 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 51.1 p90 -133.23 144.41 49.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 119.152 1.476 . . . . 0.0 107.994 157.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.08 130.38 40.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 171.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.51 130.13 34.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 163.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.99 155.35 34.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.648 1.579 . . . . 0.0 108.217 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -133.43 132.02 40.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 123.941 0.896 . . . . 0.0 111.883 -171.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.7 t -124.45 108.38 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.96 1.304 . . . . 0.0 108.561 -174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -80.65 129.2 34.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 168.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.5 mt -123.38 123.39 40.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.36 157.82 36.95 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.174 0.589 . . . . 0.0 110.053 173.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -114.2 83.18 1.83 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 169.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.9 mtm -138.62 -9.6 1.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.598 0.635 . . . . 0.0 112.205 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.9 mp0 -131.21 -102.5 0.28 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.6 m -74.58 -22.03 59.19 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 120.66 1.573 . . . . 0.0 114.347 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.03 77.42 0.5 Allowed Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.879 1.218 . . . . 0.0 112.929 173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 58.94 76.67 0.34 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 128.347 2.659 . . . . 0.0 112.214 172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -78.52 70.54 2.64 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.755 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CE1' HD11 ' A' ' 90' ' ' LEU . 34.8 p90 -142.37 147.72 36.72 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.867 1.334 . . . . 0.0 108.532 167.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.7 ttt85 -93.51 163.21 13.66 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.921 1.288 . . . . 0.0 108.227 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -122.87 139.4 49.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.105 1.362 . . . . 0.0 107.578 173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.0 mt -141.11 -177.5 5.14 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.258 1.423 . . . . 0.0 108.273 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.38 -161.02 50.87 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.347 -0.846 . . . . 0.0 111.159 -170.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.71 75.24 Favored Glycine 0 CA--C 1.522 0.503 0 CA-C-O 118.467 -1.185 . . . . 0.0 113.749 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.98 -12.49 60.96 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.661 1.73 . . . . 0.0 113.366 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 15.6 mt-10 -141.6 160.12 57.74 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 125.822 1.649 . . . . 0.0 108.817 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 31' ' ' GLU . 73.6 Cg_endo -72.12 105.92 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.129 2.552 . . . . 0.0 109.252 -168.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.85 18.07 30.86 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.661 -176.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -66.67 162.25 52.89 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 119.44 1.62 . . . . 0.0 109.323 155.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.82 140.82 68.89 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.864 2.376 . . . . 0.0 109.013 170.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.6 mt -116.04 83.61 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.06 142.27 33.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.906 -177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.6 mm -61.2 126.94 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.41 -41.12 91.27 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-O 118.272 -1.293 . . . . 0.0 112.163 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 167.01 124.42 0.01 OUTLIER 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.658 2.383 . . . . 0.0 107.768 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.47 150.03 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 124.536 1.134 . . . . 0.0 110.705 176.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.2 mm -83.32 106.99 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.64 69.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -169.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -120.06 40.59 3.4 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.2 -178.03 31.85 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 125.817 1.675 . . . . 0.0 109.92 -173.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.7 m -59.53 -28.36 67.01 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -57.04 4.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 120.126 1.33 . . . . 0.0 109.871 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -62.34 -38.25 88.75 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.928 0.87 . . . . 0.0 110.102 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.01 -8.87 52.73 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.346 1.058 . . . . 0.0 113.356 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -85.61 -17.38 36.36 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 120.393 1.452 . . . . 0.0 110.646 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.58 83.5 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.282 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -117.47 -54.52 2.37 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -166.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.67 161.28 30.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -173.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -140.65 146.02 42.84 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 121.498 -0.752 . . . . 0.0 110.166 169.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -69.24 132.3 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.788 2.325 . . . . 0.0 111.259 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.13 -2.32 78.77 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.732 1.158 . . . . 0.0 113.715 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.1 141.68 58.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 118.351 1.076 . . . . 0.0 108.777 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -86.94 121.01 28.82 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.0 mt -75.24 155.02 37.21 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.956 0.903 . . . . 0.0 110.439 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -126.79 -55.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 125.494 1.518 . . . . 0.0 109.443 174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -128.66 147.98 50.78 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.155 0.982 . . . . 0.0 109.786 -174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.5 t -138.6 118.59 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.9 t0 59.11 9.01 1.15 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.849 2.06 . . . . 0.0 114.111 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.14 -15.15 6.51 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.429 1.966 . . . . 0.0 112.898 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.4 mp -108.89 129.87 23.41 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 119.386 1.593 . . . . 0.0 108.229 -169.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.4 112.65 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.381 2.721 . . . . 0.0 109.249 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 75' ' ' VAL . 19.5 m -74.18 -7.04 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.098 0.959 . . . . 0.0 111.051 171.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.3 114.5 3.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.075 1.35 . . . . 0.0 108.599 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.32 -5.42 60.84 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.919 0.771 . . . . 0.0 113.795 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HE3' ' CZ ' ' A' ' 74' ' ' TYR . 49.3 mmtt -101.47 -172.71 2.21 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.052 1.341 . . . . 0.0 109.623 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 174.27 5.94 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.943 1.297 . . . . 0.0 110.389 176.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -49.42 -56.08 10.9 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.875 1.67 . . . . 0.0 110.331 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -52.92 -36.39 59.62 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 112.795 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.452 ' CZ ' ' HE3' ' A' ' 70' ' ' LYS . 45.2 t80 -54.2 -48.69 70.71 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.501 0.72 . . . . 0.0 110.281 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.41 HG22 ' CG1' ' A' ' 67' ' ' VAL . 5.5 t -70.29 -34.77 59.85 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 125.006 1.322 . . . . 0.0 110.211 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 mm -62.41 -37.9 79.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 119.211 0.914 . . . . 0.0 109.989 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.98 -37.95 89.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.022 0.374 . . . . 0.0 110.551 173.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -64.23 -50.74 66.81 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.429 176.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 88.6 mmm -56.98 -36.23 70.1 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.949 0.795 . . . . 0.0 111.161 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.79 -43.5 90.51 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.219 0.607 . . . . 0.0 111.335 172.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.01 -45.99 72.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.656 0.783 . . . . 0.0 111.407 175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.87 78.07 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.859 1.264 . . . . 0.0 110.42 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.83 -32.89 63.97 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.838 -1.164 . . . . 0.0 111.895 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -78.95 -29.55 44.04 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.351 1.06 . . . . 0.0 112.202 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -66.79 -22.27 66.03 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 122.01 -0.431 . . . . 0.0 110.928 168.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.88 6.51 89.07 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 121.039 -1.038 . . . . 0.0 112.484 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.04 173.12 14.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.269 2.227 . . . . 0.0 107.113 168.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -136.14 157.57 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 160.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.56 131.66 53.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 24' ' ' PHE . 26.4 mt -126.68 98.17 5.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -170.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 53.5 m -87.72 117.42 26.53 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.1 m -100.92 173.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 125.599 1.56 . . . . 0.0 108.492 170.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 17.8 ptt85 -150.13 158.83 44.57 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 120.669 -1.269 . . . . 0.0 108.581 167.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 145.83 31.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 166.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -50.3 153.7 1.43 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.652 0.739 . . . . 0.0 110.928 164.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 21.6 t -122.96 143.35 36.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.615 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.79 -74.73 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 170.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.3 t -146.33 -179.11 6.52 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.191 0.996 . . . . 0.0 109.651 157.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -144.02 130.0 3.85 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 126.129 1.823 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.37 179.24 6.36 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 123.641 2.894 . . . . 0.0 111.329 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -90.92 -46.12 8.36 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 161.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.1 t 51.87 62.73 2.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.918 1.287 . . . . 0.0 109.208 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.534 0 N-CA-C 106.733 -2.547 . . . . 0.0 106.733 -150.29 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.8 m -155.51 -43.14 0.08 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.788 1.635 . . . . 0.0 109.956 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -141.46 -72.23 0.34 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.123 1.769 . . . . 0.0 109.589 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.66 101.41 0.19 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.4 172.63 3.85 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.883 0.841 . . . . 0.0 110.439 164.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.0 m -65.64 144.32 57.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.863 0.465 . . . . 0.0 111.783 -172.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.52 -92.57 0.79 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 124.92 1.248 . . . . 0.0 110.72 169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -56.82 126.64 27.85 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -167.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -88.38 123.64 33.15 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 110.95 18.65 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 160.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mp -101.12 148.3 25.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.26 159.63 15.23 Favored 'General case' 0 CA--C 1.512 -0.482 0 O-C-N 121.312 -0.868 . . . . 0.0 110.242 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.1 t -138.44 137.56 43.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -126.16 124.87 41.48 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.296 0.953 . . . . 0.0 108.553 171.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -127.49 136.36 51.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.719 0.808 . . . . 0.0 110.153 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -89.73 154.93 19.55 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.111 0.964 . . . . 0.0 110.069 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -115.32 83.54 1.94 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.4 mtt -137.41 -34.51 0.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 118.576 -0.725 . . . . 0.0 110.987 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -88.23 -81.78 0.25 Allowed 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -122.37 -3.1 8.93 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.2 78.08 1.13 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-N 118.96 0.8 . . . . 0.0 111.699 170.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 65.82 -133.07 0.2 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.25 52.69 0.01 OUTLIER Glycine 0 C--O 1.225 -0.453 0 CA-C-N 119.8 1.182 . . . . 0.0 110.454 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 90' ' ' LEU . 47.9 p90 -137.77 172.66 12.62 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.91 0.855 . . . . 0.0 108.832 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -130.66 163.52 27.01 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.862 1.665 . . . . 0.0 106.653 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.5 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -141.24 122.64 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 -169.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 41.7 mt -139.96 179.08 6.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.605 1.562 . . . . 0.0 107.478 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.33 -166.29 48.45 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.889 -1.285 . . . . 0.0 109.889 -165.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.06 30.92 71.3 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 119.038 -0.868 . . . . 0.0 112.559 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.78 -32.48 74.19 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.698 1.749 . . . . 0.0 110.233 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -116.12 153.76 48.49 Favored Pre-proline 0 C--O 1.236 0.365 0 C-N-CA 123.33 0.652 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -75.16 90.45 1.1 Allowed 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 124.519 3.479 . . . . 0.0 107.792 -175.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.73 -3.79 5.02 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 117.96 -1.467 . . . . 0.0 113.167 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -73.44 159.23 85.26 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 119.73 1.765 . . . . 0.0 109.909 168.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.16 144.32 68.58 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.483 2.122 . . . . 0.0 109.804 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -114.68 92.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.9 160.15 15.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.448 1.899 . . . . 0.0 110.993 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm -65.82 119.86 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 167.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -57.05 -45.06 92.79 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 127.078 2.275 . . . . 0.0 112.542 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -172.51 170.17 4.95 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.962 2.105 . . . . 0.0 107.402 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.39 138.41 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 168.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.7 mm -85.41 117.39 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.19 -48.34 80.62 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.064 0.852 . . . . 0.0 112.277 -168.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.8 mmt -94.8 37.99 1.13 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -104.86 166.77 14.87 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 125.907 1.717 . . . . 0.0 109.974 177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HA ' ' HG2' ' A' ' 49' ' ' ARG . 21.2 t -75.96 -14.12 60.24 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.935 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.43 -50.63 15.22 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 119.988 1.267 . . . . 0.0 111.193 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -53.47 -59.95 3.93 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.197 1.399 . . . . 0.0 108.84 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 46' ' ' SER . 21.9 ptt180 -60.51 -15.15 24.41 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.139 0.976 . . . . 0.0 113.426 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.28 -20.77 62.17 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.404 -0.81 . . . . 0.0 111.102 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.61 32.13 25.42 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.814 1.197 . . . . 0.0 112.333 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.2 mtt-85 -139.55 -65.25 0.48 Allowed 'General case' 0 C--N 1.343 0.302 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.81 141.2 48.03 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.694 0.679 . . . . 0.0 110.009 -171.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -135.5 155.12 78.67 Favored Pre-proline 0 N--CA 1.447 -0.625 0 C-N-CA 124.48 1.112 . . . . 0.0 109.619 172.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -56.82 140.1 90.6 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.471 2.114 . . . . 0.0 110.745 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.11 1.88 86.19 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 117.939 -1.478 . . . . 0.0 114.727 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -60.56 129.11 39.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 119.988 1.894 . . . . 0.0 107.738 175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -72.94 133.01 44.17 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -87.74 148.27 24.81 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.106 1.362 . . . . 0.0 107.743 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.08 -53.73 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 CA-C-N 115.102 -0.953 . . . . 0.0 109.48 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -129.65 147.83 51.48 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.858 0.863 . . . . 0.0 109.097 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.9 t -139.77 124.79 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 64.13 4.06 1.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.527 1.531 . . . . 0.0 113.878 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.33 -14.01 12.19 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.009 1.766 . . . . 0.0 112.592 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -106.47 133.72 20.12 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 119.267 1.534 . . . . 0.0 108.878 -167.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.46 108.85 2.78 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.766 2.977 . . . . 0.0 109.689 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.03 -6.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.634 173.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.29 108.67 3.29 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.629 -1.294 . . . . 0.0 110.111 -166.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.43 14.1 69.19 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.904 0.764 . . . . 0.0 113.294 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.628 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 37.1 mmtt -82.07 -161.46 0.45 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.285 1.434 . . . . 0.0 108.234 162.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.5 p -113.06 172.16 7.11 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.336 1.055 . . . . 0.0 110.676 171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -45.51 -55.28 6.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.747 2.019 . . . . 0.0 111.399 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 -56.49 -35.34 67.88 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 121.533 -0.729 . . . . 0.0 112.338 -176.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 32.2 t80 -49.52 -51.6 35.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.345 0.593 . . . . 0.0 109.611 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 t -70.73 -39.11 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.503 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm -58.65 -37.24 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 120.025 1.284 . . . . 0.0 110.522 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -63.68 -44.36 93.95 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.254 1.421 . . . . 0.0 110.196 172.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.81 -51.6 66.43 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 118.903 -0.57 . . . . 0.0 111.382 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.7 mmm -52.97 -39.7 63.16 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.103 0.865 . . . . 0.0 111.422 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.4 -34.95 74.67 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.948 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -82.97 -36.99 24.67 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.575 1.08 . . . . 0.0 112.922 174.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.09 82.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 119.674 1.125 . . . . 0.0 109.74 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.77 -31.74 71.08 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.395 -1.441 . . . . 0.0 112.97 171.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -78.53 -36.16 45.19 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.435 1.494 . . . . 0.0 110.682 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -62.16 -15.32 45.3 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.954 1.302 . . . . 0.0 111.239 162.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 3.13 77.11 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 125.077 1.322 . . . . 0.0 112.453 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -160.85 151.76 18.61 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.136 1.468 . . . . 0.0 107.178 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.35 122.68 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -84.48 133.12 34.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 161.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 24' ' ' PHE . 16.7 mt -131.18 103.53 6.54 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 31.5 m -85.5 124.44 32.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.23 171.39 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 126.04 1.736 . . . . 0.0 107.965 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -153.04 166.76 31.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 O-C-N 121.22 -0.925 . . . . 0.0 110.239 170.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 141.76 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.434 160.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.32 155.04 29.84 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.737 0.815 . . . . 0.0 111.129 169.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.0 p -137.95 158.57 33.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 124.66 1.184 . . . . 0.0 109.315 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tp -161.52 160.61 29.3 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.811 2.044 . . . . 0.0 106.381 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 t -148.38 133.77 18.57 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -172.94 -167.27 32.64 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.472 -0.627 . . . . 0.0 112.129 -172.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.02 155.58 42.85 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.861 2.374 . . . . 0.0 110.138 166.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.5 m -76.13 -25.03 54.97 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.9 m 50.13 -153.13 0.15 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.079 1.352 . . . . 0.0 110.541 -166.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.383 0 N-CA-C 107.973 -2.051 . . . . 0.0 107.973 164.398 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.728 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -119.69 75.99 1.11 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.745 1.273 . . . . 0.0 107.822 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.1 m -83.79 160.47 21.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 164.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.21 174.45 33.37 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 m -140.47 -52.55 0.49 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.0 m -150.63 156.24 40.96 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.34 -28.34 0.12 Allowed Glycine 0 CA--C 1.524 0.603 0 CA-C-O 119.052 -0.86 . . . . 0.0 114.09 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -124.64 168.15 13.54 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.978 1.889 . . . . 0.0 109.496 167.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -122.19 131.79 54.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.35 139.89 32.75 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 163.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.76 116.79 20.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.19 -2.893 . . . . 0.0 103.19 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 10.7 p30 -80.89 153.18 27.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.214 0.916 . . . . 0.0 110.011 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.5 t -136.57 108.36 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -96.87 106.8 19.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.6 mt -103.64 130.03 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.707 0.765 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -93.44 150.1 20.71 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.999 0.92 . . . . 0.0 109.527 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 30.1 ttt85 -122.83 85.84 2.49 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.847 -1.158 . . . . 0.0 109.245 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 60.0 mtp -141.82 -3.17 1.14 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -135.31 -88.24 0.35 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -77.03 -31.22 56.17 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.74 -158.29 44.74 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.456 1.025 . . . . 0.0 111.124 -167.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 2.2 m-85 -102.56 97.24 7.48 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 117.297 0.549 . . . . 0.0 112.071 -163.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.62 60.99 4.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.905 1.241 . . . . 0.0 112.898 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.578 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.0 p90 -141.58 158.45 43.82 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.526 1.163 . . . . 0.0 109.398 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ttt180 -112.17 167.73 10.18 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 125.66 1.584 . . . . 0.0 108.169 170.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.4 130.29 20.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -143.25 -178.36 5.82 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 127.152 2.181 . . . . 0.0 108.678 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.91 -170.34 29.1 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 120.607 -1.308 . . . . 0.0 110.345 -173.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.22 35.63 91.18 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 121.747 -0.854 . . . . 0.0 111.346 -172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -67.3 -35.11 78.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 117.959 0.88 . . . . 0.0 111.07 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -120.45 160.29 44.51 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 125.059 1.344 . . . . 0.0 108.39 176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.48 57.89 5.3 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.511 3.474 . . . . 0.0 110.393 -173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.08 42.75 0.06 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.313 1.435 . . . . 0.0 110.476 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -124.88 168.12 14.21 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 126.46 1.904 . . . . 0.0 110.632 -175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -72.36 138.34 29.91 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.784 2.322 . . . . 0.0 108.979 167.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.1 mt -107.13 99.6 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 170.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 58' ' ' GLU . 10.8 mt -95.29 136.55 35.5 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.955 2.502 . . . . 0.0 109.505 176.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm -49.47 127.46 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 166.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.23 -27.38 73.78 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.79 -1.005 . . . . 0.0 113.823 -172.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 159.58 133.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 130.468 3.507 . . . . 0.0 106.339 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 m -83.41 148.69 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 119.907 1.231 . . . . 0.0 108.437 166.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.7 mm -81.86 118.55 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.4 -49.58 76.3 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 122.603 1.192 . . . . 0.0 109.632 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 mmt -85.9 54.52 3.16 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.79 158.08 29.32 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-O 122.205 0.892 . . . . 0.0 111.848 -171.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.5 m -63.07 -6.86 4.47 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -173.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.56 -48.19 14.25 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 120.961 1.71 . . . . 0.0 110.005 172.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.5 -53.15 61.01 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.71 1.204 . . . . 0.0 109.25 174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -63.45 -18.64 63.96 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.364 1.066 . . . . 0.0 112.913 -171.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 -17.35 62.69 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.943 0.897 . . . . 0.0 110.817 175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.49 18.4 73.7 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.468 1.032 . . . . 0.0 111.988 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -129.47 -70.69 0.64 Allowed 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 112.493 -161.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.27 146.29 50.72 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -134.09 143.2 46.21 Favored Pre-proline 0 C--N 1.323 -0.584 0 C-N-CA 124.041 0.936 . . . . 0.0 110.592 -177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -68.25 136.02 36.03 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 N-CA-C 107.101 -1.923 . . . . 0.0 107.101 161.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.95 -3.33 67.13 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 117.609 -1.662 . . . . 0.0 111.956 -168.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -76.54 134.13 39.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 120.425 2.112 . . . . 0.0 108.299 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.428 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.1 tt0 -87.19 128.48 35.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.944 2.098 . . . . 0.0 107.777 166.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -78.03 162.99 26.31 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.222 1.809 . . . . 0.0 111.478 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.0 t -135.62 -55.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.604 1.962 . . . . 0.0 108.704 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -129.1 149.12 51.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.446 1.098 . . . . 0.0 109.25 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -137.64 122.9 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.0 t0 57.23 17.5 3.65 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.325 1.85 . . . . 0.0 113.541 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.04 -11.07 48.51 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.17 1.843 . . . . 0.0 113.312 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.8 mp -101.67 130.26 24.97 Favored Pre-proline 0 N--CA 1.451 -0.384 0 CA-C-N 119.407 1.604 . . . . 0.0 107.671 -174.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -73.0 125.82 10.71 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.299 2.666 . . . . 0.0 108.245 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.73 -4.84 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.733 0.813 . . . . 0.0 111.81 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.71 124.94 22.32 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 121.66 -0.65 . . . . 0.0 110.318 -169.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.21 1.11 79.67 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.189 0.899 . . . . 0.0 113.958 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -88.28 171.5 10.13 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 119.616 1.708 . . . . 0.0 108.738 172.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.6 p -90.62 168.55 11.7 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.531 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -44.64 -47.89 10.5 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 126.103 1.761 . . . . 0.0 111.53 174.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -52.92 -36.81 60.12 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.596 1.158 . . . . 0.0 113.408 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.97 -49.92 65.15 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.406 0.683 . . . . 0.0 109.295 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.01 -38.03 79.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 C-N-CA 125.092 1.357 . . . . 0.0 110.772 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.59 -40.84 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 119.483 1.038 . . . . 0.0 109.819 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -39.06 91.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.205 0.602 . . . . 0.0 110.867 172.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.25 -53.93 45.26 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 118.829 -0.605 . . . . 0.0 110.626 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.2 mmm -55.03 -37.0 66.1 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.049 0.841 . . . . 0.0 111.428 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -61.97 -38.71 89.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 117.565 -1.207 . . . . 0.0 111.918 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -70.41 -48.24 57.03 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.697 1.135 . . . . 0.0 111.289 171.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.14 -42.09 80.32 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.975 1.31 . . . . 0.0 111.362 -172.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.57 -26.78 67.19 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.117 -0.99 . . . . 0.0 113.031 175.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -84.36 -36.15 22.7 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.612 1.096 . . . . 0.0 110.94 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -53.09 -34.04 54.83 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.71 61.82 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.737 1.161 . . . . 0.0 112.219 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -160.43 173.07 16.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.344 2.258 . . . . 0.0 107.251 172.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -148.21 127.89 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -80.94 127.04 32.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 161.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.4 mt -116.48 97.19 5.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 86.1 m -83.89 115.08 22.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.17 171.15 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 125.844 1.658 . . . . 0.0 108.275 174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.0 ptt85 -152.87 151.0 29.89 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 119.46 -2.025 . . . . 0.0 112.402 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mtp180 -140.69 129.61 23.23 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.677 0.791 . . . . 0.0 109.447 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.01 134.73 57.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.704 2.002 . . . . 0.0 111.243 169.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 t -100.09 136.85 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 126.483 1.913 . . . . 0.0 108.211 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.53 176.83 12.09 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 p -157.55 105.85 2.07 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.38 114.08 4.17 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 173.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.45 -21.16 30.68 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.68 1.74 . . . . 0.0 111.223 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t 61.41 -161.36 0.29 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.929 0.892 . . . . 0.0 108.606 -162.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.7 p -78.43 178.74 7.48 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 163.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 143.433 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.61 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 p -156.44 106.19 2.32 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.552 1.541 . . . . 0.0 107.234 -169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.2 m -83.31 93.6 7.76 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 49.41 84.03 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.014 1.292 . . . . 0.0 114.479 164.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t 56.09 -120.42 1.49 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 117.593 -1.194 . . . . 0.0 108.912 -163.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 p -144.34 85.58 1.79 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.558 1.543 . . . . 0.0 109.527 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.15 -114.9 0.35 Allowed Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -58.51 157.39 9.04 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.289 0.544 . . . . 0.0 110.886 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.1 ptmt -124.91 137.13 54.29 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 124.699 1.2 . . . . 0.0 108.931 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -93.71 154.47 17.78 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.736 1.214 . . . . 0.0 107.861 170.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mp -139.6 131.77 28.11 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.951 2.1 . . . . 0.0 106.701 175.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.56 133.05 33.85 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.334 1.054 . . . . 0.0 109.816 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -129.95 106.59 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -107.84 118.26 36.26 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.1 mt -110.6 148.31 32.45 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 124.135 0.974 . . . . 0.0 109.5 -176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -86.82 164.41 16.66 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 164.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.8 ttp85 -117.57 95.48 4.97 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 102.776 -3.046 . . . . 0.0 102.776 164.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 ttt -143.77 -13.01 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.111 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -133.63 -108.41 0.23 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -65.24 -31.14 72.15 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.064 1.302 . . . . 0.0 113.016 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.79 93.66 0.58 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.624 1.107 . . . . 0.0 112.539 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 43.49 71.32 0.24 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 113.54 169.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.45 54.12 4.3 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.785 -1.197 . . . . 0.0 114.98 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -121.32 175.92 5.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 118.845 1.322 . . . . 0.0 109.409 169.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.12 165.21 26.6 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 167.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.6 130.62 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -171.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.17 146.39 27.63 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.422 1.089 . . . . 0.0 108.088 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.51 177.87 19.8 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.859 -2.096 . . . . 0.0 107.859 -155.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.58 37.05 84.63 Favored Glycine 0 CA--C 1.529 0.923 0 O-C-N 121.514 -0.992 . . . . 0.0 111.705 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.75 -36.42 67.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.596 1.198 . . . . 0.0 110.481 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -137.73 160.48 64.74 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.984 2.114 . . . . 0.0 107.766 -170.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.97 72.36 6.2 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.406 3.404 . . . . 0.0 110.537 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.14 -9.96 0.06 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 127.549 2.5 . . . . 0.0 111.826 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -72.98 158.21 87.5 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.834 1.317 . . . . 0.0 110.863 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -71.45 137.73 31.23 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.77 2.314 . . . . 0.0 109.125 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.1 mt -110.11 93.55 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.4 mt -89.59 155.94 18.92 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.068 0.937 . . . . 0.0 110.36 173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.83 107.54 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 159.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.11 -41.11 71.27 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -169.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.79 175.7 12.81 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.394 1.878 . . . . 0.0 107.575 168.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.6 t -125.43 148.99 29.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 mm -89.12 112.86 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.13 7.63 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.777 1.231 . . . . 0.0 113.548 -172.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 72.7 mtm -90.04 -0.79 57.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.32 153.01 45.83 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -62.49 -6.93 3.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -174.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.88 -41.69 29.16 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 120.539 1.518 . . . . 0.0 112.188 172.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -66.09 -52.26 50.4 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 118.947 0.794 . . . . 0.0 109.813 -174.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -13.3 15.51 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 168.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -71.66 -17.73 62.23 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 120.246 1.385 . . . . 0.0 110.987 172.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.34 32.81 41.62 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 118.104 -1.387 . . . . 0.0 113.336 166.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mtt-85 -133.6 -66.34 0.65 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.343 1.572 . . . . 0.0 111.414 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.7 mt -61.69 144.68 54.21 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.556 1.142 . . . . 0.0 111.489 -170.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -130.94 151.7 79.38 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.749 1.219 . . . . 0.0 109.312 164.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -51.89 142.66 42.04 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.324 2.016 . . . . 0.0 110.694 163.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.18 64.24 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.954 -0.915 . . . . 0.0 113.798 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -64.61 134.23 53.9 Favored 'General case' 0 C--N 1.341 0.225 0 CA-C-N 119.697 1.749 . . . . 0.0 106.423 165.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.91 123.16 33.0 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.01 140.91 47.64 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.599 1.16 . . . . 0.0 109.022 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.0 t -120.8 -52.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 124.653 1.181 . . . . 0.0 108.825 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -130.03 146.74 51.72 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.3 t -132.17 124.41 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 62.17 14.44 6.63 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.056 1.742 . . . . 0.0 112.224 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.28 68.21 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.901 1.715 . . . . 0.0 112.517 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mm -101.63 126.12 35.17 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.717 1.607 . . . . 0.0 108.102 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.91 118.26 5.6 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.208 2.605 . . . . 0.0 109.209 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.6 m -77.74 -9.11 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.253 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 115.81 6.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.871 1.269 . . . . 0.0 109.71 -171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.46 3.77 61.14 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.553 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 21.4 mmtt -107.18 178.64 4.49 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 126.591 1.957 . . . . 0.0 108.728 174.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 p -95.22 -179.93 4.97 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.207 -0.308 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -49.91 -54.83 17.2 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.498 1.119 . . . . 0.0 110.924 169.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -26.83 68.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.73 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.466 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 64.9 t80 -46.54 -54.07 10.09 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.719 0.771 . . . . 0.0 110.608 169.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 t -73.04 -36.53 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 125.473 1.509 . . . . 0.0 110.082 -174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.6 mm -57.53 -41.02 78.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 119.126 0.876 . . . . 0.0 110.149 174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.27 -31.46 71.8 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.522 0.729 . . . . 0.0 111.359 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.96 -51.66 13.15 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.058 0.943 . . . . 0.0 110.828 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.6 mmm -55.09 -38.1 67.67 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 124.406 1.083 . . . . 0.0 110.867 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -60.79 2.94 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.809 1.644 . . . . 0.0 110.17 173.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -54.82 -51.08 66.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.512 1.125 . . . . 0.0 111.259 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.19 -35.92 78.48 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.028 0.931 . . . . 0.0 111.534 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.41 -23.4 66.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 120.773 -1.204 . . . . 0.0 112.194 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtt-85 -69.97 -49.91 47.04 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.207 1.367 . . . . 0.0 109.636 169.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -54.53 -38.21 66.29 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.769 0.827 . . . . 0.0 110.313 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 96.88 14.62 42.34 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.064 0.84 . . . . 0.0 111.858 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -151.36 166.76 30.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 118.802 1.301 . . . . 0.0 108.368 167.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.01 165.3 6.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -126.83 144.53 50.94 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 164.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.3 mt -138.11 97.39 3.39 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 103.061 -2.941 . . . . 0.0 103.061 -169.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.4 m -86.4 112.98 21.98 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 104.588 -2.375 . . . . 0.0 104.588 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.3 m -105.35 165.92 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.478 0.711 . . . . 0.0 109.52 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -153.08 162.61 41.12 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 120.605 -1.309 . . . . 0.0 111.962 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -150.32 147.35 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.697 1.199 . . . . 0.0 109.991 164.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -51.07 146.15 6.69 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.687 1.195 . . . . 0.0 111.358 164.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.7 t -110.83 147.91 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.277 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.08 -170.15 3.47 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.447 1.499 . . . . 0.0 108.613 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.1 m -136.94 167.78 20.83 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.665 1.586 . . . . 0.0 106.995 155.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.25 80.83 0.12 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 169.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.25 -12.98 37.87 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.658 3.572 . . . . 0.0 114.244 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 m -73.02 102.52 3.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 160.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.0 121.18 3.08 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.455 1.502 . . . . 0.0 110.629 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.348 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 168.626 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.825 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 m -127.89 -9.46 5.48 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 125.23 1.412 . . . . 0.0 114.075 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.5 t 54.67 -173.17 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.968 0.907 . . . . 0.0 110.338 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.7 134.96 5.09 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.53 129.93 39.46 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.134 1.374 . . . . 0.0 109.104 -176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.6 t -153.02 127.82 9.52 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.11 -24.92 1.05 Allowed Glycine 0 C--N 1.336 0.575 0 C-N-CA 127.081 2.277 . . . . 0.0 115.606 154.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -137.64 161.67 35.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.039 1.736 . . . . 0.0 107.466 168.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.13 138.31 54.69 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 169.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.15 145.8 28.2 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 158.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.39 121.76 33.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.015 2.126 . . . . 0.0 106.721 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -81.39 135.2 35.65 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 124.898 1.279 . . . . 0.0 109.348 175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.6 t -133.91 107.63 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.56 0.695 . . . . 0.0 109.446 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -100.02 120.77 40.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 108.776 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -123.22 124.06 42.17 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.047 1.339 . . . . 0.0 108.94 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 84.1 mtm-85 -74.44 153.18 39.3 Favored 'General case' 0 C--O 1.238 0.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.784 169.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -102.94 114.55 28.93 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.08 -69.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 169.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.49 -73.79 0.11 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.573 1.549 . . . . 0.0 110.614 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.9 t -126.11 1.92 7.2 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -148.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.21 57.48 8.41 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 123.946 0.784 . . . . 0.0 112.368 167.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 47.74 80.79 0.05 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.6 2.36 . . . . 0.0 113.006 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -74.0 75.64 1.1 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.281 0.943 . . . . 0.0 112.798 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -127.95 175.55 8.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.141 2.176 . . . . 0.0 106.187 159.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -123.02 162.46 22.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 157.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.27 127.28 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 94.6 mt -134.4 -177.29 4.53 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.552 1.541 . . . . 0.0 107.329 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.34 -156.26 48.5 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -170.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.63 -105.31 0.71 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 106.729 -2.548 . . . . 0.0 106.729 -164.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.92 -52.81 0.25 Allowed 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 129.308 3.043 . . . . 0.0 110.29 -167.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -100.39 160.87 25.8 Favored Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 125.257 1.423 . . . . 0.0 110.861 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.94 96.11 0.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 124.408 3.406 . . . . 0.0 111.563 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.33 19.24 30.86 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-O 118.372 -1.238 . . . . 0.0 113.067 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -66.11 162.06 50.34 Favored Pre-proline 0 CA--C 1.547 0.83 0 CA-C-N 118.708 1.254 . . . . 0.0 109.387 164.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.4 132.66 21.12 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.673 2.249 . . . . 0.0 109.226 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -108.84 90.46 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.7 mt -87.17 144.42 26.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.57 1.148 . . . . 0.0 110.495 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.9 mm -62.91 108.35 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -51.2 -44.31 51.62 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 127.487 2.47 . . . . 0.0 112.248 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.76 160.97 29.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 123.589 0.756 . . . . 0.0 109.618 175.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.18 115.68 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 103.21 -2.885 . . . . 0.0 103.21 161.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -66.89 121.31 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.55 -21.64 60.56 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -167.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 mmt -127.95 33.12 4.82 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.636 1.574 . . . . 0.0 108.353 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 176.65 17.64 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.831 1.205 . . . . 0.0 111.735 -172.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -61.67 -25.71 67.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.534 0.733 . . . . 0.0 112.756 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.24 -53.96 14.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.849 0.749 . . . . 0.0 109.501 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -55.86 -46.54 78.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.472 1.109 . . . . 0.0 111.735 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -28.39 65.53 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -72.49 -39.7 67.48 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.756 0.822 . . . . 0.0 110.21 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.2 35.9 19.46 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 119.495 -0.614 . . . . 0.0 111.992 171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 52' ' ' ARG . 14.9 mtp85 -124.2 -67.51 0.92 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 118.01 0.905 . . . . 0.0 110.725 -177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.8 mt -55.47 137.48 48.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 0.1 OUTLIER -124.85 149.41 62.71 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 123.901 0.88 . . . . 0.0 110.253 174.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 54' ' ' HIS . 24.4 Cg_exo -57.6 132.1 48.32 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.338 2.025 . . . . 0.0 110.38 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.04 7.38 87.6 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 117.897 -1.502 . . . . 0.0 113.617 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -65.08 142.94 58.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.141 1.97 . . . . 0.0 108.271 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.16 125.84 35.6 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.123 -0.985 . . . . 0.0 108.673 -175.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -81.19 154.37 26.72 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.275 1.03 . . . . 0.0 109.87 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.6 -51.46 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 125.25 1.42 . . . . 0.0 108.798 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.82 148.8 52.58 Favored 'General case' 0 CA--C 1.508 -0.656 0 C-N-CA 124.121 0.968 . . . . 0.0 109.705 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.92 105.54 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 -170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.5 t70 54.63 22.95 4.33 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.295 1.838 . . . . 0.0 113.189 -175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.02 -13.63 57.41 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.973 2.225 . . . . 0.0 113.027 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.43 125.56 63.13 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 119.114 1.457 . . . . 0.0 107.798 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -73.5 131.0 15.6 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.635 2.89 . . . . 0.0 109.425 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.43 -8.6 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 123.957 0.903 . . . . 0.0 111.633 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.58 137.94 57.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 121.755 -0.59 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -13.93 7.57 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-O 119.013 -0.882 . . . . 0.0 114.372 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 25.3 mmtt -95.88 -177.14 3.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.405 1.602 . . . . 0.0 110.155 179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -109.99 175.77 5.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.757 2.023 . . . . 0.0 110.739 -168.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -53.86 -57.09 12.19 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.862 0.865 . . . . 0.0 109.135 171.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -45.85 -45.86 15.33 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.887 1.275 . . . . 0.0 112.061 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 50.0 t80 -49.77 -40.24 40.58 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.682 0.614 . . . . 0.0 111.412 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.38 -41.6 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 124.452 1.101 . . . . 0.0 110.757 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.1 mm -59.45 -41.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 119.026 0.83 . . . . 0.0 109.608 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -23.97 64.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.756 1.622 . . . . 0.0 112.126 177.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -81.18 -45.12 16.83 Favored 'General case' 0 C--O 1.228 -0.044 0 C-N-CA 123.681 0.792 . . . . 0.0 110.258 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 79.7 mmm -56.87 -34.94 68.34 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.917 0.78 . . . . 0.0 111.878 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -57.87 -42.9 85.52 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.117 0.967 . . . . 0.0 111.51 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.07 -45.35 74.07 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.469 0.707 . . . . 0.0 110.699 174.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.3 -32.73 71.48 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.764 -1.21 . . . . 0.0 112.245 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.95 74.74 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.609 -0.682 . . . . 0.0 111.046 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -69.09 -36.82 77.98 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.194 0.998 . . . . 0.0 112.343 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -68.61 -12.22 61.06 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.565 0.62 . . . . 0.0 112.014 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.62 7.3 87.21 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.511 1.053 . . . . 0.0 112.936 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.6 169.11 10.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 120.843 -1.386 . . . . 0.0 107.586 -175.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.85 159.7 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 173.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -122.12 145.07 48.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 163.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 mt -138.11 99.34 3.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 m -84.58 114.02 21.67 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.8 m -99.28 170.69 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 166.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -151.27 164.21 37.13 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 120.051 -1.655 . . . . 0.0 109.885 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.36 133.57 15.27 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.537 1.135 . . . . 0.0 108.586 168.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.3 150.55 39.01 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.571 0.748 . . . . 0.0 109.178 163.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.22 142.95 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 123.426 0.69 . . . . 0.0 110.751 -170.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 tt -148.21 -71.48 0.21 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 m 52.0 46.38 26.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.088 1.355 . . . . 0.0 113.104 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.39 178.29 21.12 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 170.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.68 99.69 0.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.798 2.998 . . . . 0.0 109.584 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.4 t -65.96 137.52 57.19 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 168.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.6 p -147.65 166.55 27.08 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.989 2.116 . . . . 0.0 108.215 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 116.442 -2.31 . . . . 0.0 111.343 175.528 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.452 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 82.89 131.07 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 127.062 2.145 . . . . 0.0 110.269 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.47 179.91 8.72 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 122.16 0.981 . . . . 0.0 110.694 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.58 -172.07 22.67 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 -164.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.4 m -74.9 -44.58 48.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.485 1.143 . . . . 0.0 113.326 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m 53.5 167.59 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 118.676 0.671 . . . . 0.0 111.592 -153.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.58 -84.28 0.26 Allowed Glycine 0 C--N 1.334 0.467 0 O-C-N 119.755 -1.841 . . . . 0.0 111.913 -173.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -67.35 153.64 43.21 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.314 1.057 . . . . 0.0 108.827 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -119.68 143.09 47.93 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.109 1.364 . . . . 0.0 107.74 171.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -85.74 141.95 29.34 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 165.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.8 169.3 9.1 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.345 2.258 . . . . 0.0 107.186 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.84 128.13 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 125.856 1.662 . . . . 0.0 107.014 172.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.05 136.99 59.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 170.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -128.13 127.57 43.25 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.435 1.094 . . . . 0.0 108.165 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -128.93 155.05 45.92 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.299 1.04 . . . . 0.0 109.374 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 ptt-85 -105.29 165.86 10.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.102 0.953 . . . . 0.0 111.398 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -125.49 93.35 3.83 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 124.861 1.264 . . . . 0.0 109.211 174.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.9 mtp -144.34 -63.28 0.37 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.4 mp0 -66.43 -69.79 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.237 1.015 . . . . 0.0 110.835 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -114.76 -31.08 6.26 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.426 0.69 . . . . 0.0 111.219 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 17' ' ' ARG . . . 78.18 85.71 0.5 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 108.612 -1.795 . . . . 0.0 108.612 -164.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CD1' HG12 ' A' ' 88' ' ' VAL . 0.2 OUTLIER 72.97 -153.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 O-C-N 124.754 0.914 . . . . 0.0 108.697 167.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.9 55.14 0.02 OUTLIER Glycine 0 C--O 1.227 -0.312 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -176.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.448 ' CE2' HD11 ' A' ' 90' ' ' LEU . 38.0 p90 -143.36 172.87 12.17 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -141.35 142.27 33.8 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.023 0.929 . . . . 0.0 109.439 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 135.47 57.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD12 ' C ' ' A' ' 27' ' ' LEU 0.272 2.7 pp -148.98 -178.72 6.53 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.306 2.242 . . . . 0.0 108.644 -177.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.7 -145.92 46.09 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -173.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.48 30.55 34.12 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 118.0 0.9 . . . . 0.0 111.598 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -90.82 -7.08 53.31 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.784 0.792 . . . . 0.0 112.082 -163.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -129.7 155.59 80.13 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 126.891 2.076 . . . . 0.0 106.828 165.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -76.96 92.11 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 124.66 3.573 . . . . 0.0 108.161 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.91 -12.42 1.91 Allowed Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.627 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -79.23 159.43 72.79 Favored Pre-proline 0 N--CA 1.45 -0.437 0 CA-C-N 119.433 1.617 . . . . 0.0 112.192 -170.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.42 147.01 51.59 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.222 1.948 . . . . 0.0 108.764 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -116.77 92.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.6 mt -96.88 130.66 44.13 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.814 1.646 . . . . 0.0 109.16 -175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.6 mm -54.81 110.42 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.04 -43.58 81.13 Favored Glycine 0 N--CA 1.449 -0.436 0 O-C-N 121.442 -0.786 . . . . 0.0 111.738 -172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 139.89 14.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 m -106.43 147.15 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 159.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.5 mm -84.12 110.61 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.25 -34.72 61.39 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 123.105 1.431 . . . . 0.0 112.009 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 33.1 mmt -95.91 20.8 9.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.591 1.156 . . . . 0.0 110.506 -174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -140.26 176.11 21.54 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.202 0.906 . . . . 0.0 111.552 -165.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -20.68 64.41 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 118.225 -0.893 . . . . 0.0 113.09 -160.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.52 -63.74 1.01 Allowed 'General case' 0 C--N 1.343 0.289 0 CA-C-N 119.005 0.82 . . . . 0.0 109.743 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -56.61 -43.58 80.3 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.094 0.958 . . . . 0.0 110.751 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.2 mtp180 -70.62 -18.99 62.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.908 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -83.21 -22.6 33.1 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.616 1.553 . . . . 0.0 111.371 168.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.97 14.03 65.44 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-O 118.186 -1.341 . . . . 0.0 114.371 159.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.45 -43.81 4.45 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.381 1.591 . . . . 0.0 113.968 -169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.7 mt -80.19 155.76 27.24 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -135.6 153.47 77.59 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.172 0.511 . . . . 0.0 110.586 155.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.58 112.95 3.35 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 121.817 1.678 . . . . 0.0 110.633 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.15 -13.09 5.76 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 127.232 2.348 . . . . 0.0 110.977 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.37 131.38 48.06 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.64 122.28 28.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 120.05 1.295 . . . . 0.0 107.697 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.2 153.52 43.55 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.792 1.237 . . . . 0.0 109.788 171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.5 t -130.07 -45.58 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 125.122 1.369 . . . . 0.0 109.511 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.37 149.23 51.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 124.352 1.061 . . . . 0.0 109.636 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.4 t -137.39 122.72 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 53.58 14.28 0.58 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.33 2.652 . . . . 0.0 113.555 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.34 -9.7 30.92 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 127.447 2.451 . . . . 0.0 113.367 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 65' ' ' ILE . 3.6 mp -94.49 130.37 33.83 Favored Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 120.586 2.193 . . . . 0.0 106.895 -175.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -71.91 111.01 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.958 2.439 . . . . 0.0 108.567 -177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -72.83 -8.25 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 123.335 0.654 . . . . 0.0 110.96 172.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.65 120.42 9.44 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.719 0.808 . . . . 0.0 109.72 -171.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.12 -9.2 70.53 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.284 1.421 . . . . 0.0 114.909 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -83.03 173.59 11.62 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.067 -1.255 . . . . 0.0 109.098 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.1 p -93.83 169.86 9.99 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -51.34 -46.62 62.72 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.454 1.102 . . . . 0.0 112.052 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.3 ttp85 -59.22 -33.18 70.68 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 118.905 0.775 . . . . 0.0 112.56 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -48.1 -48.02 33.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.914 0.886 . . . . 0.0 109.554 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.62 -35.5 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 O-C-N 121.456 -0.778 . . . . 0.0 110.816 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.56 -35.21 69.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 120.91 -1.119 . . . . 0.0 110.321 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.43 -42.39 87.77 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.471 1.108 . . . . 0.0 109.82 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -47.13 85.49 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 111.491 176.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -54.88 -27.83 45.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.733 0.813 . . . . 0.0 110.493 178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.45 -45.08 63.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.567 0.621 . . . . 0.0 110.63 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -63.3 -46.86 84.77 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.922 0.889 . . . . 0.0 111.329 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -43.39 83.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.456 1.102 . . . . 0.0 110.79 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.74 -24.19 67.57 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.114 -0.991 . . . . 0.0 112.791 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.11 -59.45 2.73 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 169.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -56.84 -39.33 74.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 124.622 1.201 . . . . 0.0 109.715 -167.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.79 9.3 16.74 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.352 0.977 . . . . 0.0 112.692 170.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -149.48 175.83 11.15 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.416 HG12 ' CD1' ' A' ' 22' ' ' PHE . 10.0 p -143.5 128.46 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 156.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.27 139.32 31.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 161.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.448 HD11 ' CE2' ' A' ' 24' ' ' PHE . 41.4 mt -135.51 111.75 9.73 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.8 m -95.49 115.57 27.62 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.6 m -100.1 173.84 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 165.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -150.86 160.72 43.7 Favored 'General case' 0 CA--C 1.512 -0.513 0 O-C-N 120.392 -1.442 . . . . 0.0 110.195 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -155.34 144.46 20.87 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 160.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.24 148.6 51.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.538 2.335 . . . . 0.0 109.887 177.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.76 55.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 113.484 -1.689 . . . . 0.0 106.669 -175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 54.8 tp 64.15 166.19 0.15 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.959 2.104 . . . . 0.0 112.889 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.4 p -88.53 -174.88 4.76 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.604 1.962 . . . . 0.0 109.537 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.29 178.34 17.86 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 167.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -74.75 59.97 5.12 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.701 2.934 . . . . 0.0 110.396 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.1 t -152.43 146.88 25.65 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.963 1.305 . . . . 0.0 107.807 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 74.5 m -141.39 -6.3 1.05 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.809 0 CA-C-O 117.556 -1.691 . . . . 0.0 110.727 -174.282 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.794 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 p -158.87 -93.39 0.03 OUTLIER 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.513 0.656 . . . . 0.0 110.374 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p -91.91 156.57 17.38 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.512 1.925 . . . . 0.0 110.201 -171.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.43 126.17 2.22 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.8 m 54.57 27.75 8.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -52.63 129.26 28.79 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 168.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -176.75 -99.54 0.12 Allowed Glycine 0 N--CA 1.45 -0.382 0 CA-C-O 118.774 -1.014 . . . . 0.0 110.82 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CE1' ' HD2' ' A' ' 93' ' ' ARG . 24.7 p90 -62.39 147.64 47.86 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.054 0.927 . . . . 0.0 109.256 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -106.71 131.15 54.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -84.01 159.54 21.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 158.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.32 121.67 11.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 173.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -79.98 135.76 36.46 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 168.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.3 t -126.15 107.26 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -95.59 127.77 41.9 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 mt -121.35 124.16 43.88 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.963 0.905 . . . . 0.0 109.881 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -71.95 144.38 48.94 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 166.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 -101.47 103.94 14.85 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.0 mtm -142.91 -53.16 0.39 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.04 -105.23 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.399 1.079 . . . . 0.0 110.713 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -69.91 -21.74 63.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 120.436 1.471 . . . . 0.0 112.139 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 67.17 2.13 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -172.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 69.19 100.24 0.06 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.485 2.314 . . . . 0.0 111.369 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.06 53.42 4.47 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.29 -1.283 . . . . 0.0 112.605 -175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -134.59 170.69 15.41 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.469 1.634 . . . . 0.0 110.034 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -137.97 151.73 48.23 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.71 2.404 . . . . 0.0 109.134 178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.69 152.44 28.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.682 1.193 . . . . 0.0 107.809 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 -179.16 6.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.413 1.485 . . . . 0.0 111.026 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.36 -142.82 43.31 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.81 20.72 62.38 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 123.937 0.78 . . . . 0.0 112.028 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.76 -45.96 87.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.242 1.417 . . . . 0.0 110.021 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -108.77 155.17 41.14 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -82.91 93.8 0.86 Allowed 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 124.892 3.728 . . . . 0.0 109.528 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 136.34 2.87 2.55 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.82 1.2 . . . . 0.0 112.739 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -77.71 167.98 31.6 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 118.452 1.126 . . . . 0.0 109.824 171.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -80.57 131.7 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.304 2.67 . . . . 0.0 110.211 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.7 mt -103.81 105.76 18.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.438 HD23 ' HG3' ' A' ' 58' ' ' GLU . 15.8 mt -101.68 162.8 12.64 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.851 1.66 . . . . 0.0 112.436 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.458 HG12 ' CG ' ' A' ' 57' ' ' ASP . 41.8 mm -65.79 121.5 14.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 163.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.22 -60.87 5.58 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 122.968 0.318 . . . . 0.0 112.633 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -168.43 114.78 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.9 2.08 . . . . 0.0 106.952 -170.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 77.2 t -71.3 149.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mm -82.85 116.0 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.99 -29.74 44.43 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.312 1.845 . . . . 0.0 115.135 -165.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 23.4 mmt -135.12 10.72 3.56 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.455 1.102 . . . . 0.0 111.795 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.8 172.41 54.05 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -57.88 -11.86 2.69 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.19 -52.69 6.72 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.141 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -55.0 -43.66 73.8 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 120.184 1.356 . . . . 0.0 110.414 176.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -55.79 -28.63 57.09 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -89.84 -17.43 28.12 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.395 1.078 . . . . 0.0 111.978 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.54 23.74 67.14 Favored Glycine 0 CA--C 1.533 1.201 0 N-CA-C 115.852 1.101 . . . . 0.0 115.852 164.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 mtm-85 -122.44 -14.11 7.89 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.978 1.889 . . . . 0.0 114.31 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 mt -87.14 168.8 12.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.294 0.952 . . . . 0.0 108.636 166.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.85 18.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.133 1.373 . . . . 0.0 107.838 158.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -66.44 123.77 11.59 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.894 2.396 . . . . 0.0 109.164 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.9 34.93 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.052 0.834 . . . . 0.0 113.288 -177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.478 ' OD2' HG11 ' A' ' 92' ' ' VAL . 0.0 OUTLIER -64.39 153.83 37.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 118.643 1.221 . . . . 0.0 109.507 152.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 37' ' ' LEU . 7.2 tt0 -104.58 116.64 32.43 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.821 2.048 . . . . 0.0 108.276 166.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -78.22 136.83 37.87 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.32 2.248 . . . . 0.0 108.755 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -113.98 -52.95 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 123.596 0.758 . . . . 0.0 110.276 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -134.59 145.17 48.4 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -171.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -138.81 124.83 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.322 1.449 . . . . 0.0 107.322 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.4 t70 51.43 21.15 1.14 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.613 2.365 . . . . 0.0 112.09 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.48 -10.78 70.87 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 126.82 2.153 . . . . 0.0 113.788 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.77 133.19 38.26 Favored Pre-proline 0 N--CA 1.453 -0.292 0 CA-C-N 119.575 1.687 . . . . 0.0 107.625 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -72.01 133.94 22.46 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.024 2.483 . . . . 0.0 108.295 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.413 ' CG1' HG22 ' A' ' 75' ' ' VAL . 33.5 m -99.07 -7.53 9.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.229 178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.75 133.72 47.79 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.82 -9.04 25.87 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.29 -0.728 . . . . 0.0 113.7 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 69.7 mmtt -85.96 171.8 11.18 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.935 1.868 . . . . 0.0 108.723 169.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.8 p -92.3 172.97 8.06 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.137 0.575 . . . . 0.0 110.362 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -49.7 -56.07 11.53 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 124.717 1.207 . . . . 0.0 109.485 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -50.56 -41.77 54.56 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 125.62 1.568 . . . . 0.0 112.929 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 41.0 t80 -51.63 -47.14 63.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.753 0.787 . . . . 0.0 110.266 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' CG1' ' A' ' 67' ' ' VAL . 7.3 t -73.13 -34.35 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.791 0.836 . . . . 0.0 110.465 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.3 mm -62.44 -35.44 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 121.073 -1.017 . . . . 0.0 109.878 174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.5 -43.88 97.73 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.788 1.235 . . . . 0.0 110.105 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.22 -53.88 46.15 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.625 0.77 . . . . 0.0 111.669 177.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.7 mmm -58.59 -35.22 72.07 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.235 0.614 . . . . 0.0 111.082 -176.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -59.5 -45.14 92.57 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 118.482 -0.77 . . . . 0.0 111.2 172.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -63.62 -51.08 66.79 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.808 0.843 . . . . 0.0 111.683 174.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.77 71.82 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.121 0.873 . . . . 0.0 111.678 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.82 -36.22 78.5 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.036 -1.04 . . . . 0.0 111.288 172.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -72.14 -42.87 65.49 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.391 0.996 . . . . 0.0 111.183 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -55.35 -33.51 63.45 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.364 1.065 . . . . 0.0 110.227 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 89.63 10.64 65.01 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.182 0.896 . . . . 0.0 112.228 173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -164.66 168.86 17.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 126.751 2.02 . . . . 0.0 107.053 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.5 p -150.38 159.66 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.36 88.97 2.35 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.632 1.173 . . . . 0.0 109.294 -170.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.9 97.95 8.49 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -163.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 55.4 m -83.55 127.07 33.45 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.478 HG11 ' OD2' ' A' ' 57' ' ' ASP . 17.2 m -125.99 158.47 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 126.038 1.735 . . . . 0.0 107.051 -175.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.452 ' HD2' ' CE1' ' A' ' 8' ' ' TYR . 11.6 ptt180 -151.3 161.32 42.93 Favored 'General case' 0 CA--C 1.5 -0.956 0 O-C-N 121.674 -0.641 . . . . 0.0 111.085 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.21 146.36 22.71 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 145.52 3.43 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.0 0.92 . . . . 0.0 110.411 166.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.2 t -103.87 140.17 22.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 mp -137.8 150.99 47.66 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.6 p -166.94 73.92 0.14 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.275 1.03 . . . . 0.0 108.371 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 150.84 97.06 0.16 Allowed Glycine 0 CA--C 1.524 0.616 0 CA-C-O 118.355 -1.247 . . . . 0.0 111.63 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -69.16 135.45 31.91 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.439 2.093 . . . . 0.0 108.237 165.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.4 t 169.93 -87.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 128.76 2.824 . . . . 0.0 104.136 -170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.4 t -143.44 -175.57 4.6 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.239 1.816 . . . . 0.0 106.977 157.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.234 0 CA-C-O 118.364 -1.242 . . . . 0.0 111.598 -169.252 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.96 0 CA-C-O 118.886 -0.952 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -68.82 111.26 4.79 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.119 1.459 . . . . 0.0 108.568 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.9 t -157.83 164.1 37.32 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.997 1.319 . . . . 0.0 107.726 168.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -25.63 -92.35 0.01 OUTLIER Glycine 0 CA--C 1.524 0.628 0 C-N-CA 129.428 3.394 . . . . 0.0 115.032 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 t -160.83 173.48 15.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 m -134.53 84.26 2.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 170.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.39 -3.91 0.05 OUTLIER Glycine 0 CA--C 1.527 0.799 0 N-CA-C 114.66 0.624 . . . . 0.0 114.66 -168.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 32.4 p90 -102.52 -174.05 2.47 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 121.023 -1.28 . . . . 0.0 107.587 158.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -135.82 137.33 41.42 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 159.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -83.45 152.46 24.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 164.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 mp -121.41 163.21 19.09 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 168.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -124.98 121.37 34.24 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.207 1.803 . . . . 0.0 107.706 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 79.9 t -121.59 109.1 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -78.18 144.52 36.28 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.9 mt -140.05 128.21 22.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 124.182 0.993 . . . . 0.0 108.8 166.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 -72.95 160.06 32.71 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.741 0.416 . . . . 0.0 111.669 171.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 8.5 ttt-85 -141.5 89.65 2.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.287 1.435 . . . . 0.0 107.439 166.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 mtm -154.27 -41.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.99 0.916 . . . . 0.0 109.22 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -72.78 -163.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 142.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.4 m -64.73 8.32 0.12 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 -148.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.08 174.2 50.22 Favored Glycine 0 N--CA 1.45 -0.398 0 O-C-N 120.672 -1.267 . . . . 0.0 112.287 168.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -65.99 160.83 22.76 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -150.57 72.32 0.29 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 108.874 -1.69 . . . . 0.0 108.874 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.425 ' CE2' HD11 ' A' ' 90' ' ' LEU . 45.1 p90 -143.31 171.87 13.52 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 171.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -132.18 158.67 41.12 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.126 1.371 . . . . 0.0 107.774 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -134.75 121.38 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -170.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.81 -177.23 3.08 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.474 2.31 . . . . 0.0 107.716 -168.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.49 -144.39 49.24 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.04 19.96 47.4 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.124 0.868 . . . . 0.0 112.904 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -26.28 68.73 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.011 0.925 . . . . 0.0 111.204 -168.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -140.39 160.25 60.28 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 126.114 1.766 . . . . 0.0 109.056 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.76 112.65 1.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.798 2.332 . . . . 0.0 109.33 173.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.45 -6.07 35.89 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.923 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.91 155.61 91.36 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 119.662 1.731 . . . . 0.0 108.466 166.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.63 152.41 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.517 2.811 . . . . 0.0 110.371 169.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 75' ' ' VAL . 60.8 mt -117.78 93.98 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.993 -1.855 . . . . 0.0 105.993 165.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt -81.36 152.85 27.3 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 169.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.25 139.3 18.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 159.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.7 -56.79 1.39 Allowed Glycine 0 C--O 1.226 -0.372 0 O-C-N 121.492 -0.755 . . . . 0.0 111.639 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.84 145.76 36.66 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.42 123.78 72.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.075 -2.195 . . . . 0.0 105.075 168.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -73.61 110.62 7.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -171.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.8 149.16 11.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.269 0.98 . . . . 0.0 110.483 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 31.5 mmt 66.47 -6.75 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.988 2.115 . . . . 0.0 114.564 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.28 -151.63 5.45 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.847 1.689 . . . . 0.0 111.416 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -66.5 -63.77 1.0 Allowed 'General case' 0 C--O 1.221 -0.405 0 O-C-N 120.918 -1.342 . . . . 0.0 110.725 167.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.87 -45.26 94.55 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -157.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.52 -45.92 90.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.234 1.014 . . . . 0.0 111.535 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -62.9 -39.64 95.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.686 1.595 . . . . 0.0 112.616 175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.27 -36.89 83.45 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.152 1.381 . . . . 0.0 110.368 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.2 15.32 65.26 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 125.486 1.517 . . . . 0.0 113.24 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 -98.59 -32.85 11.22 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 125.574 1.549 . . . . 0.0 109.604 -178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.2 mt -79.48 146.7 32.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 163.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -140.05 146.87 48.33 Favored Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 124.962 1.305 . . . . 0.0 108.843 164.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -69.24 112.41 2.98 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.894 2.396 . . . . 0.0 110.674 178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.19 -15.14 5.85 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.709 1.623 . . . . 0.0 112.268 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.84 140.88 57.83 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.3 122.5 32.61 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 119.989 1.268 . . . . 0.0 108.583 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 mt -72.06 156.83 38.78 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.102 0.961 . . . . 0.0 111.202 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.14 -53.01 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 125.902 1.681 . . . . 0.0 108.933 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -129.4 148.25 51.3 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.528 1.131 . . . . 0.0 109.618 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.0 t -142.84 126.64 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 125.721 1.608 . . . . 0.0 107.019 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.1 t0 63.11 -3.83 0.32 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.921 2.088 . . . . 0.0 112.708 -176.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.58 -16.96 6.96 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 128.841 3.115 . . . . 0.0 111.914 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.27 134.87 20.96 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 118.868 1.334 . . . . 0.0 108.648 -167.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -73.16 118.83 5.7 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.382 2.722 . . . . 0.0 109.883 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.488 ' CG1' HG22 ' A' ' 75' ' ' VAL . 15.5 m -80.3 -7.3 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 111.023 173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.78 118.29 8.12 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.597 1.159 . . . . 0.0 109.992 -174.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.97 -10.01 70.0 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.657 1.122 . . . . 0.0 113.548 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -78.55 -172.53 2.96 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 108.712 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -100.63 171.89 7.43 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.685 1.194 . . . . 0.0 109.402 172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -50.81 -53.65 30.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 125.389 1.476 . . . . 0.0 109.844 168.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -63.75 -24.26 67.69 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -51.71 -48.92 63.37 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.854 0.835 . . . . 0.0 110.21 169.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.488 HG22 ' CG1' ' A' ' 67' ' ' VAL . 4.7 t -71.65 -37.18 62.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 124.572 1.149 . . . . 0.0 110.126 -177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.02 -28.35 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 121.23 -0.919 . . . . 0.0 110.204 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -45.48 72.54 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 125.476 1.51 . . . . 0.0 110.415 169.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -49.62 76.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.191 0.596 . . . . 0.0 110.775 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.0 mmm -57.74 -19.88 30.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.942 0.497 . . . . 0.0 112.331 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -47.85 21.2 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.373 0.988 . . . . 0.0 111.103 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.43 -47.04 85.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 119.016 0.825 . . . . 0.0 111.111 175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.35 -38.02 73.48 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.689 0.796 . . . . 0.0 111.713 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.78 -14.25 62.91 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.155 -1.591 . . . . 0.0 113.805 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -81.7 -43.74 18.07 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.033 1.288 . . . . 0.0 109.764 165.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -63.28 -17.35 62.42 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 124.747 1.219 . . . . 0.0 112.016 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 65.23 22.31 69.01 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.037 1.303 . . . . 0.0 112.406 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -157.31 168.7 26.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.031 1.732 . . . . 0.0 106.872 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.8 p -139.06 163.49 26.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -121.88 140.42 52.43 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 166.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 24' ' ' PHE . 13.4 mt -137.01 106.67 6.17 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -175.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.4 m -97.31 112.58 24.34 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.44 164.77 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.65 151.75 32.97 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 120.567 -1.333 . . . . 0.0 110.839 174.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -151.02 136.05 17.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -48.58 133.54 16.62 Favored 'General case' 0 CA--C 1.511 -0.519 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 166.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.8 t -84.31 162.75 2.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 170.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -166.47 -41.36 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.923 0.889 . . . . 0.0 109.689 169.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.8 m 41.39 48.66 3.33 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.16 1.784 . . . . 0.0 110.556 -173.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -119.06 -165.81 13.25 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 127.197 2.332 . . . . 0.0 110.067 -174.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -62.62 160.89 30.34 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.904 1.736 . . . . 0.0 110.726 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.8 -177.77 6.08 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.795 1.238 . . . . 0.0 110.206 -165.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.4 t -146.93 160.43 42.34 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.223 0.609 . . . . 0.0 109.722 176.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 106.917 -2.473 . . . . 0.0 106.917 -170.032 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.839 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -131.87 108.53 9.47 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 174.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m 63.57 172.43 0.17 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.236 1.414 . . . . 0.0 112.754 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.06 162.83 54.52 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.173 -0.954 . . . . 0.0 111.29 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.4 t -148.24 161.0 42.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.519 1.128 . . . . 0.0 109.154 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 m -178.75 -43.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.533 2.333 . . . . 0.0 109.336 165.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.69 -109.01 0.11 Allowed Glycine 0 C--N 1.338 0.662 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -59.95 130.6 47.53 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 122.156 0.979 . . . . 0.0 108.984 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -97.0 147.3 24.14 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 112.918 -1.946 . . . . 0.0 106.253 164.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -84.02 154.19 23.41 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 160.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.06 118.08 23.72 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 177.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.51 130.44 39.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 170.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.49 HG11 ' HG ' ' A' ' 53' ' ' LEU . 98.6 t -135.08 107.15 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -95.26 128.27 41.97 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 175.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.6 mt -119.76 165.46 14.51 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.109 0.963 . . . . 0.0 109.409 169.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -127.35 145.75 50.7 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.721 1.208 . . . . 0.0 110.899 -175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -98.94 101.48 12.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tpt -144.7 -63.51 0.36 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 170.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.28 -85.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.809 0.844 . . . . 0.0 110.536 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -95.51 -31.02 13.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 117.919 0.327 . . . . 0.0 111.803 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.68 71.66 1.27 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 66.26 83.28 0.17 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.9 1.68 . . . . 0.0 111.155 168.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.39 59.44 2.83 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.893 0.759 . . . . 0.0 112.878 -176.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 90' ' ' LEU . 39.7 p90 -135.35 175.05 9.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.082 1.353 . . . . 0.0 109.613 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -129.57 166.91 18.76 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.99 1.316 . . . . 0.0 108.563 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.05 122.69 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HA3' ' A' ' 39' ' ' GLY . 79.0 mt -140.36 -176.5 4.64 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 108.593 -173.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.27 -151.47 52.11 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 -168.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.96 33.35 20.9 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 117.427 0.613 . . . . 0.0 111.578 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -71.63 -17.09 62.28 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 121.332 -1.099 . . . . 0.0 110.62 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -132.4 160.32 68.63 Favored Pre-proline 0 C--O 1.239 0.539 0 C-N-CA 126.715 2.006 . . . . 0.0 107.694 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -80.3 79.39 3.35 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 124.105 3.203 . . . . 0.0 109.153 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.09 51.38 0.27 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 125.697 1.618 . . . . 0.0 109.296 -174.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -118.47 159.3 44.32 Favored Pre-proline 0 C--O 1.236 0.39 0 C-N-CA 125.761 1.624 . . . . 0.0 107.506 158.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 144.34 47.89 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.788 1.659 . . . . 0.0 109.018 -170.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 7.2 mt -105.37 79.17 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-O 124.189 1.947 . . . . 0.0 107.329 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.4 mt -84.34 124.37 31.2 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.316 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 mm -47.15 129.06 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' HA3' ' HG ' ' A' ' 27' ' ' LEU . . . -84.12 -0.81 89.67 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.902 2.668 . . . . 0.0 116.787 -166.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 127.35 134.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.467 1 C-N-CA 132.36 4.264 . . . . 0.0 108.824 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 32.2 t -77.41 149.89 5.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.74 117.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.36 -35.67 70.23 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -163.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 34.6 mtm -131.33 114.64 15.25 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.02 -177.84 38.08 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -173.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 m -51.84 -45.32 63.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.752 1.221 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.79 -40.84 72.32 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 118.56 -0.733 . . . . 0.0 111.369 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.11 -41.4 99.34 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.916 0.486 . . . . 0.0 110.287 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -59.58 -46.53 88.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.92 -0.562 . . . . 0.0 111.227 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -21.22 66.54 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.434 0.561 . . . . 0.0 110.59 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 0.32 30.6 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 125.33 1.443 . . . . 0.0 113.673 167.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -99.35 -21.52 15.99 Favored 'General case' 0 C--O 1.228 -0.059 0 CA-C-O 116.656 -1.64 . . . . 0.0 114.056 -171.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.49 ' HG ' HG11 ' A' ' 13' ' ' VAL . 5.6 mt -95.92 145.97 24.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.309 1.413 . . . . 0.0 108.147 172.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -140.22 -179.06 0.92 Allowed Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 125.926 1.691 . . . . 0.0 109.949 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -94.94 138.41 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.737 2.958 . . . . 0.0 111.702 175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.35 -3.69 59.87 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 125.867 1.698 . . . . 0.0 111.771 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.43 139.96 46.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.11 132.66 42.68 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 127.011 2.124 . . . . 0.0 106.878 173.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.14 152.18 23.05 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.079 1.752 . . . . 0.0 109.369 178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.01 -50.09 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.008 1.323 . . . . 0.0 108.742 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -127.74 152.37 47.83 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.024 0.929 . . . . 0.0 110.011 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.3 t -144.13 123.72 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 125.836 1.654 . . . . 0.0 106.81 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.6 t0 55.6 19.21 3.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.591 2.356 . . . . 0.0 113.319 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 111.11 -16.03 27.78 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 126.862 2.172 . . . . 0.0 113.702 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.18 131.88 22.63 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 118.778 1.289 . . . . 0.0 108.433 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -72.27 111.65 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.651 2.901 . . . . 0.0 109.004 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -75.67 -4.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.981 0.913 . . . . 0.0 112.007 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.3 126.29 27.31 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.193 0.597 . . . . 0.0 109.54 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.86 -7.47 81.68 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.301 0.953 . . . . 0.0 112.91 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -91.99 175.95 6.69 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.145 1.473 . . . . 0.0 108.974 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -95.09 167.89 11.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.76 174.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -48.78 -44.38 38.85 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 110.646 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -57.62 -35.72 70.84 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 123.631 0.772 . . . . 0.0 113.075 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -56.14 -44.14 78.91 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.27 -38.55 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 123.965 0.906 . . . . 0.0 110.406 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.3 mm -56.97 -40.61 73.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 120.093 1.315 . . . . 0.0 110.129 175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -70.73 -33.4 70.8 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.747 0.248 . . . . 0.0 111.574 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.17 -46.77 72.96 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.663 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.4 mmm -63.54 -33.15 74.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.195 0.907 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -55.06 -45.25 75.31 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.175 169.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -49.66 64.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.856 0.862 . . . . 0.0 111.422 176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.35 66.85 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 110.539 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 -23.44 64.0 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.019 -1.051 . . . . 0.0 113.327 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt180 -93.47 -31.37 14.61 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.207 1.003 . . . . 0.0 110.846 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -57.71 -25.2 60.0 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.329 0.652 . . . . 0.0 110.519 166.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.88 5.35 90.14 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 121.432 -0.792 . . . . 0.0 111.926 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -149.75 174.04 13.05 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.372 1.869 . . . . 0.0 107.195 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.48 147.84 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 160.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -115.71 108.83 16.87 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 24' ' ' PHE . 24.7 mt -99.29 140.95 32.69 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 93.3 m -120.56 114.78 22.25 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.55 171.36 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -148.67 162.2 40.2 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.512 -1.367 . . . . 0.0 109.24 170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -155.06 120.57 5.02 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 109.75 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.74 147.31 52.01 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 125.378 1.471 . . . . 0.0 110.213 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.78 164.95 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD13 ' H ' ' A' ' 98' ' ' SER . 0.2 OUTLIER -159.52 160.44 34.57 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.841 3.256 . . . . 0.0 106.822 168.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.448 ' H ' HD13 ' A' ' 97' ' ' LEU . 5.1 t -148.9 141.77 24.69 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.97 -122.55 1.11 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-O 117.964 -1.465 . . . . 0.0 109.981 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.03 -173.8 1.71 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 123.365 2.71 . . . . 0.0 111.028 173.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -151.03 -33.82 0.15 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.039 0.936 . . . . 0.0 112.876 176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.8 m -146.86 152.39 38.64 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.838 -1.164 . . . . 0.0 108.679 161.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.751 0 N-CA-C 106.849 -2.501 . . . . 0.0 106.849 -170.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.576 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m 69.4 -48.01 0.6 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.145 2.578 . . . . 0.0 114.458 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.0 m 55.68 -176.47 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.023 1.729 . . . . 0.0 113.967 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.69 110.02 3.46 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 108.821 -1.711 . . . . 0.0 108.821 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.1 m 28.83 75.8 0.03 OUTLIER 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.042 2.537 . . . . 0.0 111.994 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 m -55.8 150.23 13.32 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 96' ' ' VAL . . . -61.16 -95.58 0.01 OUTLIER Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 124.127 0.87 . . . . 0.0 112.075 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 2.5 p90 -51.88 135.76 29.57 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 121.81 0.814 . . . . 0.0 108.9 -174.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.88 133.26 33.94 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 167.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.26 152.99 24.91 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 158.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -136.42 162.71 32.3 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.53 2.332 . . . . 0.0 107.511 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.52 116.93 22.56 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 122.314 1.054 . . . . 0.0 110.559 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.7 t -105.91 136.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 168.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -129.05 107.46 9.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 123.8 46.7 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -75.21 160.66 30.13 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -124.72 99.93 6.39 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 167.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.1 ptp -132.37 6.41 4.14 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.641 0.776 . . . . 0.0 110.687 174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.2 -110.9 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 -175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.4 m -64.58 -30.42 71.44 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.551 1.069 . . . . 0.0 112.028 -175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.22 82.87 0.61 Allowed Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -169.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 67.23 -171.34 0.19 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.148 1.379 . . . . 0.0 110.167 170.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -169.58 45.88 0.21 Allowed Glycine 0 C--N 1.334 0.436 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 90' ' ' LEU . 13.3 p90 -139.58 152.05 46.53 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -108.6 167.16 10.25 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 127.703 2.401 . . . . 0.0 108.538 177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.67 135.41 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 O-C-N 120.542 -1.349 . . . . 0.0 107.733 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -138.64 -176.82 4.61 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 128.563 2.745 . . . . 0.0 106.815 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.48 -159.91 41.08 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.67 24.8 54.25 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 119.38 -0.678 . . . . 0.0 112.719 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -64.33 -28.11 69.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 118.579 1.19 . . . . 0.0 110.714 -171.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -135.09 160.67 67.4 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 126.936 2.094 . . . . 0.0 108.03 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -78.32 35.18 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.752 1 C-N-CA 125.372 4.048 . . . . 0.0 113.603 -166.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.86 20.51 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.997 1.761 . . . . 0.0 111.528 169.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -89.7 154.07 47.96 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 118.92 1.36 . . . . 0.0 111.123 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -64.84 135.14 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.916 3.078 . . . . 0.0 109.286 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -98.2 92.51 2.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.436 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.6 mt -85.15 134.87 34.16 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.494 -0.754 . . . . 0.0 111.28 -175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.5 mm -54.04 112.33 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 126.696 1.998 . . . . 0.0 105.728 165.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.1 -74.86 0.3 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.713 1.625 . . . . 0.0 113.216 -170.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.92 119.27 5.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.631 1.973 . . . . 0.0 106.756 175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.61 149.04 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.49 113.25 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.13 -23.75 56.2 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 125.156 1.382 . . . . 0.0 114.588 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 17.1 mmt -110.95 -0.05 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.915 0.886 . . . . 0.0 110.628 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.23 -178.1 22.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 124.899 1.238 . . . . 0.0 111.181 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 m -66.14 -8.34 23.35 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.25 -40.45 18.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.086 1.766 . . . . 0.0 111.332 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.7 -53.04 24.52 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.447 1.099 . . . . 0.0 110.428 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -55.32 -29.18 57.77 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.54 -21.94 65.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.766 0.826 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.16 52.65 51.23 Favored Glycine 0 C--N 1.339 0.722 0 C-N-CA 124.982 1.277 . . . . 0.0 111.022 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.78 -78.75 0.28 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -168.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.1 mt -69.13 142.05 54.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 119.054 0.843 . . . . 0.0 110.813 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -119.59 154.22 54.49 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.934 0.894 . . . . 0.0 108.978 159.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 142.89 34.83 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.85 1.7 . . . . 0.0 110.07 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.43 88.46 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-O 118.963 -0.91 . . . . 0.0 113.533 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -71.19 141.13 50.67 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 169.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.45 128.82 36.63 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.006 -1.059 . . . . 0.0 109.4 -178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -79.72 153.47 29.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.396 1.878 . . . . 0.0 110.923 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.94 -37.04 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.005 1.722 . . . . 0.0 109.516 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 66' ' ' PRO . 70.2 m-85 -137.18 151.92 49.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.084 0.953 . . . . 0.0 110.388 178.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.5 t -147.31 134.5 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 127.036 2.134 . . . . 0.0 106.954 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t0 58.83 17.03 4.91 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.299 1.44 . . . . 0.0 111.029 -172.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.8 0.82 88.85 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.732 2.11 . . . . 0.0 114.066 -172.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.3 mm -94.78 136.03 23.31 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 127.036 2.134 . . . . 0.0 108.098 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . 18.0 Cg_endo -74.07 145.59 35.55 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.358 2.039 . . . . 0.0 109.189 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.02 2.36 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 123.077 0.551 . . . . 0.0 112.379 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.8 102.14 2.78 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 122.041 -0.412 . . . . 0.0 110.239 -165.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.48 -3.8 50.53 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.529 1.061 . . . . 0.0 113.718 -178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 57.3 mmtt -78.83 -179.98 6.88 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.052 -1.264 . . . . 0.0 108.023 158.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.7 p -111.85 175.52 5.39 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.21 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -40.8 -64.24 0.56 Allowed 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.669 1.988 . . . . 0.0 109.792 170.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -55.43 -38.75 69.41 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.239 0.616 . . . . 0.0 112.577 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 9.1 t80 -55.01 -48.04 73.88 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 118.441 0.564 . . . . 0.0 109.488 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.12 -44.06 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.353 -1.308 . . . . 0.0 109.171 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.5 mm -57.16 -37.54 56.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.507 1.503 . . . . 0.0 109.785 -176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -54.52 46.02 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.053 0.941 . . . . 0.0 110.91 170.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.7 mt -62.03 -35.04 77.39 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.268 0.627 . . . . 0.0 112.154 -177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -30.48 23.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 125.335 1.454 . . . . 0.0 109.388 -171.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -64.9 -30.87 71.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.195 0.998 . . . . 0.0 111.339 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -67.09 -51.04 59.26 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 173.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.18 74.09 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.456 1.103 . . . . 0.0 111.394 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -23.34 15.36 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.533 -1.354 . . . . 0.0 112.464 171.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.0 mtt-85 -94.17 -21.73 18.9 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 117.059 -1.448 . . . . 0.0 111.926 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -61.92 -35.87 79.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.193 1.361 . . . . 0.0 110.696 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.47 -0.72 49.77 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.529 -0.732 . . . . 0.0 112.724 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -151.81 167.84 26.99 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.76 2.024 . . . . 0.0 106.672 165.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.1 p -132.02 122.13 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 162.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -80.53 128.16 33.27 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.472 HD11 ' CE1' ' A' ' 24' ' ' PHE . 14.7 mt -130.8 128.41 40.66 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.4 m -112.06 122.53 48.01 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 174.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.2 m -111.09 164.81 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.442 1.097 . . . . 0.0 109.339 175.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -152.21 146.78 25.71 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 120.596 -1.315 . . . . 0.0 110.954 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -148.82 126.88 12.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.834 0.454 . . . . 0.0 110.204 -174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.9 123.17 17.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.197 0.999 . . . . 0.0 112.361 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 7' ' ' GLY . 2.5 p -93.08 165.27 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.207 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.41 -62.49 0.09 Allowed 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 37.89 74.73 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.531 2.732 . . . . 0.0 112.364 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 170.98 44.13 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.53 162.6 41.32 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.097 2.532 . . . . 0.0 112.445 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.2 t -141.93 -35.74 0.44 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.399 1.08 . . . . 0.0 112.485 -172.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.7 m -163.63 160.62 23.08 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.204 1.366 . . . . 0.0 108.68 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.21 0 CA-C-O 116.74 -2.144 . . . . 0.0 108.067 178.775 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.809 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m 81.2 -55.23 0.29 Allowed 'General case' 0 C--O 1.232 0.156 0 C-N-CA 127.178 2.191 . . . . 0.0 112.485 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.4 m -77.28 68.17 3.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.368 1.867 . . . . 0.0 110.049 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.77 150.1 25.47 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.488 1.518 . . . . 0.0 112.002 176.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 t -84.66 93.95 8.52 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.5 m -68.79 78.51 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.693 0.797 . . . . 0.0 110.007 167.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.5 -94.43 0.24 Allowed Glycine 0 C--N 1.334 0.468 0 O-C-N 121.141 -0.974 . . . . 0.0 110.758 169.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.416 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 25.5 p90 -53.9 126.56 22.78 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 124.386 0.698 . . . . 0.0 109.605 -164.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -87.61 117.27 26.31 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -83.95 141.06 31.51 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 162.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.89 116.72 15.96 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.52 143.06 36.93 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.819 1.648 . . . . 0.0 109.176 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.4 t -136.59 108.72 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 126.248 1.819 . . . . 0.0 106.743 176.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -82.3 130.45 35.1 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 169.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -120.9 123.91 43.67 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 119.253 0.933 . . . . 0.0 109.276 164.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -74.42 158.58 33.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.185 165.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 51.9 ttt-85 -131.24 102.31 5.93 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 125.793 1.637 . . . . 0.0 107.11 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 18.2 ptp -155.66 8.77 0.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -136.75 -76.54 0.42 Allowed 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.638 -1.288 . . . . 0.0 108.41 -166.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.47 -7.7 12.83 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.66 1.584 . . . . 0.0 111.919 170.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.14 -179.95 41.43 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 124.159 0.885 . . . . 0.0 111.807 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.1 m-85 -62.48 147.08 49.9 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -130.61 51.15 0.87 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -134.7 153.51 51.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 169.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -110.97 163.93 13.32 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.666 1.987 . . . . 0.0 107.316 168.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.401 ' HA ' ' H ' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -136.46 150.23 27.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.155 1.382 . . . . 0.0 108.642 -179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -134.59 -177.29 4.54 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.856 2.062 . . . . 0.0 108.549 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.12 -140.51 37.88 Favored Glycine 0 CA--C 1.521 0.447 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 51.03 23.92 8.0 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 127.956 2.693 . . . . 0.0 112.922 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.37 -25.38 65.95 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 122.031 -0.688 . . . . 0.0 110.342 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -121.84 155.9 59.86 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 123.507 0.723 . . . . 0.0 110.145 178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -67.07 133.09 29.8 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.112 1.874 . . . . 0.0 108.684 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.43 19.32 74.36 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.018 -0.992 . . . . 0.0 113.935 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -72.59 162.38 74.39 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.603 1.201 . . . . 0.0 110.34 168.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -71.09 119.27 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.289 1.993 . . . . 0.0 109.571 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.2 mt -90.45 97.74 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.4 mt -83.73 151.77 25.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 mm -55.83 122.23 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 165.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 26' ' ' ILE . . . -67.21 -62.7 4.24 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.04 128.96 4.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.762 0.825 . . . . 0.0 108.799 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.79 128.0 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 164.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 45.5 mm -68.21 132.93 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 125.278 1.431 . . . . 0.0 108.611 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.82 65.77 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.756 1.223 . . . . 0.0 113.855 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 39.7 mtt -126.79 54.98 1.57 Allowed 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 170.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.07 169.45 12.95 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -6.99 20.31 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.325 -1.321 . . . . 0.0 114.08 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.54 -56.4 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 120.03 1.286 . . . . 0.0 110.507 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.61 -45.99 91.95 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.429 0.559 . . . . 0.0 110.562 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -18.94 48.51 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 176.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -95.96 -17.67 20.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.962 1.305 . . . . 0.0 111.835 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.71 45.38 53.05 Favored Glycine 0 CA--C 1.528 0.863 0 O-C-N 120.955 -1.091 . . . . 0.0 113.869 165.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.3 mtp85 -133.37 -48.51 0.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.765 0.783 . . . . 0.0 111.436 166.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.8 mt -74.04 148.15 42.23 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.609 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -139.77 148.5 55.79 Favored Pre-proline 0 CA--C 1.535 0.365 0 C-N-CA 125.167 1.387 . . . . 0.0 112.327 169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.94 92.59 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.816 3.011 . . . . 0.0 112.464 -174.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.87 -13.61 1.51 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.202 1.858 . . . . 0.0 113.029 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.32 154.12 28.83 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 118.957 1.379 . . . . 0.0 109.694 177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -96.32 131.78 42.49 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.81 155.83 27.69 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.11 0.964 . . . . 0.0 110.453 176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.88 -51.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 125.071 1.348 . . . . 0.0 109.332 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -132.65 146.72 52.1 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 55.5 t -143.8 116.45 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 -176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.5 t0 57.99 25.04 11.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.586 1.555 . . . . 0.0 111.522 -166.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.44 0.77 59.11 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.503 1.049 . . . . 0.0 112.815 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.9 mm -86.27 127.62 60.63 Favored Pre-proline 0 N--CA 1.454 -0.236 0 CA-C-N 119.798 1.799 . . . . 0.0 106.507 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -69.82 128.36 15.86 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.503 2.802 . . . . 0.0 109.257 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.8 m -92.16 -3.65 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 119.118 -0.468 . . . . 0.0 111.708 176.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 149.11 48.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.203 0.91 . . . . 0.0 108.848 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.25 -28.12 0.33 Allowed Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.017 1.294 . . . . 0.0 114.57 -172.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -74.71 173.72 10.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 125.054 1.342 . . . . 0.0 109.434 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 p -103.92 -177.36 3.35 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.726 1.61 . . . . 0.0 109.47 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -58.86 -55.01 40.67 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.254 1.822 . . . . 0.0 110.443 172.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -56.13 -35.27 66.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 119.382 0.992 . . . . 0.0 112.422 -175.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -47.04 -50.34 19.67 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.261 0.625 . . . . 0.0 111.165 171.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.59 -35.78 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 124.453 1.101 . . . . 0.0 110.338 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.3 mm -65.37 -27.86 42.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 119.935 1.243 . . . . 0.0 110.379 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.12 -41.28 74.16 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.354 -1.466 . . . . 0.0 110.686 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -65.98 -31.28 72.09 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.894 -1.129 . . . . 0.0 112.229 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.77 -35.02 77.93 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.024 1.33 . . . . 0.0 109.61 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.3 -60.33 3.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.486 0.714 . . . . 0.0 109.944 171.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -56.9 -49.37 75.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.351 1.061 . . . . 0.0 112.379 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.56 -34.94 79.42 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.44 -0.788 . . . . 0.0 111.721 -175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.8 -17.22 64.76 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.035 -1.04 . . . . 0.0 112.337 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -81.44 -42.59 20.13 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 110.428 166.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -61.07 -20.2 62.3 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.049 0.939 . . . . 0.0 110.708 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.87 11.61 76.37 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 124.129 0.871 . . . . 0.0 111.996 169.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.21 167.85 11.99 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 125.953 1.701 . . . . 0.0 107.046 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.7 p -150.29 150.77 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 170.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -105.29 126.09 51.71 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 164.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.65 99.27 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.496 -2.409 . . . . 0.0 104.496 -177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.4 m -87.49 116.69 25.78 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.4 m -101.86 169.85 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.436 1.095 . . . . 0.0 109.005 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.416 ' HD2' ' CD1' ' A' ' 8' ' ' TYR . 15.9 ptt180 -153.25 167.97 27.54 Favored 'General case' 0 CA--C 1.504 -0.816 0 O-C-N 120.527 -1.358 . . . . 0.0 110.858 172.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.511 HH11 ' CB ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -150.14 149.11 29.79 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.164 161.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -53.13 156.03 2.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 122.56 1.171 . . . . 0.0 111.615 161.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.5 146.69 18.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.26 -40.23 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 122.577 0.351 . . . . 0.0 110.279 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.0 m 68.21 1.9 3.02 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 155.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -140.28 118.79 1.49 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 106.838 -2.505 . . . . 0.0 106.838 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.06 163.28 36.52 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 CA-C-N 120.864 2.332 . . . . 0.0 109.605 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.6 t -141.83 166.14 25.55 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 163.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.35 109.1 4.03 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -144.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.781 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m -142.44 144.74 33.2 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.746 1.218 . . . . 0.0 108.197 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 46.94 75.77 0.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 126.544 1.937 . . . . 0.0 111.491 -176.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.47 -177.01 5.13 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.174 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t -49.65 103.57 0.05 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.571 1.548 . . . . 0.0 111.431 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -133.02 58.33 1.77 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.224 1.81 . . . . 0.0 108.946 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.67 -21.14 47.68 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.473 -1.239 . . . . 0.0 115.083 157.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -117.52 162.86 17.3 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.148 1.474 . . . . 0.0 108.519 166.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -124.0 130.45 52.6 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.83 138.18 33.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.617 -1.624 . . . . 0.0 106.617 162.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.84 134.56 53.57 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.765 2.026 . . . . 0.0 107.251 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -92.08 132.44 36.58 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.482 HG11 ' HG ' ' A' ' 53' ' ' LEU . 65.4 t -130.12 108.82 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 125.588 1.555 . . . . 0.0 106.977 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -86.4 126.89 34.69 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 168.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -117.61 123.14 45.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 119.187 0.903 . . . . 0.0 109.041 164.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -78.74 161.44 26.86 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 111.055 172.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.484 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 38.8 ttt-85 -139.88 93.62 2.67 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.741 1.216 . . . . 0.0 110.48 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.7 mtp -142.29 -8.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 161.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -131.22 -105.65 0.27 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -164.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.8 m -65.6 -23.45 66.83 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.08 -1.013 . . . . 0.0 112.285 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.44 -179.94 7.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 119.704 1.138 . . . . 0.0 111.729 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 3.1 m-85 -63.5 123.52 18.98 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 121.16 -1.2 . . . . 0.0 110.632 -165.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.75 53.42 0.59 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 124.148 0.88 . . . . 0.0 111.133 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CE1' HD11 ' A' ' 90' ' ' LEU . 32.0 p90 -142.2 167.87 21.08 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.441 1.121 . . . . 0.0 108.66 172.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.5 ttm105 -123.43 162.36 22.97 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.801 2.04 . . . . 0.0 107.503 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.98 151.73 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.17 2.188 . . . . 0.0 106.99 175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.419 HD12 ' HA2' ' A' ' 39' ' ' GLY . 97.0 mt -149.03 -177.31 5.74 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.476 2.31 . . . . 0.0 107.806 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -175.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.32 24.59 56.0 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.232 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.98 -11.0 59.74 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.906 1.853 . . . . 0.0 112.415 -170.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -132.1 160.34 68.28 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 127.225 2.21 . . . . 0.0 107.369 168.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -80.94 69.56 7.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.961 3.774 . . . . 0.0 110.058 -169.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.1 7.12 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.27 1.414 . . . . 0.0 112.599 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -63.54 160.84 39.88 Favored Pre-proline 0 C--O 1.239 0.507 0 CA-C-N 119.62 1.71 . . . . 0.0 109.76 159.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.86 140.87 51.98 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.669 1.58 . . . . 0.0 109.175 166.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.4 mt -105.79 93.2 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.4 mt -85.3 149.27 25.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.1 0.476 . . . . 0.0 110.339 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.0 mm -56.79 121.33 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 158.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 27' ' ' LEU . . . -64.49 -68.6 1.6 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 124.849 1.214 . . . . 0.0 110.081 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.9 144.55 31.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.729 1.612 . . . . 0.0 107.609 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.45 139.84 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 162.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.0 mm -86.15 110.2 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.88 144.56 11.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.893 1.277 . . . . 0.0 111.076 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.0 mmt 47.09 69.99 0.45 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.105 1.762 . . . . 0.0 110.012 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -174.01 -179.94 44.97 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -169.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 m -57.71 -38.52 75.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.906 1.353 . . . . 0.0 114.64 -165.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 -44.43 50.28 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.872 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.06 -42.49 65.86 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.212 1.005 . . . . 0.0 111.654 171.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.5 mtp-105 -77.33 -21.42 53.43 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.089 -1.007 . . . . 0.0 112.296 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -79.74 -29.32 40.53 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.189 0.996 . . . . 0.0 110.524 171.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.36 -3.49 4.49 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 127.11 2.291 . . . . 0.0 114.524 171.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.9 ttm-85 -90.33 -42.14 11.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.658 1.229 . . . . 0.0 111.695 -168.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.482 ' HG ' HG11 ' A' ' 13' ' ' VAL . 7.5 mt -69.28 160.95 30.26 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.989 0.516 . . . . 0.0 109.643 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.2 155.61 72.4 Favored Pre-proline 0 N--CA 1.451 -0.388 0 C-N-CA 124.679 1.191 . . . . 0.0 109.221 160.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -69.0 142.47 51.41 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.772 1.648 . . . . 0.0 108.838 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.26 -0.94 86.85 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.465 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -62.55 145.13 55.11 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 119.335 1.568 . . . . 0.0 107.433 166.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -93.71 133.57 36.93 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.746 1.157 . . . . 0.0 108.323 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.0 mt -88.14 153.48 21.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.373 1.469 . . . . 0.0 110.173 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.0 -47.16 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.578 1.551 . . . . 0.0 109.426 -178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.21 150.31 48.94 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.879 1.672 . . . . 0.0 108.731 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -145.44 118.46 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 69.85 -31.39 0.21 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 128.099 2.56 . . . . 0.0 112.427 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 157.63 -21.13 0.39 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 128.065 2.745 . . . . 0.0 110.485 171.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.521 HD12 ' H ' ' A' ' 65' ' ' ILE . 4.5 mp -76.82 135.69 67.5 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 127.59 2.356 . . . . 0.0 107.457 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -72.92 151.49 50.72 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.425 2.083 . . . . 0.0 110.057 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.8 m -114.26 -7.77 12.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.26 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -71.23 102.83 2.64 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -172.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.68 2.13 30.65 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.855 1.216 . . . . 0.0 113.502 -174.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -98.17 173.23 7.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 119.875 1.837 . . . . 0.0 109.387 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -89.56 172.45 8.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.319 171.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -61.57 -46.4 90.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.181 -0.949 . . . . 0.0 111.137 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -62.61 -26.94 68.87 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.64 -0.695 . . . . 0.0 112.106 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -45.86 -48.87 15.87 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.268 1.027 . . . . 0.0 110.516 168.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.62 -36.16 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.442 1.097 . . . . 0.0 109.118 -169.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.7 mm -53.14 -45.46 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.186 0.903 . . . . 0.0 109.783 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -70.35 -24.85 63.05 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -74.18 -46.71 40.46 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.477 0.711 . . . . 0.0 110.54 170.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 89.6 mmm -62.58 -24.58 67.63 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.926 1.239 . . . . 0.0 112.199 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -59.46 -50.82 72.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.934 167.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -50.45 56.58 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.291 1.836 . . . . 0.0 111.333 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.98 69.86 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.58 0.752 . . . . 0.0 111.264 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.31 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.629 -1.294 . . . . 0.0 112.15 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -69.26 -37.78 78.08 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.504 1.521 . . . . 0.0 111.187 173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -62.78 -12.39 23.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.381 0.537 . . . . 0.0 112.14 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.44 9.68 85.88 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.282 175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -170.76 166.38 7.89 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.355 1.862 . . . . 0.0 108.119 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -148.47 118.92 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -82.18 100.65 9.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 165.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CE1' ' A' ' 24' ' ' PHE . 29.2 mt -87.06 145.73 26.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 95.2 m -123.44 118.99 28.71 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 165.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 m -101.17 169.5 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 O-C-N 124.097 0.873 . . . . 0.0 108.99 170.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -151.35 161.04 43.41 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.868 -1.145 . . . . 0.0 110.183 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.83 134.46 14.53 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.531 169.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 139.28 58.27 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.915 1.286 . . . . 0.0 111.829 169.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -113.46 57.2 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.484 1.513 . . . . 0.0 108.481 -169.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 tp 51.92 13.95 0.28 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.334 1.854 . . . . 0.0 115.863 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 t -66.33 149.25 50.65 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.397 -1.439 . . . . 0.0 107.904 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.87 103.54 0.67 Allowed Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -67.97 173.57 9.09 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.362 1.375 . . . . 0.0 109.628 165.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.3 m -121.05 168.4 11.57 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 125.031 1.332 . . . . 0.0 109.693 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 m -81.31 -21.16 39.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.477 0.711 . . . . 0.0 110.648 163.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.226 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 174.34 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m -120.68 100.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.798 2.039 . . . . 0.0 106.861 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 p -141.56 166.37 24.92 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 126.643 1.977 . . . . 0.0 106.122 158.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.67 166.83 30.82 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.541 1.067 . . . . 0.0 111.323 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -77.26 149.73 35.4 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.888 -0.772 . . . . 0.0 109.004 168.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m -132.16 116.61 17.22 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -66.65 2.34 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 125.749 1.642 . . . . 0.0 113.105 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -65.44 153.45 41.31 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 117.76 0.78 . . . . 0.0 108.98 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.441 ' HE3' HD11 ' A' ' 11' ' ' LEU . 49.7 pttt -112.59 145.22 40.73 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 170.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -84.16 158.58 21.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 164.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.441 HD11 ' HE3' ' A' ' 9' ' ' LYS . 2.0 mm? -129.09 138.96 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.433 1.893 . . . . 0.0 106.925 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.13 125.89 46.31 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.063 1.345 . . . . 0.0 108.098 172.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.17 142.79 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.349 1.06 . . . . 0.0 108.677 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -130.18 125.52 35.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.422 HD13 HD12 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -124.56 165.07 18.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.927 0.785 . . . . 0.0 110.643 -174.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER -132.99 159.98 38.43 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.811 0.845 . . . . 0.0 111.333 -174.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -126.03 85.07 2.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.828 1.251 . . . . 0.0 111.04 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.4 ttm -140.4 -17.2 0.91 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.258 0.623 . . . . 0.0 111.487 169.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -91.93 -128.33 0.1 Allowed 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 169.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -67.23 -7.03 20.88 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 120.994 -1.066 . . . . 0.0 113.084 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.25 73.5 0.69 Allowed Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -165.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 74.88 156.17 0.17 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.545 2.338 . . . . 0.0 111.718 173.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.28 36.62 2.75 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.914 0.768 . . . . 0.0 111.33 -172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -130.65 166.26 21.07 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.154 0.977 . . . . 0.0 108.973 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -123.05 164.96 17.59 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.54 1.936 . . . . 0.0 107.544 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.61 125.7 46.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -173.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.5 mt -132.29 -178.25 4.83 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.546 1.538 . . . . 0.0 108.312 -174.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.58 -162.96 54.34 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -168.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.61 18.52 65.98 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.078 -1.401 . . . . 0.0 114.751 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.18 -60.43 3.34 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.107 1.453 . . . . 0.0 109.002 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -86.91 161.2 47.88 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.98 107.98 1.99 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 124.123 3.215 . . . . 0.0 109.422 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 -5.51 12.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.305 1.431 . . . . 0.0 113.382 177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -63.43 163.8 17.91 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.429 1.491 . . . . 0.0 111.47 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.25 140.48 33.98 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.937 1.758 . . . . 0.0 109.558 170.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -109.74 106.61 21.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 173.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.7 mt -99.88 153.72 18.93 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.1 mm -52.42 140.56 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 160.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.65 -124.01 0.83 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.21 116.68 29.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 126.797 2.039 . . . . 0.0 107.023 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.9 t -75.8 124.42 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.7 mm -65.78 103.83 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.0 152.5 36.68 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 59.5 mtm 47.62 43.98 16.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.4 1.88 . . . . 0.0 111.198 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' H ' ' HB3' ' A' ' 48' ' ' ASP . . . -143.89 178.75 21.74 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 125.677 1.608 . . . . 0.0 111.874 -167.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -70.15 -7.88 45.28 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -163.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.19 -53.44 3.79 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.332 1.053 . . . . 0.0 110.3 165.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -43.81 -47.35 8.09 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.728 1.611 . . . . 0.0 112.696 175.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -60.16 -38.13 82.25 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.267 1.427 . . . . 0.0 113.119 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.54 -32.96 73.05 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.892 0.477 . . . . 0.0 110.831 174.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.97 31.38 35.4 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 119.049 -0.862 . . . . 0.0 112.462 160.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -131.85 -45.64 0.95 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.006 1.403 . . . . 0.0 112.228 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.5 mt -60.93 144.98 52.01 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.682 -0.636 . . . . 0.0 110.222 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -132.27 158.97 74.18 Favored Pre-proline 0 C--O 1.236 0.363 0 C-N-CA 124.778 1.231 . . . . 0.0 108.656 161.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -65.19 145.85 85.23 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.221 1.947 . . . . 0.0 110.098 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 75.16 6.5 79.86 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.777 -1.013 . . . . 0.0 113.398 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -69.73 126.35 29.46 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.094 1.947 . . . . 0.0 107.569 174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.481 ' HG3' HD23 ' A' ' 37' ' ' LEU . 21.7 tt0 -73.8 124.74 26.66 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 118.534 0.607 . . . . 0.0 109.402 -174.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.51 150.73 31.09 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.759 0.823 . . . . 0.0 109.906 175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -130.81 -46.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 126.225 1.81 . . . . 0.0 109.108 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -130.17 145.85 51.75 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.177 0.991 . . . . 0.0 110.249 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.7 t -139.2 129.39 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.829 1.652 . . . . 0.0 107.11 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 t0 53.11 18.06 1.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.763 2.425 . . . . 0.0 113.225 -171.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.71 -11.38 62.78 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 127.385 2.421 . . . . 0.0 112.836 -177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.31 132.88 34.38 Favored Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 125.866 1.666 . . . . 0.0 108.62 -178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -70.99 116.83 4.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.863 2.375 . . . . 0.0 109.59 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.92 -7.37 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 123.388 0.675 . . . . 0.0 111.625 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.21 114.46 2.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.197 1.399 . . . . 0.0 111.032 -171.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -14.9 56.11 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 125.428 1.49 . . . . 0.0 113.02 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -94.62 170.48 9.43 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 124.747 1.219 . . . . 0.0 110.634 -172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.1 p -85.72 171.67 11.43 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.63 0.772 . . . . 0.0 111.024 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -46.82 -54.28 10.18 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 125.81 1.644 . . . . 0.0 108.831 165.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.6 ttp-105 -55.62 -37.76 68.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -55.02 -44.04 74.25 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.495 0.589 . . . . 0.0 109.918 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.15 -41.35 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-O 119.104 -0.474 . . . . 0.0 109.917 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.56 -44.43 68.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 119.234 0.925 . . . . 0.0 110.451 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.02 -45.36 95.11 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.901 1.28 . . . . 0.0 110.189 174.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.56 -45.84 71.05 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.713 0.688 . . . . 0.0 111.412 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 83.6 mmm -52.73 -36.52 57.78 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 0.0 110.275 173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.8 -18.67 60.43 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.241 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 84' ' ' ARG . 0.2 OUTLIER -85.11 -49.06 8.57 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.02 1.728 . . . . 0.0 109.216 172.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -49.07 -43.39 40.97 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.447 1.099 . . . . 0.0 109.473 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.52 -36.45 23.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.483 1.113 . . . . 0.0 113.105 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' A' ' 81' ' ' HIS . 2.0 mpt_? -68.36 -39.64 81.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -71.49 -13.83 61.93 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 124.784 1.234 . . . . 0.0 112.759 -174.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.41 4.54 90.01 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 119.404 1.002 . . . . 0.0 113.876 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 16' ' ' ARG . 6.1 pt20 -142.96 178.59 7.57 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 125.433 1.493 . . . . 0.0 109.246 175.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.4 p -152.09 128.58 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 162.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.18 139.92 30.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 15' ' ' LEU . 5.8 mt -139.78 125.59 19.52 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 121.532 1.969 . . . . 0.0 107.374 -174.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 89.7 m -116.13 115.11 25.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 170.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.6 m -99.5 167.99 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -144.81 152.79 40.86 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 120.523 -1.36 . . . . 0.0 108.857 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.6 mtp180 -151.5 143.39 23.81 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.087 1.355 . . . . 0.0 109.633 173.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 141.22 9.6 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.512 1.125 . . . . 0.0 110.263 169.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -90.8 155.17 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 166.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.21 130.5 11.26 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.4 m -66.04 -60.31 2.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 118.389 0.54 . . . . 0.0 111.783 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.7 -167.82 39.46 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-O 119.311 -0.716 . . . . 0.0 111.541 -169.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.66 151.23 2.07 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.255 3.303 . . . . 0.0 112.98 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -159.51 176.75 11.69 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.539 1.135 . . . . 0.0 108.962 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.9 m -146.38 -162.95 1.63 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.331 1.452 . . . . 0.0 107.316 150.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.63 0 N-CA-C 103.16 -3.976 . . . . 0.0 103.16 -141.902 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.376 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -147.97 119.78 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 172.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m 62.28 172.58 0.13 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 112.151 -164.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 121.97 -102.99 0.83 Allowed Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.611 1.1 . . . . 0.0 110.75 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.1 m -79.25 52.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.238 1.015 . . . . 0.0 110.917 170.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.0 m -59.12 140.36 55.93 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 167.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.86 -72.38 0.35 Allowed Glycine 0 C--N 1.33 0.201 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.037 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE2' ' HD2' ' A' ' 93' ' ' ARG . 36.0 p90 -70.45 161.53 30.37 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 119.06 1.43 . . . . 0.0 110.008 168.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.85 137.43 53.17 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.489 170.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -83.09 151.5 25.74 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 161.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.98 155.21 50.36 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 171.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.55 123.62 28.35 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 124.885 1.274 . . . . 0.0 108.538 -178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' A' ' 52' ' ' ARG . 86.1 t -101.91 151.01 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.734 2.014 . . . . 0.0 106.225 176.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -128.26 120.89 28.06 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.546 1.539 . . . . 0.0 108.615 166.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.8 mt -118.85 123.51 44.89 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.8 153.05 20.52 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 117.902 0.319 . . . . 0.0 110.147 166.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.6 ttt180 -119.69 93.79 4.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.138 2.175 . . . . 0.0 105.718 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.29 -13.78 7.11 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.046 0.538 . . . . 0.0 110.69 170.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -135.86 -112.45 0.19 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -65.2 -18.69 65.51 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -172.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.96 -173.65 53.55 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-O 122.101 0.834 . . . . 0.0 112.39 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 4.1 m-85 -71.82 111.14 6.83 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.433 0.693 . . . . 0.0 110.11 -164.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.26 46.47 3.64 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.419 1.009 . . . . 0.0 114.241 -171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -135.1 163.39 30.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.222 1.511 . . . . 0.0 110.368 176.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -120.27 157.29 29.47 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.294 1.838 . . . . 0.0 107.876 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.62 135.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.93 -178.85 6.02 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.213 1.405 . . . . 0.0 107.463 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.71 -154.35 46.93 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 52.34 34.25 40.89 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.281 0.943 . . . . 0.0 112.402 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 -46.44 43.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -167.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.09 157.96 32.71 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 124.423 1.089 . . . . 0.0 108.537 170.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -72.69 96.04 0.82 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.723 2.949 . . . . 0.0 108.129 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.13 -24.56 2.06 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.942 1.734 . . . . 0.0 111.44 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -73.73 150.71 88.77 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 119.399 1.599 . . . . 0.0 112.753 -171.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.38 149.55 69.45 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.588 2.858 . . . . 0.0 109.377 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.6 mt -113.45 88.72 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.43 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.2 mt -93.3 125.98 38.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.9 mm -43.83 120.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 126.484 1.913 . . . . 0.0 106.87 -174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.96 -56.68 23.35 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 124.925 1.25 . . . . 0.0 111.709 -172.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -154.58 153.48 31.48 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.1 t -112.96 112.79 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 164.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.5 mm -56.34 118.89 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.981 1.712 . . . . 0.0 108.368 -173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.53 124.55 12.37 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.113 0.965 . . . . 0.0 110.536 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . 0.252 20.4 ptp 46.81 20.39 0.11 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.701 2.4 . . . . 0.0 115.283 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.74 -173.19 42.72 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 m -58.84 -39.06 80.13 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-O 116.862 -1.542 . . . . 0.0 114.217 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.07 -28.59 60.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 121.679 2.036 . . . . 0.0 111.973 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -67.56 -47.62 69.31 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.052 0.941 . . . . 0.0 109.241 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 74.3 mtt-85 -60.51 -40.21 90.62 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.497 0.719 . . . . 0.0 111.177 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -64.16 -23.5 67.34 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.388 1.475 . . . . 0.0 111.929 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.18 21.82 72.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.214 1.388 . . . . 0.0 113.121 167.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HG22 ' A' ' 13' ' ' VAL . 1.9 mmp_? -122.72 -13.2 7.97 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-O 117.864 -1.065 . . . . 0.0 113.147 -163.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' HG ' HG21 ' A' ' 13' ' ' VAL . 17.5 mt -119.99 151.3 39.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 119.907 1.23 . . . . 0.0 107.885 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -132.35 149.21 72.51 Favored Pre-proline 0 C--O 1.234 0.24 0 C-N-CA 124.164 0.986 . . . . 0.0 109.671 164.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.44 134.92 40.47 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.678 1.585 . . . . 0.0 108.203 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.17 1.05 76.27 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.243 -1.309 . . . . 0.0 113.961 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -65.12 140.68 58.82 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.563 2.181 . . . . 0.0 107.354 161.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HG3' HD23 ' A' ' 37' ' ' LEU . 24.3 tt0 -85.96 128.24 34.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 120.549 1.522 . . . . 0.0 108.767 173.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.8 mt -72.26 158.0 36.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 118.887 0.767 . . . . 0.0 110.175 171.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -129.86 -53.29 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 126.499 1.919 . . . . 0.0 107.708 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -132.59 148.46 52.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.845 1.258 . . . . 0.0 108.894 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 53.1 t -137.65 121.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 63.43 -2.48 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.431 2.293 . . . . 0.0 112.222 -169.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.93 -3.3 31.8 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 127.361 2.41 . . . . 0.0 112.096 -172.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 mm -95.3 125.31 50.55 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -69.73 127.02 14.01 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 123.136 2.557 . . . . 0.0 108.555 -173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 m -90.03 -2.94 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.836 0.854 . . . . 0.0 110.565 176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.24 120.29 14.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.901 0.88 . . . . 0.0 110.687 -169.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.89 -12.24 37.16 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.777 1.18 . . . . 0.0 112.75 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.7 mmtm -78.42 177.35 8.57 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.08 1.352 . . . . 0.0 107.814 166.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -105.3 175.33 5.53 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.622 0.769 . . . . 0.0 110.431 -172.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -52.05 -48.61 64.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.365 1.066 . . . . 0.0 110.781 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -55.37 -35.09 64.9 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -52.38 -50.3 62.71 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.43 -40.49 82.31 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 C-N-CA 124.035 0.934 . . . . 0.0 110.909 -178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.2 mm -50.66 -42.26 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 119.586 1.084 . . . . 0.0 111.231 177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.58 -39.2 70.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.705 0.402 . . . . 0.0 110.57 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.19 -50.18 73.65 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 122.917 0.487 . . . . 0.0 110.616 172.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.31 -40.14 85.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.317 0.508 . . . . 0.0 110.944 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -32.35 73.84 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.41 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -70.73 -57.46 4.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.523 1.529 . . . . 0.0 111.133 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.81 -28.42 69.85 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.103 0.961 . . . . 0.0 111.303 -172.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.48 -37.09 72.35 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 120.582 -1.324 . . . . 0.0 111.09 169.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -73.73 -35.92 65.13 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 117.389 -1.291 . . . . 0.0 111.704 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -56.52 -25.82 52.75 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.082 0.855 . . . . 0.0 110.031 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.44 9.2 86.77 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 123.936 0.779 . . . . 0.0 111.571 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -160.28 165.62 31.04 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.037 1.419 . . . . 0.0 109.279 170.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.33 127.32 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 171.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.17 139.13 35.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 160.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.8 mt -134.71 105.66 6.57 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 -176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.8 m -91.04 121.19 32.64 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -107.01 170.17 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.492 ' HD2' ' CE2' ' A' ' 8' ' ' TYR . 31.2 ptt180 -150.83 166.24 31.12 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.307 -1.496 . . . . 0.0 108.818 167.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -155.12 146.76 23.2 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 162.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.437 ' HD3' ' H ' ' A' ' 96' ' ' VAL . 1.5 tmtm? -61.5 163.39 6.92 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.871 1.269 . . . . 0.0 111.17 168.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.437 ' H ' ' HD3' ' A' ' 95' ' ' LYS . 25.7 t -128.66 165.09 29.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.793 1.637 . . . . 0.0 109.552 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.0 tp -167.37 -169.4 1.23 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 129.856 3.262 . . . . 0.0 104.321 -175.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -63.4 173.76 1.48 Allowed 'General case' 0 C--O 1.244 0.802 0 O-C-N 120.398 -1.439 . . . . 0.0 109.678 152.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -70.03 -178.59 23.39 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 121.338 -0.851 . . . . 0.0 111.05 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.39 169.91 17.34 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.096 2.531 . . . . 0.0 110.362 171.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.9 m 73.06 82.47 0.13 Allowed 'General case' 0 C--O 1.231 0.121 0 C-N-CA 126.635 1.974 . . . . 0.0 109.604 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.9 m -134.96 175.11 9.88 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.972 2.109 . . . . 0.0 107.59 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.887 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -160.427 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.644 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.06 169.13 5.71 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.539 -0.977 . . . . 0.0 108.84 162.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -70.05 170.32 11.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.565 -0.709 . . . . 0.0 109.412 162.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.09 -157.68 30.26 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.47 101.88 10.28 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 170.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -69.87 155.85 39.94 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 144.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.94 -7.3 6.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-O 118.527 -1.152 . . . . 0.0 115.397 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -119.93 171.29 8.54 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 119.446 1.623 . . . . 0.0 108.769 166.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -128.91 129.46 45.53 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -83.79 146.13 28.31 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 166.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.4 116.66 21.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.84 130.57 34.92 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 52' ' ' ARG . 61.4 t -133.7 130.41 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 125.507 1.523 . . . . 0.0 107.29 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -126.46 122.12 34.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -169.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.1 mt -119.63 123.38 43.74 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -75.04 158.28 33.44 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.384 0.612 . . . . 0.0 109.645 169.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 16.7 ttt85 -125.48 88.28 2.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 168.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 17.9 ptm -142.33 -12.81 0.81 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 173.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -132.83 -71.99 0.52 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.639 1.576 . . . . 0.0 107.657 -171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.9 m -119.34 0.06 11.05 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.35 -156.97 52.57 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.702 1.137 . . . . 0.0 112.452 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 1.8 m-85 -108.94 105.16 14.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.75 0.82 . . . . 0.0 110.158 -169.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.95 41.83 3.11 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.307 1.908 . . . . 0.0 114.296 -171.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -132.32 150.54 52.13 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 119.632 1.716 . . . . 0.0 110.166 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -103.06 160.21 14.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.739 1.616 . . . . 0.0 108.952 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.79 138.34 27.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 174.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 pp -148.76 163.12 38.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.205 2.202 . . . . 0.0 106.0 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.62 176.09 42.06 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.11 90.07 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 107.882 -2.087 . . . . 0.0 107.882 -149.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.8 -26.41 65.18 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.658 0.783 . . . . 0.0 110.437 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -121.64 160.53 46.04 Favored Pre-proline 0 C--O 1.238 0.484 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 168.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.95 53.01 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 124.688 3.592 . . . . 0.0 109.651 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.73 58.13 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -136.27 161.65 61.04 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.471 1.908 . . . . 0.0 111.569 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -73.31 132.31 17.64 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.955 2.437 . . . . 0.0 109.409 170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -99.65 108.1 21.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 58' ' ' GLU . 5.3 mt -100.01 149.66 23.23 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 mm -49.55 118.28 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.6 -72.81 0.84 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -171.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.1 117.15 4.83 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.861 0.865 . . . . 0.0 109.024 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.267 0.6 OUTLIER -80.0 149.26 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-O 121.308 0.575 . . . . 0.0 109.451 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.0 mm -80.82 107.59 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.22 146.36 15.4 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 mmt 64.0 -10.86 0.12 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.236 1.814 . . . . 0.0 112.72 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.88 169.39 53.68 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 110.384 -1.087 . . . . 0.0 110.384 -177.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.4 t -60.78 -23.03 64.7 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-O 118.122 -0.942 . . . . 0.0 112.335 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.13 -45.19 42.63 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.782 1.628 . . . . 0.0 110.96 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.13 -51.45 69.53 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.292 1.437 . . . . 0.0 109.138 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -64.24 -34.53 78.32 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.489 -0.757 . . . . 0.0 112.237 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -61.76 -29.59 70.23 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.287 0.948 . . . . 0.0 110.792 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.39 28.32 52.89 Favored Glycine 0 C--N 1.336 0.548 0 CA-C-O 118.739 -1.034 . . . . 0.0 112.816 161.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB3' HG22 ' A' ' 13' ' ' VAL . 60.1 mtp85 -136.78 -18.5 1.39 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.432 1.116 . . . . 0.0 113.343 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -90.01 148.25 23.18 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 168.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -135.32 157.04 77.47 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 125.062 1.345 . . . . 0.0 107.643 157.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.8 149.71 86.53 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.443 1.429 . . . . 0.0 108.881 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.63 -2.63 72.18 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 118.502 -1.166 . . . . 0.0 113.623 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -66.6 136.82 56.17 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.934 1.867 . . . . 0.0 107.276 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.519 ' HG3' HD23 ' A' ' 37' ' ' LEU . 33.6 tt0 -85.37 127.36 34.34 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 119.766 1.166 . . . . 0.0 109.581 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mt -79.09 153.58 30.05 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.228 1.011 . . . . 0.0 110.224 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.3 t -131.5 -46.51 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 126.165 1.786 . . . . 0.0 109.055 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.4 148.42 42.8 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.403 1.081 . . . . 0.0 110.553 -176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.0 t -145.49 131.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 125.857 1.663 . . . . 0.0 107.849 -177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.7 t70 61.29 14.01 5.32 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.205 1.402 . . . . 0.0 111.333 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.08 -5.73 75.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 127.112 2.292 . . . . 0.0 113.444 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.9 mm -104.36 133.99 19.92 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 121.069 2.434 . . . . 0.0 109.381 -168.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.61 120.92 7.24 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.313 2.675 . . . . 0.0 110.786 -174.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.0 m -81.62 -2.27 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.754 1.222 . . . . 0.0 112.62 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.62 125.12 22.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.357 1.063 . . . . 0.0 110.274 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.47 -7.12 9.07 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.367 0.984 . . . . 0.0 114.535 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 74' ' ' TYR . 14.6 mmtt -82.88 174.29 11.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.412 1.485 . . . . 0.0 108.778 167.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.8 p -111.82 175.48 5.41 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.616 0.766 . . . . 0.0 110.696 -171.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -38.69 -62.89 0.56 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.044 1.338 . . . . 0.0 110.586 165.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 ttp-105 -56.42 -34.09 66.43 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -173.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.595 ' CE1' ' HE3' ' A' ' 70' ' ' LYS . 76.0 t80 -58.12 -44.43 87.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.315 0.578 . . . . 0.0 110.978 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.97 -31.75 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 121.292 -0.88 . . . . 0.0 110.232 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.2 mm -60.92 -41.48 89.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.265 -1.522 . . . . 0.0 111.272 174.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -57.88 -52.04 67.13 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.511 1.524 . . . . 0.0 109.042 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -51.3 69.78 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.277 0.631 . . . . 0.0 111.141 -175.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 78.2 mmm -61.98 -21.67 65.03 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.802 -0.561 . . . . 0.0 112.497 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.71 -32.59 53.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.723 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -66.27 -47.39 73.84 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-N 119.318 0.963 . . . . 0.0 110.126 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.05 70.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.52 -32.41 73.99 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.9 -1.75 . . . . 0.0 112.887 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -68.68 -49.88 55.51 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.29 -20.6 7.41 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.432 1.493 . . . . 0.0 112.213 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.15 71.27 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.338 1.923 . . . . 0.0 111.329 170.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -177.47 170.56 2.05 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.441 2.296 . . . . 0.0 107.223 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.11 149.92 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -107.31 137.22 45.76 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 165.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.3 mt -136.44 106.83 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 -173.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -97.09 111.41 23.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.4 m -99.61 173.45 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -151.36 164.87 35.71 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 120.741 -1.225 . . . . 0.0 109.514 170.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.2 146.76 25.02 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.959 1.304 . . . . 0.0 108.322 164.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 144.15 41.46 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.665 1.186 . . . . 0.0 110.632 170.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -97.43 151.49 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 124.896 1.278 . . . . 0.0 108.436 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.69 127.47 25.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 103.663 -2.718 . . . . 0.0 103.663 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 64.2 m -162.81 86.05 0.55 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -153.84 98.18 0.18 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.807 -1.552 . . . . 0.0 110.615 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.93 131.78 23.19 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.275 2.65 . . . . 0.0 110.062 172.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 m 60.83 101.11 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.412 1.885 . . . . 0.0 112.653 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -150.37 167.48 26.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.465 1.106 . . . . 0.0 108.401 160.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.35 0 N-CA-C 105.581 -3.008 . . . . 0.0 105.581 -164.067 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.361 0 N-CA-C 108.086 -2.006 . . . . 0.0 108.086 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 m 75.67 158.98 0.21 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.355 1.862 . . . . 0.0 112.534 166.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 m -54.94 131.91 45.6 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.201 1.4 . . . . 0.0 111.871 -172.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.92 156.11 22.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.073 1.32 . . . . 0.0 110.481 168.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m 58.86 102.17 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.533 1.933 . . . . 0.0 111.874 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -55.16 143.6 26.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.004 0.522 . . . . 0.0 110.114 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.1 1.54 88.67 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.971 0.796 . . . . 0.0 112.992 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -133.53 167.72 19.94 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 168.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 135.37 52.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 172.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -84.28 145.14 28.44 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 164.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.71 116.83 21.56 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 173.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -102.56 111.09 23.24 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.805 1.642 . . . . 0.0 107.766 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 t -111.95 150.24 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.369 1.868 . . . . 0.0 107.356 -169.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -128.53 119.71 25.35 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.875 1.67 . . . . 0.0 111.59 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.7 mt -116.55 123.01 46.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -72.72 146.55 46.37 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 165.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.83 101.25 13.17 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 103.694 -2.706 . . . . 0.0 103.694 152.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 22.1 ptm -133.98 -9.75 2.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 119.356 -0.354 . . . . 0.0 111.057 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -138.04 -98.43 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.7 p -66.75 -20.41 65.95 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -162.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.78 73.62 0.66 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 54.74 93.7 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.187 2.595 . . . . 0.0 113.512 169.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -79.94 55.7 4.53 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.149 -0.806 . . . . 0.0 112.564 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 90' ' ' LEU . 33.9 p90 -129.31 175.16 8.96 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.932 1.293 . . . . 0.0 108.311 167.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 -137.74 153.54 49.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.011 1.324 . . . . 0.0 107.573 170.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.42 140.02 47.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 pp -148.98 160.77 43.0 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.829 2.052 . . . . 0.0 105.662 -173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 -178.86 52.34 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.06 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.68 48.72 79.22 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 106.836 -2.506 . . . . 0.0 106.836 -143.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -63.98 -37.87 88.98 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.86 161.5 55.24 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 126.667 1.987 . . . . 0.0 108.904 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.39 53.98 4.95 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 125.208 3.938 . . . . 0.0 112.288 -163.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.57 0.95 0.03 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 126.552 2.025 . . . . 0.0 112.077 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -75.12 163.94 64.61 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 120.042 1.921 . . . . 0.0 111.398 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -74.5 143.49 30.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.025 2.483 . . . . 0.0 110.13 171.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.42 104.85 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' A' ' 58' ' ' GLU . 4.6 mt -98.32 155.27 17.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.6 mm -55.67 118.79 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 161.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.87 -56.35 5.93 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.24 155.3 42.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.292 1.037 . . . . 0.0 109.257 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.25 149.28 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 C-N-CA 127.425 2.29 . . . . 0.0 107.224 166.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.3 mm -91.68 108.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -173.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.7 138.68 10.57 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.496 1.118 . . . . 0.0 110.146 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 13.8 mmt 59.8 0.95 0.27 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.043 2.137 . . . . 0.0 113.856 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.76 -175.99 28.23 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 125.783 1.659 . . . . 0.0 110.845 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 58.7 m -54.37 -35.85 63.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -164.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.85 -51.81 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.011 0.823 . . . . 0.0 110.438 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -58.55 -45.88 88.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.419 0.688 . . . . 0.0 110.687 -177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 37.3 mtt-85 -60.21 -31.34 70.07 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.728 0.811 . . . . 0.0 113.028 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.85 -21.43 64.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.081 0.401 . . . . 0.0 111.728 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.58 45.99 86.78 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.446 1.022 . . . . 0.0 112.875 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 46.8 mtm-85 -143.53 -47.63 0.29 Allowed 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.379 1.471 . . . . 0.0 112.173 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.7 153.64 41.08 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 118.662 0.664 . . . . 0.0 109.489 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -142.36 155.63 64.34 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.211 1.004 . . . . 0.0 110.436 162.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -57.36 134.87 66.53 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.644 2.229 . . . . 0.0 108.957 167.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.4 7.09 69.98 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.44 0.543 . . . . 0.0 113.694 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -77.71 123.12 26.27 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 171.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.42 ' HG3' HD23 ' A' ' 37' ' ' LEU . 37.7 tt0 -73.05 123.78 24.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.7 mt -77.42 149.87 35.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.921 0.888 . . . . 0.0 109.253 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.11 -52.12 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -134.09 147.44 50.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.381 1.072 . . . . 0.0 109.464 -176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.8 t -145.51 123.32 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 -171.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 64.14 -56.38 0.23 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.398 2.279 . . . . 0.0 109.107 -160.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.37 -7.58 0.03 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.694 2.093 . . . . 0.0 110.847 164.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.524 HD12 ' H ' ' A' ' 65' ' ' ILE . 4.3 mp -73.48 139.05 77.83 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 127.242 2.217 . . . . 0.0 107.442 174.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -78.57 127.76 8.26 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.099 2.532 . . . . 0.0 112.704 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.73 -9.14 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.711 0.804 . . . . 0.0 113.103 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.41 129.86 43.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.926 0.891 . . . . 0.0 110.525 -170.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.49 -12.7 2.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.427 1.013 . . . . 0.0 115.456 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE3' ' CE2' ' A' ' 74' ' ' TYR . 69.0 mmtt -75.34 179.03 5.42 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 119.624 1.712 . . . . 0.0 108.134 169.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.5 p -115.52 171.34 7.79 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.768 -0.582 . . . . 0.0 110.043 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -34.58 -60.21 0.44 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 126.538 1.935 . . . . 0.0 112.142 176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -53.33 -37.41 62.29 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 124.946 1.298 . . . . 0.0 113.111 -175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.444 ' CE2' ' HE3' ' A' ' 70' ' ' LYS . 49.6 t80 -52.14 -45.45 65.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.992 0.917 . . . . 0.0 110.01 177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -75.82 -37.92 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 124.785 1.234 . . . . 0.0 110.188 -175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 27.8 mm -62.22 -35.27 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 121.539 -0.725 . . . . 0.0 110.104 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.69 -39.85 95.34 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.676 0.79 . . . . 0.0 111.331 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.39 -37.4 68.72 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.106 0.962 . . . . 0.0 111.033 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.35 -38.92 78.18 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.056 0.942 . . . . 0.0 109.604 175.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -43.8 97.32 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.374 -0.822 . . . . 0.0 111.682 178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.35 -46.9 72.02 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.303 0.956 . . . . 0.0 110.555 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.79 -34.61 69.8 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.156 0.582 . . . . 0.0 111.802 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.26 82.77 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.604 -0.685 . . . . 0.0 111.301 173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -72.63 -41.34 65.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.332 1.053 . . . . 0.0 110.123 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -55.66 -24.27 32.96 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 125.554 1.541 . . . . 0.0 112.389 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.15 5.95 63.49 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.156 1.836 . . . . 0.0 113.039 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -171.51 160.74 6.04 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 119.365 1.583 . . . . 0.0 109.048 -170.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.7 p -142.29 121.88 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 122.284 1.04 . . . . 0.0 109.253 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -80.42 132.51 35.75 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 162.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 24' ' ' PHE . 43.3 mt -127.65 106.06 8.89 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.7 m -94.98 111.63 23.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -99.33 171.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -150.75 161.42 42.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 120.203 -1.561 . . . . 0.0 110.136 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.25 136.54 20.02 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.844 0.831 . . . . 0.0 111.049 165.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.07 126.97 31.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 128.558 2.743 . . . . 0.0 111.843 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.2 t -70.43 151.37 9.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.747 1.619 . . . . 0.0 109.519 -176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.82 131.53 7.9 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 176.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 39.0 m -139.22 68.37 1.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.265 1.026 . . . . 0.0 108.648 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.86 175.3 6.95 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.945 1.259 . . . . 0.0 112.314 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -73.26 -52.94 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.591 2.194 . . . . 0.0 112.57 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.4 p -174.88 98.3 0.08 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.22 1.008 . . . . 0.0 109.678 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 39.3 m 62.19 111.81 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 127.252 2.221 . . . . 0.0 113.429 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -170.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.507 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 m -153.58 113.57 3.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.783 1.633 . . . . 0.0 107.933 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.26 -108.29 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 168.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.37 118.39 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 107.066 -2.414 . . . . 0.0 107.066 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m 175.66 162.4 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.542 1.537 . . . . 0.0 111.241 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.3 p -145.47 -175.18 4.62 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.3 1.84 . . . . 0.0 106.446 142.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -82.38 -161.34 29.22 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 107.801 -2.12 . . . . 0.0 107.801 144.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 p90 50.2 -176.43 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.77 1.228 . . . . 0.0 112.252 -172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.5 mtpt -132.83 130.15 39.43 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.7 120.95 26.63 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 116.82 33.6 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -87.66 129.88 34.98 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.932 2.093 . . . . 0.0 109.07 -175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.3 t -131.14 148.84 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.509 1.523 . . . . 0.0 107.107 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -130.72 133.98 46.52 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 167.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.57 129.36 50.44 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 124.011 0.819 . . . . 0.0 110.482 175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -80.35 163.19 24.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.899 0.857 . . . . 0.0 110.136 169.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -114.92 102.38 9.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 164.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.616 ' HG3' ' H ' ' A' ' 19' ' ' GLU . 8.9 ptp -146.62 -62.4 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.616 ' H ' ' HG3' ' A' ' 18' ' ' MET . 1.8 tm-20 -66.46 -171.55 0.13 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.004 1.721 . . . . 0.0 108.998 151.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -64.87 11.21 0.06 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.073 2.949 . . . . 0.0 117.006 -152.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.87 78.66 0.83 Allowed Glycine 0 N--CA 1.45 -0.401 0 O-C-N 121.155 -0.966 . . . . 0.0 112.343 160.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.04 81.71 0.13 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.985 2.114 . . . . 0.0 111.907 171.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.59 58.99 3.77 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.017 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -133.75 167.52 20.39 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.902 1.351 . . . . 0.0 109.808 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -118.64 163.98 16.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 127.008 2.123 . . . . 0.0 106.85 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 128.71 20.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.517 1.927 . . . . 0.0 106.319 -175.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.5 mt -137.8 161.77 35.7 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.625 0.726 . . . . 0.0 110.149 -177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.94 -160.24 34.75 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -171.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.83 28.58 60.65 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -150.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.28 -30.81 62.27 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.054 0.542 . . . . 0.0 110.318 -162.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -104.05 161.51 22.71 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 126.911 2.085 . . . . 0.0 107.948 163.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.69 100.43 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.849 3.033 . . . . 0.0 108.809 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.75 6.51 7.16 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.241 1.401 . . . . 0.0 114.18 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -82.82 157.13 67.17 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 119.339 1.57 . . . . 0.0 110.862 172.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.72 138.89 39.02 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.49 2.127 . . . . 0.0 110.514 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.9 mt -102.56 95.36 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 mt -88.05 145.67 25.86 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.5 mm -61.81 117.03 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.74 -52.65 47.04 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 125.289 1.423 . . . . 0.0 111.471 -168.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.19 156.64 22.02 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.232 3.013 . . . . 0.0 105.137 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.2 t -107.7 130.48 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 169.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.64 117.12 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.16 -31.02 63.0 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.0 mmt -127.72 33.5 4.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.31 170.58 17.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.6 m -62.03 -12.94 21.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -172.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.22 -51.26 13.75 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 120.165 1.348 . . . . 0.0 109.668 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -58.07 -45.87 86.39 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -54.67 -46.73 74.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.304 0.502 . . . . 0.0 112.007 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.28 -30.51 71.38 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.8 0.273 . . . . 0.0 111.196 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.47 -37.69 3.13 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 127.437 2.446 . . . . 0.0 112.436 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mtm180 -65.37 -21.88 66.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.548 1.139 . . . . 0.0 113.774 -174.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 mt -87.5 132.89 33.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.4 m170 -125.87 157.19 69.92 Favored Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 124.442 1.097 . . . . 0.0 109.309 160.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.28 148.45 74.27 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.431 1.421 . . . . 0.0 109.45 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.43 -7.19 79.95 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 118.529 -1.15 . . . . 0.0 112.562 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.04 128.97 37.75 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.497 1.648 . . . . 0.0 106.798 176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -82.55 125.02 30.67 Favored 'General case' 0 C--O 1.22 -0.472 0 O-C-N 120.81 -1.181 . . . . 0.0 109.12 -175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.13 145.51 37.73 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.405 1.082 . . . . 0.0 109.773 174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 t -120.13 -54.21 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 127.081 2.152 . . . . 0.0 108.245 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -128.57 146.03 50.96 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.128 1.371 . . . . 0.0 108.97 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.1 t -140.04 121.32 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t0 53.7 16.22 0.95 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.163 1.785 . . . . 0.0 111.963 -168.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.99 69.7 Favored Glycine 0 C--N 1.339 0.738 0 C-N-CA 127.455 2.455 . . . . 0.0 114.199 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.5 mp -84.12 125.9 71.32 Favored Pre-proline 0 N--CA 1.449 -0.501 0 CA-C-N 120.834 2.317 . . . . 0.0 106.269 177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.14 117.3 5.03 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.055 2.503 . . . . 0.0 108.466 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' A' ' 75' ' ' VAL . 26.6 m -79.1 -6.33 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.723 0.809 . . . . 0.0 111.669 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.52 121.35 16.86 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.146 0.578 . . . . 0.0 110.373 -171.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.41 -9.39 75.66 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 124.902 1.239 . . . . 0.0 112.978 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.431 ' HB3' ' CG ' ' A' ' 74' ' ' TYR . 66.5 mmtt -74.93 -164.34 0.29 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.282 1.433 . . . . 0.0 108.13 166.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.5 p -120.86 170.02 9.88 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 121.46 -0.775 . . . . 0.0 109.685 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -38.46 -61.44 0.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.956 1.702 . . . . 0.0 109.414 165.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -42.99 -46.22 5.38 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 128.46 2.704 . . . . 0.0 112.645 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CG ' ' HB3' ' A' ' 70' ' ' LYS . 42.3 t80 -58.83 -40.91 85.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.298 0.571 . . . . 0.0 111.118 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' CG1' ' A' ' 67' ' ' VAL . 18.9 t -75.44 -32.23 25.06 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 O-C-N 121.372 -0.83 . . . . 0.0 109.225 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 mm -60.35 -40.2 83.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 119.763 1.165 . . . . 0.0 109.763 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.15 -45.69 92.21 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.056 0.942 . . . . 0.0 110.269 171.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.61 -48.96 78.52 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.644 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.8 mmm -60.11 -33.36 72.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 119.239 0.927 . . . . 0.0 111.047 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -61.92 -45.3 94.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.208 0.603 . . . . 0.0 110.044 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -58.96 6.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 125.224 1.41 . . . . 0.0 111.355 175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.65 73.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.192 1.397 . . . . 0.0 110.581 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.03 -34.74 63.76 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.961 -1.087 . . . . 0.0 111.003 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 21.9 mtt-85 -70.43 -41.78 72.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 117.852 -1.07 . . . . 0.0 111.79 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.01 -10.31 9.55 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.981 2.113 . . . . 0.0 113.365 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.76 1.5 83.91 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.012 1.291 . . . . 0.0 113.269 175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -159.71 -178.59 7.18 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.979 2.112 . . . . 0.0 108.043 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.9 p -152.58 131.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.77 1.628 . . . . 0.0 106.752 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.69 141.89 34.44 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 162.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -135.8 122.81 21.41 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -115.7 113.18 23.15 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 173.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.24 168.71 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 172.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -149.92 148.91 29.68 Favored 'General case' 0 CA--C 1.512 -0.498 0 O-C-N 119.678 -1.889 . . . . 0.0 110.208 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -147.2 123.99 11.23 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -173.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.28 145.4 10.99 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.461 1.504 . . . . 0.0 111.373 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.34 122.18 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.2 -47.6 0.23 Allowed 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.454 -171.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.8 m -162.02 163.93 28.54 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.775 2.03 . . . . 0.0 107.563 168.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.95 -96.57 1.5 Allowed Glycine 0 C--N 1.334 0.469 0 CA-C-O 117.77 -1.572 . . . . 0.0 111.7 -166.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.72 110.5 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.022 3.148 . . . . 0.0 109.725 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.8 m -87.39 64.02 8.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.177 0.991 . . . . 0.0 108.448 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.9 p -75.94 75.54 2.85 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.908 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 -171.26 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -86.21 -74.3 0.42 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.55 0.675 . . . . 0.0 109.476 -173.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.9 m -75.99 65.86 2.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.428 1.491 . . . . 0.0 110.957 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 149.55 92.06 0.1 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 121.204 -0.935 . . . . 0.0 112.436 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.4 m -70.22 103.26 2.3 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 158.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m 39.22 67.63 0.43 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.05 2.14 . . . . 0.0 113.259 174.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.02 -86.66 1.17 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' LYS . 30.9 p90 -59.66 160.42 7.31 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.712 0.292 . . . . 0.0 110.349 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -122.53 141.96 51.11 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.3 159.53 21.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 166.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mp -139.54 146.82 40.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.374 1.47 . . . . 0.0 107.39 162.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -102.42 139.01 38.58 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 126.281 1.833 . . . . 0.0 109.322 175.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.2 t -137.52 107.42 4.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 169.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -100.66 139.3 36.54 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.9 mt -134.83 149.99 50.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.767 0.827 . . . . 0.0 109.976 -175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -97.84 151.26 20.4 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.392 1.077 . . . . 0.0 109.447 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 60.6 ttt-85 -125.92 76.89 1.63 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.703 1.201 . . . . 0.0 108.835 177.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.0 ptm -143.61 13.48 1.74 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.232 0.613 . . . . 0.0 111.151 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -147.82 -121.58 0.06 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.362 1.865 . . . . 0.0 106.935 -175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.9 -31.13 71.88 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.078 -1.639 . . . . 0.0 111.826 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.23 -177.28 39.73 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -69.86 155.29 40.78 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.9 0.88 . . . . 0.0 110.393 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -144.72 63.23 0.47 Allowed Glycine 0 C--N 1.337 0.639 0 C-N-CA 124.294 0.95 . . . . 0.0 111.902 -170.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 90' ' ' LEU . 37.4 p90 -128.79 170.36 13.44 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.882 1.273 . . . . 0.0 109.098 172.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -122.16 163.36 19.66 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 156.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.26 133.63 68.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.1 mt -142.85 121.73 12.73 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.52 179.51 15.76 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.21 29.93 76.53 Favored Glycine 0 CA--C 1.521 0.439 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -167.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -66.47 -20.45 66.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 117.573 0.687 . . . . 0.0 110.166 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -129.57 155.32 80.44 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.914 1.686 . . . . 0.0 110.103 165.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -72.43 81.88 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 125.094 3.863 . . . . 0.0 115.165 -165.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 144.92 -12.75 1.92 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 124.974 1.273 . . . . 0.0 112.033 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -66.82 157.14 85.08 Favored Pre-proline 0 CA--C 1.536 0.404 0 CA-C-N 117.55 0.675 . . . . 0.0 110.529 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -72.69 113.04 3.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.733 2.289 . . . . 0.0 111.777 -172.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.6 mt -77.56 105.16 6.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 169.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.458 HD23 ' HG3' ' A' ' 58' ' ' GLU . 14.4 mt -93.43 158.48 15.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.421 1.088 . . . . 0.0 109.704 166.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.43 126.04 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 154.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.91 -77.88 0.18 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 108.329 -1.909 . . . . 0.0 108.329 172.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.35 144.9 29.07 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.636 1.175 . . . . 0.0 108.602 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . 0.27 1.2 m -98.79 140.06 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 C-N-CA 123.88 0.872 . . . . 0.0 110.14 169.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -83.83 111.35 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.64 -39.83 68.38 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 121.256 0.551 . . . . 0.0 112.053 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 29.6 mmt -106.12 44.42 1.05 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.002 0.921 . . . . 0.0 109.053 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.85 165.09 27.73 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.8 1.667 . . . . 0.0 109.643 175.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.7 m -69.11 -10.32 57.07 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 115.653 1.724 . . . . 0.0 115.653 -164.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.9 -53.05 56.55 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.092 1.315 . . . . 0.0 109.348 170.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.89 -43.5 92.71 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.141 0.9 . . . . 0.0 110.058 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 88.4 mtt-85 -55.82 -43.04 76.57 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.242 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -63.33 -18.48 63.68 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.621 1.1 . . . . 0.0 112.643 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.26 54.64 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 124.448 1.023 . . . . 0.0 113.078 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -134.5 -38.46 0.83 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 -171.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.1 mt -74.16 170.16 16.09 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.777 1.171 . . . . 0.0 109.418 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -147.08 152.22 42.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 124.15 0.98 . . . . 0.0 109.445 156.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.94 120.08 6.79 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.11 2.54 . . . . 0.0 108.585 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.62 6.2 54.91 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.378 -1.235 . . . . 0.0 112.951 -176.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.67 142.41 58.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.654 1.727 . . . . 0.0 108.383 159.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' HD23 ' A' ' 37' ' ' LEU . 6.4 tt0 -86.72 125.8 34.14 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.312 1.045 . . . . 0.0 109.466 173.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.624 HD23 HG12 ' A' ' 92' ' ' VAL . 12.2 mt -79.75 156.43 27.5 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.038 1.335 . . . . 0.0 110.809 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.39 -54.5 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.583 1.953 . . . . 0.0 111.693 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -132.61 143.87 49.98 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.508 1.523 . . . . 0.0 110.777 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.3 t -133.46 111.99 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 72.32 -38.02 0.41 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 129.102 2.961 . . . . 0.0 111.25 -172.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 65' ' ' ILE . . . 164.32 -3.55 0.06 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 130.617 3.961 . . . . 0.0 109.797 175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 65' ' ' ILE . 1.0 OUTLIER -100.11 125.87 38.41 Favored Pre-proline 0 N--CA 1.439 -1.023 0 O-C-N 120.562 -1.552 . . . . 0.0 107.058 -168.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -65.19 141.03 67.48 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.903 1.735 . . . . 0.0 109.662 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -90.15 -9.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.234 170.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.72 117.87 5.48 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.152 0.981 . . . . 0.0 110.12 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -1.04 83.12 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.849 0.738 . . . . 0.0 114.307 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HG3' ' CE2' ' A' ' 74' ' ' TYR . 26.3 mmmt -87.01 -171.83 3.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.304 1.441 . . . . 0.0 107.495 167.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 p -130.58 -179.55 5.35 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.168 0.987 . . . . 0.0 109.893 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -53.82 -57.44 10.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.661 0.784 . . . . 0.0 111.057 176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -28.75 70.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.276 0.944 . . . . 0.0 112.879 -171.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.472 ' CE2' ' HG3' ' A' ' 70' ' ' LYS . 58.2 t80 -46.78 -59.67 2.9 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.038 0.935 . . . . 0.0 109.819 167.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.97 -36.61 76.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 C-N-CA 123.37 0.668 . . . . 0.0 109.286 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mm -63.35 -32.63 57.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 O-C-N 120.652 -1.28 . . . . 0.0 111.507 -178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -72.84 -33.86 66.43 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 120.156 -1.59 . . . . 0.0 110.904 168.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.412 HD23 ' CE2' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -72.59 -32.81 66.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.108 0.963 . . . . 0.0 111.357 -173.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 62.3 mmm -58.58 -36.81 74.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.57 1.148 . . . . 0.0 111.279 166.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -73.04 -45.74 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.11 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -51.14 -55.55 17.24 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 125.257 1.423 . . . . 0.0 110.962 170.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.437 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -58.71 -42.75 89.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.776 0.831 . . . . 0.0 111.058 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.0 -14.64 60.91 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 120.464 -1.397 . . . . 0.0 113.058 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.4 mtt180 -85.7 -36.67 20.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.83 1.195 . . . . 0.0 111.068 165.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 70.0 m-20 -62.67 -15.85 54.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.85 21.03 79.18 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.935 1.731 . . . . 0.0 112.546 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -164.78 177.05 8.24 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.755 2.022 . . . . 0.0 106.811 178.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.437 HG23 ' CB ' ' A' ' 82' ' ' ALA . 5.0 p -154.58 160.16 2.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -141.76 91.09 2.33 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.68 0.792 . . . . 0.0 108.907 -170.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 24' ' ' PHE . 21.3 mt -98.24 99.5 10.73 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.49 1.516 . . . . 0.0 107.815 -170.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 85.0 m -87.9 131.35 34.61 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.624 HG12 HD23 ' A' ' 59' ' ' LEU . 33.2 m -120.4 167.7 13.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 126.411 1.884 . . . . 0.0 108.211 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 ptt85 -152.39 151.85 31.32 Favored 'General case' 0 CA--C 1.519 -0.227 0 O-C-N 121.031 -1.043 . . . . 0.0 110.292 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -145.02 134.82 23.56 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.478 0.711 . . . . 0.0 109.116 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -63.1 118.0 7.29 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 126.39 1.876 . . . . 0.0 111.112 170.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.3 t -87.53 35.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 127.562 2.345 . . . . 0.0 111.114 -171.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.21 87.8 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.039 1.735 . . . . 0.0 111.418 -178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.1 p -138.79 155.31 48.28 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.115 1.366 . . . . 0.0 107.487 169.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 163.33 77.23 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 174.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -64.03 -36.19 49.91 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.771 2.981 . . . . 0.0 111.483 -173.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.27 94.9 2.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 164.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 t -79.85 41.61 0.51 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 161.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.237 0 N-CA-C 106.214 -2.754 . . . . 0.0 106.214 -164.367 . . . . . . . . 0 0 . 1 stop_ save_